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THESIS ABSTRACT 
The overall contribution of this thesis has been the application and development of 
growth modeling methods for analysing continuous longitudinal data arising from 
long-term observational studies in epidemiology, with a special emphasis on how 
these techniques can be used to investigate pathways leading to important 
cardiometabolic risk factors or deleterious cardiovascular disease outcomes in 
adulthood. These risk factors (obesity, dyslipidemia and hypertension) and clinical 
outcomes (pre-atherosclerosis, and type 2 diabetes mellitus) are important because 
they are associated with increased risk of developing heart disease and stroke. 
This general aim was addressed in three parts: 
1. First, analytical strategies and key issues relative to the application of growth
curve modeling methods to continuous non-linear response data were
identified, reviewed and compiled. In this phase, specific emphasis was
placed on the technical considerations of data arising from cohort sequential
studies where there were less than 10 time points per person collected across
the life course, and where the time between sequential measures is not
balanced between participants. This aim was addressed in Chapter 2, detailed
below.
2. Second, growth curve modeling theory was tailored and extended to develop
a Bayesian “trajectory divergence” method in Chapter 4. This method allows
the identification of the point or age, in the life course when participants who
develop important health outcomes later in life begin to diverge in their non-
linear trajectories of continuous modifiable risk factors, compared with those
who remain healthy.
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3. Third, the reviewed and developed growth curve methodologies in part one
were applied to model and analyse the longitudinal trajectories of a number
of continuous measures of cardiometabolic risk. Data from the
Cardiovascular Risk in Young Finns Study (YFS) was used. The Young
Finns Study is an accelerated prospective cohort study that has collected
cardiometabolic risk factor data in a large sample of Finnish participants from
childhood to mid-adulthood across eight waves of follow-up over the course
of 31 years. These analyses were written as a series of 4 original papers
included in Chapters 3 to 6, which have been  (or will be) submitted to
journals.
.  
Chapter 2, the literature review, provides the background and foundation for the 
methodological component of the thesis. This chapter notably reviews traditional 
person-based growth modeling methods as well as key aspects to be considered when 
deciding to implement them in the multilevel (MLM) or in the latent growth curve 
(LGCM) modeling framework. It introduces the implementation and model building 
strategies of different complex growth models in the frequentist and Bayesian 
framework, with particular emphasis on analytical challenges that accompany the 
analysis of data from accelerated longitudinal study designs. In addition to person-
based growth modeling approaches, it reviews an alternative approach to growth 
modeling, also known as Latent Class or group-based methods, and highlights how 
they can be used complementarily to traditional trajectory modeling approaches. By 
showing the unaddressed issues and difficulties when analysing scarce longitudinal 
data, this chapter motivates the research and the contribution that the thesis sought to 
make. 
Chapter 3 addresses research aims 1 and 2 of the thesis. This chapter demonstrate 
how frequentist IGC modeling, a person-based approach to trajectory analyses can be 
used to investigate associations between longitudinal response profiles of complex 
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shapes and important individual cardiometabolic risk marker (in this case, genetic 
factors). Its main aim was to quantify for the first time the contribution of a 
multigenic lipoprotein score to adverse levels of circulating lipoproteins, important 
risk factors for cardiovascular disease in the YFS cohort. It was found that for LDL-
C, HDL-C, and triglycerides, the polygenic effect of GWAS-identified risk alleles 
was present from early childhood (from age 3 years). In addition, it was shown that 
while the polygenic effect on LDL-C levels remained and consistent across the life 
course as YFS participants aged, the multigenic effect on HDL-C levels became 
weaker as participants aged, with environmental, lifestyle and behavioral factors such 
as diet, smoking, physical activity, potentially becoming more important determinants 
of HDL-C levels in mid-adulthood. 
Chapter 4 formulates and develops a Growth curve modeling methodology based on 
Bayesian hierarchical piecewise regression (BHPR) to investigate trajectory 
divergence in non-linear continuous response profiles between two or more groups of 
participants in cohort studies and to determine when groups of interest begin to show 
different non-linear trajectories in continuous response data. To represent the 
curvilinear development of BMI between age 6 and 49 years, this method uses a two-
piece linear–linear spline model as the functional form of the MLM growth curve 
model. The application of this novel Bayesian regression analysis method is then 
outlined by modeling individual BMI trajectories in a subset of YFS participants, 
showing that the participants who developed adult T2DM in adulthood, a major 
metabolic disease, maintain their childhood BMI rate for up to 12 years longer, 
compared with those who did not develop T2DM. In a simulation study, the age and 
confidence interval at divergence is estimated and compared to more traditional 
approaches. A simulation study demonstrates that the developed approach is superior 
to traditional trajectory divergence approaches commonly used used by 
epidemiologists. 
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Chapter 5 uses the BHPR approach developed in Chapter 4 and extends it to suit the 
estimation of a multiple-group growth model to estimate and compare developmental 
BMI trajectories in groups of clinical interest in the YFS. These groups were four a-
priori determined child to adult adiposity status groups the YFS; participants who 
either remained obese, resolved obesity, remained non-obese, or became obese based 
on their BMI status between two YFS follow-up examinations: one in childhood 
(baseline study) and the latest available individual BMI assessment in adulthood. It 
was shown that participants who overcame childhood high-BMI by adulthood had in 
fact lower average BMI levels from age 6 and slower yearly increase in BMI in 
childhood compared with participants who remained obese adults, confirming that 
efforts to reverse adverse BMI trajectories should ideally begin before age 6 years. 
The method allowed identifying critical age windows for the development and 
resolution of adverse adiposity status in this large cohort, which is crucial to help 
understand the dynamics of pathological vs. normal BMI trajectories across 
developmental periods, since its potential to inform weight management 
interventions.  
Chapter 6 investigates potential heterogeneity in BMI development in the YFS 
population from a life course perspective using Latent Class Growth Mixture 
Modeling, to determine whether distinct long-term BMI developmental patterns result 
in different cardiovascular risk in adulthood in the YFS. It was hypothesised that 
different BMI trajectory patterns exist within the YFS population, which could not be 
identified using the traditional person-based growth modeling approaches (such as the 
BHPR method). The analyses revealed that 6 subgroups shared different trajectories 
in BMI from childhood though middle age in the YFS, and that higher BMI 
trajectories were associated with higher adult cardiovascular risk factors of T2DM, 
dyslipidaemia, hypertension (high blood pressure) and preclinical atherosclerosis, a 
condition considered as the major underlying cause of cardiovascular disease.  
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Chapter 7, the discussion chapter, puts in perspective how the reviewed, developed 
state-of-the-art growth curve modeling approaches applied in the four original studies 
can be used to characterise longitudinal trajectories in cardiometabolic risk factors 
and their determinants, as well as potential heterogeneity that may arise in these 
trajectories within a population or groups of interest. The benefits, drawbacks and 
remaining technical challenges that come with applying these approaches to scarce 
long-term epidemiological data is discussed. 
In conclusion, this thesis demonstrates the potential of sate of the art and tailored 
growth curve methods for the analysis of long term observational studies on 
cardiometabolic risk, and how they can be used to provide unique insight into the 
development of high-risk cardiometabolic profiles from childhood to adulthood that 
might help inform prevention and intervention strategies. 
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1. INTRODUCTION
Longitudinal data, collected on the same participants at multiple times during their 
lives or throughout an intervention, are common in epidemiological studies1-4. 
Longitudinally collected data enables the natural history of disease or progression in 
risk factors in a study sample to be characterised, and can be used to evaluate the 
effect of behavioural or pharmaceutical interventions on the outcome5, 6. When 
collecting these data, researchers are interested to determine, estimate, or capture the 
defining characteristics of change in health markers over time, and relate these to 
potential exposures or individual factors7. For conditions with a long latency period 
such as those that develop into clinically manifest diseases over decades, there is a 
growing interest in identifying the patterns of change in modifiable health markers 
that distinguish those who develop later diseases 8-10, and to identify the critical 
phases of change that may help inform prevention or intervention11-17.  
Growth curve, or trajectory, modeling is a universal term commonly used to refer to a 
number of similar contemporary methods to analyse longitudinal data5, 18-22. These 
methods are flexible in their application and overcome many of the limitations of 
traditional approaches to repeated measure data analysis23, 24. One of the strengths of 
growth curve modeling approaches is that they allow outcome trajectories to be 
modeled at the population and at the individual level simultaneously. This group of 
methods thus enables the explicit investigation of between-person differences in 
intra-individual change, as well as determinants of change over time25-29.  
Initially developed and used in the fields of psychology, education, and 
developmental research, growth curve modeling has developed considerably in the 
last 30 years and remains the object of ongoing development. Although complex, 
these methods have gained popularity across disciplines, and are increasingly easy to 
implement thanks to the development of powerful statistical software and ongoing 
advances in bioinformatics and computer technologies. However, the technical nature 
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of the published literature and inconsistencies in nomenclature used, make it 
challenging for many investigators, including epidemiologists, to understand the 
current state of the growth curve modeling literature, and how and when to apply the 
most appropriate techniques across different practical situations5. 
Another potential reason for the lack of up-take of trajectory models among 
epidemiologists is that applying these methods to longitudinal data from long-running 
observational studies comes with an additional set of specific technical challenges. 
These challenges include sporadic follow-up of participants over large and varied 
time-windows, that can span from childhood through to older age, and generally high 
rates of loss to follow-up or intermittent drop-out – all factors that can influence the 
choice and implementation of trajectory models. Many prospective studies are also 
conceived as multi-cohort studies or accelerated designs to span the age-range of 
interest in a shorter period of time than with a single cohort to make the study more 
cost effective4, 22. In growth curve modeling, joining repeated-measure data collected 
from multiple birth cohorts to model and compare longitudinal change in response 
across the ages spanned by the entire cohort is not straightforward. Another 
significant challenge is the potential non-linearity of the biological response of 
interest as a function of time or age. Many trajectory-modeling applications in the 
literature consider linear change over time18, 19. Although this may be a reasonable 
assumption for some biological processes when the time-window is relatively short, 
many variables are likely to behave non-linearly over time or across several 
developmental phases. Being able to model non-linear responses over time with only 
a few measures per participant is a difficult and often overlooked aspect of growth 
curve modeling in the literature, which complicates the application of these methods 
to long-term prospective cohort study data. 
  30 
1.1 General and specific aims of the research 
The general aim of this thesis is to examine growth-modeling methods for continuous 
longitudinal data with a special emphasis on how these techniques can be used to 
investigate pathways leading to deleterious cardiometabolic disease outcomes in 
adulthood. 
 
The specific aims are to:  
 
Aim 1. Identify, review and compile the different key issues and analytical strategies 
relative to the application of growth curve modeling to continuous response data 
arising from long-term observational studies with relatively few (<10) and sparse 
time points per study participant. The particular focus is on how these strategies can 
be implemented and used to analyse non-linear response profiles when individual 
follow-ups span several developmental periods across the life course (i.e. childhood, 
adolescence and adulthood) and when the study sample comprises several birth 
cohorts (i.e. accelerated longitudinal designs or multi-cohort studies). 
 
Aim 2. Tailor and extend growth curve modeling theory to develop a “trajectory 
divergence” method, providing a new tool to help inform prevention and intervention 
strategies. Specifically, the “trajectory divergence” method was developed to identify 
the point in the life course at which participants who develop adverse health 
outcomes in later life begin to diverge in their non-linear trajectories of continuous 
modifiable risk factors, compared with those who remain healthy.   
 
Aim 3. Apply the statistical methods reviewed in Aim 1 and developed in Aim 2 to 
model and analyse the longitudinal trajectories of a number of continuous measures 
of cardiovascular risk from the YFS study, an accelerated longitudinal prospective 
study that has collected cardiometabolic disease risk factor data in a large sample of 
participants from early childhood to mid-adulthood across eight waves of follow-up.  
  31 
 
1.2 Importance of cardiometabolic disease 
Although longitudinal statistical methods, and growth curve modeling in particular, 
were the primary motivation for this thesis, the questions of interest arising from the 
YFS drove the direction of the research. This section provides a brief overview of the 
importance of cardiometabolic disease that sets the scene for the formulation of the 
specific research questions examined by this thesis.  
 
Cardiometabolic disease is a collective term referring to cardiovascular disease 
(CVD) as well as metabolic disorders such as the type 2 diabetes mellitus (T2DM)30. 
CVD is single biggest killer worldwide30, 31. More people die annually from CVDs 
than from any other cause. The World Health Organisation report that an estimated 
17.5 million people died from CVDs in 2015, representing 31% of all global deaths. 
Although the general trend of death from CVD has been declining since the 1950s in 
developed countries, thanks to advances in pharmacological intervention and 
favourable changes in risk factor distribution, they are becoming an increased burden 
to low-and middle-income countries, with over three quarters of CVD deaths taking 
place in developing countries as of 201530.  Atherosclerosis, a condition in which 
plaque builds up inside the arteries is recognised as the main cause of CVD32. 
Although the major clinical complications of atherosclerosis do not typically present 
until middle or older age, the atherogenic process has been shown to begin in early 
life and to progress from an asymptomatic phase to a clinically manifest disease over 
decades12, 33.  
 
T2DM is a progressive chronic condition in which the body becomes resistant to the 
normal effects of insulin or gradually loses the capacity to produce enough insulin in 
the pancreas34. T2DM greatly increases the risk of heart disease and stroke, as the 
condition tends to cluster with other interrelated cardiometabolic risk factors 
including obesity, hypertension, and dyslipidemia35, 36. Adults with T2DM are two to 
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four times more likely to die from heart disease than adults without diabetes, and 
more than 80% people 65 years or older with diabetes die from some form of heart 
disease or stroke37. The American Heart Association considers diabetes to be one of 
the seven major controllable risk factors for cardiovascular disease38. 
 
There are a number of well-identified risk factors for cardiometabolic diseases. While 
some are not modifiable such as genetics, sex, and increasing age, many risk factors 
such as obesity, hypertension, dyslipidemia and smoking are amenable to lifestyle 
changes and therapeutic interventions. Most cardiometabolic diseases can be 
prevented by addressing behavioural risk factors such as tobacco use, unhealthy diet 
and obesity, physical inactivity, poor cardiorespiratory fitness and harmful use of 
alcohol using population-wide strategies 39-41. In fact, the trend of decrease in CVD 
death since the 1950s has been largely attributed to intervention on these modifiable 
risk factors in adults. 
 
In trying to determine the origins of cardiometabolic disease, there has also been an 
increased interest since the 1970s in studying the progression of these risk factors 
across the life course with the motivation to better understand who is at risk of 
developing clinical complications in later life and how or when to intervene to reduce 
the incidence of cardiovascular disease in the general population42-46. The rationale is 
that if children with one or more of the major modifiable risk factors are at an 
increased risk of developing clinically significant disease later in life, then controlling 
these cardiometabolic risk factors in early life may help reduce the incidence of 
clinical disease or cardiometabolic-related mortality later in life. 
 
Among the modifiable risk factors for cardiometabolic disease, the role of excess 
adiposity (termed overweight and obesity and usually based on an individual’s body 
mass index, derive from and individual’s weight and height) in youth is one important 
risk factor that has been linked with incident cardiovascular events 47-51 and with early 
markers of cardiovascular disease (such as increased carotid intima media thickness 
  33 
(cIMT) and increased arterial stiffness, which indicate early stage atherosclerosis) in 
young adulthood 33, 52.   
 
Additionally, as with findings in adult populations, there is growing evidence that 
blood lipid and lipoprotein levels (e.g. cholesterol in the blood) measured early in life 
also play an important role in the development of cardiometabolic disease 46. 
Prospective cohort studies have shown that lipoprotein levels track strongly from 
childhood and adolescence to adulthood 11, 53, so that children with high lipid and 
lipoprotein levels have a greater risk of having elevated adult levels than their peers 
with lower levels 50, 54, 55, although most of these children do not have adult levels that 
meet cut-points for intervention. There is also evidence that adverse lipoprotein levels 
in early life may induce arterial changes that contribute to adult atherosclerosis, thus 
contributing to CVD risk 56-58.  
 
In the absence of carefully controlled studies, prospective longitudinal studies and 
accelerated cohort studies of cardiometabolic risk where participants are examined 
multiple times from childhood through adulthood are particularly useful to study risk 
factors influencing the development of adverse cardiovascular profiles and 
deleterious cardiometabolic outcomes across the life course, while addressing key 
limitations of cross-sectional studies. They provide a chance to investigate who is at 
highest risk of developing significant risk factors or early stage cardiometabolic 
disease, at what time in the life course, and factors associated with their development. 
It is thus crucial to have the right statistical tools to analyse data arising from this type 
of studies. 
 
Devised to examine the childhood origin of adult CVD, the YFS is a large ongoing 
Finnish population-based prospective cohort of cardiovascular risk factors and their 
determinants. It is one of only few studies worldwide to have collected 
cardiometabolic risk factors data since childhood with follow-up measurements 
occurring through to adolescence, young and middle adulthood59. This thesis takes 
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advantage of the eight examination waves of data collected on the same YFS 
participants from childhood to adulthood over the course of 31 years. A number of 
cardiometabolic risk factors and health markers measured at these eight examinations 
were used to study the aims of this thesis. Detailed descriptions of the YFS, including 
study design, participant characteristics, and attrition analyses have been published 
previously60-62. Appendix 1.1 provides some background on the YFS study that is not 
covered in subsequent chapters. 
 
1.3 Thesis structure 
This thesis has been written as a series of original papers included in Chapters 3 to 6, 
which have been  (or will be) submitted to journals and have been left in their 
entirety. These chapters each address the pivotal aims 2 and 3 of this thesis. When 
relevant, material included as supplementary only material in the corresponding 
manuscripts was integrated into the chapters.  
 
Chapter 2, the literature review provides the background and foundation for the 
methodological component of the thesis and gives more detailed grounding than is 
incorporated in each paper. It reviews traditional person-based methods and special 
considerations when applying these methods to long-term prospective cohort data, as 
well as key aspects to be considered when deciding to implement them in the 
multilevel (MLM) or in the latent growth curve (LGCM) modeling framework. It 
discusses the implementation of growth models in the frequentist and Bayesian 
framework, with particular emphasis on analytical challenges that accompany the 
analysis of data from accelerated longitudinal study designs. Chapter 2 discusses 
model-building strategies and different parameterisations of growth curve models 
within the MLM framework to adequately represent the non-linearity of the 
continuous biological responses over time. It also introduces the piecewise 
parameterisation of the MLM growth model and key aspects of its estimation within 
the Bayesian framework, which are used and developed further in Chapter 4. Finally, 
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it presents the increasingly popular and often complementary alternative to 
individual-based growth models, also known as Latent Class or group-based 
approaches, which allow participants to be clustered according to their developmental 
progressions in the outcome over the life course and identify underlying trajectories 
that may not be identifiable when using classic growth models and a-priori 
classification rules of participants.  
 
Chapter 3 addresses research aims 1 and 2 in the frequentist framework for 2442 YFS 
participants for whom genetic information was available for a total of 76 lipid-
associated Single Nucleotide Polymorphisms (SNPs) reported in the literature. The 
primary aim was to quantify the contribution of a multigenic lipoprotein score to 
adverse levels of circulating lipoproteins, important risk factors for cardiovascular 
disease. A second question addressed whether multigenic predisposition to adult 
dyslipidaemia, having an at-risk lipoprotein profile, was modified by the magnitude 
of the change in body mass index (BMI) from childhood to adulthood, used as a 
proxy indicator for lifestyle trajectory. In this chapter, the clustering of participants 
arises due to individual characteristics, that is, belonging to a given genetic risk 
category. Multilevel Growth Curve models, parameterised with higher-order 
polynomial terms of age to represent the non-linear lipid trajectories within-
participants, were used to investigate if the change in lipid over time was different in 
high-risk participants compared with participants classified as low-risk.  
 
Chapter 4 formulates and develops a Growth curve modeling methodology based on 
Bayesian hierarchical piecewise regression (BHPR) to investigate trajectory 
divergence in continuous response profiles between two or more groups of 
participants in cohort studies and to determine when groups of interest begin to show 
different non-linear trajectories in continuous response data. To represent the 
curvilinear development of BMI between age 6 and 49 years, this method uses a two-
piece linear–linear spline model as the functional form of the MLM growth curve 
model. The piecewise parameterisation of the growth curve model overcomes some 
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of the numerical and interpretation issues commonly encountered with higher order 
age-polynomials by comparing the growth rate between different periods of 
development that results in biologically meaningful coefficients. To test for between-
group divergence in key aspects of the longitudinal response, the method introduces 
dummy variables that represent group membership as time-invariant predictors of 
model parameters at level-2, which shifts the marginal means of different growth 
parameters in one group compared with the other groups. Because the focus was to 
estimate the position of the change-point in each group and allow for between-person 
heterogeneity in the age at which each participant switches developmental phases (i.e. 
individual change-points), a hierarchical random change-point model in a fully 
Bayesian framework was implemented that introduced key aspects related to 
Bayesian model estimation, comparison, and validation. The application of this 
method is outlined by modeling individual BMI trajectories in a subset of 2540 YFS 
participants to investigate the mechanism of childhood to adulthood BMI trajectory 
divergence between participants who developed adult T2DM in adulthood, a major 
metabolic disease, compared with those who did not develop T2DM. In a simulation 
study, the age and confidence interval at divergence is estimated and compared to 
more traditional approaches.  
 
Chapter 5 uses the BHPR approach developed in Chapter 4 and extends it to suit the 
estimation of a multiple-group growth model. Specifically, a slightly modified 
parameterisation of the conditional BHPR model was formulated to estimate and 
compare developmental BMI trajectories among four a-priori determined child to 
adult adiposity status groups in 2717 YFS participants. This four group-classification 
identified participants who either remained obese, resolved obesity, remained non-
obese, or became obese based on their BMI status between two YFS follow-up 
examinations: one in childhood (baseline study) and the latest available individual 
BMI assessment in adulthood. Using this classification method, a large-scale multi- 
study previously found that participants who resolved adverse BMI levels between 
their child and adult assessments had similar cardiovascular risk levels to those who 
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were never obese. It was also found that obese adult participants were at increased 
cardiovascular risk, irrespective of their childhood adiposity status. Since some 
population samples in this multi-cohort study had only two waves of data collection, 
the BMI trajectories of participants within these four groups of clinical interest had 
not been investigated. Taking advantage of the eight measurement time-points in the 
YFS, the aim of Chapter 5 was thus to characterise and compare the average BMI 
trajectories from childhood to adulthood within these four adiposity groups to 
identify critical age windows for the development and resolution of adverse adiposity 
status in this large cohort. This is crucial to help understand the dynamics of 
pathological vs. normal BMI trajectories across developmental periods, which could 
help inform weight management interventions.  
 
Chapter 6 investigates potential heterogeneity in BMI development in the YFS 
population from a life course perspective, asking whether distinct long-term BMI 
developmental patterns result in different cardiovascular risk in adulthood. Indeed, 
the clustering of participants into the four adiposity status groups considered in 
Chapter 5 was performed on the basis of only two time points only and the definition 
of adiposity cut-points in childhood and adulthood was done in a subjective manner. 
This approach ignored the potentially different dynamics of obesity resolution or 
onset within a given adiposity group. It was hypothesised that different BMI 
trajectory patterns exist within the YFS population, which could not be identified 
using the traditional person-based growth modeling approaches (such as the BHPR 
method), and that these underlying trajectories may be differently associated with 
adult CVD risk. Therefore, among a subset of 2631 YFS participants, latent class 
growth mixture modeling (LCGMM) was applied to: (1) identify subgroups who 
share similar trajectories in BMI from childhood though middle age; (2) provide a 
preliminary characterisation of these participants and BMI trajectories; and (3) 
determine the independent association of identified latent life course BMI trajectories 
with adulthood cardiovascular risk factors of T2DM, dyslipidaemia, hypertension 
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(high blood pressure) and preclinical atherosclerosis, a condition considered as the 
major underlying cause of cardiovascular disease. 
 
Chapters 3 to 6 have been written as a journal articles, for which Buscot Marie-
Jeanne is the first author and are presented in their entirety. Declaration of 
contribution of authors to these research articles in Chapters 3 to 6 can be viewed in 
in the statement of authorship. Additionally, a description of how each chapter fits 
with the specific aims of this thesis is provided at the beginning of each chapter, in 
preface sections.   
 
1.3 Overview of the YFS Study   
 
Since they examine different cardiometabolic risk factors or outcomes and address 
different research questions, thesis chapters 3, 4, 5 and 6 each include a different 
subset of YFS participants. For each study, inclusion criteria of participants are 
covered in detail in relevant chapters, along with the statistical methods specifically 
employed to address the different research questions and the identified aims of this 
thesis. This appendix aims at providing a general overview of the YFS study, the 
primary data source utilised to examine the aims of this thesis.  
 
Study sample 
The YFS study is an on-going five-centre epidemiologic study of atherosclerosis risk 
factors and precursors from childhood to adulthood. It was devised in the late 1970s 
as a collaborative effort between the departments of paediatrics or medicine of 
Helsinki, Kuopio, Oulu, Tampere, Turku university hospitals to assess biological and 
lifestyle factors underlying cardiovascular disease and their determinants in children 
and adolescents of various ages in different parts of Finland.  It was then pursued 
over 31 years to study these risk factors and their determinants from childhood to 
adulthood in the Finn population. 
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The YFS study design and sampling procedure have been described in details 
previously, but we will provide a summary here. The first main cross-sectional 
(baseline) study was performed in 1980, where 3596 children aged 3 to 18 years, 
randomly chosen from the Finnish Social Insurance Institution’s national population 
register from five regions in Finland, were assessed for many cardiovascular risk 
factors including anthropomorphic measures, blood samples, blood pressure, lifestyle 
information, They belonged to 6 birth cohorts each separated by 3 years (i.e. years of 
birth of baseline participants were 1977, 1974, 1971, 1968, 1965 and 1962). 
Thereafter, follow-up studies were conducted at intervals of three years until 1992. 
Three adult follow-ups of the sample were conducted 21, 27 and 31 years later 
respectively, in 2001, 2007 and 2011. At the latest adult follow-up in 2011, the 1999 
participants seen in clinic (55 % of the original cohort) were aged 34, 37, 40, 46 and 
49 years old. The study was conducted according to the guidelines of the Declaration 
of Helsinki, and local ethics committees approved the study protocols. Written 
informed consent was obtained from all participants in 2001 and their parents in 
1980. 
 
This thesis takes advantage of these 8 examination waves of data collected on the 
same participants from childhood to adulthood over the course of 31 years. A number 
of CVD risk factors and health markers measured at these 8 examinations were used 
to study the aims of this thesis.  
 
Measures 
Detailed descriptions of data collection procedures of the different follow-up clinics 
can be found elsewhere. At each examination, a questionnaire that collected data on 
socioeconomic status, living environment, health, physical activity, and parent and 
grand-parent health was mailed to the participants. Series of measurements were 
collected at the time of the physical examination, including anthropometry, blood 
pressure, blood samples, and ultrasound studies of the brachial and carotid arteries (in 
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2001, 2007 and 2011). Relevant to this thesis are the anthropometry measures and 
blood samples. 
 
Blood collection and biochemistry 
All serum lipid determinations were done on fasting samples in duplicate in the same 
laboratory. In 2001, serum cholesterol and triglyceride concentrations were 
determined enzymatically (Olympus System Reagent, Olympus Diagnostica, 
Hamburg, Germany) in a clinical chemistry analyser (AU400, Olympus Optical, 
Mishima, Japan). HDL cholesterol was analysed after precipitation of very low-
density lipoprotein and LDL with dextrane sulphate 500 000. The concentration of 
LDL cholesterol was calculated using the Friedewald formula. Details of the methods 
in earlier studies have been previously published. Due to changes in determination 
methods and kits during study years, lipoprotein levels from 1980 were corrected to 
those in 2001 using correction factor equations (this information is detailed in 
Chapter 3 Methods). T2DM status was assessed at adult follow-ups in 2001, 2007 
and 2011.  
 
Participants were considered diabetic if they had a fasting plasma glucose level of 7 
mmol per liter (126 mg per deciliter) or higher, reported the use of oral glucose-
lowering medication or insulin but had not reported having type 1 diabetes, or had 
received a diagnosis of T2DM from a physician at any of their adult follow-up 
examinations. 
 
Anthropometry 
Height and weight measures were taken at all examinations using the following 
protocols. Height was measured using a wall-mounted Seca stadiometer with 0.5 cm 
accuracy, and weight was measured in light clothing without shoes with a digital Seca 
scale to the nearest 0.1 kg. Baseline and follow-up BMI measures were determined 
from weight and height measurements recorded at each clinic using the formulat BMI 
= Height (m) / weight2 (kg2).  
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2. LITERATURE REVIEW: GROWTH CURVE MODELS 
FOR LONG-TERM COHORT STUDIES  
 
Longitudinal designs, with data collected on the same participants at multiple times 
during their lives or throughout an intervention, are increasingly popular in a variety 
of disciplines, including clinical and observational epidemiology1. They are very 
valuable either to characterise the natural history of disease or risk factors in a cohort 
or to evaluate the effect of behavioural or pharmaceutical interventions on the 
outcome over time63. Researchers are often interested in understanding, estimating, 
and capturing the defining characteristics of change processes or progression in 
outcome data, and relate these characteristics to potential predictors, such as exposure 
or risk factors. Growth curve or trajectory modeling, a catch-all term for a number of 
similar regression based techniques traditionally developed in psychology and 
developmental research, have gained popularity across disciplines thanks to the 
development of powerful statistical software5, 64.  
 
Growth Curve Modeling (GCM) allows outcome trajectories to be modeled 
simultaneously at the population and the individual level, to explore between-person 
differences in intra-individual change, as well as determinants of change 18, 19, 23, 24. 
Because the framework of growth modeling bridges both Structural Equation 
Modeling (SEM) and Multilevel Modeling (MLM) traditions, many terms refer to 
broadly equivalent techniques, including Hierarchical Modeling of change (HLM) 65-
67, Mixed Effect / Random Effect Modeling68, and latent growth curve models 
(LGCM)69-72. Many statistical textbooks describe these different growth-modeling 
techniques, but most are highly mathematical and often outside the reach of most 
epidemiologists. Few focus specifically on the application of these methods to 
epidemiological data, and since each field has a preferred nomenclature, it makes it 
challenging for epidemiologists to understand the current state of the growth curve 
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modeling literature, as well as to identify what is the most appropriate technique in 
different practical situations. Although MLM and LGCM models have been widely 
adopted for over two decades in fields such as education, sociology and psychology, 
where they are routinely used to model growth and change in behavioural and 
cognitive processes, these approaches remain underused in observational 
epidemiology5, 73-76. ‘Traditional’ longitudinal data analysis methods tend to be 
employed, suggesting that the field has yet to realise the potential and possibilities of 
these methods. This is particularly unfortunate in light of the extensive and 
informative databases that have been collected over the past century through 
observational studies, to help understand conditions that have long latency periods 
before clinical manifestations, particularly chronic conditionas such as cardiovascular 
diseases and cancers. Additionally, the misuse of traditional approaches, if underlying 
assumptions are not met, can lead to inappropriate and inefficient analysis, producing 
inaccurate results, and simplistic or incorrect interpretation of findings. 
 
The lack of popularity of trajectory modeling techniques among epidemiologists and 
population health investigators can also be partly explained by the set of specific 
technical challenges faced by researches when applying these methods to longitudinal 
data from long-running observational studies. This includes high rates of missing 
data, and multi-cohort data, both of which can influence the type of trajectory model 
to be used in the analyses4, 22, 77, 78. Another complication to the application of these 
models to cohort studies, is that across fields, many applications and examples of 
growth modeling in the literature consider and model linear change patterns in the 
response over time, because of their simplicity and interpretability. However, many 
biological, developmental processes, and empirical data are often more complex, and 
are not adequately characterised by linear rates of change over time 79-81. This is 
particularly true in long-running observational or life course studies, where responses 
of interest may be collected on participants followed sporadically over relatively long 
time-windows, sometimes spanning from childhood through to older age. Although 
some biological continuous outcomes are expected to have specific non-linear 
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trajectories over time, in many situations there might not be any existing theories 
regarding the nature of the trajectory of the continuous outcome over time. Whether it 
is conceptualised as a SEM or a MLM, there are several ways in which the basic 
linear growth model has been developed and expanded in recent years to model 
complex non-linear relationships between the continuous response variable and the 
relevant time variable. However, correctly specifying the functional form for the 
within-person change over time (i.e. the form of the average relationship between age 
or time and the outcome) is crucial in the specification of the growth model and the 
choice of the non-linear functional form of change within-person is not 
straightforward.  
 
In this chapter, an organised overview of different growth curve modeling techniques 
for analysing response data in epidemiology, including model specification, 
estimation, and validation, is provided. Specifically, the different conceptual 
paradigms, strengths, and limitations of a number of approaches to model potentially 
complex non-linear trajectories of continuous outcomes are highlighted.  The specific 
challenges that arise in these methods when the longitudinal data comprises several 
birth-cohorts is also discussed, since many long-term prospective observational 
studies in epidemiology are designed as accelerated longitudinal designs, also known 
as multi-wave or multi-cohort panel studies. These studies typically include 
participants from multiple birth cohorts, which may be followed for a few years or 
sporadically over a few decades over the same study period. Accelerated longitudinal 
designs enable researchers to study individual change over a long interval of the life 
course by gathering data during a comparatively short interval of time, and provide 
opportunities to separate developmental effects from period and cohort 78. However, 
these types of designs also confront researchers with a special set of inferential 
challenges and introduce significant complexity into statistical modeling. 
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In this chapter, the critical aspects of the different growth curve modeling approaches 
are highlighted, and situations in which some methods may reveal more appropriate 
than others are suggested. This background provides the methodological foundation 
and background of this thesis, and identifies critical technical aspects that pertain to 
using a range of growth curve modeling methods to analyse continuous data from 
long-running prospective cohort studies. 
 
2.1 Introduction: Longitudinal data in epidemiology 
In this section, the advantages and challenges of longitudinal panel studies are 
discussed, including situations where traditional methods, such as repeated measures 
and multivariate Analysis of Variance (ANOVA), can be used and where they are not 
appropriate for this type of data.  
 
2.1.1 Longitudinal panel studies 
Longitudinal assessments offer significant advantages over cross-sectional studies as 
they allow the separation of within- and between-subject variability and they are less 
prone to confounding82. Experimental and observational epidemiologists are often 
interested in understanding and capturing change processes in continuous measures of 
health outcomes, and to estimate the defining characteristics of these changes among 
individuals 5, 83, 84. This is useful to help identify adverse as well as beneficial factors 
that influence healthy and pathological change in health outcomes over time, or 
understand what factors may mitigate adverse change in these outcomes. To do so, 
many epidemiologic studies routinely collect repeated measures of continuous health 
outcomes on a number of participants, often stratified in a-priori groups.  
 
Longitudinally collected data arise from many observational study designs (case-
control, retrospective and prospective cohorts) as well as in experimental studies 
(randomised control trials or non-randomised control studies). In clinical trials, 
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subjects can be followed for a few days, weeks or months, to investigate how an 
intervention of interest affects specific health outcomes.  While outcomes measures 
are often measured at least twice (i.e. classic ‘pre-post’ design), intermediate 
measures have become increasingly common, as medical researchers become 
interested in the change patterns themselves to try and understand pathways or 
trajectories that lead to disease or remission. In prospective observational studies, 
especially in the case of adult-onset disorders, such as heart disease, cancer, and 
diabetes, investigators tend to follow study participants sporadically over relatively 
long periods to determine how a number of individual characteristics, risk factors, 
their interactions, and normal aging may impact the onset and the progression of 
disease in the population85. In other cases, the outcome of interest may be a 
continuous risk factor variable (blood lipid level, blood pressure value).  When 
looking at longitudinal data clustered in groups, investigators often want to be able to 
distinguish an overall group effect (time-average effect) from a time-dependent group 
effect. In these instances, the question of interest might be how average response 
profiles of people with or without certain characteristics (sex, ethnicity) or with 
different levels of covariates (BMI, waist circumference) might change over time, and 
whether their outcome trajectories follow the same pattern or diverge as they age 63, 
86. The overarching aim in many longitudinal studies, is to be able to detect a 
significant difference between two (or more) groups of sequential observations, 
ascertaining the validity of the categorical “grouping” as a predictor of the response 
of interest 6.  
 
One of the reasons for the popularity of longitudinal cohort studies is that despite 
remaining observational in essence, they are more useful for inferring causal 
relationships than cross-sectional studies which typically provide a snapshot of 
disease and risk factor distribution over a fixed period of time 2. The advantages of 
longitudinal designs in epidemiology are numerous: they allow the recording of 
incident events, the prospective ascertainment of exposure, the measurement of 
individual change in outcomes and the separation of time effects (e.g. cohort, period, 
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age), and allow to control for cohort effects1. They also allow the researcher to 
consider the effect of aging and provide an opportunity to disentangle its interaction 
with specific health factors when analysing health and disease trajectories 7. Indeed, 
temporal variations in the incidence of rare, chronic or degenerative diseases have 
become a subject of great interest to public health epidemiologists who look for 
recognisable patterns and associations with putative causal factors in order to gain 
etiological clues and possibly predict the incidence of disease in population groups. 
The longitudinal information is particularly valuable for traits that develop over time 
or have a variable age of onset. Prospective cohort designs are particularly suitable to 
study chronic diseases such as cardiovascular diseases, where large numbers of 
people are followed up for long periods before sufficient cases manifest, and where 
there is an expected long induction period between exposure and the manifestation of 
disease.  
 
Many longitudinal study samples related to cardiovascular and cardiometabolic 
disease, collect anthropomorphic measures, biochemical markers of cardiometabolic 
disease, and behavioural information on the same participants for several decades, 
sometimes spanning from childhood to adulthood. These longitudinal or panel data, 
repeatedly observed or measured on a temporal basis of time or age, provide the 
foundation of the analysis of processes, which evolve over time, often referred to as 
growth or trajectory models. The statistical approaches to examine the role of growth 
trajectories in the developmental origin of health and disease have attracted 
considerable attention among medical and epidemiological researchers over the past 
three decades 28. With repeated measure data, the researcher’s interest often lies in 
describing a number of characteristics of the change process, including the within-
person change, average change, between-persons’ differences in change, and 
determinants (or predictors) of change 67, 87. Moreover, in many research areas, 
individual subjects' trajectories themselves are increasingly considered promising 
biomarkers for early stage diagnosis, tracking of disease progression and monitoring 
of potential treatments. 
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In summary, longitudinally collected data offer numerous benefits to many branches, 
however the analyses of data arising from such designs pose a number of technical 
challenges. The critical aspect of data obtained from longitudinal studies is the 
inherent within-subject correlation that arises due to multiple measurements made on 
a single subject (or other experimental unit). It is necessary to allow for this 
correlation since it reflects the heterogeneity in the response at the population level 
that leads to specific deviations from the overall temporal response pattern. In 
additional to subject-level characteristics, the measurement errors in longitudinal data 
often exhibit temporal dependence (i.e. autocorrelated residuals) and 
heteroscedasticity 1, 63, 88. 
 
2.1.2 Traditional methods for longitudinal data analysis  
Traditional longitudinal methods for the analyses of repeated measure data include 
the (univariate or within-subject) repeated measures analysis of variance (RM-
ANOVA), or the multivariate analysis of variance (MANOVA, including analysis of 
covariance (ANCOVA)). Both methods belong to the GLM (generalised linear 
model) procedure and handle correlated residuals that may arise in longitudinal data, 
but do not allow one to explicitly model the change at the individual level, which is 
treated as error variance87. In these approaches, time is treated as a categorical factor. 
The RM-ANOVA is the simplest method but also the most restrictive and is most 
suited for well balanced longitudinal designs with the same, relatively few and 
usually evenly spaced sampling occasions in time for each subject with no missing 
values and only accommodates time-invariant covariates 63, 84. The RM-ANOVA is 
an omnibus statistical procedure that tests the null hypothesis that the means of the 
response are equal1. If the null hypothesis for between/within subject effect 
interaction is rejected, then the between-group differences vary across time. However, 
post-hoc group comparisons are required to investigate where the between-group 
differences occur. The RM-ANOVA rely on the assumption of sphericity of the 
covariance structure, of which compound symmetry is a particular form1. To provide 
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valid inference, the RM-ANOVA therefore requires equal variances at each time 
point and equal covariance between any time point, or it can lead to incorrect decision 
if these assumptions are violated 5, 63, 87. Therefore, this technique is only appropriate 
if the investigators have a reason to believe that the correlations between all pairs of 
repeated measures are identical, which is rarely the case in longitudinal studies 5, 63. 
Some correction factors such as the Greenhouse-Geisser, lower bound correction, and 
Huynh-Feldt methods were developed to adjust the degrees of freedom of the test so 
that the RM-ANOVA can be used when the sphericity assumption is not met 89 90 , 
but a well-documented drawback of these adjustment procedures is that they tend to 
be overly conservative and to incorrectly reject the null hypothesis.  
 
The MAN(C)OVA (or multivariate ANOVA) approach transforms the repeated 
measures into adjacent differences, so that the null hypothesis becomes that the 
differences in pairs of means are equal to zero64, 87, 91.  It is more flexible than the 
RM-ANOVA in that the assumption of sphericity is not required and polynomial 
contrasts or trends can be implemented to compare differences among time periods 2, 
87, but there must be no interaction between the covariate and the independent 
variable (also called homogeneity of regression slopes). However, both RM-ANOVA 
and MANOVA models require complete data and fixed measurement occasions for 
all study participants, and both approaches conceptualise change as incremental rather 
than a continuous developmental process that unfolds over time 23, 24. Guidance and 
further considerations on multiple testing issues and multiple comparisons among sets 
of repeated measures in RM-ANOVA have been well defined 64, 92 2, 93-95. 
 
2.2 Person-based approaches: Linear Growth Curve Models 
There are two approaches to modeling linear growth curves, MLM models and latent 
LGCM models that use the SEM framework. In Section 2.2.1, the differences 
between these two approaches are outlined. Section 2.2.2 outlines the formation of 
the linear growth curve model, section 2.2.3 describes the treatment of the time 
Literature Review 
 
 50 
variable, and section 2.2.4 describes how to formulate the hierarchical structure of the 
model. 
 
2.2.1 Introduction to person-based Growth Curve Models  
Growth curve modeling as provided a more flexible set of tools to model growth or 
change in outcome variables over time. This class for longitudinal analysis methods 
allows summarizing a set of within-subject time-ordered response variables with only 
a few parameters. Compared to the more traditional approaches described above, 
GCM permit one to describe and test hypotheses about inter-individual differences in 
intra-individual pattern of change, as well as predictors of these differences in the 
response trajectories over time 18, 19, 23, 67, 96.  Individual-based approaches to growth 
curve analysis examine the specific trajectory of the response variable for each 
participant and estimates informative characteristics of the growth pattern. 
Additionally, GCM allows one to further link observed change with specific 
exposures 97 by identifying covariates or mediating variables that might influence the 
patterns of response over time, in order to explain some of the between-participant 
variability in the response profiles (i.e. the determinant of change)1, 98.These methods 
have become a popular framework in many disciplines, in particular in psychology, 
social sciences and education, due to their ability in helping researchers understand 
why and how individuals follow different developmental paths 25. In medical 
research, GCM is an invaluable tool to understand the natural history of health 
outcomes, as well as risk factors trajectories 28, 97, 99. 
 
Broadly, all person-based GCM approaches follow the same main steps: after 
selecting an appropriate function for age (or other time relevant variable) in order to 
model the average relationship between time and the longitudinal outcome, individual 
deviations from the intercept and age coefficient(s) are computed to capture each 
individual’s deviation from the average trajectory. These individual summaries of the 
outcome or risk factor trajectory are often of interest and can be extracted and related 
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to later outcome using a two-step process 100 101-103, or in a single step process in 
multivariate models 104, 105 using person-based GCM models. For example, to 
estimate the effects of change in weight at different life stages on health status in later 
life, a two-stage approach may be adopted. This consists of estimating changes in 
body size or growth velocity in different growth phases during the life course; then 
regressing health outcomes in later life on these estimated growth variables. 
Alternatively, growth trajectories as well as body size and their effects on later health 
outcomes can be estimated in the same model. 
 
In contrast to RM-AN(C)OVA and MANOVA, GCM treats change as a continuous 
process that occurs between time points 24. They are more flexible, and can 
accommodate the specificities of data arising from long-term prospective 
observational cohort data, such as those with partially missing data (e.g. intermittent 
loss to follow up or study drop-out), unequally spaced time points (unbalanced 
designs), non-normally distributed outcome measures, complex non-linear or 
compound-shaped trajectories, as well as the inclusion of time-varying covariates 63, 
106, 107. By convention, growth modeling assumes that the data is drawn from a single 
underlying population, with all subjects assumed to have developmental curves of the 
same functional form 24. As mentioned previously, parameters describing individual 
curves may differ between-persons, so that growth curve analyses can be used to 
contrast the change process between multiple sub-populations of interest within the 
data sample 18, 19.  
 
Compared to traditional approaches to repeated measure analyses, there are few data 
restrictions for GCM analysis. To reliably estimate a growth model, the number of 
individuals and the number of repeated measured per individual are important as they 
influence statistical power. Sample sizes of at least 60 participants at the highest level 
are typically preferred for hierarchical growth curve modeling using maximum 
likelihood (ML) techniques, but samples as small as 20 might be sufficient if the 
interest lies in the average growth parameters and not the estimate of the variance 
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components 99. A recent simulation study showed that a small sample size of 50 or 
less at level-two (i.e. individual levels) leads to biased estimates of the second-level 
standard errors. In all of the other simulated conditions, estimates of the regression 
coefficients, variance components, and standard errors were unbiased and accurate 
108. There are many rules of thumb on the required sample size for MLM models (e.g. 
15 units per cluster22, 30 cluster/30 units per cluster rule 109, and the 50 clusters/20 
units per cluster rule for detecting cross-level interaction effect 99). However, none of 
these rules can provide an accurate estimation of the sample size required, given the 
power and target effect size 110. Generally, a large number of higher-level units 
(participants in the case of observational studies) can increase the power for detecting 
the effects of higher level predictors and the cross-level interaction effects between 
within- and between-individual predictors 110. 
 
Although it is possible to apply growth models to two-wave data, the traditional pre-
post design is not optimal, especially if one intends to model individual heterogeneity 
in growth, since it is not possible to separate error variance from individual 
heterogeneity in change with only two time points 23, 24. Furthermore, the existence of 
a functional form of change (time trend) more complex than a straight line cannot be 
identified with only two data points. In general, the simplest possible growth model 
requires at least three waves of data, but more reliable estimates for individual growth 
models can be obtained with a relative large number of measurements waves (e.g. 8 
or more) 108, 110. 
 
In GCM approaches, repeated measure data can be partially missing for a portion of 
the individuals if it is considered MAR (missing at random) 97, 107. MAR is true when 
the probability of an observation being missing is related to other variables for that 
individual, but does not depend on the true value of the missing observation 111. 
Under the MAR assumption, all individuals with at least one observation can 
contribute to the growth curve model. This is particularly important for longitudinal 
studies designed as accelerated or sequential cohort designs, where study attrition or 
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drop-out is frequent, and where subjects with a few or sparse observations across the 
study period will still contribute information to the analysis. An increased number of 
measurements usually positively affects the statistical power and reliability of the 
assessment of individual change 67. In the case of cohort sequential designs, where a 
number of birth cohorts are followed over the same period of time to accumulate the 
age range of interest for a given longitudinal outcome, power is most influenced by 
the total life-span not the number of measures per birth cohort 4. However, the 
number of repeated-measurements per individual, as well as the number of 
individuals per cohort or per age needs to be considered. The greater the number of 
cohorts, the longer the timespan in the trajectory analysis, but the risk of cohort 
differences in the change process becomes greater. Compared to traditional analytic 
approaches (e.g., RM-ANOVA) for the analysis of repeated measure data from 
between-group designs, growth models were shown to have greater statistical power 
at detecting a difference in linear slopes (i.e., time by group interaction) in small to 
moderate sample sizes 112. 
 
Because different disciplines refer to broadly similar person-based GCM methods 
using different terminology (e.g., MLM23, 113, individual growth curve analysis 
(IGC)18, 19, 75, HLM22, 67, mixed or random-effect models of change84, 114, 115, random 
coefficient models116 latent trajectory analysis96, 97, 107, or 117, 118 ), epidemiologists 
may find it challenging to understand the current state of the growth curve modeling 
literature, as well as identify what is the most appropriate approach to growth curve 
analyses in different situations. There are two approaches to traditional GCM models 
for longitudinal data: the MLM regression framework and the LGCM framework, 
which is a special case of SEM for longitudinal analysis 5, 28, 96, 117, 119. Although they 
have different underlying assumptions, both approaches are closely connected and 
often numerically identical 97, 120 when it comes to analysing growth curves. Both 
LGCM and MLM growth models can accommodate a range of non-linear shapes for 
the outcome over time. In general, these models are fit using maximum likelihood 
(ML) or restricted maximum likelihood (REML) which can provide more accurate 
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results especially if the number of higher level units (e.g. often study participants) is 
small67, 99.  Full ML estimation allows comparison of the goodness of fits of both 
fixed and random parts between nested models, whereas REML only compares the 
goodness of fit of the random part between nested models. REML estimation has 
been recommended by several authors to select the appropriate variance covariance 
matrix for the random effects 110, 121, 122. Bayesian estimation of growth models is also 
possible in both MLM and LGCM frameworks, by addition of prior distribution 
assumptions on the parameters of the models, and by using combinations of Gibbs, 
Metropolis-hasting and reversible jumps Markov chain Monte Carlo (MCMC) 
sampling methods to generate posterior probability distribution for parameters 123. 
Bayesian inference for hierarchical or multilevel models has been detailed by Gelman 
et al.124 and Congdon125. Bayesian estimation is sometimes preferable to the 
traditional ML if the sample size is small, because it is less dependent on asymptotic 
assumptions 124. As is shown in the next sections, some complex growth curve 
models may also be easier to estimate, or are only estimable, in the Bayesian context.  
 
Because they differ in several analytical aspects, LGCM and MLM models require 
different software for estimation 97, and they differ in the type of criteria used for the 
assessment of model fit and approaches to compare multiple growth models. In the 
MLM framework, there is no stand-alone measure of overall model fit; model 
adequacy is assessed using comparison of potential candidate models. If models are 
nested, it is done using likelihood ratio tests, which compare models’ deviances and 
the number of degrees of freedom based on the Chi-square difference statistics 67, 115. 
If they are not nested, growth models can be compared using Akaike or Bayesian 
information criteria indices 126. Pinheiro and Bates 114, 127  and Zuur et al. 121, 128 
provide useful examples on how to compare competing growth curve models in the 
frequentist framework. On the other hand, the LGCM framework offers a number of 
indices for assessing model fit (i.e. root mean square error of approximation 
(RMSEA), Comparative fit index (CFI) and Tucker Lewis Index (TLI), among 
others). For a detailed overview on model fit and comparison in LGCM and MLM, 
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we refer to Hox et al.  99. Applied epidemiologists can be confused about the 
differences and similarities between these two person-based growth modeling 
approaches. In the following section, the basic linear growth model is reviewed, and a 
number of selected analytical aspects that should be considered in the decision to 
apply one or more of these approaches is provided. For more thorough and technical 
descriptions of the MLM approach to growth curve modeling, we refer to 18, 19, 23, 24, 
67, 116 and to 71, 107, 117, 120, 129 for LGCM modeling. 
 
2.2.2 Linear Growth Curve Model 
The simplest growth curve model is often a linear growth model, and like many other 
growth curves models, it can be estimated both as a latent growth curve model 
(LGCM using SEM) and as a HLM/ or MLM. Both one-stage and two-stage 
approaches can use the MLM or LGCM methods to model the growth trajectories and 
relate them to a later health outcome. This section will predominantly consider the 
two-level MLM/HLM model where the level-1 model represents the individual 
response trajectory over time (observation level) and the level-2 model considers 
changes in trajectory across subjects (between-person level). In this model, change or 
“growth” in the outcome variable is modeled simultaneously at the individual level 
and at the between individual level 130. To illustrate the equivalence and differences 
of corresponding growth curve models formulated as LGCM in the SEM framework, 
LGCM model notation is used when necessary.  
 
Unconditional model 
The unconditional linear growth curve model is the model with no predictors or 
covariates at level-2. In multilevel (or hierarchical) notation, the level-1 part of the 
linear unconditional growth model corresponds to the repeated measures nested 
within-individual22, 67. It can be written as: 
 Level	1 ∶ 	()* = ,-.) + 01234). .,64)* + 7)*    (2.1) 
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where for time point t and participant i:  ()* are the repeated measures of outcome ( 
for participant i (i=1,2,..,N) , .,64)*	are the time related variables at the measuring 
occasion t  (t=1,2,..T). Individual intercepts ,-.)	and slopes	01234) are the random 
coefficients. ,-.) represents each participant’s predicted score when t=0 (or any other 
time point that was used for centering the time variable); 01234) represents the linear 
growth rate, which is the participant’s predicted amount of change in ( for a one unit 
change in t (or t/k, if a constant k was used to scale the time predictor to facilitate 
interpretation of the slope). The level-1 time-specific residuals	7)*, also known as 
error variance or occasion-level residuals, are often assumed to be distributed as 8 0, ;<= .	They represent the measurement error and have constant variance although 
the model can be extended to incorporate more complex variance structure at the 
occasion level75, 131 (see in section 2.3.2). Level 2-sub models can be written as:  
 
Level 2 model:              (2.2) ,-.) = >?? + @?) 01234) = >A? + @A) 
 
where >??	and >A? are the mean intercept and mean linear slope in the population (i.e. 
population expectation for the fixed effects), and @?) and @A)	are the level-2-random 
effects that allow the individual intercepts and growth rates to vary around the 
common trajectory specified by the population parameters. These level-2 random 
effects are in the most general case multivariate normal distributed as:  
 
BCDBED ~	8 00 , ;B?= ;B?A;B?A ;BA=            (2.3) 
 
where ;B?=  can be interpreted as the between-participant variability in the intercept, ;BA=   , the variability in the rate of change and where  the covariance between random 
effects ;B?A represent the degree of correlations between individual’s slopes and 
intercepts.  
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Equivalently, the linear curve growth model where each subject have their own linear 
regression curve with intercept and slopes varying randomly by subject, can be 
written as a LGCM ‘measurement model’ using the SEM notation as follows:  
 ()* = ,-.). G)H* + 01234). GIJKL< + 7)*  (2.4) 
 
In the LGCM formulation, ,-.) and 01234) in 1.2 are referred to as latent variables, 
and time is introduced in the model via factor loadings	G)H* and GIJKL<. By convention 
for ,-.), 	G)H* are all set to 1, and factor loadings	GIJKL< for 01234) are set to the values 
of time t at each different measuring occasion, as in the MLM notation (i.e. [0,1,2,3] 
for a 4 time points design). Similarly to the MLM linear growth model, the latent 
variables have means (M)H* and MIJKL<) and variances (;)H*=  and	;IJKL<= ) describing the 
population trajectory in the outcome and heterogeneity around the population curve.  
 
Conditional model 
In both the LGCM and MLM frameworks, it is often of interest to extend the linear 
‘level-1’ or ‘measurement’ model by including time-varying predictors (TVC) and 
subject-level predictor (or time-invariant predictors (TIC)) of between-person 
heterogeneity in growth parameters at level 2 (also known as ‘structural model’ in the 
LGCM formulation). This allows testing whether certain groups of participants start 
with different response levels or change in a different way over time. Although all 
participants are assumed to have the same average trajectory over time (i.e. functional 
form of change), it is thus possible to examine how certain a priori groups deviate 
from the average population trajectory. 
In the MLM framework this is sometimes referred to as the ‘conditional’ growth 
model since the individually varying growth parameters (i.e. intercept and slopes) are 
now conditioned on other predictors variables and not only on the time predictor.  In 
the MLM notation, this is done by expanding the 2.1 and 2.2 equations as follows: 
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Level-1:          (2.5) 
 N)* = ,-.) +	01234). .,64)* + >.. OPQ)* + R)* 
 
Level-2:          (2.6) ,-.) = >?? + >?A. OSQ) + 	@?) 01234) = >A? + >AA. OSQ) +	@A) 
 
Where >?A is the mean difference in the intercept, >AA, is the mean difference in the 
linear slope, each respectively associated with the participant characteristic TIC; and 
where >*	accounts for the error variance within individual that is associated with the 
time varying predictor, TVC. The TICs thus directly predict the growth parameters, 
and the TVCs predict the repeated measures while controlling for the influence of the 
growth parameters 97. If the subject level characteristic is a categorical variable (such 
as sex or binary coded dummy variable representing a grouping of interest), the 
categorical variable is used to shift the marginal mean of the growth parameters in 
one group to model difference in trajectories between clusters of individuals 97. It is 
possible to build a more complex level-1 model with interaction between the relevant 
time predictor and the TVCs to test if the effect of the TVCs is constant over time 
(see 132). Equations 2.1 and 2.2 show the inclusion of single TICs and TVCs 
covariates into the model, but multiple predictors can be included in the same way 22, 
67. Because of their quasi equivalence, we refer the reader to Hox and Stoel 2005 99  
for an exact mathematical representation of how TIC and TVC are incorporated into 
the basic linear LGCM model.  
 
In the model presented in 2.1 and 2.5 we considered normally distributed model 
residuals, but it is important to note that growth curves model are not restricted to 
normal continuous outcome data. Growth models continue to be actively developed 
to address further restrictions imposed by empirically collected data, such as non-
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normality of the response and multivariate responses. Through the use of link 
functions, linear mixed models can also be extended to allow for correlated response 
variables that have error distribution models other than a normal distribution  (i.e. 
Poisson, binomial, exponential). Generalised mixed model and latent growth models 
for binary and ordinal outcomes are the subject of much ongoing research in the 
MLM and LGCM framework 3, 133-136.  
 
2.2.3 Treatment of time in Growth Curve Models 
The equations 1.1 and 1.2 presented for the basic linear growth model above, show 
that although they model the response within-person in the same way, the LGCM and 
MLM growth models differ fundamentally in the way the relevant ‘time’ variable 
enters the growth model, which has certain consequences for the analyses. In the 
MLM framework, time is incorporated as a fixed predictor variable (i.e. variable "."	in 1.1), while in SEMs time is introduced through parameters called factor 
loadings (G)H*and GIJKL<), which are constrained to represent time in LGCM models 
96. As a consequence, MLM can be seen as a univariate approach, where time points 
are treated as different observations of the same ‘time’ variable, while LGCM can be 
seen as a multivariate approach where each time point is considered a separate 
variable99. This makes growth curves from LGCM generally best suited to analyse 
fixed occasion designs (i.e. subjects were assessed at the same follow-up clinics). In 
MLM, it is by design simple to include subjects chronological ages at each time point 
(i.e. UV4)W	) rather than measurement occasions themselves (i.e. .,64)W	) as the 
relevant time-variable. MLM growth models also deal naturally with incomplete data 
that may arise due to panel attrition or incidental dropout (under the MAR 
assumption 66 ). It is thus generally best to use MLM if subjects were seen at varying 
occasions, if they were seen a different number of times, and if groups are of unequal 
sizes.  
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As mentioned previously, prospective observational cohort studies often include 
participants from multiple birth cohorts, which may be followed for a few years or 
sporadically over a few decades for the same study duration, so that the different 
cohorts remain age-heterogeneous at the end of data collection 4, 22, 78.  
These accelerated, or “sequential-cohort” longitudinal designs, where the growth 
curve is estimated on a combination of cross-sectional and longitudinal data, are 
increasingly popular in epidemiology and other disciplines to study age-outcome 
trajectories over a broad age span during a study of short duration28 22. In these cases, 
participants contribute data at different occasions and different numbers of occasions, 
with some overlap in their measuring occasions, so that a sample developmental 
growth curve spanning a longer period can be constructed using a number of groups 
that contribute different parts of the overall curve. Because the observable age-
trajectories of different cohorts initiate and end at different ages, each cohort 
contributes to different and, to some degree, overlapping segments of cohort 
member’s life course. Since response trajectories might differ across birth cohorts, 
(especially if the sample contains a mixture of generations) 65, 137, 138, it is necessary to 
take into account possible cohort effects When modeling the change in the outcome 
for the entire length of time spanned by the ages of the participants in all cohorts, The 
term ‘cohort effect’ in epidemiology, sometimes referred to as birth or age cohort 
effect, refers to the systematic difference in response trajectories between people born 
at different times4. 
 
To draw valid inference regarding growth parameters from accelerated longitudinal 
or cohort-sequential designs requires no cohort difference among the cohort-specific 
trajectories 139. Indeed, the existence of age-by-cohort interaction effects may be due 
to demographic differences or to the effect of intervening variables that may lead to 
cohort differences in the age-outcome association 22, 65, 140. Using data pooled from 
multiple cohorts may be inadequate to recover information concerning the entire 
longitudinal curve, and may yield distorted inference concerning the age-related 
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change. There are a number of strategies to deal with potential between-cohort 
heterogeneity in individual trajectories in the growth modeling framework 4.  
 
In the MLM framework, early guidance on how to accommodate such accelerated 
designs in growth curve models was shown with data coming from 2 cohorts 65. In a 
more recent paper, Miyazaki and Raudenbush 78 refer to this problem as “the test of 
convergence”, that is,  if the trajectories do not vary by birth cohort, the multiple-
cohort design is thus considered “convergent’. In MLM models, testing for 
convergence in trajectories is usually done using dummy variables that represent 
cohort membership to augment the second-level model. This is sometimes referred to 
as the “fixed-effect” approach to cohort effect modeling. This consists of modeling 
cohort effect by including cohort interactions with each trajectory parameter of 
interest (i.e. intercept, linear change, quadratic change)19, 23, 67. The significance of 
age-by cohort interactions can then be tested using a Likelihood Ratio Test (LRT), in 
which the full model that includes dummy variables allowing for trajectories to differ 
by cohort is compared to a reduced model without the dummy variable, which posits 
a common trajectory model across all multiple cohorts 65, 78. Another strategy is to 
adjust for any potential birth cohort effect by including centered “year of birth” or 
“age at first visit” of study participants as a level-2 covariate for all trajectory 
patameters141. This strategy considers that the fixed growth parameters vary linearly 
with year of birth, which is a simpler alternative than allowing for a completely 
different time trend in the response for each birth cohort. This approach results in 
more parsimonious models, and tends to be preferred when it is computationally 
difficult to estimate cohort-specific trajectories 4, 78.  
 
Sometimes, trajectory models consider parallel longitudinal linear trends for the 
different cohorts but shifted by the intercept term (i.e. the cohort effect is only 
considered on the initial response level). If the curves for different cohorts are similar 
in regions of overlap, it may not be of concern that hypothesis tests indicate a 
significant difference in fixed effects parameters. This situation is likely to arise if the 
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regions of overlap are small, so that the information on the age range covered by a 
given birth cohort comes largely from that cohort 4. As explained in Galbraith et al. 
2014 4, in this situation it is possible to derive fixed effects tests for differences 
between cohorts by integrating the absolute value of the difference between the 
estimated curves over the age range of overlap and to obtain standard errors via the 
delta method. Another, less popular, method that allows modeling between-cohorts 
differences in response trajectories is to add a third level to the MLM/ hierarchical 
model by including cohort-specific random effects. Appendix 2.3 illustrates how to 
model these fixed or random cohort effects on polynomial MLM models in practice 
in R, using the nlme()and lme4() functions.  
 
Recent versions of SEM software (i.e. Mx and Mplus) now also allow to estimate 
LGCM models for designs with irregular time points, by modeling all existing 
occasions and viewing the varying occasions as missing data 21. In the LGCM 
context, testing for cohort effects is conceptualised as a “ multiple-group” approach, 
where cohorts represent a different pattern of “missingness” 140 and adjacent 
segments of limited longitudinal data from different age cohorts are linked together to 
determine the existence of a common developmental trend, or growth curve 72. 
Several SEM indices can be used to assess “convergence” of trajectories from 
multiple cohorts in LGCM models 139 . Thus, when the number of cohorts is limited, 
and the maximum number of possible occasions remains limited across the study 
sample as a whole, SEM can now be used to fit LGCM models with sequential-cohort 
data 142,143 ,140. However, it remains easier to test and adjust for cohort effects in the 
MLM framework since it can easily deal with attrition producing data missing at 
random. In SEM, each subpopulation in the multiple-group approach has to have the 
same data collection pattern. These models tend not to reach convergence as the 
number of time points increases and the number of missing-data patterns becomes 
large78.   
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Many longitudinal data sets in epidemiology can present truly unique, individually 
varying time points, particularly if the time is measured precisely (i.e. age in days or 
months rather than years) or if data collection schedules are truly individual-specific. 
MLM remains the preferred framework for growth curve modeling in this situation, 
although some recent extensions in LGCM software and theory have been developed 
to handle this type of data (e.g. Mplus, Mx and Open Mx).  Sterba 2014 70 recently 
published a paper that illustrates how to use linear and non-linear LGCM models for 
data with subject-specific measurement schedules. However, this novel method is 
complex and due to convergence issues, it remains a challenge to estimate LGCM 
models with widely varying numbers of measuring occasions 70.   
  
To summarize, the identification of the relevant time-metric is crucial as it impacts 
the choice of the approach to growth curve analysis, and it ultimately depends on the 
research question. In literature relevant to cardiometabolic research, when the interest 
lies in describing change patterns in cardiometabolic-related outcomes as a function 
of subjects ages, applications often use MLM growth curve models 74, 144-146. This is 
the case of Heo et al 130, who used MLM models to develop BMI growth curves in 
overweight and obese adults. If study participants ages are not rounded up by year, 
but expressed in refined time scales such as days or months, it is likely that there will 
be a lot of ‘unique’ ages in the data and again, MLM will easily handle this situation. 
When the focus is on analysing the trend of an outcome over secular time, while 
controlling for subjects ages at first measurement, investigators tend to fit growth 
models as LGCM, within the SEM framework. For example, in a recent paper, 
Akbarzadeh et al147, used LGCM to evaluate the trajectories of change in three 
anthropometric measurements within and between families seen at four measuring 
occasions separated by three years. The aim was to obtain an idea of the trend in 
obesity across 12 years, so although participants had various ages at the first wave (3 
to 89 years), age was not the relevant time variable in the analyses (although the 
growth curve methods allowed to estimate the effects of age and sex on the growth 
rate of obesity indices). With the linear trajectory model (LCGM or MLM), with a 
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linear slope and no asymptotic constraints, individual trajectories of the outcome will 
project towards infinity if projected onwards. One should be cautious that even if 
appropriate to describe the change in outcome over a specific period (e.g. between 
ages 2 and 10 years), the model is not likely appropriate to make estimates outside of 
the study period.  
 
2.2.4 Hierarchical data structure  
The second important aspect to consider when choosing a growth curve modeling 
approach for a particular data set is the hierarchical structure of the observed 
outcome. In epidemiology repeated measures can arise from subjects sampled from a 
number of doctors, hospitals, or regions. In this instance, growth curve models must 
acknowledge the 3-level structure to produce unbiased results, because observations 
made by the same observer will be more similar than observations made by another 
observer.  Defining ‘clinician’, as an extra level of nesting, allows to the results to be 
generalised to all clinicians (or a ‘population’ of doctors), so that inference is not 
restricted to the specific ‘doctors’ who made the observations in the study sample. 
Although confusion may arise with level identification in complex study designs, in 
general, “levels” are different to subject-level grouping variables (such as sex, 
ethnicity), in that they can be can be viewed as a random sample of a population of 
units. The MLM growth model expands naturally to higher levels of nesting (e.g. 
repeated measures nested within participant, nested in turn within clinicians, nested 
within hospital or region). Accounting for heterogeneity in the outcome trajectories 
due to nesting at higher level is more limited and technically difficult for growth 
models fit as LGCM. Traditional SEM software handle conventional two-levels 
models with repeated measures within individual at level-1 and predictors of 
between-subjects heterogeneity in trajectory at level-2 (Mplus, Lisrel) 148, but 
specific extensions of the method are required to estimate more general hierarchical 
structures via SEM, and the procedure is far more complex than MLM 149,148. MLM 
growth curve models remained preferred if there are more than 3 levels of nesting in 
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the longitudinal data 99.  For example, Briollais et al 150 used a MLM approach to 
model the longitudinal systolic blood pressure pedigree data arising from the 
Framingham Heart Study. In this application, individual repeated measurements 
(Level-1) where nested within individuals (Level-2), in turn clustered within genetic 
pedigrees (Level-3), which was a potential source of heterogeneity in the 
development of the systolic blood pressure profiles over age.  
 
Effect of time-varying covariates and alternative variance-covariance structures 
Although the linear growth model presented in both frameworks (equations 1.1. and 
1.2) considered equal variances of the residuals at all measuring occasions and a 
unique effect of a TVC on the outcome across time points, these can be restrictive 
assumptions in many practical situations. For example, if the longitudinal outcome is 
blood pressure measured across the life course, and BMI is the time-varying predictor 
of interest, the researcher might be interested to test whether the effect of BMI on 
time-varying blood pressure is constant, or if it gets stronger or weaker as the subject 
ages. Because each occasion and TVC is considered a separate variable in LGCM, it 
is easy and often default to estimate all variances and covariances, as well as to 
estimate the effect of the TVC on the outcome at each time point 97. With extensive 
development in statistical software and packages in the last decades, it is now 
possible to test for and fit alternative error structures for the residuals and time-
specific variances in MLM models (i.e SAS Proc Mixed, MLwiN, LME, nlme and 
lmer packages in R). The same holds for the inclusion of TVCs whose effect is not 
constant across time, which can be dealt with by including residual error structures 
and TVC by time interactions in the MLM approach 97, 99, 132.  
 
2.3 Person-based approaches: Extensions of the Linear Growth 
Curve Model 
In this section, linear growth curve models are described with multiple outcome 
variables (section 2.3.1) and with a structured correlation matrix (section 2.3.2). 
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2.3.1 Multiple outcome variables 
In some applications, the research interest may not be restricted to characterising the 
pattern of change in a single process, but rather to model the change of several 
outcome variables simultaneously (e.g. cross-domain analysis of change 29) .  To 
illustrate, suppose a situation where the interest was whether longitudinal change in 
BMI in childhood can be used to predict insulin level at adolescence, this would 
require regressing insulin level on the growth rate of BMI in childhood. In such a 
situation, where intercept and slope factors of the growth curve models are to be used 
as predictors of some separate distant outcome, LGCM tends to be preferred because 
it is straightforward to embed the growth curve model into a larger path model 
specified via SEM99. Most MLM software allow the estimation of covariances 
between growth parameters in multivariate models, but do not allow expanding the 
structural part of the model directly. Also, SEM can readily estimate all means and 
covariances between latent growth parameters97, 107 so that growth models can easily 
be extended to estimate the interrelationship amongst change patterns in different 
outcomes, association of change with covariates, and investigate the indirect or 
mediating effect of covariates on growth processes (see 151). For example, Breeze et 
al. 2015 employed latent growth curve modeling to simultaneously estimate 
trajectories for multiple metabolic risk factors for diabetes (BMI, fasting plasma 
glucose, systolic blood pressure, and blood lipids), to predict joint correlated risk 
factors trajectories over a 16 year period 152. The analysis revealed that change in 
glycaemia was positively correlated with systolic blood pressure and negatively 
correlated with HDL cholesterol. As another example of extended growth curve 
model, Chien et al. used a bivariate LGCM approach to simultaneously estimate the 
effects of change in systolic blood pressure and serum LDL cholesterol on the 
trajectory of cIMT, a marker of atherosclerosis, during a 6 year follow-up in a 
Taiwanese population 56. It would not be possible to implement such analyses in one-
step using the traditional MLM approach to growth curve analysis. However, 
alternative estimation methods to ML , especially sampling based methods such as 
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MCMC, can be used for the joint modeling of several longitudinal outcomes within 
the Bayesian hierarchical framework153, 154.  
 
2.3.2 Modeling the covariance structure of Growth Curve Models 
One of the advantages of person-based growth curve modeling is that it offers great 
flexibility in modeling the covariance structures for both the between-individual 
random effects and within individual errors. 
 
Modeling the covariance structure for the between-person random effects 
Many MLM or LGCM software consider an unstructured covariance matrix for the 
random effects (Equation 1.3). As mentioned above, it is the least restrictive but also 
the most complex structure since all unique elements of the matrix (variances and 
covariances between all random effects) are free for estimation. While it may be of 
interest to fit such models to investigates, for example, if one’s person outcome level 
at baseline (i.e. intercept) is correlated with its change in outcome over time (i.e. 
linear slope), complex growth curve models with multiple random effects may not 
converge or be overparametrised 114. One may also wish to explicitly model the 
variance-covariance matrix to obtain higher explained variances 110. Most software 
offer a number of simpler alternative structures for the random effect variance 
covariance, such as the diagonal, block diagonal structure, which constrain some 
elements of the matrix to zero. The difference in the -2 Log Likelihood values 
between two nested models follows a chi-square distribution with 1 degree of 
freedom. A number of authors discuss the redistribution of the variance between 
random effects and different likelihood ratio testing strategies to assess the optimal 
random effect variance structure 110, 114, 121, 122. 
 
Modeling the covariance structure for the within-person random errors 
When analysing longitudinal data under the MLM framework, researchers typically 
assume the within-individual errors to be independently and identically distributed 
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(i.i.d)) with mean 0 and homogenous variance ;<=	63, 82 .The simplification of the 
within-individual covariance structure to the identity structure can potentially bias the 
estimates of the standard error for the fixed effects 63. By allowing errors to be 
correlated or residual spread to vary per stratum of a nominal variable (or to increase 
or decrease along a continuous explanatory variable), the conditional assumption of 
the MLM model will be relaxed 63. Researchers can search for optimal variance 
covariance structure, which theoretically results in higher statistical power and 
increases the precision of estimates of fixed effects in growth curve models 76, 98, 155. 
Choosing the optimal error structure is an important task in MLM, since it is a key 
element to estimate proper effect sizes and to account properly for missing values 23, 
24.  
 
Many authors report that unless highly cyclical, longitudinal data almost always have 
a proximally autocorrelated structure, since adjacent waves of measurements 
correlate more highly than adjacent waves, and the more remote in time, the lower the 
correlation (i.e. time-decaying dependency) 2, 110. This is the correlation structure used 
in many LGCM based analyses 97, 107. For this reason most LGC and software come 
with the first-order autoregression AR(1) structure for the within-person error by 
default. This structure contains two parameters, the error variance and the 
autocorrelation coefficient (see Pinheiro and bates for a matrix representation of the 
AR(1) 127). The AR(1) model is one of the few correlation structures that can be 
expanded to continuous time measurements (i.e. continuous AR(1) or CAR(1)), 
which is a popular choice for MLM models where the response is a function of age 
and not measuring-occasion127. A number of alternative temporal error structures, 
such as Toeplitz, and ARMA (if time points are regularly spaced), or spatial error 
structures (for data measured irregularly in time) are usually available in most MLM 
software. One possible way to diagnose autocorrelation of residual error is to plot the 
difference between consecutive level-1 residuals for the same individual against the 
time difference between the consecutive measures121, 128. Another option is to 
Literature Review 
 
 69 
compare nested models with and without the autocorrelated residual error to decide if 
the addition to the model is an improvement (by the means of LRT tests) 114, 127 .  
 
Similarly, since standard model formulation does not account for differential 
variability across population subgroups, it is possible to extend the MLM growth 
models to allow, estimate, and test for heterogeneous within and between-subject 
variance terms 66,  In fact, Littell et al. warn that failure to account for heterogeneity 
can lead to inefficient and possibly misleading inferences for fixed effects 156. The 
ratio of the between-subject variance to the total variance, also known as ICC (intra-
class correlation coefficient) can be used to parametrise random-effect models with 
varying variance per groups, or trend in the variances across groups 106,157. Most 
MLM and LGCM software implement a number of variance structures that can be 
used to incorporate varying between- and within-subject variance, including the 
fixed, identical, power, exponential and combination variance structures 114, 127. The 
choice of the variance is based on the nature of the variance covariate (nominal vs. 
continuous), the presence of one identifiable structure in the model residuals 
validation plots (e.g. fixed variance structure if residual spread appears proportional 
to one covariate), or the a priori biological knowledge of a certain type of 
heterogeneity. However, in most cases it is best judged through model selections 
using information criteria tools such as the Aikeke Information Criteria  (AIC) or the 
Bayesian information Criteria (BIC) (as in 128). As for residual correlation structures, 
the optimal variance structure can be assessed via likelihood ratio test (LRT) if 
compared growth models are nested (see 110, 115 for more details). 
 
2.4 Person-based approaches: Non-linear patterns of change 
over time 
Many outcome variables collected or measured in longitudinal studies, especially in 
epidemiology, are characterised by systematic growth processes. As such, some 
degree of non-linearity in the functional form of the mean response over age or 
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secular time may be present, particularly if the period spanned by the study stretches 
across distinct developmental phases for the subject being assessed. Non-linear 
change is posited by developmental theories in many documented areas of research in 
psychology and education 70. While linear change might be a reasonable assumption 
for short-term processes, the trajectories of many biological and developmental 
processes over the life course are complex and likely to be non-linear over time 70, 99, 
158, 159, particularly if the time-window is large 83, 160. Researchers must thus consider 
growth curve models capable of representing non-linear change patterns with a 
relatively small number of measurement occasions per participant (often <10 time 
points) and be specific about where between-participant heterogeneity appears in 
those patterns. Although strategies have been developed to incorporate this potential 
non-linearity in GCM models in several ways, most examples in the literature present 
linear GCMs. Specifying an adequate non-linear form of the average outcome over 
time can be challenging, and may be responsible for the relative lack of uptake of the 
approach in observational studies where subjects are followed for a long time span 
161.  
 
A typical example of non-linear biological measure often collected in observational 
cardiometabolic related studies, is BMI, a well-established risk factor for metabolic 
conditions and cardiovascular outcomes 162, 163. Many large-scale cardiovascular 
longitudinal studies collect repeated BMI measures on participants over varying study 
time frames, often with an interest in using BMI trajectory information in childhood 
or adulthood, rather than BMI at one point in time to predict (or improve the 
predictions) of later body-size related CVD outcomes 51, 164-166. BMI typically 
exhibits separate developmental phases from infancy throughout childhood, as well 
as from childhood to adulthood, which manifests through non-linear individual BMI-
age curves 15, 163, 167. The successive periods of stable growth, acceleration or 
deceleration, can not be adequately characterised by a straight line. Also, a lot of 
between subject heterogeneity in development over time is expected, with some 
individuals reaching height or weight milestones sooner or later than others, at 
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different periods in their lives. Similarly, empirical research has shown that blood 
lipid and blood pressure age-related changes in healthy individuals are not linear 
across-childhood 168 or adulthood 169. To properly model longitudinal change in 
continuous outcomes such as BMI or blood lipids across the life course, the statistical 
model must be able to accommodate non-linear pattern for the response (i.e. 
functional form) and allow for between-subject differences in several key aspects of 
the change in outcome over time, such as difference in starting BMI level, difference 
in timing of increase in lipid level during puberty, and differences in rates of change 
in these different periods. 
 
Identifying the shape of the outcome over time is a critical first step in any person-
based GCM model, as an incorrect choice of functional form will lead to bias when 
expanding the initial growth model with predictors of growth or conducting multiple 
group analysis 97.  Ideally, before any trajectory modeling exercise, the investigator 
should consider what is known about the development of the outcome that they 
intend to model 79, 170. When possible, the model of change should be informed by 
theory on the development of the system under investigation25, so that the model 
parameters can be useful to interpret the longitudinal change and its determinants. In 
some cases, knowledge on biological processes such as the effect of puberty onset on 
growth, or the asymptotic nature of human weight and height, can be incorporated in 
the growth models to obtain an accurate and interpretable representation of change 
over time. However, for many outcomes there may not be any established theories 
regarding the form of the longitudinal change, and the optimal functional form of the 
trajectory over time has to be determined from the data itself 79, 170.  
 
An early approach to deal with non-linearity of the outcome over time was to impose 
a transformation on either the repeated measure outcome or on age, to make the 
relationship between the response and time (or age) approximately linear 160. 
However, this approach is not very flexible and results in growth curves that are 
difficult to interpret. In the following section, flexible alternatives that can be used to 
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model non-linear patters of change over time within individuals in the MLM, LGCM 
frameworks or both are presented. It is also shown that these can be extended to 
investigate how and where these patterns change between individuals.  
 
2.4.1 Higher-order polynomial growth models 
When a straight line does not appear to be a reasonable model for within-person 
change in the outcome over time, many investigators often consider a quadratic, or 
cubic time (or age) parameter to account for the curvature of the response 18, 19, 67, 97, 
107.  Following the general notation introduced above, for a Pth degree polynomial, the 
GCM model can be rewritten:  
 ()* = ,-.) + 01234). . + 01234=)	. .= +	…+ 01234Y)	. .Y + 4)*   (2.7) 
 
In the multilevel framework, .Y is the vector of the time-relevant predictor brought to 
power P, and 01234Y)	, the corresponding random coefficient (i.e. subject-specific Pth 
order growth rate). In the SEM framework, each additional 01234Y)	is a latent variable 
with factors loadings values set to	.Y 171.  Similarly to what was shown for the 
intercept and linear slope in the basic linear growth model, higher-order slope terms 
have means (MIJKL<Y) and variances  (;IJKL<Y= ) and a full covariance matrix of 
dimension Z + 1 ∗ (Z + 1). In epidemiology, like in many other fields, polynomial 
functions such as fractional, orthogonal and natural polynomials, are a popular choice 
to model continuous individual responses that change non-linearly over time 130, 165, 
172. The quadratic or cubic growth models are often considered first, and if they do 
not fit the data, a broader range of curves can be considered using fractional 
polynomials. Briefly, fractional polynomials consist of fitting a series of models 
using each of eight power of time or age (-2, -1,-0.5, 0.5, 1, 2, 3, where a power of 
zero is the log function), followed by models incorporating each combination of pairs 
of these powers 173, 174. For more complex models, all combinations of multiple 
powers can also be compared165. The best fitting of these fractional polynomial 
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models is then selected as the functional form, often by comparing the deviance 
across each model175. 
 
In general, polynomial approximations of a non-linear function are attractive because 
polynomial growth models allow testing of known fully-parametric forms of the 
change over time, which is usually computationally easy to estimate with standard 
linear modeling procedures. Polynomials have well known and understood properties, 
and are not dependent on the underlying metric if raw data needs to be rescaled 99. 
They allow a flexible range of shapes for the response, in particular non-monotonic 
responses where the rate of change signs over the data range (i.e. U-shaped curves) 
can easily be modeled. Polynomial growth models also have a number of limitations 
such as poor fitting at the edges of the time-window, poor extrapolary properties 
outside the range of the data, and poor asymptotic properties due to its parabolic 
change patterns (i.e. they do not accurately reflect trajectories characterised by ceiling 
effects). This last limitation makes them unlikely to provide a good representation of 
many biological and developmental outcomes, asymptotic by nature (i.e. many 
human anthropomorphic measurements as a function of age will tend to a maxima). 
Additionally, polynomial models exhibit a particularly poor trade-off between shape 
and degree to model data with a complicated structure, the degree of the model. Thus, 
if the non-linear trajectory of the response is complex, the number of model 
parameters, must be high, which often results in highly unstable models and issues of 
multicollinearity between the many growth parameters. A number of data 
transformations and modeling strategies exist to avoid these issues 176,177 .  
 
Another downfall of polynomial growth models is that individual higher order growth 
parameters (such as 01234=)	 and 01234Y)	), can be difficult to interpret, in particular 
in the presence of interactions. In polynomials GCM, the rate of change is assumed to 
be constantly changing and higher order polynomial terms can be interpreted as the 
change to the rate of change, which has little biological meaning. While larger 
absolute values of polynomial slopes indicate a more rapidly changing growth rate, 
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resulting in steeper curvatures in the trajectories 107, the estimated polynomial 
parameters do not have a direct interpretation in terms of the hypothesised change 
process, since the growth rate is constantly changing. Thus, interpretation is most 
often based on inspection of plots of average or typical individual growth curves 18, 
129, which allows a greater understanding of the estimated model parameters and how 
they relate trajectories of different groups of participants. 
 
Some strategies allow reparametrizing polynomial growth models so that the 
estimated parameters are interpretable and reflect important features of the growth 
curve178. That is, the initial level and times at which the individual reached their 
highest and lowest value for the response 158. When it comes to determining the 
optimal order of the polynomial for the measurement model (i.e. level 1 model), 
parsimony is necessary. A rule of thumb is that at least three data waves per subject is 
necessary to fit a quadratic within-person model, four for a cubic model and so on. A 
number of papers discuss formal ways to assess the significance of higher order 
growth parameters of polynomial growth curves fitted in LGCM 142 and in MLM115, 
as well as modeling strategies to include TVC and TIC covariates in higher-order 
polynomial growth curve models 75, 135, or in fractional polynomial growth curve 
models 173, 174 . 
 
When using age-term polynomials to describe the observed relationship between the 
response variable and age, the resulting growth model does not include any 
theoretical considerations about the underlying mechanism producing the data. The 
shape of the response is empirically determined, and the models are only designed to 
detect specific hypothesised overall trends in the time-series, beginning and ending at 
specified time points 82.  
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2.4.2 Latent basis growth models 
The latent basis growth model 25, also called shape-factor, unspecified 129, or freed-
loading 107, is a special case of LGCM, where no constraint is applied to the shape of 
the trajectory of the within-person response variable over time 117. It does not have an 
equivalent in the MLM framework. Because no specific functional form is used, this 
semi-parametric approach is very flexible and can adequately capture a range of non-
linear change patterns. The model can be written:  
 ()* = ,-.) + 01234). ^* + 4)*  (2.8) 
 
All parameters in 1.4 have the same interpretation as shown for equation 2.2, but in 
this case, ^*are known as basis coefficients. The main difference with the general 
LGC model resides in ^*, which unlike the factor loadings for the linear slope, are 
estimated from the data itself to closely represent the change process in the response, 
rather than fixed to progress in a linear manner. To be able to estimate the shape 
factor 01234), the convention is to set constraints for basis coefficients for at least two 
time points (e.g. anchor loadings), so that all coefficients in-between can be estimated 
freely (i.e. fix the first and last points and estimated ^=to ^*_A). If anchor loadings are 
set to ^A = 0	and ^`=1,  ,-.)	can be interpreted as the subject’s level in response at 
the first time point, and 01234), the total amount of change that occurred between the 
first and last time points (i.e. t=1 to t=T), but alternative formulations are possible 70. 
In this case, estimated basis coefficients ^=to ^*_A represent the proportion of total 
change that has occurred up to that point in time.  So, as in the LGCM model, the 
only parameter of change over time is 01234), but here it is not necessarily constant 
across time, as it changes proportionally with the basis coefficients. Unlike the 
polynomial growth curve models, one advantage of the latent basis growth model is 
that it is very parsimonious, regardless of how complex the non-linear shape of the 
outcome over time. As 01234) will always be the single parameter to describe 
between-person heterogeneity in the change process, it will have less degrees of 
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freedom than adding a quadratic or cubic slope to the model 117 . Because the time 
variable is scaled to achieve optimal model fit, the latent basis model will always be 
the best fitting model using SEM fit criteria. Latent basis LGCM are often used in 
case of balanced measurement occasions across the study sample, but they have 
recently been developed so they can be re-expressed to accommodate individually 
varying time scores70. However, SEM estimation of the basis coefficients remains 
computationally difficult if designs have many truly unique measurement occasions. 
Zhang et al. recently presented a Bayesian estimation of a latent basis trajectory 
model, which they compare with the traditional ML estimation of this model 123. To 
summarize, the latent basis growth model is extremely flexible in terms of response 
shapes, and parsimonious, but like the polynomial model, its parameters can not be 
interpreted in terms of what is known about the change of the outcome. Additionally, 
like any SEM model, the latent basis model can not be used for inference outside the 
sample’s study period 99, 117.  
 
2.4.3 Piecewise growth models 
A third option for modeling curvilinear growth trajectories over time is to break up 
the model into several linear or low-order polynomial segments to approximate a 
more complex underlying form 22, 67, 179, 180. The distinct ‘pieces’ or curve segments 
attach together at knot points, also called ‘transition points’, or ‘change points’, so 
that each segment represents a different phase in the development of the outcome 
over time, characterised by specific growth factors (i.e. intercept and slopes). 
Piecewise growth models are semi-parametric models that can be seen as a 
compromise between the restrictiveness of polynomials and flexibility of latent basis 
growth models. Because of many possible options in terms of the number of 
segments, the algebraic form of each piece, and the degree of smoothness at the 
change points, piecewise growth models are able to model many non-linear processes 
181. Piecewise growth models can be fit in the LGC and MLM frameworks that like 
polynomial trajectory models, appear to slowly converge in their capabilities, due to 
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the development of methodological extensions 99. The choice of framework and 
estimation method ultimately depends on how one wishes to treat the knots in the 
model.  
 
Depending on the area of application, piecewise change models are also known as 
multiphase, linear spline, broken-stick, change point models or segmented growth 
models 25, 83, 103, 181, 182. Piecewise growth models are particularly useful if there is an 
interest in contrasting change rates between different periods, potentially separated by 
a theorised known or unknown data-driven transition point 21, 24. Indeed it assumes 
approximately linear change over limited periods of time, piecewise regression 
readily allows the estimation and comparison of growth rates in different periods 
marked by either an expected transitional change, or an experimental intervention 
point 24. The model can also be easily extended to accommodate multiple piecewise 
segments and multiple nodes for complex longitudinal profiles 25.  
 
The simplest piecewise growth model is the linear-linear broken stick trajectory 
model, also known as two-segment linear spline model. Although alternate 
parameterisations are possible, a commonly used formulation can be written:  
 ()* = ,-.) + 012341). . −	QZ) + 012342). . −	QZ) c+	4)*           (2.9) 
 
Where ()*, is the repeated-measure response vector for participant i and 4)* the 
residual error at each time point. The subscript “+” is an indicator function with . −	QZ) c = (. − QZ)) for t >QZ) and zero otherwise, so that 012341) is the 
common linear slope for individual i, 012342) is the deviation from the initial 012341) 
(i.e. slope in second segment is equal to: 012341) +	012342)), QZ)	is the individual-
specific transition point between the two linear phases, and 	,-.) is the overall 
intercept for individual i (i.e. overall response level across all measurement 
occasions). As shown for the other models above, each intercept, slopes, and change 
point parameter have their own means and (co)variances (in the case of the linear-
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linear piecewise model with random change points, defined a 4 x 4 full-covariance 
matrix99), which can be estimated to investigate average and (co)variation between 
identified aspects or phases of the trajectories70,183.   
 
Piecewise growth models can be used to model outcomes that are characterised by 
documented multiple-phases of growth or development across different life-stages, as 
the model naturally maps onto what is known about the development of such 
outcomes over age163,28, 83, 161. They are also particularly useful if there is a shift in the 
outcome trajectory at some point in the event window, such as an acceleration or a 
deceleration in the change rate of the outcome from one point in time (or age) 83, 180, 
181, 184, 185. Authors have noted that well-fitting polynomial MLM models estimating a 
non-linear curve can be very useful to describe the average pattern of growth and to 
assess the relationship between early exposure and later growth. However, they are 
not conducive to exploring associations between growth and later outcomes, or for 
comparing growth across populations since the polynomial terms (and their 
associations with other variables, especially time-varying) are not easily interpreted 
83, 103. In particular, in applications concerned with determinants and consequences of 
healthy growth and development across different periods in the life course, linear-
spline MLM is a useful approach to derive individual summary measures of growth. 
Linear-spline MLM models overcome several issues such as collinearity of repeat 
measures and bias due to missing data175,83 .Linear splines (linear piecewise 
regression) are the simplest possible type of splines where two or more linear 
segments are joined (smoothly or not), but more complex non-linear splines (i.e. 
piecewise polynomials) are also possible both in the frequentist and Bayesian GCM 
framework. The use of such complex splines function in MLM growth modeling 
includes notably cubic splines 161 and extended splines functions186. 
 
In equation 1.5, we presented the most general, but also most complex, form of the 
linear-linear piecewise growth curve model, where the change point is subject-
specific. In some applications, the change point might be treated as an a –priori 
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known parameter, determined by existing knowledge on the system being studied 163, 
187. Sometimes, the aim of the model is precisely to estimate the time (or age) at 
which the transition occurs in the outcome trajectory over time. In cardiometabolic 
research, piecewise growth MLM models with predetermined transition points have 
been used to model BMI profiles from pre-pubertal age to adulthood 163, 187. The 
piecewise growth model is particularly suited to model several typical features of 
normal BMI development across the life-span, such as the rapid linear growth in 
middle-childhood until people reach their asymptotic adult sizes 188 , followed by a 
markedly slower increase rate past that point in time 188 that markedly decelerates 
after puberty once people reach their adult sizes163, 189. Because relevant and 
meaningful aspects of BMI change are directly incorporated as model parameters in 
the piecewise growth model, the points of interest in the trajectories can be retrieved 
in one-step, and the researcher does not need elaborate mathematical techniques to 
derive interesting aspect of growth post-hoc. To illustrate the retrospective way to 
retrieve meaningful aspects of change in outcome over time a posteriori using a more 
traditional GCM approach, Wen et al. 2012 used a fractional polynomial approach to 
model individual BMI growth trajectories from infancy to 18 year. As fractional 
polynomial coefficients do not have a straightforward interpretations in terms of the 
BMI age-curves, the two childhood turning points of BMI profiles (infancy peak and 
adiposity rebound milestones) were determined a-posteriori based on a change of 
signs in the first derivative of estimated individual BMI-levels over a range of 
possible ages, which represented the velocity at each measurement occasion 165.  
 
Piecewise linear trajectory models have been used to model developmental processes 
with fixed known change points in the frequentist MLM 23, 67, 106, 190 and SEM 107, 129, 
148, 185 frameworks, mostly in fields such as education, psychology and intellectual 
development 191. Other applications have focused on estimating the change point 
location in time, notably for the monitoring of longitudinal biological markers where 
shifts in the outcome trajectory are considered potential indicators of diseases such as 
Alzheimer, dementia, and some cancers 154, 192, 193. In the MLM framework, 
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estimating the unknown (fixed or population-level) change point is well-established, 
and usually achieved by profiling the log-likelihood over a search grid of possible 
change points 190, 192, although Bayesian methods can also be used. Some recent work 
compares the traditional ML and Bayesian estimation methods for a range or 
piecewise growth models with estimated fixed change points182. In the LGCM 
context, recent papers have also demonstrated techniques to estimate population-
average change points 159, 180. An interesting approach used to select and derive the 
number and position of knot point for modeling BMI development across childhood, 
was to use fractional polynomials to derive a smooth function for the curve and then 
use the derivative of this curve to decide the position and number of change point for 
the piecewise function 101, 194. Other options include starting with a large number of 
knot points and gradually reducing the number until a ‘smooth’ curve is achieved 83, 
to place knot points at the centiles of the distribution of age, or use stepwise 
regression where there is statistical evidence of a difference between linear slopes 
either side of the knot point195. Subject knowledge of the underlying biology of 
growth parameters may also help in the choice of change point positions, as does the 
availability of the data (i.e. frequency and intensity of data collection; studies with 
few measurement occasions may only be able to place knot points at the mean age of 
each data collection)175. Howe et al. 2013 present a very useful suggested workflow 
for the application of linear spline MLM growth models 83. 
 
In contrast, segmented growth models with subject-specific (i.e. QZ) in equation 1.5) 
rather than population-averaged change points, are relatively novel and technically 
challenging, and are the object of ongoing research in the MLM and LGCM contexts. 
This extension of the piecewise growth model is crucial as it allows individuals to 
make the transition from one phase to another at different ages or, depending on the 
design, after different lengths of receiving the treatment or intervention. Between-
person heterogeneity in the timing of the transition between growth-phases is 
expected in many normal or pathological development processes  (e.g. inter-
differences in age at puberty, differences in age at which cognitive decline 
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accelerates) 154, 196. However, it complicates the model estimation greatly. Between-
person variability in the timing of the change point between segments was first 
considered in the MLM framework, by treating the knots as random coefficients in 
the model 181. In the general broken-stick piecewise growth model (i.e. linear-linear 
piecewise model), the absence of a gradient between the successive pieces results in 
an undefined derivative at the change point making it notoriously difficult to account 
for random knots using classic likelihood methods 184,190 . Until recently, piecewise 
growth models with random knots have been investigated mostly in a Bayesian 
perspective 197, notably in AIDS research 198, 199, cognitive decline and dementia154, 
200, 201. In the Bayesian context, Congdon 2001 present a thorough presentation of the 
inference and estimation of piecewise mixed effect model for panel data125. 
Considering a smooth transition, rather than an abrupt one, between the different 
phases of the trajectory has allowed, in some cases, the traditional ML burden of 
estimation to be overcome 154. However, due to its great flexibility and performance 
at estimating numerous random effects, Bayesian inference still remains popular to 
estimate a range of ‘bent-cable’ segmented models with smooth transitions functions 
for the change point, such as the smooth polynomials, and Bacon-Watts random 
change point models 153, 202. Beyond offering numerical advantages for model 
estimation, smooth random segmented growth models may provide a better 
representation than the broken-stick model, in cases where an abrupt transition 
between growth phases is not biologically plausible for the outcome. However, 
smooth random change point models generally require more time points, and if the 
data around the real change-point is sparse, the smoothing terms might not be 
identified or biased 197, 202. Unless data consists of many available measurement 
occasions per subject, which is rarely the case in fixed occasions prospective cohort 
studies, it is advisory to consider the (random) broken-stick growth model and avoid 
smoothed parameterisations of the model. Recent papers have also developed a 
method to estimate segmented mixed models with random change point 184 in the ML 
framework 203. 
 
Literature Review 
 
 82 
While a few applications showed how to estimate the change point in the SEM 
framework, until very recently, it was not possible to estimate subject-specific change 
points in piecewise LGCMs due to the coefficients entering the model non-linearly. 
Preacher and Hancock 2015 204 demonstrate a novel method that allows estimation of 
knots as random parameters in the segmented LGCM model in a study sample where 
the complete data was balanced (i.e. relatively low maximum number of possible 
measuring occasions across the sample). Although promising, the method is complex 
and involves reparametrizing the model, approximating the function by a first-order 
Taylor series, and treating the resulting problem as a standard linear model that is 
estimable via SEM. In consequence, when the sampling occasions are truly 
individual-specific, or when they are many missing measurement occasions due to a 
sequential cohort data structure, most authors advise to fit the random change point 
segmented growth model within the MLM framework using Bayesian inference.  
 
To sum up, the piecewise growth model with or without random change points are 
very flexible models to represent non-linear change over time and are often preferable 
to more general non-linear continuous model (such as polynomial) if the number of 
measuring occasions is small 67. Although computationally demanding, random 
change point models are easily fit as Bayesian multilevel (hierarchical) models. 
 
2.3.4 Exponential and other non-linear Growth Curve Models 
As opposed to growth curve models illustrated so far (polynomial, latent basis, and 
piecewise growth models), the ‘non-linear’ growth curve models that will be 
discussed in this section refer to growth curve models that follow specified 
mathematical parametric functions to represent non-linear patterns over time. An 
example of algebraic non-linear functions is the exponential growth curve, which has 
been used successfully to model development in language acquisition and cognition 
using a number of modified formulations, notably a dual increasing-decreasing 
change over age. 205-207. Several formulations of empirical sigmoid (s-shaped) curves, 
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such as Brody, Weibull, Verlhust, logistic, Van Berthalanffy, and Gompertz functions 
have been used for decades by population ecologists and microbiologists to model 
processes characterised by an initial period of slow growth, followed by a rapid 
growth phase and a decelerated growth when the system under study approaches its 
maxima or carrying capacity 208, 209. In such sigmoid functions, the instantaneous 
growth rate is assumed to be proportional to the momentary system’s size and the 
fraction of resources that are still available in the ‘habitat’. Apart from biology and 
ecology, sigmoid curves have been used to describe change in processes such as 
progress in skill learning 205 in psychology and  are routinely used to model dose-
response curve in pharmacodynamics and pharmacokinetics 80, 210, and in medicine to 
describe tumour growth 211. However, they are still rarely implemented for the 
analysis of longitudinal data within the growth-modeling framework 170, 212. The few 
examples of the use nonlinear functions in growth curve modeling are confined to the 
fields of psychology and cognition 207. In epidemiology, an example of such models 
is one Australian study that used a double logistic function of time to represent the 
change in HDL cholesterol over time in a sample of peri-menopausal woman 
measured yearly up to five times as they passed through menopause213. 
 
In the MLM framework in particular, two authors have contributed to the 
development of  a number of nonlinear mixed models for repeated measure data 80, 
127. In the growth modeling literature, authors further distinguish non-linear growth 
curves based on how the random coefficients (or latent variable) enter the model. In 
additive non-linear (or partially non-linear) models159, subject specific growth 
parameters are linear in the growth model, while in multiplicative (or fully non-
linear) growth, the random effects are non-linear 214. Consider an additive logistic 
growth model of the form:  
 ()* = ,-.) + 01234). ( AAc<de.(fdg)) + 4)*  (2.10) 
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Where, ,-.)	and 01234) are the lower and upper symptote respectively (if the 
estimated rate of change ^	is positive), and G is the time at which ^	reaches its 
maximum (i.e. infection point). In this model, the expected outcome values ()* for 
subject i are obtained by summing the participant’s random coefficients (i.e. ,-.) and 01234), with means, variances and covariances as in 1.3) each multiplied by a 
function of time  (here AAc<de.(fdg)	) that is invariant across subjects.  In contrast, in the 
multiplicative logistic growth curve models, the rate of change varies between 
individuals (i.e ^ becomes ^)) and the model formulation multiplies two random 
effects (i.e. 01234). ( AAc<deD. fdg )).   
 
Additive non-linear models can be estimated in most MLM and LGCM software, but 
because a single person-specific parameter (i.e. 01234)) controls two distinct aspects 
of change (rate and total amount of change), 01234)	can be counfounding random 
parameter. Multiplicative non-linear models, although more flexible, can also 
constitute a non-trivial complication for model fitting due to the multiplication or 
division between parameters, and need to be solved numerically since they generally 
lack analytical solutions. Not all MLM or SEM software can handle the estimation of 
non-linear random effects, which require a number of approximation methods. 
Grimm and Ram provide an in-depth discussion on the matter, as well as code 
examples to fit a number of sigmoid growth curve models of both types of growth 
models in LGCM and MLM frameworks using Mplus and SAS PROCNLMIXED, 
which use a number of fitting algorithms 79. In R, non-linear mixed effect models can 
be fit in R using the nlme or lme4 packages, that use an adaptive Gauss-Hermite or 
Laplace approximation to the log-likelihood114, 127. The use of build-in non-linear 
mixed models in these R packages remains quite restricted, with model 
parameterisations that are not necessarily appropriate for non-linear growth curve 
modeling. Notably, some popular build-in functions in these packages do not offer to 
model individual initial response level as one of the model parameter, which can 
prove problematic when fitting non-linear growth models where this parameter is of 
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biological interest. A piece of code showing how one can custom-build self-starting 
functions for the estimation of popular non-linear Gompertz and Richards Growth 
curve models in Ris shown in Appendices 2.1. Compared to similar functions 
implemented in nlme or lme4, the model parametrisation in these custom-build 
functions allows the estimation of the starting level in response as an additional 
trajectory parameter. In Appendix 2.2, a second annotated piece of code illustrates 
how these custom-build functions can be used in practice to estimate both the 
additive and multiplicative form of a given model using simulated sequential-cohort 
data.  
 
Bayesian estimation of such non-linear models is also possible 207, 215, and the 
incorporation of prior information or knowledge into the model has proved 
particularly beneficial in non-linear growth modeling when sample sizes is small. 
 
To summarize, an advantage of non-linear growth model is that there are many 
possible functional forms so that various complex patterns of change are able to be 
modeled (i.e. see the FlexParamCurve package in R that allows to select the best 
fitting non-linear form among an array of 36 possible monotonic or non-monotonic 
non-linear models based on double-Richards curves 216). Because they aim to model 
the mechanisms giving rise to the observed data, non-linear growth curve models 
allow extrapolating beyond the observed conditions. Additionally, non-linear GCM 
generally use fewer parameters than competing linear models, such as polynomial 
GCM , giving a more parsimonious description of the data, and their parameters are 
most often easy to interpret since they inform different aspects of the change process. 
For example, the key parameters used to describe sigmoid curves include the rate of 
acceleration, the lower and upper asymptotes, the location of changes and the degree 
of symmetry in the acceleration and deceleration 79. One of the disadvantages of non-
linear GCM is that the fitting process is iterative in nature and usually more complex 
than for linear GCM models 80. Convergence issues may arise, particularly with 
complex-shaped models and multiplicative random effects, and one needs to have an 
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a-priori idea of values of each growth parameter to allow the model to be estimated 
(i.e. starting values of parameters). Non-linear GCM are also fundamentally 
mechanistic, in that they allow for testing specific theory-based hypotheses about 
change, that is the shape of the response over time is not obtained from the data itself 
as in other methods, but rather imposed onto the data217. While in psychology and 
development the expected functional form of many longitudinal processes have been 
well characterised and studied (e.g. the 8 parameters Berkey-Reed 1st order function 
of age 218 or the 5 parameters  Preece-Baines models219 to represent post-natal human 
growth in weight and height). In many situations, epidemiologists may not have any 
prior knowledge or idea on the nature of the change process they intend to model, so 
have no reason to choose one particular mathematical non-linear function over 
another28. It can prove useful, however, to consider familiar non-linear functions for 
growth curve modeling when exploring the shape of the response over time. A 
limitation for using non-linear GCMs in long-term observational studies might be the 
number of measurement occasions and the number of available repeated measures per 
participant. Non-linear models need, in general, more data than linear models, and as 
there can be many random coefficients, it can become difficult to distinguish between 
different change components when the measurement occasions are sparse 79, 80. 
Unstable estimates due to overfitting are a common issue when trying to fit such 
complex models to sparse data 80.  
 
2.5 Group-based approaches: Growth Mixture and Latent Class 
Growth modeling 
This section considers a second and increasingly popular framework for trajectory 
modeling that allows the identification of multiple unobserved sub-populations, the 
description of longitudinal change within each unobserved sub-population, and the 
examination of differences in change among unobserved sub-populations. In section 
2.4.1 group-based approaches to GCM are introduced, and basic elements of the 
standard Growth Mixture model briefly reviewed in section 2.4.2. 
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2.5.1 Introduction to group-based Growth Curve Models 
GCM approaches discussed so far, MLM and LGCM, have the same central 
underlying assumption that all individuals come from a single intrinsically 
homogenous population with common trajectory parameters. That is, that they follow 
the same basic pattern of change in outcome over time with random variation about 
that pattern 5, 99, 130. These approaches are sometimes referred to as “ person-based” 
Growth Curve modeling approaches, since their main feature is the ability to model 
individual trajectories for each subject for the outcome over time. As discussed in the 
previous sections, in classic growth curve modeling the shape of the response profile 
is forced to be the same for every subject in the population, and determined either by 
existing theory, or by empirical model building. These methods thus assume average 
trends and express variation in terms of variance around the average response in the 
population (i.e. with any between-person heterogeneity in these trajectories being 
absorbed into random growth parameters)120,129. MLM and LGCM allow one to test if 
the predictors are associated with some aspects of the change in the response (e.g. is 
lower parental education associated with higher sex-and age-specific BMI z-scores at 
baseline). If the focus is on comparing how response profiles vary between known 
groups of subjects determined a-priori (e.g. sex or grouping based on a distal 
dichotomous health outcome), the grouping variables are often also treated as 
predictors of the different growth parameters. Doing so, part of the subject-to-subject 
variability in different aspects of the change over time is then explained by belonging 
to one or the other group (e.g. when compared with a reference group, one group may 
have steeper increase in the response over time). The group variable thus serves to 
shift the marginal means of the different parameters describing change over time (i.e. 
intercept, linear change), allowing the description of group-specific prototypical 
growth curves 21, 97, 107. 
 
In contrast, group-based trajectory modeling approaches have been developed 
considerably in the last decades to provide a different set of tools to disentangle 
population heterogeneity and move beyond a ‘one size fits all’ approach to describing 
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developmental and change processes across the lifespan 220, 221. Group-based 
modeling approaches include Growth Mixture Model  (GMM), Latent Class Growth 
models (sometimes called Latent Class Analysis (LCA) or Latent Class Growth 
Mixture models (LCGMM)), and semi-parametric clustering analysis 26, 97, 222. The 
main goal of these three methods is to identify trajectories for two or more latent 
classes representing sub-populations hypothesised to exist within the sample, but that 
can not be observed by direct measurement 223. Although substantial differences exist 
between these methods, they assume heterogeneity in the response profiles in the 
population 26. Also, they consider that the study sample is composted of a finite 
number of unobserved, latent categories characterised by similar developmental 
responses, and that each subjects belong to only one of these latent classes. Instead of 
subject variation about a single mean growth curve, the growth mixture model has 
different classes of individuals varying around different mean growth curves 221, 223. 
These methods thus different developmental pathways to be identified from the data 
itself and allows subjects to be assigned to one of the identified trajectories based on 
their individual profiles. 
 
In Latent Class methods (i.e. Latent Class Growth Modeling  / Latent Class 
Analysis), while different trajectories are identified for a number of classes, subjects 
within each class are assumed to have identical intercept and slopes (i.e. no within-
class variability around the estimated class-specific trajectories)224, 225. In contrast, 
within-class variations are allowed in the estimation of class-membership in growth 
mixture modeling (GMM), allowing for more heterogeneity within-class226, 227.  In 
that sense, Latent Class models can be considered a special case of GMM where all 
within-class variations are constrained to zero 28. Due to this absence of random 
effect in the underlying trajectory parameters, Latent Class models are sometimes 
considered semi-parametric models, and the approach has been recommended as a 
way to generate starting values for more complex Growth Mixture models 228, 229 . 
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2.5.2 Formulation of the basic Growth Mixture Model 
The most simple GMM as defined by Muthen 230 can be written as follows:  If N) = (	(A), (=), …, (`)) denotes the longitudinal sequence of observations for participant i 
over T occasions, let P(N)) be the unconditional probability of the sequence N); Pk(N)), 
be the probability of N)		given membership in class k; and hi, be the probability of a 
randomly chosen participant of the population belonging to class k. The unconditional 
probability of the observed data N) is: 
 Z N) = hijikA Zi(N)) (2.11) 
 
where the group membership probabilities hi are constrained by hijikA = 1 .This 
is the sum across all K classes of the probability of N) given participant i’s 
membership in class k weighted by the probability of membership in class k. 
Categorical latent variable l) represents the unobserved sub-population membership 
for subject i, with	l) = 1,2, … , m and where c is the latent class (or trajectory class) 
variable. The growth parameters and the class membership	l) can also be influenced 
by covariates. Here, time-invariant covariate x is considered, and a multinomial 
logistic regression model is used to predict the latent class variable c by the covariate 
x for each of the K classes. 
 Z l) = n|p) = <qCrsqErtD<qCusqEutDvuwE   (2.12) 
 
The GMM considers separate growth models for each of the K latent classes with 
difference in all possible trajectory parameters (i.e. fixed effects of intercept and 
slope(s)). It can also be extended to predict a categorical distal outcome where the 
latent trajectory class is used with the covariate x to predict the outcome by the means 
of logistic regression.  
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A particularly attractive feature of this group of methods is that the influence of 
covariates or predictors can be considered in a number of ways. For example, as part 
of each participant’s profile description, as predictors of class membership, or as 
predictors of growth parameters for each class. 
 
Firstly, identifying characteristics that make trajectory group members distinct form 
other trajectory groups can be done using posterior probabilities of class membership. 
These probabilities represent a measure of a participant’s likelihood of belonging to 
each of the k classes of trajectories. Posterior probabilities of class membership are 
computed post-model estimation, using the coefficient estimated when fitting the 
GMM 220.  For a given model, each individual obtains a posterior probability estimate 
for each latent class computed as a function of the model parameter estimates and 
each participant’s observed values using Bayes’ theorem225. For each individual, the 
kth class with the highest posterior probability determines the individual’s likely 
trajectory class membership. This measure can also be used to access the 
discrimination of a given model to see if the model clearly differentiates in which 
class participants belong. Ideally, average posterior probability of at least 0.7 for all 
groups indicates that the model provides good class discrimination 225 . These 
measures of class membership can be used to investigate the subject-level 
characteristics, which may be associated with belonging to one or the other trajectory 
group, allowing to “profile” people within each group. This can be particularly useful 
in trying to determine determinants that will identify people most at risk for following 
deleterious trajectories of risk factors or health markers over time 226, 231, 232. 
 
Secondly, the GMM and latent class models can include both TICs and TVCs 
covariates, where they act as adjustments to the intercept or interaction with the slope 
parameters 225,233.  
 
Thirdly covariates can be introduced as predictors of trajectory group membership by 
the mean of a multinomial logistic regression model specifying the functional 
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relationship between the probabilities of class membership hi for the kth group of K 
groups, and a set of M predictors px), estimated simultaneously with the trajectory 
parameters 118. The probability of belonging to class k can be defined as: 
 Z l) = n|px) = <qCrsqErtEDs⋯sqzrtzDs⋯sq{rt{D<qCusqEutEDs⋯sqzutzDs⋯sq{ut{DvuwE   (2.13) 
 
Where the logistic regression parameters |xj are set to zero for the last class K (i.e. 
the reference class). 
 
For k=1: 12V }E		(~zD	)}	(~zD	) = 	 4ÄCEcÄEE~EDc⋯cÄzE~zDc⋯cÄ{E~{D  (2.14) 
 
2.5.3 Aspects of Growth Mixture Modeling and recommendations 
The identification of predictors of group-membership is a particularly interesting 
feature of this class of models for cardiometabolic research, since it can potentially 
inform prevention intervention. For example, it allows investigating whether parental 
obesity is associated with the probability of belonging to BMI trajectory groups with 
differences in overweight/obesity onset mechanisms over time. There has been 
discussion in the literature as to whether TIC covariates should be included in the 
trajectory part of the model or the logistic prediction of group-membership part. In 
general, when trying to include these predictors in both, the variable becomes a non-
significant contributor of group membership, such that covariates in the predictor part 
of the model should be restricted to those measured at baseline only 233 225.   
 
A frequent critique of group-based approaches to growth curve modeling is that 
different model specifications of the within-class random structure can lead to very 
different models derived in terms of the “best” number of growth mixtures, their size, 
and their composition. In general, more latent classes will be required to represent the 
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population heterogeneity when fitting Latent Class compared to Growth Mixture 
models 226, 231. When possible, the underlying random structure in these types of 
models should be informed by, and understanding of, the underlying cause of 
variation. It is thus necessary to note that the results of such methods must be 
interpreted with caution, and in full knowledge of how the model was specified, 
especially since the nomenclature used to describe the modeling approach can be 
confusing or misleading. 
 
There are a number of statistical indices that were developed to select the ‘best’ 
Growth Mixture model 227 221, 223, 234 . The methods used to determine the number of 
classes which best represent the data for frequentist models include the likelihood 
ratio test 235, the BIC that captures competing models parsimony by adjusting the 
likelihood by the number of parameters and sample size, the Lo-Mendell-Rubin 
likelihood ratio test 236, and the bootstrap Likelihood Ratio Test (BLRT) 237. Although 
simulations studies indicated that the BLRT and BIC are the most reliable methods to 
assess GMM models 227, their usefulness is sometimes limited in practice, in 
particular in situations where these indices indicate that increasing the number of 
classes past 6 or 7 keeps improving model fit 28. In general, many authors recommend 
that researchers need to draw a balance between model complexity and 
interpretability, since the selection of the optimal model is not always 
straightforward.  
 
In summary, although a number of theoretical and technical issues may arise with 
group-based approaches to trajectory modeling, compared with methods that assume 
that all subjects follow the same functional form (i.e. person-based MLM and LGCM 
growth curve models), partitioning the variability in this way may allow for a better 
understanding of change in response over time and provide another means of 
detecting critical periods, which can complement the classic individual-based 
approach to growth curve modeling. Indeed, person-based trajectory modeling such 
as Latent Class Analysis, or Growth Mixture modeling may reveal the existence of 
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potential sub-categories within a population that one may not have been able to detect 
when the grouping of the curves was determined a priori. In cardiometabolic 
research, group-based approaches to trajectory analyses have allowed epidemiologists 
to study the potential heterogeneity in the development of BMI to identify different 
mechanisms of obesity incidence and their determinants in a number of populations. 
In particular, several studies have prospectively explored BMI trajectories in the 
periods of early childhood crossing over adolescence, using raw BMI, or BMI z-
scores 238. This approach provides an opportunity to identify distinct underlying 
mechanisms of obesity resolution in the population (i.e. early onset resolution vs. late 
onset resolution), which were not feasible using traditional MLM or LGCM 
approaches. Being able to identify distinct age-related trajectories among incident 
obese or resolving obese subjects is crucial, especially if predictors of latent class 
membership can be determined. This could help identify children at higher 
probability of becoming obese at earlier or later points in life, which may further help 
refine and target obesity interventions suggested by the individual-based GCMs.  
 
In addition, since it provides an empirical means of identifying clusters of individuals 
following both typical and atypical courses of risk factor development, the analysis of 
developmental outcome trajectories using a group-based method may be used as a 
confirmatory approach to judge the appropriateness of the subject-based GCM 
strategy (i.e. MLM/LGCM models). Even in situations when the primary interest 
might lie in contrasting outcome trajectories between groups based on predetermined 
groups of participants, the group-based approach can be used to assess the 
concordance between estimated latent trajectories and those modeled in the groups of 
interest, as well as get a sense of whether the chosen functional form in the GCM can 
be used to describe all trajectory groups 226, 231. 
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2.6 Summary  
This chapter has provided the methodological foundation and background of this 
thesis. It reviewed specific aspects that pertain to Growth Curve modeling of 
continuous longitudinal outcome data arising from long-running cohort studies in 
epidemiology. More specifically, the difference between person-based and group-
based growth curve modeling approaches, and the different techniques that allow 
estimating these types of models was reviewed. A number of modeling strategies that 
accommodate for potential non-linear responses over time within-person (or age) was 
presented within each framework, as well as critical aspects of study design and 
specific research questions that should be considered to guide the choice of modeling 
approaches in different practical situations. In particular, when the continuous 
response data arises from accelerated cohort designs with less than 10 repeated-
measures per participants, Table 2.1 and 2.2 provide a visual summary of the type of 
analyses, advantages and drawbacks of each Growth Curve modeling approach 
reviewed in this chapter. 
  
 
In addition, by (1) Identifying, reviewing and compiling the key technical difficulties 
and issues that remain when implementing the different existing growth curve 
modeling strategies to sparse continuous longitudinal data, such as those arising from 
long-term observational studies, and by (2) showing the lack of appropriate 
methodology to investigate group-divergence in non-linear trajectories of continuous 
response overtime, this chapter introduces the specific aims that the thesis will be 
addressing (aims 1 and 2), i.e. the tailoring, extension and modification of existing 
growth curve modeling theory for the analysis of accelerated longitudinal designs or 
multi-cohort studies, and the development of a novel statistical tool approach to 
identify the point in the life course at which participants from different groups of 
interest start to diverge in their non-linear trajectories of continuous response 
overtime.” 
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Table 2.1. Summary table of applications, statistical assumptions advantages and drawbacks of person-based Growth Curve 
Modeling approaches reviewed in Chapter 2  	 Applications	 Features/Assumptions	 Framework	 Form	of	change	 Advantages	 Disadvantages	
Pe
rs
on
-b
as
ed
	G
ro
w
th
	C
ur
ve
	M
od
el
in
g	
-	Estimate	inter-individual	variability	in	intra-individual	patterns	of	change.			-	Find	determinants/	predictors	of	between-person	difference	in	response	profiles.		-	Test	the	association	between	individual-or	group-specific	change	in	outcome	over	time	and	realisation	of	a	binary	health	outcome	in	later	life	(i.e.	one-step	analysis	(LGM)	or	two-step	analysis	(HLM/MLM)).		
-	Estimates	individual	and	population-average	trajectories.		-	Possible	to	model	simultaneously	trajectories	in	multiple	a-priori	groups	(e.g.	sex,	family	history).		-	‘Initial	status’	and	‘change’	modeled	as	growth	parameters	(HLM)	or	latent	variables	(LGM)	(i.e.	intercept/slopes),	and	can	be	related	to	predictors.		-Specific	form/shape	of	time-	or	age-related	change	is	determined	empirically	from	data	(population-average	response).		-	All	persons	in	the	population	assumed	to	follow	the	same	pattern	over	time	(i.e.	heterogeneity	around	average	curve	captured	by	random	effects).		-	All	person-based	models	can	be	estimated	in	the	frequentist	or	in	the	Bayesian	framework.		-	Handle	ignorable	missing	data	(MAR/MCAR).		
Latent	
Growth	
Modeling,	
(LGM)	(special	case	of	Structural	Equation	Modeling)		-	Requires	outcome	measured	approximately	at	the	same	age	for	all	cohort	members.		
OR:		
Hierarchical	
/Multilevel	
Linear	
Modeling		
(HLM/MLM)	
	-	Easily		handles	unbalanced	time-spacing	data	structure	and	dependency	among	observations.			-	Best	
Polynomial	
Growth	
Curve	
-	Very	flexible	to	model	a	range	of	complex	non-monotonic	within-person	profiles	over	time.		-	Useful	to	explore	the	non-linear	shape	of	the	response	among	groups	of	interests.		
-		Polynomial	coefficients	difficult	to	interpret	biologically.		-	Poor	fit	at	the	extreme,	numerically	unstable	if	the	pattern	of	change	is	complex.		-	Does	not	allow	a	direct	estimate	of	age	at	divergence	between	groups.	
Non-linear	
Growth	
Curve	
-	Many	forms	to	choose	from,	including	complex	semi-/non-parametric	functions	(such	as	splines).		-	Common	non-linear	functions	can	adequately	represent	asymptotic	change	within-person	over	time		-Easier	to	interpret	than	polynomial	GCMs.		
-	Larger	number	of	repeated	measures	per	person	(>10)	needed	to	fit	most	curves	(many	estimated	parameters	per	person).		-	Convergence	issues	common.		-	Choice	of	form	must	be	guided	by	biological	knowledge.	Can	only	model	monotonic	change	over	time.		-	Does	not	allow	direct	estimate	of	age	at	divergence	between	groups.	
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-	Time-independent	variable	predict	the	growth	parameters.	Time-varying	predictors	predict	observation	level-error	at	each	time	point.	
framework	to	estimate	Growth	models	with	cohort-sequential	designs.	 Piecewise	
Growth	
Curve	
	(aka:	linear	spline,	segmented,	broken-stick	growth	curve)	
-	Allows	modeling	multiphase	processes	using	meaningful	growth	parameters.	Possible	to	compare	growth	rates	at	different	periods.		-	Easy	to	interpret,	often	map	onto	known	aspects	of	outcome	development.		-	Fit	better	than	polynomial	curves	with	few	data	points.		
-	Computer	intensive.		-	Biological	theory	needed	to	guide	demarcation	of	successive	phases.		-	Approximate	estimation	methods	needed	if	change	points	between	successive	growth	phases	are	to	be	modeled	as	random	parameters	(i.e.	subject-specific	change	points).	
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Table 2.2 Summary table of applications, statistical assumptions advantages and drawbacks of group-based Growth Curve 
Modeling approaches reviewed in Chapter 2  
 Applications Features/Assumptions Advantages Disadvantages Type of models 
Gr
ou
p-
ba
sed
 gr
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th
 cu
rv
e m
od
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ng
 
 
 
- Identify distinctive 
subgroups (latent 
classes) a posteriori in 
the population that 
follow different change 
patterns over time. 
 
-  Estimate class sizes 
and participant 
characteristics within 
each trajectory class. 
 
- Identify predictors of 
latent class 
membership  (i.e. 
multinomial logistic 
regression). 
 
- Test whether class 
membership predicts a 
distal health outcome 
(i.e. logistic 
regression). 
 
 
 
- Estimates individual 
trajectories over time.  
 
- Mixture model: the study 
sample is a mixture of latent 
(unobserved) subpopulations. 
 
- Specific functional forms for 
different groups within the 
population are estimated from 
the data itself. Type of (non-
linear) change needs to be 
specified in advance (i.e. 
linear, polynomial, piecewise 
forms). 
 
- All group-based models can 
theoretically be fit in the 
frequentist and Bayesian 
framework (although 
Bayesian framework is less 
developed at present). 
 
- The probability of belonging 
to each latent class is 
generated for each subject.  
 
- It can handle ignorable 
missing data (MAR/MCAR). 
Suitable for cohort-sequential 
designs 
 
 
- Allows the 
identification of 
different 
developmental 
pathways in the 
outcome in an 
underlying population 
that would be 
considered as error 
variance in person-
based methods. 
 
- Straightforward to 
test association 
between patterns of 
change over time 
(latent classes) and 
distal outcomes in one 
stage. 
 
- Computer intensive.  
 
- Convergence is often an 
issue. 
 
- Model building is not 
straightforward: many 
increasingly complex 
models need to be run and 
compared.  
 
- Some degree of 
arbitrariness in model 
specification and difficulty 
to select the optimal 
model (despite several 
statistical indices that can 
be used to decide of the 
best model) 
 
- Need to draw a balance 
between model 
complexity and 
interpretability. 
 
- Different model 
parameterisations can 
result in very different 
interpretations (i.e. # of 
classes and composition). 
 
- Crucial to specify the 
random structure using 
biological understanding 
of causes of variations. 
 
(Latent) Growth Mixture 
model (LGMM) 
 
- Within-class variance 
estimated for each latent 
class. 
 
- Possible to compare 
different within-class 
variance structures. 
 
Latent Class Analysis 
(LCA) 
 
- Special case of LGMM 
with within-class variance is 
constrained to 0. 
 
- More latent classes than in 
LGMM are usually required 
to capture population 
heterogeneity since no 
random effects estimated for 
each class. 
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3. THE COMBINED EFFECT OF COMMON GENETIC RISK 
VARIANTS ON CIRCULATING LIPOPROTEINS IS EVIDENT 
IN CHILDHOOD 
 
3.1 Preface 
In this chapter, the aim was to demonstrate the applicability of person-based multilevel 
growth curve models specified as higher-order polynomial function of age to analyse non-
linear continuous responses across the life course with frequentist methodologies. This 
approach is useful in situations where there is no existing biological theory to guide the 
specification of the functional form of the response over time a priori. Individual-trajectories 
of circulating blood lipid levels from age 6 to 49 years old in the YFS cohort are modeled and 
the combined effect of identified risk alleles on the development of blood lipid trajectories 
from childhood- to adulthood are investigated. Specifically, this chapter illustrates how to 
examine the combined time-averaged and the time-dependent effect of GWAS-derived 
genetic risk scores on the atheroprotective HDL-C, and on LDL-C, and triglycerides (TG). 
Additionally, how to test for effect modification within the MLM framework is demonstrated 
by investigating whether the multigenic predisposition to adult dyslipidemia might be 
modified by the magnitude of BMI change from childhood to adulthood, used as proxy 
indicator of trajectory of lifestyle-related factors.  
 
In summary, in line with general aim 1 and 3 of this thesis, this chapter illustrates how careful 
implementation of MLM growth curve modeling can help gain insight into the complex 
influence of genetic factors on developmental trajectories of lipid protein. 
 
3.2 Introduction 
Cardiovascular disease (CVD) is the leading cause of death and a major health burden 
worldwide 239. Although modified by diet, obesity, lifestyle and other environmental factors, 
circulating lipoproteins represent a crucial partly heritable risk factor for atherosclerosis and 
CVD57, 240. Notably, elevated levels of total cholesterol and low-density lipoprotein 
cholesterol (LDL-C), have shown association with preclinical atherosclerosis in children and 
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adolescents 42, significantly contributing to adult atherosclerosis. LDL-C, in particular, plays 
a major role in the initiation and progression of atherosclerotic lesions 241, 242. The relevance 
of high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG) to cardiovascular risk 
has been extensively debated in the last two decades. Although recent findings have 
questioned the causal relationship between genetically-defined HDL-C levels and 
atherosclerosis 243, 244, numerous prospective and case-control epidemiological studies have 
reported an inverse association between HDL-C levels and the risk of CVD17, 245, 246. Low 
HDL-C is therefore considered an independent risk factor for an increased risk of coronary 
artery disease, although pathways to its potential antiatherogenicity, are still not well 
understood 247. High TG levels are markers for several types of atherogenic lipoproteins 
involved in atherosclerosis. In contrast to LDL-C, the epidemiologic evidence-base for 
elevated TG as a CVD risk factor is generally less clear 248-250. However, recent evidence 
suggests that genetically-defined plasma TG levels are associated with coronary artery 
disease risk, even after correcting for confounding effects due to LDL-C or HDL-C levels251. 
In light of these associations, managing dyslipidemia remains a continuing trend both in 
primary and secondary prevention and risk reduction of CVD worldwide252. 
 
While the greatest deviations from normal levels of lipoproteins are principally monogenic, 
the majority of adverse circulating lipid profiles arise as polygenic disorders with a 
substantial environmental component (e.g. diet, smoking, obesity)253. Although dyslipidemia 
is common, the complex interplay between various genetic and environmental risks that lead 
to onset and progression of the condition are still poorly understood. In the past 10 years, 
multiple genetic linkage analyses, candidate gene analyses, and large-scale genome-wide 
association studies (GWAS) have pinpointed a number of common genetic variants of 
candidate genes associated with inter-individual variation in plasma lipid levels 240, 254-259, 
indicating a genetic predisposition to dyslipidemia. Most lipid-associated SNPs (single 
nucleotide polymorphisms) are characterised by relatively small effect sizes, however some 
of the reported loci contain genes of clear biological and clinical importance, implicated in 
established mechanisms of lipoprotein metabolism 260. Because most individual risk variants 
only explain a small fraction of those traits’ heritability, the development of multilocus 
genetic risk scores that combine or accumulate the influence of validated susceptibility 
markers have proliferated in the hope of improving genetic CVD and other disease risk 
prediction 261-263.  
Chapter 3-The combined effect of common genetic variants on lipoprotein profiles from childhood to adutlhood 
 
 101 
 
Unfortunately, it is currently largely unknown whether reported lipid-associated risk alleles 
have any clinical relevance for a genetic predisposition to elevated adult or childhood lipid 
levels. With most GWAS leveraging cross-sectional samples from middle-aged adult 
populations, the relative contribution of these genetic factors to the early stages and 
development of dyslipidemia between childhood and adulthood remains poorly understood264 
265 266. Moreover, whether identified risk alleles or GWAS-derived genetic risk scores predict 
lipid trait levels at all ages or whether they are associated with the intra-individual 
progression of serum lipids over time is unknown. 
 
The combined time-averaged and time-dependent effect of validated genetic risk alleles on 
lipoprotein trajectories across the life course was examined in the YFS Study. Tikkanen et al. 
have reported population specific cross-sectional associations of 95 GWAS-derived 
individual SNPs with lipid levels in the Finnish cohort 267. However, no study to date has 
investigated the association between lipid genetic risk scores and the development of lipid-
trajectories across the life course at the individual level. The primary aim was to quantify the 
contribution of a multigenic lipoprotein score to elevated levels of the LDL-C (14 risk SNPs) 
and triglycerides (24 risk SNPs) as well as depressed levels of the atheroprotective HDL-C 
(38 risk SNPs) from childhood to adulthood. It was also investigated whether a multigenic 
predisposition to adult dyslipidemia might be modified by a lifestyle trajectory indicator such 
as the magnitude of BMI change from childhood to adulthood. 
3.3 Methods 
3.3.1 Participants 
The YFS tudy is an ongoing population-based prospective cohort that started in Finland in 
1980. It was designed as a collaborative effort between the five medical schools in Finland to 
investigate cardiovascular risk factors and their determinants from childhood to adulthood 62. 
A varying number of participants from the original cohort (consisting of 3596 children aged 3 
to 18 years in 1980) were measured through middle adulthood (maximum age 49 years) in 
2011 for numerous traits related to CVD development, and have as many as seven follow-up 
measurements (Tables A and B in Appendix 3.1, Figure B in Appendix 3.2). Among the traits 
measured at multiple times, serum lipoproteins (plasma concentrations of LDL-C, HDL-C 
and TG) were collected at baseline and all seven follow-ups. For this study, analyses of the 
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association between polygenic risk scores and circulating lipoprotein trajectories from 1980 
to 2011 were pursued. These analyses included up to 2442 participants for whom genetic 
information was available for each of 76 risk SNPs identified in the literature.  Participants 
reporting use of lipid lowering medication in 2001, 2007 and 2011 were excluded from the 
analyses (n= 7, 46 and 77 participants excluded respectively for the analysis of LDL-C, 
HDL-C and TG life course trajectories). Participants or their parents provided written 
informed consent, and the study was approved by local ethics committees (The Ethics 
Committee of the Hospital District of Southwest Finland) in agreement with the Declaration 
of Helsinki.  
 
3.3.2 Measures 
Blood lipid and lipoprotein measurements 
All serum lipid determinations were performed in duplicate on fasting samples using standard 
methods in the same laboratory. HDL-C was determined enzymatically after precipitation of 
very low-density lipoprotein and LDL-C with dextran sulfate 500 000 (Olympus System 
Reagent, Olympus Diagnostica, Hamburg, Germany) in a clinical chemistry analyzer 
(AU400, Olympus Optical, Mishima, Japan) 268. The concentration of LDL-C was 
determined indirectly by the Friedewald formula, so those participants with triglycerides  
>4.0 mmol/L (n=32) were not included in the LDL-C evaluation 269. Specific details on the 
lipid determination methods used in earlier 270 and later 61 follow-up studies have been 
published previously. To adjust for changes in kits and determination methods across study 
years, lipoprotein levels from early follow-ups were corrected to those measured in the most 
recent follow-up using correction factor equations, which were determined with linear 
regression analysis utilizing standardised principal component adjustment 61, 271. For each 
lipid, the specific calibrating equations and the dates at which analyzers and reagent suppliers 
changed along study years are presented in the Appendix 1 of 270 and in 271. HDL-C profiles 
were the focus of this study because measures of other HDL-C fractions were not available at 
all time points in the YF study sample. 
 
Adverse levels of lipoproteins (i.e. abnormally high LDL-C/triglycerides, and low HDL-C), 
which identify participants at increased risk of developing atherosclerotic CVD (normal risk 
vs. high risk), were defined using the National Cholesterol Education Program (NCEP) 
adolescent and childhood cut points (for participants under 19 years) 272 and NCEP adult-
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treatment panel guidelines (for participants 19 years old and older) 273.  The NCEP has not 
defined desirable and undesirable TG levels for children and adolescents, so high risk TG 
levels are classified using cutoffs suggested in AAP and AHA pediatric guidelines 274 . The 
cut points used to define ‘normal’ and ‘high risk” lipid levels are shown in Appendix 3.6.  
 
Genetic measures and genetic risk scores 
In the 2001 follow-up, a, subset of original participants (1,123 males, 1,319 females) were 
successfully genotyped using a custom Illumina BeadChip containing 670,000 SNPs, for a 
final list of 546,677 SNPs that passed quality control and allele frequency filters. The exact 
custom content of the probes, as well as initial clustering, filtering, and data exclusion are 
described by Smith et al. 260. Genotype imputation was performed using MACH275  with the 
HapMap haplotypes as a reference panel (phase II, release 22 CEU, NCBI build 36, dbSNP 
126). In the present analyses, we used 38 HDL-C, 24 TG and 14 LDL-C associated SNPs 
identified by genome wide meta-analysis conducted by the Global Lipids Genetics 
Consortium (GLGC) on 46 lipid GWAS carried out in over 100,000 European individuals of 
Caucasian descent 258. Three composite genetic risk scores (wGRSs) (LDL-C, HDL-C and 
TG wGRS) were constructed as the arithmetic sums of these 38 HDL-C lowering, 24 TG-
raising and 14 LDL-C raising alleles respectively, weighted by their effect sizes (in mg.dl-1) 
as established from a published large-scale meta-analysis 258, 263 (Appendix 3.5). To avoid 
redundancy and overlap of genetic information, in each lipid wGRS, only the SNPs that 
showed the strongest independent associations among the 3 lipid traits in the meta-analysis 
were included258. The variant rs9411489 was not included in the LDL-C wGRS because it 
was missing on the chip and not available in the HapMap 2 reference panel. For 
comparability of metrics and to estimate the wGRSs ability to discriminate between extreme 
lipoprotein phenotypes, participants were categorised into ‘high’ and ‘low’ genetic risk 
groups categories defined as the cohort-specific lower (25th percentile) and upper (75th 
percentile) quartile of each composite risk score variables (HDL-C wGRS, TG wGRS and 
LDL-C wGRS). In each case, the remaining 50% of participants, lying in the interquartile 
range, were classified as ‘medium’ genetic risk (Table 3.1).  Histograms of each lipid’s 
wGRS are presented in Figure A in Appendix 3.2. This approach is commonly preferred to 
case-control dichotomy when investigating the association between genetic factors and 
disorders implicating quantitative traits continuously distributed over the population (such as 
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dyslipidemia), because it increases the statistical power of testing the variants for 
association 276.  
 
3.3.3 Statistical analyses 
Association between longitudinal lipoprotein profiles and composite genetic risk scores 
The principal outcome was the association between the categorical polygenic risk score status 
(High vs. Low wGRSs) and longitudinal trends in HDL-C, LDL-C and TG levels from 1980 
through 2011. To determine whether sex and genetic risk group membership modifies 
average lipoprotein level or the growth parameters of the participants’ lipoprotein trajectories 
over time, individual growth curve analysis (IGC) was used. IGC is an advanced multilevel 
mixed effect regression technique that allows the simultaneous modeling of inter-individual 
differences in intra-individual systematic changes over time (i.e. repeated individual 
measurements) 18, 19, 23, 97. An IGC model comprises 3 main components: (A) the functional 
form of the response variable, which partitions and quantifies the variance across 
people and time, (B) the fixed effects (i.e. group-level predictors of change), and (C) the 
stochastic part of the model, which includes the random effects (i.e. individual effects on 
growth parameters), and the residual error covariance structure. While there is, in the 
literature, a few variants in the specification and the procedure of IGC model building 
(sometimes also referred to as ‘growth curve analysis’ (GCA)18), the modeling strategy 
suggested by Singer and Willett 23 was followed, with a few adaptations (see Appendix 3.8. 
for a step by step protocol of the modeling approach,  and explicit parametrisation of the IGC 
submodels).  
 
Prior IGC analysis, individual empirical growth plots and generalised additive mixed models 
(GAMMs) were used to explore the functional form (shape) lipid profiles across the life 
course in the YFS cohort 277 and inform the modeling procedure. For each lipid, the IGC 
analyses then consisted of testing several submodels as follow: (1) an unconditional mean 
(UM) model (i.e. null model), examining any difference in average lipid levels between 
individuals, (2) a linear unconditional growth (UG) model (with no group-level predictors), 
used as a reference to explore the functional shape of the lipid growth over time (3) two or 
more higher-order polynomial UG models to test if the lipid rate of change was accelerated or 
decelerated as subjects aged (i.e. curvilinear age-related change), (4) models for slope(s) 
variability, to test for random trajectory parameters between participants, (5)  a set of models 
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to assess the within-subject error structure of the best UG model to test if incorporating (a) an 
autoregressive structure with serial correlation, and (b) heterogeneity of  the residual error 
will improve model fit, and (6) a conditional growth (CG) model, where wGRSs, sex  and 
their cross-product are introduced as subject-level predictors of each growth parameter 
variability (i.e. intercept, linear -, quadratic- and cubic (and quartic) growth). CG models 
allows assessing average wGRSs effect effect at baseline and whether or not there was an 
age-dependent effect of wGRS score on each lipid’s trajectory parameters  (i.e wGRS*age, 
wGRS*(age)2,…) . CG models also examine whether individual variability in lipid intercept 
and slopes estimates can be accounted for by the interaction of wGRSs and sex.  Throughout 
the IGC analyses, when comparing increasingly complex submodels, the improvement in 
model fit is assessed by likelihood ratio test (LR-test) or using Akaike’s and Bayesian 
Information Criterion (AIC and BIC). The significance of each estimated model growth 
parameter in the final CG model is assessed with t-statistics (i.e. defined as the ratio of 
parameter estimate and SE) (Appendix 3.8). A flowchart of the IGC modeling approach is 
outlined in Appendix 3.4. 
  
Prior to introducing sex and wGRSs as time-independent predictors of individual variability 
in lipid trajectories, consideration was given to minimise for confounding by (1) birth cohort 
and (2) period effect. We tested whether “year of birth”, calendar “year” at examination or 
both modified the age-related trajectory of lipids across the life course. This was performed 
by adding the variables (1) birth year (“yob”, categorical variable with 6 levels) and (2) year 
at follow-up (“year”, centered around baseline (1980)), and their interactions with trajectory 
parameters to each lipid’s sex-specific UG model (Appendix 3.8). Birth cohort does not 
appear to significantly modify the lipid profiles across the life course in this study sample 
(i.e. later birth cohorts do not show significantly different lipid trajectories compared to 
earlier birth cohorts). However, as significant linear yearly secular trends were found for each 
lipid (see Results section 3.4.1), “year” was adjusted for in all subsequent steps of the IGC 
analyses.  
 
HDL-C and LDL-C distributions were reasonably close to normal (Appendix 3.9). Because 
TG levels showed very long tails skewed to the right, we applied the Box-Cox procedure to 
determine the optimal transformation to remediate deviations from the assumptions of the 
linear regression model 278. As the best transformation (λ=-0.2) was close to the logarithmic 
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case, natural logarithm was used to transform triglycerides levels prior all analyses. Ages of 
participants at each measurement were treated as continuous covariates, and centered around 
youngest age at baseline (3 years old) to avoid collinearity problems with higher-order 
polynomial age terms and their interactions in the multilevel mixed models 85. As an index of 
fit of the different linear mixed effect models (i.e. final CG models), and to estimate how 
much the genetic predictors contribute to the variation of the lipoprotein profiles outcome, 
the novel conditional R2 and marginal R2 for linear mixed models developed by Nakagawa & 
Schielzeth, 2013 279 and adapted by Johnson, 2014 280  was used to accommodate for random 
slopes. For a given mixed effect model, the marginal R2 describes the proportion of variance 
explained by the fixed effects alone, while the conditional R2, describes the proportion of 
variance explained by both the fixed and subject- level random factors. In the case of IGC 
models, which are typically hierarchical mixed models, these two novel coefficients of 
determination are superior to the pseudo-R2 often reported for linear mixed model (i.e. 
squared correlation between the fitted and observed values) which ignores the variance 
components at multiple levels of the random factors by choosing to calculate R2 relative to 
only the residual variance. All analyses were performed in R 3.0.1 9 281 using the nlme 
3.1.102 114 and mgcv 282 packages. 
 
To complement the categorical analyses and make inferences at the population levels, a 
similar age- and sex- adjusted mixed modeling growth curve analysis approach was used to 
examine the association of the continuous wGRSs and the longitudinal trends of HDL-C, 
LDL-C and triglycerides. As per above, main effects (age-averaged) as well as age-dependent 
effects of continuous lipoprotein risk scores on lipoprotein trajectory parameters were 
assessed. Z-scores were calculated for the wGRS prior to these continuous analyses so that 
for LDL-C, HDL-C, and, TG the estimated effects (i.e. the regression parameters bs) indicate 
the change in mmol/L lipoprotein level per 1-sd change in wGRSs. For triglycerides, the 
regression coefficient bs were exponentiated for ease of interpretation, so that exp(bs) 
correspond to changes in the ratio of the expected triglyceride level per1-sd change in 
wGRSs. 
 
Secondary analyses 
Age- and sex stratified linear regression analysis 
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To ascertain the age at which the polygenic effect on the lipoproteins is first detectable and 
examine the strength of association between continuous genetic risk scores wGRSs and 
lipoprotein levels across age groups, sex-specific age-stratified linear regression models 
adjusted by study year were used. Trends in the associations between age-groups were 
assessed using LOESS curves. Additionally, a table summarizing sex-specific associations 
between categorical genetic risk scores and lipid levels at ages 3 years, 15 years, 24 years and 
45 or 46 years is presented (Appendix 4.7). The reported mean effect sizes are in mmol/L for 
the number of risk allele differences between high and low wGRSs for each lipid. 
 
Indication of polygenic gene-lifestyle interaction on adult lipoprotein 
Because lifestyle factors relating to weight status (i.e. dietary, exercise, and sedentary habits) 
are known to strongly correlate with blood lipids, it was determined whether the polygenic 
effect of risk loci on adult lipoproteins might be modified by an individuals’ BMI trajectory 
from childhood to adulthood. For this, we test for an interaction between continuous wGRS 
and change in standardised BMI between childhood and adulthood, DBMIi, in sex- and age-
adjusted linear regression models of adult lipoproteins (n=2100 for adult LDL-C model, 
n=2062 for adult triglycerides, and n= 2034 for adult HDL-C model). For each participant i, 
this measure was calculated as:  
 ∆"#$% = '. )*+,-	"#$ /0123 4 − 67-,68-	('. )*+,-	"#$ :;420;<<0 4) (3.1) 
 
with z-score BMI(adult)  defined as the sex-specific BMI z-scores observed at the latest follow-
up attended in adulthood for adults 30  years old or older in 2001, 2007, or 2011 (i.e 
participants younger than 30 years old in 2001 were excluded) ; and average(z-score 
BMI(childhood)) defined as the participant’s average of sex-and age-specific BMI z-scores 
measured at multiple occurrences in childhood (ages at follow-ups ranging 3 to 18 years). 
The significance of the interaction term (wGRS *D BMI) as a predictor of either adult 
lipoprotein levels was assessed by likelihood ratio test.  
 
3.4 Results 
Participant characteristics for lipoprotein levels and genetic risk scores considered in the 
longitudinal analyses are shown in Table 3.1. The difference in the number of risk alleles 
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between subjects in the high wGRS and low wGRS group ranged between 4 and 7 alleles on 
average for LDL-C and HDL-C, respectively (Appendix 4.7). When stratified by life stage 
(i.e. childhood (ages 3 to 15 years), young adulthood (ages 18 to 27 years) and middle 
adulthood (ages 30 to 49 years), average concentrations of each of the three lipoproteins were 
mostly consistent with pediatric and adult healthy cholesterol and fasting triglycerides levels 
(NCEP guidelines 2010), and the standard deviations were homogeneous over time. For each 
lipid, a histogram of the continuous wGRSs distribution also showing the quartile 
stratification into ‘low’, ‘mid’ and ‘high’ genetic risk is shown in Figure A in Appendix 3.2. 
Additional descriptive statistics showed that the wGRSs were not strongly linearly correlated 
with the lipoproteins overall when ignoring the effect of participants age (Pearson’s r = 0.21 
for LDL-C, 0.19 for HDL-C and 0.18 for triglycerides).  
 
3.4.1 Longitudinal lipoprotein profiles 
Significant decreasing secular trends were observed for LDL-C and TG between 1980 and 
2011 (β yearLDL-C=-0.09 (se =0.007) and β yearTG =-0.003 (se =0.0008) respectively, p-
values<0.05), but the decreasing trend was not significantly different between males and 
females. Conversely, HDL-C showed a modest yearly increase (β yearHDL-C=0.005 (se 
=0.001), p-value<0.05) for both sexes. However, calendar year at examination did not appear 
to modify the average age-related trajectories of either lipid in the cohort (i.e. all 3-way 
year*sex*age-terms interactions were non-significant, p-values >0.05).   
 
The sigmoidal function of age developed by Wineinger et al. 2013 283 did not fit the 
lipoprotein profiles in the YFS study sample (lipoprotein (t) ~ intercept + sin(p/2 * ((2 * age(t) 
– max(age)/min(age)) *sex), and the best non-linear fits were achieved by using a 4th degree 
polynomial age term for HDL-C profile and 3rd degree polynomial age term LDL-C and 
triglycerides profiles  (i.e. models yielding the lowest AIC and BIC values). Final IGC 
models assess the effect of sex, wGRSs and their interaction as predictors of the individual 
variability in lipid growth parameters over the life course. Model selection for the optimal 
random effects structure revealed that a continuous first order autoregressive correlation 
structure was needed in each model for the error term, implying that the within-subject 
correlation between lipid measures drops exponentially with increasing temporal separation 
(see Appendix 3.10 for model validation plots of the final IGC model). Fig 3.1 shows the 
predicted average sex-specific lipid trajectories for the participants in the upper and lower 
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wGRSs quartiles with corresponding 95% confidence intervals, determined from the 
estimated parameters and SEs of the final IGC models (i.e. prototypical growth curves). Sex-
specific prototypical growth curves show that trends in lipoproteins from age 3 to 49 years 
were different for males and females in the cohort. When stratified by sex, participants from 
high or low genetic risk groups (upper and lower wGRSs quartiles) showed differences in 
average levels of each lipoprotein from age 3, but displayed average profiles of globally 
similar shapes over time (Fig 3.1). 
 
Participants 10 years and younger already had high-risk or close to high-risk average levels 
of LDL-C (especially for participants in the high genetic risk group, and females in the 
lowest LDL-C wGRS quartile) as defined by the NCEP pediatric and adolescent cut points 272 
(Fig 3.1). The decrease in HDL-C levels in the cohort was noticeable above the age of 30 
years and was more pronounced among males, who in early life had higher average HDL-C 
levels compared with females, independent of their wGRS status. Similarly, triglyceride 
profiles in the cohort show a sex-dependent divergence over time, with males tending to 
exhibit higher average triglyceride levels compared with females from their early to mid 20’s 
both in the high and low wGRS groups. Fig 3.1 also suggests the divergence by sex in 
adulthood is more pronounced in the high risk TG wGRS participants, suggesting males in 
this group have exacerbated average triglyceride levels from age 25 years onwards. 
 
The output of the wGRS group- and sex-adjusted individual growth curve models corroborate 
the observations that the genetic effect is already present in childhood for each of the three 
lipids, with significant time independent effects of polygenic genetic risk score categories on 
baseline lipoprotein levels (Table 3.2, bs high-low and bs high-mid). Indeed, participants in the low 
and mid LDL-C wGRS group have LDL-C concentrations lowered by 46%, and 23% 
respectively (p-values <0.0001) as compared to participants in the high LDL-C wGRS. The 
analysis of HDL-C profiles revealed that participants in the low and mid HDL-C wGRS had 
average baseline HDL-C levels increased by ~16.8% and ~8% respectively compared with 
participants in the high risk score group (p-values <0.0005) (Table 3.2). Similarly, 
participants in the low and mid TG wGRS had average baseline triglyceride levels lowered 
by ~20% (i.e. log (0.8)) and ~10% (i.e. log (0.9)) respectively compared with participants in 
the high risk score group (p-values <0.0005).
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Table 3.1 Average lipid concentrations in childhood, young adulthood and middle adulthood, across 1980-2011 (all reported in mmol/L), and genetic 
risk factors (no unit) considered in the longitudinal lipoprotein profile analyses.  
 
  Males Females 
HDL Analysis  (N=1064**) (N=1244**) 
 Average HDL-C* 1.37 (0.36) (N†=9043) 1.51 (0.32) (N†=10540) 
 3-15 years 1.58 (0.34) (N†=2649) 1.57 (0.30) (N†=3078) 
 18-30 years 1.28 (0.30) (N†=3374) 1.52 (0.33) (N†=3937) 
 33-49 years 1.19 (0.29)(N†=3020) 1.42 (0.31) (N†=3525) 
    
 Genetic risk:   
 Average HDL wGRS 32.46 (3.36) 32.62 (3.41) 
 High score  (wGRS >34.8) N=253 (25%) N=324 (25%) 
 Mid score (30.1<wGRS≤34.8) N=541 (50%) N=613 (50%) 
 Low score (wGRS ≤30.1) N=270 (25%) N=307 (25%) 
    
LDL Analysis  (N =1121**) (N = 1314**) 
 Average LDL-C* 3.22 (0.86) (N†=9530) 3.17 (0.81) (N†=10834) 
 3-15 years 3.12 (0.83) (N†=2781) 3.32 (0.84) (N†=3255) 
 18-30 years 3.07 (0.85) (N†=3563) 3.06 (0.80)  (N†= 3856) 
 33-49 years 3.41 (0.85) (N†=3186) 3.07 (0.74) (N†=3723) 
    
 Genetic risk:   
 Average LDL wGRS  42.1 (6.6*)  41.9 (6.9*) 
 High score (wGRS >46.1) N=278 (25%) N=332 (25%) 
 Mid score (37.5<wGRS ≤46.2) N=553 (50%) N=665 (50%) 
 Low score (wGRS ≤37.5) N=290 (25%) N=317 (25%) 
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Triglycerides Analysis  (N =1121*) (N = 1314*) 
 Average Triglycerides* 1.17 (0.96) (N†=9513) 1.00 (0.56) (N†=11148) 
 3-15 years 0.73 (0.32) (N†=2776) 0.79 (0.34) (N†=3257) 
 18-30 years 1.17 (0.69) (N†=3557) 1.06 (0.53) (N†=4163) 
 33-49 years 1.56 (1.10) (N†=3180) 1.15 (0.89) (N†=3728) 
    
 Genetic risk:   
 Average TGwGRS 32.71 (15.81)  131.91 (15.72) 
 High score (wGRS >142.3) N=280 (25%) N=334 (25%) 
 Mid score (121.61<wGRS ≤142.3) N=280 (25%) N=660 (50%) 
 Low score (wGRS ≤121.6) N=275 (25%) N=322 (25%) 
    
*Data are sex-specific averages (SD) for lipoprotein concentration and for continuous genetic risks cores (wGRSs) collected for the entire study sample 
between 1980 and 2011 (the average age of male participants was 24.2 (11.8) years and the average age of female participants was 24.2 (11.8) years over the 
study period, which was not significantly different). Presented are also average (SD) lipoprotein levels stratified by age group (i.e. childhood (3-15 years), 
young adulthood (18-27 years), and middle adulthood (30-49 years). The grouping of wGRSs into categories was based on whole-cohort 25th and 75th 
percentiles (See methods). 
Abbreviations: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol. 
**Indicates the number of participants included in the longitudinal lipoprotein profile analyses. 
† Indicates the number of available measurements for the calculation of each average lipoprotein concentration.  
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Fig 3.1. Scatterplot of serum lipoprotein longitudinal profiles of participants according to their 
sex and wGRSs status (High and Low wGRS*) (N=2435, N= 2308 and N=2435 for LDL-C, 
HDL-C, and triglyceride (TG) profiles respectively). 
Solid and dotted lines represent estimated sex-specific average age-related lipid trajectories for 
participants in high and low genetic risk score, respectively (i.e. prototypical growth curves); blue and 
red coloured bands around the growth curves represent approximated 95% prediction CI. Overlaid 
with the prototypical lipid trajectories are the age-specific cut points for lipoprotein status (normal vs. 
high risk) as defined by the NCEP adolescent and childhood classification 272 and NCEP adult-
treatment panel guidelines 273 ). The cut points represented in green/red blocks are used to identify 
those at significantly increased risk of developing atherosclerotic CVD in adulthood. * Mid wGRS 
risk group are not presented in the figure for the purpose of readability.  
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Analyses of interaction terms revealed no time-dependent polygenic effects of the 14 risk 
SNPs on circulating LDL-C, implying that there is no worsening effect of LDL-C levels over 
time among those belonging to the high genetic risk group compared with those in the low or 
mid genetic risk group (all linear, quadratic and cubic βwGRS *age interactions p-values >0.3). 
On average at baseline, males had 7% higher LDL-C levels and 15% lower HDL-C levels 
compared with females (p-values <0.004). Sex appears to be the variable that drives the 
longitudinal trajectory of LDL-C levels in this cohort (βsexMale*f(age)=0.019, se=0.0007, p-
values <0.001), rather than wGRS group membership (linear, quadratic, and cubic rate of 
change not significant, Table 3.2).  
 
For HDL-C however, a significant linear and quadratic age-dependent interactions were 
found between participants belonging to the high and low wGRS group (β[wGRS *f(age)]=0.022 
and  β[wGRS *f(age-square)]=-2.6 x10-04) (Table 3.2), suggesting that genetic group membership is 
a modifier of the HDL-C trajectory. The positive effect of high wGRS on the linear age term 
implies that, for children in the high wGRS category, the effect of the combined variants 
leads to an initial increase that is faster by 2.2% per year compared with children in the low 
wGRS group (i.e. slightly steeper linear increase). Similarly, the negative effect on the 
quadratic rate of change also indicates that for participants in the high wGRS group, the 
positive genetic effect on HDL-C levels will decelerate in time slightly slower (by on average 
0.026%) than it does in the low GRS group around adolescence. This small difference in 
HDL-C trajectories between high and low wGRS groups is not easily distinguished in Fig 
3.1, as the modifying effect of the variants on the trajectory parameters is relatively mild. 
These age-dependent interactions were not modified by sex (all 3-way interactions were not 
significant p>0.05), so that the effect of wGRS categories on HDL-C trajectory parameters 
were not significantly different in males and females. 
 
For triglycerides, the linear, quadratic, and cubic age-dependent interactions between 
participants belonging to the high and low wGRS group are not significant in females (Table 
3.2). However, for males, genetic risk group membership modified the linear change if 
triglycerides (3-way interactions between linear age-dependent change rate, sex, and TG 
wGRS group membership) were significant both for low vs. high genetic risk group 
(expβ[male*wGRS  *f(age)]=0.96, se=0.003, p-value=0.0009), and for mid vs. high genetic risk 
group (exp β[male*wGRS *f(age)]=0.99, se=0.002, p-value=0.01). That is, males belonging to the 
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high genetic risk group tended to have a linear increase in TG levels by 4% (i.e. log(0.96)) 
and by 1% (i.e. log(0.99) for participants in the mid genetic risk group. As these effects are 
also moderate, it does not result in strong divergences in the prototypical triglyceride 
trajectories  (Fig 3.1). 
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Table 3.2. Time-averaged and time-dependent effects of the categorical combined genetic risk scores (HDL-C , TG and LDL-C 
wGRSs) on lipoprotein concentrations (mmol/L) from childhood through adulthood. Regression coefficients (bs) are in % change vs. 
the reference group (i.e. high genetic risk group). 
 
  Main wGRS effectsa Time-dependent wGRS effectsb  
Lipoprotein  b(se) p-value b(se) p-value Goodness of fit 
HDL-C† High vs. Low -0.17 (0.01) 0.0001* L: 0.022 (0.0015) 0.005* Marginal R2: 0.21 
    Q: -2.6x10-4 (1.1x10-3) 0.02* Conditional R2:0.72 
    C: 2.5x10-6 (3.4x10-6) 0.47  
    4th: 4.0x10-7 (2.4-x10-7) 0.09  
 High vs. Mid -0.08 (0.012) 1.0x10-4* L: 0.0014 (0.0009) 0.11  
    Q:- 1.0x10-4 (9.0x10-5) 0.28  
    C: 2.5x10-6 (5.1x10-6) 0.40  
    4th: 1.0x10-7 (2.1x10-7) 0.67  
LDL-C†† High vs. Low -0.46 (0.04) 1.0x10-4* L: - 7.0x10-3 (0.002) 0.72 Marginal R2: 0.11 
    Q: 2.8x10-5 (9.5x10-7) 0.76 Conditional R2: 0.71 
    C: 3.0x10-6 (6.6x10-7) 0.71  
 High vs. Mid -0.23 (0.03) 1.0x10-4* L: 6.1x10-2  (1.9x10-2) 0.52  
    Q: 6.3x10-5  (6.1x10-6) 0.45  
    C: 1.3x10-9 (1.0x10-9) 0.94  
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Triglycerides ††† High vs. Low  0.80 (0.025) 0.0001* L: 0.995 (0.001) 0.11 Marginal R2: 0.18 
    Q:  0.99 (6.8x10-5) 0.08 Conditional R2:0.68 
    C: 1.00 (4.9x10-7) 0.37  
 High vs. Mid 0.90 (0.022) 1.0x10-4* L: 0.999 (0.001) 0.15  
    Q:- 0.997 (5.8x10-5) 0.09  
 
Abbreviations: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; High/Mid/ Low, categorical genetic risk 
score groups (for either lipoprotein trait); L, Q, C and 4th, Linear/quadratic/cubic/ and quartic rate of change (in either lipoprotein concentration as a 
function of age). 
† / †† / ††† wGRS effects  refer to the combined effect of the 38-, 14- and 24 SNPs associated respectively to HDL-C, LDL-C  and fasting 
triglycerides levels (see methods section 3.3).  
* Indicates that the estimated regression parameter is significant at the 0.05 significance level. 
a,b For ease of interpretation of the estimates of main and time-dependent effects of wGRSs, all age terms were centered around youngest childhood 
age at baseline (1980) in the cohort (3 years old) prior regression analysis. For triglycerides, regressions coefficients bs of main and time-dependent 
effects were exponentiated so they are presented in the original scale for ease of interpretation. 
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When using the wGRSs values as continuous predictors, the final IGC models for the age-
related trajectories of LDL-C, HDL-C and triglycerides profiles achieved a conditional R2 of 
0.64, 0.68 and 0.61 respectively, with the fixed predictors (age, sex, and continuous wGRS) 
jointly accounting for 12%, 27% and 19% of deviance respectively in each model. Consistent 
with the categorical analyses, the time-averaged genetic effect of the combined genetic risk 
score on lipoprotein profiles was significant (p<0.0001) for all traits (Table 3.3). The 
polygenic effect size was stronger for LDL-C associated risk SNPs, with LDL-C wGRS 
increasing LDL-C levels by 18.2% per SD increase in score (as compared to a 6.8% increase 
in HDL-C levels per SD increase in wHDL-C GRS). Additionally, wHDL-C GRS was a 
significant predictor of the linear, quadratic and quartic changes in HDL-C levels over time 
(p-values <0.01, Table 3.3), implying that the slope of the genetic risk score variable 
on HDL-C concentration changes as participants age from childhood through adulthood. 
These time-dependent interactions are best visualised by computing and plotting the marginal 
effect of the combined genetic risk score on HDL-C levels (Fig 3.2 A). The downward trends 
of the slopes of the continuous risk score on HDL-C level with age for both males and 
females, suggests that the association between HDL-C levels and of the 38 HDL-C risk SNPs 
gets weaker as participants aged in this population, although the combined genetic effect of 
these loci on HDL-C was consistently stronger among females. 
 
For triglycerides, continuous analyses revealed that while on average, TG wGRS did not 
modify the linear, quadratic or cubic change in triglyceride level, but when clustering 
participant by sex, TG wGRS effect on the linear change rate in triglyceride levels became 
significant for males (three way interaction exp βwTGgrs24*sexMale*f(age)=1.0038, se=0.0011, p-
value=0.001). This difference between sexes can also be visualised by plotting the marginal 
effect of the TG combined genetic risk score on triglyceride levels (Fig. 2.2 B). For females, 
a 1-sd increase in risk score will result in 9% higher serum triglyceride on average (regardless 
of their age; log (1.1)=0.09). For males, the effect size of TG genetic risk score is age-
dependent and lower in childhood than for females, it increases linearly to become larger in 
females from age 25 onwards, reaching 13% at age 49 years (log(1.14)=0.13).  
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Table 3.3. Time-averaged and time-dependent effects of the continuous combined genetic risk scores (HDL-C , LDL-C and TG wGRSs) on 
lipoprotein concentrations (in mmol/L) from childhood through adulthood.  
 
 Main wGRS effectsa Time-dependent wGRS effectsb  
Lipoprotein b(se)** p-value b(se)** p-value Goodness of fit 
HDL-C † 0.0064(0.002) 1.0x10-4* L : -6.1 x10-3 (2.0 x10-4) 0.003 * Marginal R2: 0.27 
   Q: 2.0 x10-5 (4.1 x10-6) 0.014* Conditional R2: 0.68 
   C: 4.0 x10-6 (1.2 x10-7) 0.07  
   4th: -1.0 x10-7 (7.8 x10-9) 0.05  
LDL-C†† 0.182 (0.001) 0.0003* L:  2.7x10-4 (1.2 x10-3) 0.85 Marginal R2: 0.13 
   Q: -9.5 x10-5 (1.5x10-4) 0.44 Conditional R2: 0.64 
   C: 3.0 x10-6 (2.6 x10-6) 0.23 
 
 
Triglycerides††† 1.094 (0.008) 1.0x10-4* L : 1.0 (9.8 x10-4) 0.47 Marginal R2: 0.20 
   Q: 1.0(8.0 x10-5) 0.31 Conditional R2: 0.65 
   C: 0.99 (1.7 x10-7) 0.20  
Abbreviations: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; L, Q, C and 4th, Linear/quadratic/cubic/ and 
quartic rate of change (in either lipoprotein concentration as a function of age). 
† / †† / ††† wGRS effects refer to the combined effect of the 38-, 14- and 24 SNPs associated respectively to HDL-C, LDL-C  and fasting 
triglycerides levels (see methods).  
* Indicates that the estimated regression parameter is significant at the 0.05 significance level. 
a,b For ease of interpretation of the estimates of main and time-dependent effects of wGRSs, all age terms were centered around youngest childhood 
age at baseline (1980) in the cohort (3 years old) prior regression analysis. 
**Regression coefficient bs are in mmol/L per 1-sd change in wGRS for HDL-C and LDL-C. For triglycerides, regressions coefficients bs of main 
and time-dependent effects were exponentiated so they are presented in the original scale for ease of interpretation.
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Fig 3.2. Sex-specific marginal effect* and 95% CI of (A) combined continuous HDL-C 
wGRS on HDL-C levels (effect size expressed in mmol/L lipoprotein level change per 1-sd 
change in wGRSs); and (B) combined continuous TG wGRS on fasting triglyceride levels 
(effect size expressed in odds ratio lipoprotein level change per 1-sd change in wGRSs). 
Colour code: dark grey; females, light grey; males.  
*Plotted marginal effect includes the significant linear slope, quadratic and quartic rates of change 
(cubic trajectory parameter not significant in the final model); Horizontal black dashed line shows 
where the slopes are not significantly different from zero). 
 
3.4.2 Age-stratified linear regression 
Cross sectional analyses confirmed that combined wGRSs were significantly associated 
with the three lipoproteins at all ages for both sexes (Fig 3.3, all p-values <0.05). 
Confirming that the joint effect of the 14 risk SNPs on LDL-C levels is consistent across 
time, the fitting of a LOESS regression lines to the ages- and sex-specific regression 
parameters did not reveal any striking trend over time (Fig. 3.3, upper panel). It may be 
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that the variations in effect sizes between different age-groups were mostly attributable to 
differences in sample sizes and differences in the number of birth cohorts used in the 
regression analysis (only one birth cohort for the 3 year old age-group, against a mix of up 
to 5 birth cohorts for the 15 and 18 year old group). However, the age- and sex- stratified 
analysis of the association between HDL-C levels and HDL-C genetic risk, confirmed that 
the effect size of HDL-C wGRS on HDL-C decreased almost by half, on-average, for age-
groups >30 years in males and females. For triglycerides, the results of the age-stratified 
regression analysis are consistent with the results of the individual growth curve analyses, 
showing very stable effect estimates for females throughout age groups, and a clear 
upward trend in effect size estimates for males. Sex-specific mean effect sizes for 
categorical wGRS at chosen ages  (i.e. 3, 15 24 and 45/46 years) are consistent with the 
results of the sex-and stratified cross sectional analyses of the continuous risk scores 
(Appendix 3.7). 
 
3.4.3 Evidence for polygenic gene-lifestyle interaction on adult 
lipoprotein levels 
Change in BMI z-score between adulthood and childhood (D BMI) was highly predictive 
of each adult lipoprotein levels independently of the wGRSs in multivariable models 
adjusted for sex and age at baseline and follow-up (Appendix 3.3). However, the LR tests 
revealed no evidence for gene-lifestyle interactions (D BMI *wGRSs) on adult lipoprotein 
concentrations, as the combined effect of candidate genes on adult lipoprotein levels does 
not appear to be modulated by the trajectory of BMI from childhood in this cohort 
(χ2(df=1)=0.24 p=0.62; χ2(df=1)=2.04, p-value=0.15 and χ2(df=1)=1.17 p-value=0.11 for 
HDL-C, LDL-C, and triglycerides respectively).  
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Fig 3.3. Age- and sex- stratified estimated effects of LDL-C wGRS (upper panel), HDL-C  
wGRS (middle panel) and TG wGRS (lower panel) on LDL-C, HDL-C and triglycerides 
levels (mmol/L) respectively with colour coded significance levels and studentised 
bootstrapped non-parametric 95% CI . 
For each age, the continuous error bars correspond to males and the dashed error bars directly next 
to them correspond to female models. Effect sizes are in mmol/L change per 1-sd change in wGRS 
for LDL-C and HDL-C and in odds ratio lipoprotein level change per 1-sd change in wGRS for 
triglycerides. Point sizes of the beta estimates reflect sample size (number of participants included 
in each age- and sex-specific regression analysis) Parameter estimates significance : Light grey, 
0.05<p-val<0.01; Dark grey, 1.x10-3<p-val<1.X10-6; Black, p-val≤1.X10-6. Black lines: smooth 
trend curves fitted by LOESS (Locally weighted non-parametric  regression) to help visualise 
trends in the cross-sectional associations. 
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3.5 Discussion 
This is the first study to investigate the combined effect of dyslipidaemia–predisposing 
variants on longitudinal blood lipoprotein profiles from childhood to adulthood. Rather 
than considering individual-validated risk lipid-SNPs alone, usually characterised by weak 
to moderate effect sizes in large lipid GWASs, the approach used here weighted genetic 
risk scores that combine multiple loci identified in meta-analyses of large lipid GWAS. 
Collectively, our findings suggest that genetic factors influence age-specific lipoprotein 
values and developmental trajectories already from the age of 3 years. 
 
The use of polygenic risk scores has become increasingly popular in recent years for the 
purpose of genetic prediction of a number of quantitative traits, with the increasing 
recognition that a substantial part of heritability comes from many susceptibility markers 
individually characterised by low predictive power 261. For circulating lipids in particular, 
when combined, multiple common genetic variants with small effects on circulating lipid 
levels, were reported to be highly predictive of individual trait measures 263 and showed 
association with subclinical and clinical cardiovascular outcomes 262. Despite these 
promising associations between SNPs (or genetic risk scores) and lipoproteins, 
susceptibility alleles are often identified from cross-sectional adult GWASs, and it remains 
unclear whether the within-individual level of genetic risk carried by these variants is 
stable through life or changes with age. This uncertainty greatly impedes the assessment of 
the abilities of individual SNPs (or polygenic GWAS-derived risk score) for prediction of 
quantitative traits collected across the life course and their clinical usefulness in the 
primary prevention of dyslipidemia.  
 
Independent of participant age-related lipid trends, significant decreasing secular linear 
trends in LDL-C and triglycerides across the 31 follow-up years were found, which is 
consistent with what has been reported in previous studies 284.  These trends may be 
partially due to a wider use of statins or improvement in diet in the last decades252. 
 
Multilevel individual growth curve (IGC) analysis revealed an expected difference in 
lipoprotein profiles from childhood to adulthood between males and females, and although 
baseline HDL-C, LDL-C and TG levels were not significantly different between sexes (at 
age 3 years), the trajectories of lipid levels from childhood to adulthood were largely sex-
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driven. A time-averaged association between lipid wGRSs and each of the three serum 
lipid levels was observed, suggesting that composite genetic risk scores were robust 
predictors of average lipoprotein levels, as well as predictors of lipoprotein levels in 
childhood (from age 3 years). The time-averaged effect of the 14 risk alleles on LDL-C 
levels was stronger on average than the effect of the 38 risk SNPs on HDL-C levels, 
suggesting that the genetic predisposition to high serum LDL-C is stronger compared with 
a predisposition to low HDL-C levels and high triglycerides levels. The LDL-C wGRSs 
did not modify the linear, quadratic, or cubic trajectory of lipoprotein level, so that the 
combined effect of the 14 candidate SNPs is not only present in young childhood, but also 
consistent across a person’s life course as he/she ages (from age 3 to 49 years). Categorical 
analyses revealed the 38 risk SNPs modified the linear and quadratic component of HDL-
C trajectory over time, although the effect sizes of the age-dependent terms were small, 
such that it does not translate to clearly divergent profiles between high- and low-risk 
participants. However, when plotting the estimated marginal effect of HDL-C wGRS over 
time (within-individual), for a given male participant the magnitude of the effect of the 
combined genetic risk score on his HDL-C levels will attenuate with age. This is also 
confirmed by the cross sectional age-stratified analyses, where childhood HDL-C levels 
were strongly related to genetics, but where the main effect of HDL-C wGRS diminished 
by half in age-groups over 30 years old. Although significant at all ages, the collective 
effect of the HDL-C risk score on HDL-C levels becomes weaker as participants age, with 
environmental, lifestyle and behavioural factors such as diet, smoking and physical 
activity, potentially becoming more important determinants of adult circulating HDL-C.  
 
For triglycerides, it was found that the combined effect of the 24 risk SNPs on triglyceride 
levels appears consistent over time for females from childhood through adulthood. For 
males however, both the cross sectional regression and IGC analyses suggest that the 
association between TGwGRS and fasting triglycerides levels increases linearly with age, 
becoming stronger on average than in females from around 25 years of age. These findings 
suggest that in adulthood, males at risk may respond less efficiently than females to 
lifestyle interventions targeting the reduction of fasting triglyceride levels 
 
For lipids, it is largely unknown how a conventional age-varying ‘lifestyle-related’ risk 
factor such as adiposity modifies the genetic risk of developing abnormal lipid over the life 
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course. This is a particularly relevant topic as identifying people whose risk is amplified by 
a combination of genetic and behavioral factors might facilitate interventions to prevent or 
delay the onset of cardiometabolic diseases. Change in BMI z-score (Δ BMIi), a proxy 
retrospective indicator of ‘adiposity trajectory’, was computed for each participant to 
summarize both the directionality and magnitude of change in their weight status-related 
lifestyle factors over their life course relative to the average change in the cohort. In these 
analyses, the change in BMI z-score from childhood to adulthood predicted adult 
lipoprotein levels in 2011. This observation is consistent with the fact that adult BMI is 
important for many adult metabolic factors including lipids and that associations between 
lipids and BMI generally strengthened with age 167. However, the effect of BMI z-score 
change since childhood on adult concentration is not modified by the wGRS for any of the 
lipoproteins, signifying that the detrimental consequences of an above average change in 
BMI since childhood on circulating lipoprotein levels does not appear to be exacerbated in 
adults that are genetically predisposed to high-risk lipoprotein profiles. However, this 
analysis is preliminary, and although it considers the overall direction of change in BMI z-
score between childhood and adulthood, it does not fully account for the age-varying 
nature of BMI as a confounder and how it might interact with wGRS at different age-or 
developmental stages (childhood, adolescence, young adulthood). A study looking at the 
importance of the age at which obesity developed in associations between adult lipids and 
weight status, showed that although obese adults had adverse levels of lipoproteins, these 
levels did not vary with childhood weight status or with the age at the onset of obesity285. 
However, it remains unknown if specific age of obesity onset modifies the effect of a 
genetic predisposition to averse lipoprotein levels, and whether primary prevention 
measures could be improved by specifically aiming at resolving obesity before a certain 
‘critical’ age-window in individuals genetically at-risk to develop dyslipidemia, as has 
been shown for apparently healthy individuals 33. 
 
3.6 Strengths and limitations  
The present work has a number of strengths and limitations. Strengths included the study 
of a large, randomly selected cohort of men and women followed up at eight occasions 
over the course of 30 years since early childhood. The extensive longitudinal lipoprotein 
phenotypic and genotypic data offered a rare opportunity for a refined analysis of the 
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association between genetic risk and serum lipoprotein trajectories. The hierarchical mixed 
effect IGC modeling approach allowed the comprehensive modeling of between-individual 
changes in within individual outcome trajectories. The multivariable models of adult 
lipoprotein allowed estimating the ability of the polygenic GWAS-derived lipoprotein risk 
scores to predict adult lipoprotein concentration over other conventional childhood risk 
factors.  
 
Limitations were also present. Because the YFS cohort is of European descent, the results 
are only generalisable to individuals with a similar ancestry. Loss to follow-up from the 
original cohort more often occurs for males, therefore the sex-specific time-averaged and 
time-dependent effect of multi-loci risk scores might be slightly biased. We also suggest 
that to validate causal inference, these findings should be tested for potential confounding 
effects of other variables such as additional adiposity indicators, which are known to 
correlate highly with lipoproteins and vary over time. However, additional adiposity 
phenotypes have not been collected at each study wave in the YFS study.  
 
3.7 Conclusion 
This study demonstrates the significance of GWAS-derived genetic risk scores as 
predictors of lipoprotein levels at all ages. Additionally, for the first time, an age-
dependent effect of the 38 HDL-C risk SNPs is shown on HDL-C and of the 25 TG risk 
SNPs on TG levels was found among males, suggesting that the genetically-determined 
effects on these lipoproteins tends to change as a person ages. These findings are clinically 
significant, as they may help refine interventions targeted at the prevention of worsening 
of lipid profiles as people age. Because this study focused on modeling individual lipid 
profiles across the life course, it did not consider how lipid levels of each participant in 
adulthood translate in terms of dyslipidemia status. Further studies would be needed to 
characterise how this polygenic effect translates in terms of disease status prediction from 
childhood to adulthood, especially to investigate whether polygenic risk scores can help 
improve the prediction of adult disease beyond traditionally used clinical factors, such as 
lipid levels in mid-childhood. 
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KEY POINTS 
 
• This chapter investigates for the first time the combined effect of 
dyslipidaemia–predisposing common genetic variants on blood lipid profiles 
from childhood to adulthood in the YFS cohort.  
 
• For LDL-C, HDL-C, and triglycerides, the polygenic effect of GWAS-
identified risk alleles was present from early childhood (from age 3 years).  
 
• The strongest time-averaged polygenic effect size was observed for the LDL-
C associated variants suggesting that the multigenetic predisposition to high 
serum LDL-C at all ages is stronger compared with a predisposition to low 
HDL-C and high triglycerides levels. 
 
• The polygenic effect on LDL-C levels remained and consistent across the life 
course as YFS participants aged.  
 
• The multigenic effect on HDL-C levels became weaker as participants aged, 
with environmental, lifestyle and behavioral factors such as diet, smoking, 
physical activity, potentially becoming more important determinants of HDL-
C levels in mid-adulthood. 
 
• The detrimental effect of the 24 risk variants on triglyceride levels increased 
linearly with age for males, suggesting that from mid-adulthood onwards, 
males at risk may respond less efficiently to lifestyle interventions targeting 
the reduction of fasting triglyceride levels. 
 
• This chapter demonstrate how IGC modeling, a person-based approach to 
trajectory analyses can be used to investigate associations between 
longitudinal response profiles of complex shapes and important individual 
cardiometabolic risk marker, such as genetic factors.  
 
Box 1. Summary of key points from Chapter 3: The combined effect of common 
genetic risk variants on childhood to adulthood trajectories of circulating 
lipoproteins in the YFS 
 
Chapter 4 – Bayesian Hierarchical Piecewise Regression and trajectory divergence between-groups 
 
 
127 
4. BAYESIAN HIERARCHICAL PIECEWISE REGRESSION 
MODELS: A TOOL TO DETECT TRAJECTORY DIVERGENCE 
BETWEEN GROUPS IN LONG-TERM OBSERVATIONAL 
STUDIES 
 
4.1 Preface 
In this chapter, the aim was to demonstrate how linear-linear segmented regression model can 
be used at level-1 instead of the commonly used higher-order polynomial within-person 
submodel, to formulate a MLM growth curve model able to compare longitudinal change in 
non-linear continuous responses between distinct developmental periods. Based on this model 
formulation, a sequential modeling approach was used to allow the estimation of the point in 
time (or the age) at which two groups of individuals go onto separate curvilinear trajectories. 
The proposed Bayesian Hierarchical Piecewise Regression approach (BHPR) is suitable to 
investigate mechanisms of trajectory divergence between groups, allows avoiding some of the 
limitations of higher order polynomial growth models, and yields parameter estimates that are 
easily interpretable and that map onto what is known of the development of BMI from 
childhood to adulthood. The approach consists of fitting a series of growth curve models where 
group-differences in the conditional means of the growth parameters are sequentially introduced 
at level-2. These models are estimated in a fully Bayesian framework since not only the focus is 
to estimate the points at which the groups of interest change growth patterns, but also to allow 
for subject-to subject variability in these change points (i.e. ages at which they change growth 
pattern). This novel approach is illustrated by applying the developed methodology to identify 
age at divergence in the BMI trajectory of YFS participants who go on to develop adult T2DM 
as opposed to participants who remain healthy in adulthood. The clinical interest of this method 
is that it could help identify critical windows to intervene to normalise modifiable risk factors 
for later cardiometabolic outcomes. Additionally, this approach can be used to test and adjust 
for potential between-cohort heterogeneity in the response variable that may be present in multi-
cohort designs. Through simulation, it is demonstrated that this method is superior to a 
commonly used approach to determine age at divergence between groups, that is, the pairwise 
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comparison of predictions form a categorical mixed models between-group (i.e. least-square 
means) at each time point. 
 
In summary, in line with general aim 2 and 3 of this thesis, this chapter has developed a novel 
GCM approach which allows to determine between-group trajectory divergence in long-term 
observations studies, and illustrates the use and relevance of the proposed approach by 
identifying the age at which YFS participant who develop T2DM go on to different BMI paths 
compared to those participant wo do not develop T2DM.  
 
4.2 Introduction 
Child to adult trajectories of health markers are likely to have implications for the risk of 
chronic diseases in later life, such as obesity, T2DM and CVD; it is therefore important to 
understand their development throughout the life course 286-288. Observational studies that 
follow the same study participants over long periods of time that span from early childhood to 
adulthood are especially suited to studying adult-onset disorders such as cardiometabolic 
disease, since they allow characterising the development of normal vs. pathological processes 
over time. A goal of such studies is often to determine how a number of individual 
characteristics, modifiable risk factors profiles, their interactions, and normal aging may impact 
the onset and progression of disease over time, in order to identify time periods of divergence in 
these factors. 28, 62, 285.  
 
Depending on the condition being studied, longitudinal risk factors of interest range from 
biological markers (e.g. blood lipids, glucose, inflammatory markers) for which there is no a 
priori or expected systematic pattern of change across the life-span, to anthropomorphic growth 
characteristics (e.g. height, weight, BMI, and adiposity), for which trajectories often consist of 
several well studied and identified consecutive developmental periods. In particular, it is now 
recognised that human growth and development at different life-stages are associated with adult 
chronic disease 286, 289 with increased sex- and age-adjusted BMI, playing an important role in 
the development of conditions such as T2DM290-292, CVD 49, 144, 285 and some cancers 293. 
 
A key statistical issue in these studies is often to determine if risk factor levels vary over time 
between and within-groups of participants, and whether different groups are changing in a 
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similar or different fashion over time 84, 115. Depending on the study, the stratification of 
participants into groups can relate to participants’ characteristics or exposure (smoking status, 
sex), intervention arm (i.e. control vs. medication), or the grouping factor could be a later health 
outcome (e.g. disease status in mid-adulthood). When participants are grouped according to a 
distal dichotomous health outcome, longitudinal data provide the foundation to understand 
pathways to deleterious risk factor profiles, which may help inform the timing of public health 
intervention to prevent or delay adverse health outcomes in adulthood 28, 62, 285.  
 
When it is established that groups of interest start with similar initial outcome levels, but do not 
change similarly over time, it is often of interest to determine the point in time or age at which 
groups begin to diverge in their trajectories 69, 143, 187, 194, 294. Being able to determine how and 
when the change manifests between groups of participants is important, since it can help 
pinpoint periods in the life course that are critical in the development of abnormal risk factor 
profiles 295. However, there is little methodological guidance in the literature on statistical 
techniques to achieve this, and several studies have noted a lack of relevant methods to 
investigate trajectory divergence between groups 161, 194, 295. 
 
A common attempt is to fit a mixed model with time (or age) treated as categorical variable (i.e. 
non time-ordered /ordinated 5) to retrieve linear predictions at each age for each group of 
interest from this model (i.e. means of least squares predictions, sometimes called LS-means  
296-298), and to test for a group difference in these predictions using a number of contrasts (i.e. 
post-hoc pairwise comparisons). In this case, the age at which the difference between-groups 
emerge is often the age at which a significant between-group difference materializes in the LS-
means 2, 5, 91. Mixed models that assume an unstructured mean response by treating age or time 
as categorical variables are attractive because they make no assumption about the shape of the 
mean trajectory of the outcome over time. Several studies have used this approach to determine 
at “what times the groups means are different” (e.g. between-subject effect or post-hoc pairwise 
group comparison, if there are more than two groups), or “at what times the means differ” 
within each group (within-subject effect testing) 2, 109, 299. However, even when adjustments are 
applied for multiple tests 2, 64, 89, 90, many authors advise against the unrestricted use of multiple 
comparisons among marginal means due to well-documented multiple testing issues, especially 
the increase in false positive rate as the number of hypothesis tests increases 94, 95, 299. Mixed 
models that assume an unstructured mean response by treating age or time as categorical 
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variables tend to be over parameterised and may be inefficient at detecting main effects 300. 
Although pairwise mean comparisons are often only meaningful among groups at the same 
measurement time point, or across time points within the same group, few software offer 
custom hypothesis testing and most tend to compute and display all possible pairwise 
comparisons (i.e. differences between LS-means) by default. This leads to unnecessarily 
conservative results, since the multiplicity adjustment gets more severe as the number of 
comparisons involved increases 2, 86, 301, 302. Beyond these issues, another crucial disadvantage of 
this approach, is that it only tests for the difference in means between groups at each time point 
and does not provide any information on subject-specific response evolution in time 75, 84, so 
that the age (or point in time) at which the group difference manifests is ultimately a question of 
sample size and statistical power.  
 
In contrast, continuous time models such as individual-based trajectory modeling methods, 
including mixed effect 115, hierarchical 67, multilevel 66, and the closely related structural 
equation and Latent Growth Curve models 129, have become invaluable tools to understand the 
natural history of health outcomes as well as risk factor/determinant trajectories 23, 28, 97, 99. They 
have well-documented advantages over traditional approaches to repeated-measure data 
analysis in terms of flexibility, with their main advantage being that they allow summarizing 
each participant’s outcome trajectory with a few trajectory parameters 75, 303. In addition, they 
permit the explicitly modeling of inter-individual differences in intra-individual change, 
permitting inference regarding the average response trajectory over time and how this evolution 
may vary with participant characteristics (i.e. participant-level predictors) 18, 19, 21, 130. 
 
Despite their flexibility, these models are not often used to analyse sparse long-term 
observational data since accelerated longitudinal designs 28, 161, 175 and non-linear response over 
time 70, 99, 158, 159 both introduce significant complexity into the growth curve modeling approach 
22, 65, 137, 138. Indeed, being able to represent non-linear patterns with a relatively small number of 
measurement occasions per participants (often <10 time points) and be specific about where 
between-participant heterogeneity appears in those patterns is a statistical challenge.  
 
Many applications often rely on higher order time (or age) polynomials or latent basis 
coefficients 27, 28, 81, 99, 103, 194, with strengths and limitations of these approaches well-described 
1, 82, 173, 174, 303. In the context of this study, the polynomial parameterisation of the growth model 
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does not specifically yield an age or point in time when the growth pattern is changing within-
and between-groups. Alternatively, piecewise models, also known as linear splines or broken 
stick models, can be used to break up a non-linear or curvilinear growth trajectory into several 
separate linear components 191. They are particularly useful to compare growth rates in different 
periods over time if the functional form of the response is characterised by different phases of 
development, or if there is a shift in the outcome trajectory at some point in the event window 
(i.e. an acceleration or a deceleration in the response change rate from one point in time (or 
age)) 24, 83, 180, 181, 184, 185. Piecewise linear trajectory models have been used to model 
‘multiphase’ developmental processes primarily with ‘fixed’ transition points in a variety of 
applications in the frequentist multilevel 23, 67, 184, 203 and structural equation modeling 
framework 129, 148. Bayesian applications of these processes are often referred to as ‘random 
change point model’ where the position of individual breakpoints is also estimated, allowing for 
between-person variability in the transition points 125, 154, 190, 192, 193, 196, 198-201. Univariate 
Bayesian change point models have notably been used to model various clinical endpoints such 
as cognitive function decline in dementia sufferers 153, 154, progression of viral loads in HIV 
patients in response to treatments 196, 198, and change in marker levels of prostate and ovarian 
cancers 193.  
 
Few studies have, however, investigated the inclusion of categorical covariates or grouping 
variables as level-2 predictors of the variability in the change point, and the random Bayesian 
change point model has not been formulated to test specifically for the existence of a ‘trajectory 
divergence’ between two (or more) known groups of participants that have longitudinal 
responses characterised by distinct developmental phases. 
 
 In this chapter, the use of Bayesian hierarchical piecewise regression modeling to detect 
trajectory divergence between groups of participants is illustrated using longitudinal BMI data 
from the YFS Study. Previously published work on these data, based on categorical mixed 
modeling, suggested that BMI levels became statistically different between those who develop 
T2DM in adulthood and those who did not from the age of 15 years 292. These data are 
reanalysed to demonstrate how the Bayesian method can be used to: (1) model the BMI profiles 
to better understand the natural history of the BMI trajectories in those who do and do not 
develop T2DM in adulthood while controlling for potential cohort effects; and (2) obtain a 
refined estimate and confidence interval of the age at which the two groups begin to diverge 
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from one another, translating into significantly different BMI from a certain age onwards. In 
this application, we postulate that the proposed methodology for the analysis of longitudinal 
BMI measurements taken periodically (~ 3 yearly) from childhood across adolescence and 
young adulthood could help identify those at increased risk of developing adult T2DM based on 
their individual BMI developmental trajectories from childhood to adulthood, potentially 
increasing the prediction of adult T2DM compared to approaches considering only one BMI 
measurement in childhood. In addition, a series of short simulations are conducted to illustrate 
the difference in the estimates of age at divergence when using the traditional approach (i.e. 
pairwise comparisons of marginal means from a categorical mixed model) vs. the proposed 
trajectory modeling approach. 
 
The Methods present the proposed statistical approach to formally test for and characterise the 
trajectory divergence mechanisms between 2 or more groups of participants, and describe the 
BMI and T2DM data from the longitudinal YFS as a motivating example to illustrate this novel 
modeling approach. The Results investigate the heterogeneity in BMI development between 
YFS participants who did and did not develop T2DM using the Bayesian Hierarchical 
Piecewise Regression method to determine the age at which the divergence occurred between-
groups while accounting for potential birth cohort effects, and present the results of a series of 
short simulations to illustrate the difference in the estimates of age at divergence when using the 
traditional approach (i.e. pairwise comparisons of least-square means estimated from a 
categorical mixed model) vs. the proposed trajectory modeling approach. We then discuss the 
proposed approach. 
 
4.3 Methods 
4.3.1 No-covariate model 
To accommodate the curvilinear developmental pattern in an individual continuous response 
over time while providing and adequate representation of its developmental theory, a linear-
linear piecewise regression model was considered as the functional form of change in the 
trajectory model. This change point model consists of two joining linear segments and involves 
four individual specific random effects, representing two known natural developmental phases 
of the outcome of function of age (or time), The change point (CP) represents the age (or time) 
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at which the transition to a different growth rate occurs. Throughout, “age” will be used rather 
than “time” as the relevant time variable. The following unconditional (no covariates) 
multilevel model was considered: 
 
 
Level-1 model: 	        (4.1)  "#$%&'#() = 	 +,( +	+.(/0#()	. (1 − 5678(/0#())) + 	+:( /0#() − ;<( . 5678 /0#() + =()   
 
 
Level-2 model:         (4.2) +,( = >,, + ?,( +.( = >., + ?.( +:( = >:, + ?:( ;<( = ;< + ?67( 
 ?,(?.(?:(?67( ~A
0000 ,
DE,: … ⋯ …DE,. DE.: … …DE,: DE.: DE:: …DE,67 DE.67 DE:67 D67:            (4.3) 
 
Where, at age j for participant i, "#'$%&'#() is the repeated continuous outcome measures, and /0#()		is the corresponding time related variables, centered around its grand mean. 5678(/0#()) 
is a unit heavyside step function where 5678(/0#())=1 if /0#() ≥ ;<( and 5678 /0#() = 0  if /0#() < ;<(. The random trajectory parameters +,(, +.( and +:( correspond to the individual 
intercept, the slope before and slope after the person-specific change point ;<(, respectively. 
For each person i, +,(, controls the individual baseline level (or initial status) for the outcome Y 
and its interpretation depends on the centering of the age- or time-variable (e.g. if age is 
centered around 25 year, +,( will be the expected participant-level response at 25 years of age 
given they are in the first phase of growth +.(). +.(, +:( and ;<(, are the expected linear increase 
per year of age in the first phase of growth, the expected linear rate of increase after the change 
point, and age at which the linear perturbation to the initial trend occurs, respectively. =() is the 
level-1 residual (i.e. random within-person error for person i at age j and is independent and 
normally distributed (i.e. =()~JJK	A 0, DL: , and ?,(, ?.(, ?:( and ?67(	are the level-2 random 
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effects multivariate normally distributed with zero mean and variances DE,:  ,	DE.:  , DE::  and	D67:  
respectively and full covariance matrix shown in 1.3 . >,,, >.,, >:, and CP are the fixed effects 
(i.e. population average of each trajectory parameter). In this model, the level-1 residual 
variance DL: can be interpreted as the deviations around an individual’s trajectory and level-2 
residuals as between-participant variability in the overall intercept (DE,: ), in the rate of change 
before and after the change point ;<( (DE.:  and DE::  respectively), and in the change point itself 
(D67: ), respectively.   
 
4.3.2 Model with group-effect 
To explore heterogeneity in individual trajectories between groups of interests, the 
unconditional segmented growth model can be expanded by including time-varying covariates 
(TVCs) at level-1 and time invariant covariates (TICs) at level 2, while simultaneously 
adjusting for the effects of variables measured on participants at all time points. Whereas TICs 
directly predict the growth parameters, TVCs directly predict the repeated measures while 
controlling for the influence of the growth parameters 97, 132. If the TIC variable is a binary 
dummy grouping factor (“GRPi”), identifying participants coming from two identified groups, 
the model can be rewritten as follows:  
 
Level-1 model:         (4.4) 	"#'$%&'#() = +,( +	+.(/0#()	. (1 − 5678(/0#())) + 	+:( /0#() − ;<( . 5678 /0#()+ +. MN;() + =()  
  
 
Level-2 model:         (4.5) +,( = >,, + >,OPQR"<( + ?,( +.( = >., + >.OPQR"<( + ?.( +:( = >:, + >:OPQR"<( + ?:( ;<( = ;< + >67R"<( + ?67( 
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Where >,,, >.,, >:,	 and CP are the expected trajectory parameters for the reference group (at 
zero values for other potential covariates); >,OPQ,	>.OPQ, >:OPQ	/&K	>67 are the expected 
intergroup variations in these parameters for participants in the second group (i.e. respectively, 
in the mean response, in the linear age effect, in the deviation from linear rate after the CP and 
in the CP timing); and	?,(, ?.(, ?:( and ?67(		are the level-2 residuals person i for intercept, 
slopes, and age at the change point after controlling for group differences. To test for a 
between-group difference in one trajectory parameter only, ‘GRP’ can be included as a level-2 
predictor for the parameter of interest, and model all other growth parameters as random effects 
only (as in 4.2). For each of the p+1 individual growth parameters, additional participant-
specific covariates (TICs) can be included in a similar fashion to have multiple predictors at 
level 2 as follows: +Q( = >Q, + >QSTQSU. VS( + 5Q(, with VS(, the qth measured TIC; >QS ,the 
effect of the TIC VS( on the (p+1)th trajectory parameter; and 5Q(, the (p+1)th  random effect. 
The set of p+1 random effects for person i assumed to be multivariate normally distributed with 
covariance matrix of dimension $ + 1 ∗ ($ + 1), although simpler variance-covariance 
structures of the random effects can be considered during model building (i.e. mutual 
independence of the random effects). It is advised to standardise TVCs in order to stabilise the 
variance, improve normality of errors and linearity of the mean 132. The common assumption for 
the error structure is =()~JJK	A 0, DL:  but it can be relaxed to include time specific variances or 
residual error correlation such as AR(1) errors. 
 
The same approach can be used to expand the hierarchical piecewise trajectory model with 
grouping factors that have more than two levels. This is one of the possible approaches to test 
for a cohort-effect on the development of curvilinear responses over time when data arises from 
multi-cohort or accelerated longitudinal designs. If study participants belong to one of k 
possible birth cohorts, k-1 binary dummy variables are created to identify observations coming 
from people born in the same calendar year, and as in 2.2, these new k-1 grouping variables are 
introduced as level-2 predictors of the different trajectory parameters in the model. The binary 
dummy variables are introduced to sequentially shift the conditional means of each of the 
different trajectory parameters. The fixed effects will be the average trajectory parameters for 
the cohort chosen as the reference cohort in the study sample, and each	(>XYZYP[)...\]. 
coefficient will thus be interpreted as the variation in growth parameters in the corresponding k-
1th cohort compared to the reference cohort. The fixed effects will be the average trajectory 
parameters for the cohort chosen as the reference cohort in the study sample, and 
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each	(>XYZYP[)...\]. coefficient will be interpreted as the variation in growth parameters in the 
corresponding k-1th cohort compared to  the reference cohort.  
 
4.3.3 Trajectory divergence mechanisms  
The equation 4.4 above, allows for between-group difference in each of the four trajectory 
parameters of the piecewise model (i.e. intercept, slope before and after the CP, and CP itself). 
If the focus is to determine and model the divergence in the trajectories between group, then 
model 2.2 can be modified by forcing the intercept and slope before the CP to be invariant 
across groups by setting >,OPQ	and >.OPQ to zero at level 2 in equation 4.4. As illustrated in Fig 
4.1, three possible ways in which continuous outcomes trajectories can diverge over time 
between groups are illustrated: (1) Type 1, the two groups have different slope after the CP; (2) 
Type 2, the two groups have different change points; and (3) Type 3, the two groups have 
different CP and post-CP slopes. To test for group-difference at different stages of the outcome 
development, the approach consists of fitting these three possible conditional Bayesian 
hierarchical models to the data and comparing model fit to determine which mechanisms 
provide the best representation of the underlying development of the outcome between groups 
of participants. 
 
4.3.4 Bayesian estimation of the hierarchical piecewise model  
The main technical challenge in multilevel models with random change points is that the 
likelihood does not have a closed-form expression, and parameter estimation often requires 
approximate likelihood or sampling-based inference methods 197, 201. A Bayesian approach was 
chosen to estimate and summarize the parameters of interest in the conditional multilevel 
piecewise model (equation 4.4). With many random change points and participant-level 
trajectory parameters, repeatedly sampling from the conditional posterior distribution for each 
parameter in the model helps avoid the computational challenges of the ML framework when 
estimating models with a large number of random effects. In our illustrative example, all 
models were fit in RJAGS and R2JAGS in R, two packages that implement the Gibbs sampler 
for Bayesian inference and perform similarly to WINBUGS with the advantage of the flexibility 
of the R interface for the data manipulation and model formulation. In combined Bayesian 
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notation, the trajectory model with a binary grouping status ‘GRP’ as the TIC covariate 
interacting with all four trajectory parameters can be written as follows:  
 
 "#'$%&'#()~A%^_/`(_5(), D:)  (4.6) _5() = 	 ?,( + >,OPQR"<( + 	(?.(+>.OPQR"<()/0#()	+(	?:(+>:OPQR"<()(/0#() − (?67( + ;<OPQR"<())	 
 
To ensure that the effect of ‘group’ on each trajectory parameter can be either positive or 
negative and that the prior information does not dominate the likelihood, uninformative priors 
were set for the fixed group effects >,OPQ, >.OPQ, >:OPQ, ;<OPQ as	A	~ 0,10a . In vector 
notation, the random effects ?(	 = 	 ?Y(, ?.(	, ?:(	, ?XQ(	 bare assumed to follow a multivariate 
normal distribution with mean > and unstructured 4 x4 variance-covariance matrix	c as in 1.3, 
where	> = >,, >., >:, ;< b, the vector of population means. Traditionally in Bayesian analysis 
for random effects, InvWishart(Σ,k) is used as a conjugate prior to the unknown variance-
covariance matrix of multivariate normal distributions, where Σ is a positive definite inverse 
scale matrix of degree of freedom k 124. Inverse-Gamma (λ1, λ2) is often used as the conjugate 
prior to the variance of univariate normal distribution (i.e. for mutually independent random 
effects, and model error variance D:). Alternative prior distributions may be used for level 2 
variances of independent random effects or for the variance components of multivariate normal 
distributions 66, 124, 304. 
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Fig 4.1. Three hypothetic models of between-group divergence in curvilinear response trajectories over time.  
Red and black solid lines indicate the average response curve of participants belonging to one or the other group; dashed lines show the position and age at 
change point(s) for the two groups of participants, or the age at which trajectories diverge between the two groups. Graph obtained using simulated data.
C
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4.3.5 Significance of group-differences in trajectory parameters 
Testing for group-differences in trajectory parameters is equivalent to investigating 
the significance of the grouping covariates parameters at level-2 in the hierarchical 
change point model. In the Bayesian context, this is achieved by examining the 
posterior probability density for the ""#$%" parameters in 2.2. (i.e. 	"'#$%,	"(#$%., ")#$%.and "*+) of the estimated covariate parameters. For example, the effect of 
‘GRP’ on each trajectory parameter is significant if the 95% Bayesian credible 
intervals (CI) of the estimated regressors (i.e. each “	"#$%”) exclude zero, in which 
case, the estimated “	"#$%” can be interpreted as the shifts in each trajectory 
parameter in one group compared to the other group 124, 125, 305 . 
 
4.3.6 Model convergence, fit and adequacy 
The choice of the best model among the suite of candidate (conditional) Bayesian 
hierarchical models can be based on several criteria. 
 
The first criteria is the deviance information criterion DIC 306, 307, a Bayesian 
equivalent of AIC, is an index of quality of fit that is commonly used for Bayesian 
model comparison 126. DIC is a two-term measure of model fit or adequacy (, 
posterior expectation of the deviance) and a penalty term for increasing model 
complexity (pD, effective number of parameters), estimated as half the average within-
chain variance of the deviances in JAGS (DIC = ,+pD). pD can be interpreted as the 
expected reduction in uncertainty due to estimation. The interpretation of DIC is 
similar to that of the AIC as a summary of the relative fit between the model being 
tested and the ‘true’ model generating the data, while balancing model complexity 
with the information available from the data. The smaller the DIC, the better the fit. 
Appendix 4.7 shows a R function that was written to retrieve DIC directly from the 
MCMC samples in RJAGS.  
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A further way to investigate model adequacy in Bayesian analysis is to conduct 
posterior predictive checks of the likelihood of each fitted model. By looking for 
systematic discrepancies between real and simulated data, posterior predictive checks 
consist of simulating replicated data under each candidate model and comparing these 
to the observed data 66. Although posterior predictive p-values (PP p-values) are not 
suitable for model comparison, they offer a reliable index of stand-alone model fit in 
that they estimate the probability that the data could have been generated under the 
candidate model. A PP p-value close to 0 or 1 suggests the observed data has an 
extreme test statistic and that the model may not be adequate. A PP p-value close to 
0.5 means that the model predictions resemble the data. In this application, a posterior 
predictive plot and PP p-value were calculated in jagsUI for each candidate model, 
using the sum of residuals as a discrepancy measure. 
 
4.3.7 Study sample 
The application of the proposed Bayesian piecewise modeling approach is illustrated 
to investigate the divergence in child-to-adult trajectories of BMI between 
participants who do and do not develop adult T2DM in a well-studied ongoing 
population-based prospective cohort, the YFS 62. Details on study design and on the 
collection of cardiovascular risk factors between 1980 and 2011 are published 
elsewhere 60 and summarised in Appendix 4.2. 
 
In previously published research on the YFS cohort, Sabin et al. 292 showed that 
elevated BMI in children between 9 and 18 years was associated with an increased 
risk of developing T2DM in adulthood 292. Additionally, a sex- and insulin-adjusted 
mixed model incorporating participants ages as a categorical variable suggested that 
differences in average BMI values between those who do and those who do not 
develop adult T2DM tended to emerge during adolescence, becoming marginally 
significant from the age of 15 years onwards. In this approach, the between-group 
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difference at each age group was assessed by pairwise comparisons of the predicted 
Least-square means, and did not incorporate BMI trajectory information at the 
individual or population level. In contrast, the proposed hierarchical piecewise 
regression approach considers and makes full use of individual trajectory information 
to test for group-differences at specific stages of BMI development from childhood to 
adulthood. Unlike categorical approaches, the proposed growth model provides a 
clearer representation of the underlying pathological BMI development among those 
who develop T2DM in adulthood.  
 
In the illustration, data on 2540 YFS participants (1401 females and 1139 males) is 
included. These participants were followed-up a maximum of six times between 1980 
and 2011 (Fig 1. in Appendix 4.1). Information on adult T2DM status was collected 
on participants at their latest individual adult follow-up (i.e. dichotomous outcome 
coded 0 for participants without T2DM and 1 for those with T2DM in 2001, 2007, or 
2011). Included participants had at least one BMI measure available in childhood (i.e. 
in 1980, 1983 or 1986 between age 3 and 18 years). Participants had on average 4.98 
repeated measures of BMI over the study period, with 90.7% of participants having 4 
or more BMI measures (Fig 2. and 3. in Appendix 4.1 File). 88 included participants 
(3.5%, 44 females and 44 males) had T2DM in adulthood. BMI observations made 
among those aged 3 years in 1980 were excluded because only 3 participants in this 
birth cohort developed T2DM in adulthood. Furthermore, the lack of BMI measures 
between 3 and 6 years prevented modeling the downwards slope from infancy peak, 
nor the age at adiposity rebound, which usually occurs before age 6 years in normal 
weight children 14, 145. Using BMI data collected on participants aged 6 years and 
over, it was assumed that most included participants had already reached this 
important childhood milestone, and that a linear trend was thus an appropriate 
functional form to model childhood BMI growth from that age. Fig 4.2. shows that 
individual BMI responses are not linear between 3 and 49 years of age and that there 
are important between-person differences in BMI trajectories. 
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Since sex differences in childhood growth and pubertal timing are well documented 
308, subsequent BMI trajectory modeling between age 6 and 49 years was conducted 
among males and females separately 309. BMI, especially in adulthood, is slightly 
right skewed, but using log10 transformed BMI in the modeling approach presented 
below did not alter the conclusions drawn. For ease of interpretation, the results are 
presented using untransformed BMI only. 
 
 
Fig 4.2. Spaghetti plot of the individual trajectories of those with T2DM in adulthood  
(N=88) and those who did not develop T2DM in adulthood (N=2452).  
Red solid line: loess smoother curve indicating the average longitudinal trend in each group. 
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Visual inspection of the sex-specific smoothed BMI trajectories confirms the 
presence of a divergence between the two groups in adolescence (Fig 4.3). Compared 
with participants who remain healthy, those who develop T2DM seem to have greater 
average BMI levels by the time they are young adults, although it is unclear whether 
this divergence results from a group-difference in the timing at which the transition to 
a slower BMI growth rate happens (Type II divergence) from a group-difference in 
rate itself after puberty (Type I divergence), or from both (Type III divergence). 
 
 
Fig 4.3. Scatterplot of the life course BMI data (in kg/m2) stratified by sex.  
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Solid lines and grey bands: loess smoothed average trajectories and confidence intervals for 
each group (adult T2DM vs. non-T2DM group); dashed lines: age-specific averages of BMI 
levels. 
 
Although the distal outcome of ‘adult T2DM’ is the grouping factor of interest in this 
illustrative trajectory divergence analyses, it is also demonstrated how the same 
modeling approach can be used to investigate potential inter-cohort variation in 
childhood to adulthood BMI trajectories by considering models with ‘year of birth’ as 
a categorical level-2 predictor of each of the four trajectory parameters. Individual 
age- and sex-specific BMI Z-scores at baseline (in 1980) were also included as level-
2 predictors of each BMI trajectory parameters to investigate if systematic deviation 
from participants of comparable age and sex at baseline had any influence on the 
development of BMI trajectories later in life. All continuous covariates used in the 
analyses were standardised in order to stabilise the variance, improve normality of 
errors and linearity of the mean. 
 
Specific values used for the hyperparameters used in the illustrative analyses are 
provided in Table 4.1, with normal distributions parameterised in terms of a mean 
and a precision (i.e. 1/variance), and multivariate normal distribution parameterised in 
terms of a mean vector and precision matrix. While in principle - can be 
unstructured, when applied to the serial BMI YFS data, convergence for some 
parameters could not be reached when considering an unrestricted covariance 
structure between all four random effects in the unconditional change point model 
(equations 4.1 and 4.2), probably due to over parameterisation. Because initial 
analyses suggested a correlation between the slopes before the change point (b1i) and 
the difference in slopes after the change point (b2i), the model was constrained by 
including a non-zero correlation between these two random effects but setting 
independence for all other random effects, leading to a block diagonal structure	./	-	 
(Table 4.1). Based on DIC, this covariance structure was preferred over mutually 
independent random effects for both males and females (Appendix 4.5), and used 
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when expending the trajectory models with level 2 predictors. In this application, 
prior sensitivity was investigated by fitting the unconditional BMI trajectory model 
using three sets of priors for the hyperparameters (Appendix 4.5). Because that the 
choice of hyperparameters had a minor influence on the marginal posterior 
distributions, for subsequent (conditional) analyses, reported posterior estimates of 
parameters were estimated using the set of priors that yielded the lowest DIC in the 
sensitivity analyses (Table 4.1). In this set, the priors for the means of the change 
points were based on the sex-specific estimates that maximize the profile log 
likelihood for the fixed (population-average) breakpoints in the unconditional model 
(estimated at 16 years for females and 22 years for males, see estimation method in 
Appendix 4.4). Using these priors for the change point means also kept computation 
running times reasonable.  
 
Table 4.1 Priors and hyper priors used in the conditional trajectory models analyses.  
(Note that priors listed for "#$% refer to both "0)12#$% and all "3454$6 in the analyses). 
 
Second stage:  Priors for random effects 7(87)8 | "(") ~	;<= "(") , Σ@(@)  7'8	|"', AB'	~		=("', AB') EF8	|G*+, A*+	~		=(G*+, A*+) 
Third stage:  Hyperpriors for population parameters "(") ~	;<= 00 , 10 00 10  Σ@(@)~	invWishart 0.1 00 0.1 , 2  "'	~		=(25,0.001) and AB'	~	Gamma	(0.01,0.01)	 G*+	~		=(16,0.001) (for females) or G*+	~	= 22,0.001 (for	males) and A*+	~	]amma(0.01,0.01)	 
Chapter 4 – Bayesian Hierarchical Piecewise Regression and trajectory divergence between-groups 
 
 
146 
All  "#$%~	=(0,0.001) (i.e. "'#$%, "(#$%, ")#$%, EF#$%	for each growth parameter) "8^868_`a2bcdce34$f ~	=(0,0.001) 
And g8h|A8	~	=(0, A8) &	A8	~	Gamma	(0.01,0.01) 
 
Priors for time-varying variables included in the analysis (sex- and age-specific BMI 
z-scores at the first visit and birth cohort) were set to N~ (0,0.001) for all 
corresponding parameters (i.e. all  "3454$6 priors and "8^868_`a2bcdce34$f). To remain 
consistent with previous analyses of these data 292, time-varying measures of fasting 
insulin were log-transformed and standardised before being included as a level-1 
predictor in the Bayesian hierarchical models to improve right skewedness and to 
linearize its relationship with BMI. About 17% of the insulin measures were not 
available in the data. The missing data mechanism for insulin was considered non-
informative, as there was no reason to believe that the probability of an individual 
insulin measure being missing depended on the true value of this missing insulin 
observation (although it may be related to other observed variables for that 
individual). Insulin was therefore considered to be missing at random (MAR), and a 
prior was specified for this covariate 310. Since log (insulin) is approximately normally 
distributed, we specify a =~ G`4# 8^ei`8^ , A`4# 8^ei`8^ 	 	likelihood for log(insulin)i  
and place a vague prior on its variance (i.e. A`4# 8^ei`8^ ~	j_kk_('.''(,',''()	). Under 
this parametrisation, the posterior predictive distribution for Glmn 8^ei`8^  
and	Almn 8^ei`8^ 	 is informed by the observed part of the data only. Although 
individual insulin measurements change at each data collection point, by adding 
log(insulin) as a level-1 covariate in the multilevel model, the estimated relationship 
between insulin and BMI development remains constant across time 23. This is a 
reasonable assumption in this application, since data exploration did not suggest any 
systematic patterns of change in insulin levels at the intra-individual level as people 
age. That is, the age smoother estimate obtained by fitting a generalised additive 
mixed model had an estimated degree of freedom (edf) close to 1 and was not 
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significant (p-value >0.3), which did not suggest a non-linear relationship between 
log(insulin) and age 277. 
 
Approximate posterior distributions of the parameters of models considered 
throughout the analyses are obtained via MCMC simulations. Each model ran with 
four independent parallel chains of the Gibbs sampler (see Appendix 4.6 for an 
example of code). For each model, the first 50000 iterations were discarded in a burn-
in run, and the draws from the posterior were thinned by a factor of 10 to reduce 
serial correlation of the chains. The following 20000 iterations were used to obtain 
posterior distributions of the model parameters and individual-specific random effects 
by mixing the four sequences. Visual checking of multi-chain parameter MCMC 
iterations traceplots and the Gelman-Rubin diagnostic o <1.1 were used to assess that 
the chains converged to stationary distribution 124. Residual errors were plotted to 
confirm they approximately followed a normal distribution.  
 
4.4 Results 
4.4.1 Divergence of BMI profiles in T2DM and non-T2DM YFS 
participants  
Following the modeling approach presented in the Methods and the priors and their 
corresponding hyperparameters (Table 4.1), the following set of conditional Bayesian 
hierarchical piecewise models was fitted for each sex: unconditional (Model A), adult 
T2DM status adjusted intercept (Model B), adult T2DM status adjusted childhood 
slope (Model C), adult T2DM status adjusted adult slope (Model D), adult T2DM 
status adjusted CP (Model E), adult T2DM status adjusted CP and adult slope (Model 
F), adult T2DM status adjusted change point, childhood and adult slopes (Model G), 
adult T2DM status adjusted intercept, and change point (Model G), and a model with 
all four parameters adjusted for adult T2DM status (Model H). As mentioned above, 
previous research on these data set suggested BMI levels were not significantly 
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different between the two groups in childhood 292. Models C (i.e. group difference in 
childhood slopes) and B (i.e. BMI response consistently higher in one group across 
the life course) were thus fitted to demonstrate the modeling approach. An annotated 
extract showing the RJAGS code syntax used to fit Model E is available in Appendix 
4.6. 
 
For both sexes, the lowest DIC was obtained when fitting model E, which was also 
the best fitting model with PP p-values close to 0.5 (Table 4.2). Posterior density 
plots of all estimated parameters, traceplots of the four chains across the 20000 
iterations are shown in Figure A and B in Appendix 4.8. Additional model diagnostic 
statistics such as the Geweke, Gelman-Rubin, Heidelberger-Welch, and the Raftery-
Lewis diagnostics, respectively, are shown in Appendix 4.9, and a pairwise 
correlation plot of all model parameters is given in Appendix 4.10. 
 
 
The best fitting model, Model E, supported the Type II divergence mechanism where 
a difference in BMI levels emerged between the two groups due to a group difference 
in the change point timing. BMI growth rate in adulthood for both sexes was 
decreased by two-thirds compared with childhood (i.e. 0.67 vs. 0.18, and 0.61 vs. 
0.15 kg/m2 per year in childhood and adulthood for females and male, respectively), 
and participants who developed T2DM had similar BMI yearly rates of increase in 
adulthood compared with those who remained healthy (β2T2DM effect not significant in 
model F for both sex Table 4.3). However, females who developed T2DM reached 
their developmental transition in BMI rate on average 12.37 years later (Table 4.3). 
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Table 4.2. Analyses of the divergence in BMI trajectories between T2DM adults and 
non-T2DM adults: assessment of Bayesian model complexity (effective number of 
parameters pD), and fit (deviance information criteria DIC) for each candidate model.  
Reported for each model are DIC(pD), and posterior predictive p-values (PPp-val). Best 
fitting models are indicated in bold characters.  
 
 
Similarly for males, estimated BMI growth rates were not markedly different between 
the two T2DM groups in childhood or in adulthood, and were comparable with those 
estimated in females (Table 4.3). Compared with healthy adults, those who developed 
T2DM reached their slower BMI growth rate on average 6.47 years later. 
 
The effect of the time-varying covariate of insulin at level 1 was significant for both 
males and females, with a 1-sd increase in log(Insulin) resulting in a BMI observation 
increased by 2.6 and 2.8 kg/m2 respectively (i.e. exp("`4#	(8^ei`8^)),Table 4.3). To 
assess potential differences in the magnitude of the insulin effect as a function of 
between-person characteristics, model E was expanded by including an interaction 
between ‘adult T2DM status’ and log(insulin). For each sex, the estimated parameters 
 Model 
Females DIC(pD) PP p-val Males DIC(pD) PP p-val 
Unconditional A 	26910 (2544) 0.47 19837 (2223) 0.55 
T2DMgroup (int β0) B 26670 (2366) 0.45 19741 (2270) 0.43 
T2DMgroup (childhood slope β1) C 26780 (2510) 0.6 19865 (2247) 0.58 
T2DMgroup (Adulthood slope β2) D 26701 (2401) 0.58 19828 (2242) 0.62 
T2DMgroup (change point CP) 
T2DMgroup (CP + β2) 
E 
F 
26076 (2777) 
26504(2430) 
0.52 
0.6 
19762 (2213) 
19860 (2271) 
0.51 
0.54 
T2DMgroup (CP + β0) G 26436 (2751) 0.55 19896 (2242) 0.45 
T2DMgroup (all 4 parameters) H 26532 (2978) 0.52 19920 (2435) 0.51 
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were not statistically significant (95% CI included zero), suggesting that the effect of 
insulin on BMI was homogenous between the two groups and across sexs.  
 
The estimates of the variance-covariance parameters of model E, showed that the 
correlation between an individual’s BMI growth rate in childhood and adulthood is 
equal to 0.61 for females and 0.47 for males, suggesting that children who have 
greater yearly BMI increase rates also have greater adult rates of increase (correlation 
estimated as: 
p@(@) p@() ∗ p@)) , Table 4.3). The between-participant variation around 
the change point p*+ was comparable between males and females (Table 4.3). Fig 4.4 
shows the estimated population-average prototypical trajectories for each sex and 
T2DM group, obtained from the estimated parameters for Model E, along with 100 
trajectories predicted for each sex and T2DM group from Model E by Monte Carlo 
simulation. This illustrates a range of credible individual profiles generated under this 
model. 
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Table 4.3. Posterior mean parameter estimates for Bayesian hierarchical Piecewise BMI 
trajectory for best fitting trajectory divergence models in males and females (Models E).  
Posterior standard deviations (uncertainty in the parameters) are reported in brackets 
(Posterior mean (PSD)). Reported β0 coefficients are in kg/m2, β1 and β2 are in kg/m2 per year, 
CP and CP T2DM are in years. All σ coefficients are standard deviations for the corresponding 
growth parameters and the residual error. "lmn	(rstulrs) coefficients are in kg/m2 for a 1 sd 
increase in log(insulin) level.  
 
  
Females 
Model E 
mean (PSD) 
Males 
Model E 
mean (PSD) 
β0 I 26.5 (0.20) 27.46 (0.16) 
β1 S1 0.67 (0.012) 0.61 (0.01) 
β2 
CP 
S2 
CP 
-0.49 (0.015) 
16.02 (0.29) 
-0.46 (0.06) 
21.62 (0.42) 
CP T2DM 
σβ0 
σβ1 
σβ2 p@(@) p*+ p 
CP 
 
12.37 (1.21) 
2.07 (0.05) 
0.02 (0.005) 
0.07 (0.006) 
0.11 (0.05) 
3.1 (0.26) 
1.33 (0.02) 
6.47 (1.23) 
2.36 (0.07) 
0.06 (0.004) 
0.05 (0.004) 
0.14 (0.03) 
4.3 (0.2) 
1.21 (0.01)  "lmn	(rstulrs)  1.01 (0.04) 0.98 (0.03) 
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Fig 4.4. Sex-specific population average prototypical BMI trajectories for healthy and 
T2DM adults in the YFS cohort (solid blue and solid red lines, respectively) and 
prediction of 200 individual trajectories for each sex (100 per T2DM status group).  
The dashed trajectories were obtained by MC simulation using sex-specific posterior 
estimates of mean and variance of growth parameters for the best fitting models (Model E). 
In these predictions, time varying measures of log(insulin) were set to the average 
log(Insulin) observed in the cohort. 
 
For each sex and adult T2DM status group, Fig 4.5 shows a box and whiskers plot of 
the estimated individual BMI slopes obtained from Model E after the average change 
point in the healthy group and before the T2DM groups reach their average CP (i.e. 
slopes between 16.02 and 28.4 years in females, and slopes between 21.62 and 28.09 
years in males). It illustrates that individual rates of change after puberty provides 
better discrimination of participants who went on to develop T2DM from those who 
Chapter 4 – Bayesian Hierarchical Piecewise Regression and trajectory divergence between-groups 
 
 
153 
did not, compared with individual BMI levels at age 15 or 18 years for females, and 
ages 21 and 24 years for males (Fig 4. in Appendix 4.1). While the distribution of 
BMI levels at age groups surrounding the age at divergence overlap considerably, 
individual slopes allow to differentiate participants who have switched to a rate 
consistent with a normal slowing down of BMI development after puberty, from 
those who are still on the trajectory of increasing BMI. 
 
 
Fig 4.5. Box and whisker plots of fitted individuals random slopes between 16.02 and 
28.4 years for females (A); and between 21.62 and 28.09 years for males (B).  
Individual random slopes are estimated from the Bayesian hierarchical random change point 
model E. Solid lines in the boxplot indicate the group-specific median for the slopes 
(equivalent to the 50th percentiles of the posterior distribution). 
 
4.4.2 Effect of age-and sex-specific childhood Z-score on BMI 
trajectories 
To investigate if BMI z-scores in childhood predicted additional between-person 
heterogeneity in the trajectories of BMI, individual age-and sex-specific BMI z-
scores at the first clinic were included as continuous level-2 predictors of each of the 
four growth parameters in sex-specific models. The only significant effect observed 
was for the childhood BMI slope, with a 1-sd increase in BMI z-score associated with 
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a 0.056 (sd=0.012) and a 0.038 (sd =0.009) increase in childhood (in kg/m2 per year) 
for males and females respectively. This suggests that in the YFS sample, higher age- 
and sex-adjusted BMI at first visit in childhood were associated with faster BMI 
increase in childhood, but not with the age at transition in BMI development nor the 
change rate in adulthood. 
 
4.4.3 Between cohort heterogeneity in BMI trajectories 
Although the loess smoothed birth cohort-specific BMI profiles did not suggest 
obvious divergences in BMI trajectories between birth cohorts (Fig 4.6), five binary 
dummy variables identifying BMI observations of people born in different years (i.e. 
1962, 1965, 1971, 1974 and 1977) were introduced as level-2 predictors of BMI 
growth parameters in sex-specific models (with year 1971 as the reference level) in a 
similar manner, to test whether year of birth was associated with between-participant 
heterogeneity in the development of BMI from age 6 to 49 years. The following set of 
Bayesian hierarchical piecewise models was fitted separately in males and females: 
unconditional (Model A); birth cohort adjusted intercept (Model B); birth cohort 
adjusted childhood slope (Model C); birth cohort adjusted adult slope (Model D); 
birth cohort adjusted “Age at transition in BMI growth” (i.e. change point CP) 
(Model E); birth cohort adjusted change point and adult slope (Model F); and birth 
cohort adjusted change point, childhood and adult slopes (Model G). Convergence 
was not reached for the most complex model where all four trajectory parameters 
(i.e.β0, β1, β2, and CP) were adjusted for birth cohort effects. 
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Fig 4.6. Birth cohort-specific scatterplot and loess smoothed BMI profiles (solid lines). 
YOB: year of birth (in years).  
To improve readability, confidence intervals around cohort-specific smooth lines are not 
shown in this figure, and the upper range of displayed BMI data has been limited to 35 kg/m2. 
 
As can be seen in Table 4.4, the models with the lowest DIC varies between males 
and females. Increasing the complexity of the model did not improve model fit for 
males, and the lowest DIC is obtained for the unconditional model (Model A) 
suggesting that their life course BMI trajectory is more stable across birth cohorts. 
For females, model E marks a significant improvement in model fit, suggesting that 
the most significant predictor of between-cohort variations reside in the timing of the 
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CP, although the best model was obtained when adjusting for a cohort effect on both 
the adult BMI growth rate and CP. 
 
Table 4.4. Analyses of inter-cohort differences in BMI trajectories: assessment of 
Bayesian model complexity (effective number of parameters pD), and fit (deviance 
information criteria DIC) for each candidate model.  
 
Reported are: DIC(pD), and posterior predictive p-values (PP p-val) .Best fitting model for 
each sex indicated in bold characters. 
 Model 
Females DIC(pD), PP  p-val Males DIC(pD), PP  p-val 
Unconditional A 26910 (2544) 0.72 197837(2223) 0.52 
Birth cohort (int β0) B 26811 (2455) 0.70 19872 (2232) 0.70 
Birth cohort (childhood slope β1) C 26759 (2489) 0.34 19849 (2175) 0.63 
Birth cohort (Adulthood slope β2) D 26645 (2358) 0.67 19857 (2263) 0.68 
Birth cohort (change point CP) E	 26395 (2599) 0.60	 19862 (2211) 0.63 
Birth cohort (CP and β2 ) F	 26390 (2671) 0.49 19877 (2255)	 0.43	
Birth cohort (CP, β2 and  β1)	 G	 26783 (2775)	 0.48	 19945 (2342)	 0.53	
 
For each sex, the posterior mean parameter estimates of the best fitting model are 
presented in Table 4.5. The results show that most of the between cohort variation for 
females is due to slight trajectory differences in two specific birth cohorts: those born 
in 1968, who reached the transition to adult BMI growth rate on average 2.89 years 
later than the 1971 birth cohort, and those born in 1974 who had adult BMI yearly 
rates increased by 0.06 (e.g. adult slopes of 0.24 compared with 0.18 kg/m2 per year 
on average for the other 5 birth cohorts). Because inter-cohort differences in BMI 
development over age were not pronounced, cohort effect was not adjusted for the 
models estimating the effect of T2DM status on BMI. 
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Table 4.5. Posterior mean parameter estimates for best fitting birth cohort adjusted 
trajectory model for each sex; Model E for females and Model A for males.  
Posterior standard deviations in brackets. x 95% credible interval includes zero (reference 
cohort is 1971). Reported β0  coefficients are in kg/m2. All β1 and β2 coefficients are in kg/m2 
per year, CP coefficients are in years. σ coefficients are standard deviations for the 
corresponding growth parameters and the residual error. "lmn	(rstulrs) coefficients are in kg/m2 
for a 1-sd increase in log(insulin) level. 
 
Parameters Females  (Model E)  
mean (PSD) 
Males (Model A) 
mean (PSD) 
β0 26.92 (0.27) 26.510 (0.17) 
β1 0.63 (0.017) 0.62 (0.011) 
β2 -0.45 (0.02) -0.48 (0.01) 
CP 16.04 (0.5) 21.83 (0.46) 
β2 yob62 0.011 (0.01) x - 
β2 yob65 0.01 (0.01) x - 
β2 yob68 0.03 (0.025) x - 
β2 yob74 0.06 (0.02)  - 
β2 yob77 0.01 (0.03) x - 
CP yob62 0.24 (0.69) x - 
CP yob65 0.53 (0.4) x - 
CP yob68 2.89 (0.8)  - 
CP yob74 0.33 (0.8) x - 
CP yob77 0.7 (0.73) x - p@' 2.08 (0.05) 2.38 (0.06) p@( 0.01 (0.003) 0.07 (0.004) p@) 0.18 (0.005) 0.05 (0.01) p*+ 3.22 (1.07) 5.79 (0.21) p@(@) 0.11 (0.05) 0.14 (0.03) p 1.37 (0.03) 1.21 (0.02) "lmn	(rstulrs) 1.00 (0.04) 0.99 (0.03) 
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4.4.4 Simulations 
A short series of simulations was conducted to compare difference in estimates of the 
age at which the groups diverge when using the proposed Bayesian piecewise growth 
modeling approach compared to a more traditional approach based on pairwise 
comparison of LS-means estimated from a categorical mixed model. Repeated 
measure data was simulated from a Type II divergence model (i.e. group-difference 
in the change point timing only), using the posterior estimates of mean growth 
parameters for the model fitted for females (average parameters are set to:	"v= 
26.5,	"( = 0.67, CP = 16.02,  "j$4i%*+=12.37, ") = -0.49, matching Model E 
posterior estimates for females in in Table 4.3), and both a participant-level random 
effect (pf$$4$) = 2.77) and an observation-level residual error (pf$$4$) = 2.47).	Under 
this model, “CP”, the change point for the first group to depart from the population-
average childhood slope represents the age at which the two groups of participants 
diverge in their outcome trajectories (i.e. the second group maintain their increase his 
rate of change for 12.30 years longer). To closely resemble the YFS BMI data, ages 
at the first visit for each participant was simulated by randomly sampling baseline 
ages of real YFS participants. These simulated baseline ages were then subtracted by 
25 years, and data was simulated as 6 non-missing repeated measures 3, 6, 9, 21, 27, 
and 31 years later for each participant. 	We considered 3 scenarios of sample sizes for 
the number of participants in each group (group 1/group 2): (1) 100/100, (2) 50 /100, 
and (3) 30/100. For each of the three scenarios, we simulated 100 datasets and fitted 
both a mixed model with age as a categorical variable and the Type II divergence 
Bayesian Hierarchical piecewise model using the set of priors defined in Table 4.1 
For each piecewise model, we recorded the posterior estimate for the “CP” parameter, 
and for each fitted categorical mixed model, we applied pairwise comparison of the 
least-square means (LS-means) with Tukey adjustment for multiplicity to retrieve: (1) 
the earliest age at which the group-difference in means was found significant 
(p<0.05); and (2) the midway point between two consecutive ages that had a 
minimum number of non-significant differences in means before, and significant 
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differences in means after. The “midway point” method (2) is a potential alternative 
definition of age at which the group-difference appears in the LS means. Compared 
with the “ earliest age with p-val<0.05” method (1), the “midway” point definition 
minimises the impact of simulations where some tests show significance at a young 
age, even though tests for the surrounding ages are not. For each scenario, estimated 
ages at divergence using the three methods were averaged across the 100 simulations. 
Fig 4.7. presents the simulation results in term of the quartiles distribution and means 
of these estimates of age at divergence across the 100 simulations.  
 
When sample size decreases for one group of participants, the pairwise LS mean 
comparison method will tend to overestimate the age at divergence, with significant 
variability in the estimates arising due to random variation, especially when age at 
significance is determined using the first age at which a p-value <0.05 occurs (Fig 
4.7). In contrast, the hierarchical Bayesian piecewise model was less sensitive to 
sample size, and the true age at divergence is consistently within the estimated 
interquartile range of the produced estimates, indicating that the Bayesian trajectory 
divergence model outperforms the LS mean method in both accuracy and precision, 
regardless of the way “age at divergence” is defined from the model output. 
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Fig 4.7. Boxplots and mean “Age at divergence” (x) estimated across 100 simulations 
using the 3 methods. 
Bottom and top of the boxes are the lower (Q1) and upper quartiles  (Q3), respectively; the 
bands near the middle of the boxes are the medians, the lengths of the boxes represent the 
interquartile range (IQR =Q3-Q1); the upper whiskers are defined as min(max(x), Q3 + 1.5 * 
IQR)  and the lower whiskers as max(min(x), Q1 – 1.5 * IQR). Means of age at divergence 
across the 100 simulations for each scenario are indicated with empty circles. The horizontal 
dashed line indicates the true age at divergence set in the simulations (16.02 years old). 
 
 
4.5 Discussion 
Using the repeated BMI data from the YFS study, we demonstrated how Bayesian 
hierarchical piecewise regression (BHPR) modeling may be used to investigate 
between-group trajectory divergence in non-linear longitudinal outcomes that are 
marked by developmental transitions. 
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The non-linearity in BMI development across the life course is well documented in 
the literature, with changes in BMI corresponding to a number of identified 
developmental phases 188, 308, 311. In particular, BMI rate decelerates after puberty 
once people reach their adult height, translating to a leveling-off of the BMI 
trajectory in adulthood 163, 189. Although many recent applications have relied on such 
approaches 15, 145, 146, 165, 312, 313, traditional polynomial parameterisations of growth 
curve models are not well suited to analyse BMI development, especially if the focus 
is to identify transitional changes or determine divergence between groups. 
 
In contrast, piecewise linear regression is useful to break up a non-linear or 
curvilinear trajectory into separate linear components. For example, it allows 
comparison of the growth rate of different periods 191, marked either by a transitional 
change or separated by an experimental intervention point, creating a discontinuity in 
the outcome 182.  Piecewise regression is particularly suited to model BMI across 
different life-stages as its parameters map onto what is known about the natural 
development of BMI over time 25. Since ‘change points’ (or milestones in the case of 
BMI) are model parameters in the piecewise model, there is no need to use elaborate 
techniques to retrieve these points of interest 102, 103, 165. Piecewise models are also 
often preferable to more general continuous non-linear models if the number of 
repeated measurements per participant is small (i.e. 3 to 6 data points each as in 163, 
187) as is often the case in long-running observational prospective studies 145, 165.  
 
Piecewise linear trajectory models, also known as linear spline, broken-stick and 
change point models 314, have been used to model developmental and longitudinal 
processes both in the MLM and SEM methodologies, with a wide range of 
applications in cognition 154, 190, 200, 201 and HIV research 196, 198, 199, and in prostate 
cancer detection 193. Piecewise linear regression has been used to model sex-specific 
BMI developmental trajectories from childhood to adulthood in the multilevel setting 
163, 187, where the breakpoints represent the transition in BMI growth at adolescence, 
but the position of the change points in these applications was based on likelihood 
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profiling 315 or fixed at given ages chosen based on previous knowledge derived from 
developmental theory 187. In many instances, allowing individual heterogeneity in the 
change points, and modeling of the age at transition at the individual-level, is more 
likely to provide an adequate representation of non-linear processes over time, since 
for many continuous outcomes, participants may vary in the age at which their rate 
changes. 
 
This chapter demonstrated how piecewise multi-level regression models may be used 
to characterise the divergence mechanisms in non-linear responses between groups by 
modeling change points as random parameters and introducing grouping factors as 
predictors of the between-person heterogeneity in responses over time. Although the 
main goal was to characterise how and when the developmental patterns of BMI 
diverged between those who did and did not develop T2DM in the YFS, the utility of 
the method to investigate cohort effects in the outcome response was also 
demonstrated.  
 
Previous analyses of the YFS BMI and T2DM data considered categorical mixed 
models and tested for differences in the estimated BMI levels between the two T2DM 
groups at different ages by pairwise comparisons of the BMI predicted marginal 
means (i.e. Least-Square means) averaged over sex while adjusting for multiple 
testing (i.e. Tukey adjustment). This approach suggested that from age 15 years, the 
T2DM group had significantly higher BMI levels than those without T2DM. 
However, these analyses ignored the potential confounding effect of birth cohorts, 
and each existing “age” was treated as a non time-ordered categorical variable so that 
no inference could be made on individual or group-specific age-related BMI 
trajectories. Some age groups comprised those from up to five separate birth cohorts, 
while others only comprised those from a unique birth cohort (i.e. those aged 3 and 
27 years). Having substantially fewer participants in one or both T2DM status groups 
at some age points results in a decreased power to detect a significant difference 
between groups (i.e. the observed difference at age 27 years was not significant in 
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either sex-averaged or sex-adjusted LS-means, Table 1 and Fig 1. in Appendix 4.3). 
Because BMI development is known to progress differently in males and females, 
and the oldest and youngest cohorts in the YFS sample are almost a generation apart 
(~15 years), not taking these confounders into account may result in biased 
inferences. In fact, when adjusting the LS-means for sex, the age at which the 
difference between T2DM groups becomes significant is not as clear since in males 
the difference is not significant at age 21 and 24 years, suggesting the true divergence 
in BMI between T2DM groups for males occurs more around those ages (Table 1 and 
Fig 2 in Appendix 4.3). 
 
In contrast, the method illustrated here is not as sensitive to sample size and uses 
developmental theory to inform a model that allows between-group differences in 
within-person BMI trajectories at four possible levels for males and females to be 
examined (i.e. the overall BMI level, the childhood BMI growth rate, the adult BMI 
growth rate, and the age at which the transition between the two phases of change 
occurs). 
 
Applied to the example data set, this novel approach allowed us to characterise group 
differences in the non-linear development of BMI and to identify a critical age 
window at which weight intervention programs might be best applied to help reduce 
or delay the incidence of T2DM in adulthood. The findings support the theory that 
girls who keep on gaining weight at the same rate they did in childhood past the age 
of 16 years are more likely to develop T2DM in adulthood. Similarly, for males, the 
natural deceleration in BMI velocity occurs, on average, at 21 years of age. Those 
who stay on their childhood BMI trajectory past that age may be at increased risk of 
developing T2DM. 
 
Longitudinal studies often aim to make inferences on differences among average 
population health marker trajectories. Typically, this involves comparing change rates 
(or slope differences) in healthy participants vs. those with pathological development, 
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specific treatment conditions, or groups following certain lifestyle patterns. Using our 
Bayesian hierarchical piecewise regression approach, serial measures of patient’s 
weight and height, often routinely collected in paediatric, general practice, and 
healthy or well child clinics, could be used to determine if an individual is on a path 
to an healthy adult weight status, or if their BMI trajectory places them in a category 
more susceptible to develop adult metabolic conditions such as T2DM. 
 
4.6 Strengths and limitations 
 
This study has developed a novel GCM approach to assess the mechanisms of 
trajectory divergence between groups of participants in long-running observational 
studies where the response profiles are non-linear. Simulation studies demonstrate 
that this novel approach allows overcoming the limitations of traditional methods 
often used to estimation of the age at divergence between groups of continuous 
response trajectories in the literature. This method is also flexible and can be 
extended to model response profiles with more complex non-linear shapes, and can 
consider more than two groups.  
 
One potential limitation of this study is that the accuracy of the estimated age at 
divergence between the two groups may be hindered by the fact that BMI information 
was only available every 3 years. With higher resolution sampling (more available 
ages), the accuracy of the estimates would likely have been improved. Another 
limitation in this study is the lack of BMI measures in early childhood in the YFS 
(ages 3 and under). Under the premises of the foetal origin of adult disease 
hypothesis, it has been shown that birth size in conjunction with rapid compensatory 
growth in childhood can have an inverse relationship with health outcomes in later 
life 286. It would be interesting to conduct further research in a cohort study with 
many individual BMI measures from birth throughout childhood to investigate 
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whether distinctive early-life growth patterns can be distinguished in those who 
develop adult T2DM. 
 
4.7 Conclusions 
Studying within-person and between-person differences in the development of 
continuous outcomes as a function of age in long-running multi-cohort observational 
studies is crucial to better understand the natural history of healthy vs. pathological 
risk factor profiles. Due to the typically unbalanced data designs, loss to follow-up 
and expected non-linear responses, it remains methodologically challenging to 
analyse such data. When the substantial focus is on when and how two or more 
groups of participants grouped according to a distal dichotomous health outcome 
have diverged in their response trajectories, traditional parameterisations of 
curvilinear growth model do not allow to identify an age at which the group that 
developed the condition moved onto a different path compared to the group that 
remained healthy. In contrast, the hierarchical piecewise multi-level modeling enables 
the separation of multiple aspects of change in complex developmental processes 
such as individual and group differences in the rates of change at different periods, 
and potential heterogeneity in the timing at which individuals from identified groups 
enter each developmental phase, providing a powerful tool to help inform 
intervention. Understanding fine-scale longitudinal change in risk factors trajectories 
over time may improve prediction of adult-outcomes, compared to approaches that 
summarize risk factor information by only looking at one childhood value, or a 
change in risk factor between specific ages. The methodology illustrated here focuses 
on a response with only one developmental change point, but it could easily be 
extended to more complex non-linear responses with multiple transitions. 
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KEY POINTS 
 
• This chapter formulates a sequential Bayesian Hierarchical Piecewise Regression 
(BHPR) modeling approach to investigate and characterise the mechanisms of 
divergence in curvilinear longitudinal trajectories of continuous outcomes 
between two (or more) groups of participants.  
 
• The proposed approach is applied to determine the age at which YFS participants 
who develop adult T2DM diverge in their BMI trajectories compared with those 
who do not develop T2DM. 
 
• YFS participants whose BMI kept increasing at the same rates it did in childhood 
past age16 years for females and past age21 years for males may be at increased 
risk of developing adult T2DM.These data suggest weight interventions targeted 
at reducing the incidence of adiposity-related T2DM in adulthood should be 
undertaken before these ages 
 
• In simulation studies, compared to multiple pairwise comparisons of predictions 
from categorical mixed models, the proposed BHPR modeling approach is less 
dependent on sample size and estimates the age at divergence between-groups 
more accurately.  
 
• This chapter introduces and illustrates a novel person-based growth modeling 
approach based on linear-linear spline regression with random change points to 
investigate trajectory divergence between groups in long-term observational data, 
when the longitudinal continuous response is curvilinear.  
 
Box 2. Summary of key points from Chapter 4: Bayesian hierarchical piecewise 
regression models: A tool to detect trajectory divergence between groups in long-
term observational studies 
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6. QUALITATIVELY DISTINCT CHILD TO ADULT BODY MASS 
INDEX (BMI) TRAJECTORIES AND ADULT 
CARDIOMETABOLIC OUTCOMES 
 
6.1 Preface 
This chapter builds on results from chapter 5 that suggested potential residual variability in the 
way BMI developed amongst the adiposity four groups of interest in the YFS defined using a 
two time point approach. To overcome this, a life course approach was used to characterise 
underlying between-person heterogeneity in long-term BMI patterns in the YFS cohort. Unlike 
the person-based Bayesian Hierarchical piecewise regression approach used in Chapter 5, Latent 
Class Growth Mixture Modeling (LCGMM), a group-based approach to trajectory modeling, 
allows participants who share similar features in their longitudinal response profiles to be 
grouped. Unlike the GCM approaches used in chapters 3, 4 and 5, LCGMM can be viewed as a 
semi-parametric clustering approach that allows the identification of sub-populations that are 
unable to be identified when using a-priori stratification of participants. To refine our 
understanding on how longitudinal BMI influences cardiometabolic profiles in mid-adulthood, 
latent BMI trajectory classes identified with this approach were introduced as predictors of 
important adult cardiometabolic risk phenotypes: dyslipidemia, high cIMT, hypertension and 
T2DM in logistic regression models. 
 
In summary, in line with general aim 1 and 3 of this thesis, this chapter illustrates a relatively 
novel and complex person-based GCM approach, which allows the identification of clusters of 
distinct developmental trajectories that may exist in cohort study samples. In addition, it 
highlights how this approach can compliment other modeling strategies, resulting in enhanced 
understanding of the importance of developmental trajectories of cardiometabolic risk factors in 
the prediction of later cardiometabolic outcomes. 
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6.2. Introduction 
Over the past three decades the prevalence of overweight and obesity have increased 
substantially in both adults and children, and these trends are predicted to keep increasing 40, 41, 52, 
55, 60, 242, 249, 250, 290, 291, 332. Excess weight and weight gain in children are associated with adverse 
cardiometabolic profiles in cross-sectional studies, and childhood obesity is known to track into 
adulthood 146, 316, 317, 319, 321, 323. Childhood adiposity is associated with adverse long-term 
cardiovascular risk markers in adulthood and with increased CVD morbidity and mortality 40, 291, 
316, 319, 320, 355-357. 
 
To date, many epidemiologic studies examining associations between obesity and adult CVD 
risk have focused on assessing BMI at a single or limited number of time points 33, 43, 357, 358, 
ignoring the dynamic changes of BMI over time and the potential diversity in child to adult BMI 
developmental patterns.  
 
Recent developments in statistical techniques allow the investigation of the heterogeneity of 
BMI trajectories that may exist within a population 223, 226, 231, 234. A number of studies have 
prospectively explored BMI trajectories in the periods of early childhood crossing over 
adolescence using raw BMI, or BMI z-scores 8, 166, 234, 359, but none have examined a study period 
large enough to encompass the life course from young childhood until mid-adulthood. As a 
result, the progression of BMI from adolescence into adulthood is less well-described 16. Recent 
data suggest that obese individuals that become non-obese between childhood and adulthood 
have a normalisation of adult CVD risk 326. However, it is unknown if the shape of BMI 
developmental patterns across the life course, and in particular whether different patterns of high 
BMI incidence, resolution, or stabilisation from childhood to adulthood play a role in predicting 
cardiometabolic risk in middle-adulthood. From a public health perspective, determining 
whether developing or resolving abnormal BMI status at different ages is useful in predicting 
specific cardiometabolic risk in later life would help inform policy and interventions.  	
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Qualitatively different child to adult BMI trajectory patterns are likely to exist within 
populations.  We hypothesised that those with consistently higher BMI levels or faster rates of 
increase in BMI in early life would have greater CVD risk in mid-adulthood compared to either 
those who maintained an ideal BMI trajectory from childhood to mid-adulthood, and also those 
who develop overweight or obesity at an older age, and have experienced a shorter duration of 
adverse BMI status.  
 
Using data from the 31-year prospective YFS study in which participants have up to eight 
measures of BMI from childhood onwards, the aims of this study were to (i) identify subgroups 
of participants who share similar trajectories in BMI from childhood though middle age and (ii) 
determine the independent association of these BMI trajectories with high cardiomeabolic risk 
phenotypes in mid-adulthood.  
 
6.3 Methods  
6.3.1 Study sample  
This study considers a subset of 2631 YFS participants (1208 males and 1428 females) whose 
height and weight were measured on at least three occasions between 1980 and 2011 (1980, 
1983, 1986, 1989, 1992, 2001, 2007 and 2011), including the initial childhood measure (at 
baseline in 1980) and at least one of the adult follow-ups (2001, 2007, or 2011).  
 
BMI at each follow-up was calculated as óò~ℎí	 ö~ õò~ℎí) ê .	At baseline in 1980, 
participants were aged 3 to 18 years, and at the most recent follow-up in 2011 were aged 34 to 
49 years. On average, included participants had 5.4 individual BMI records and 72% had 5 or 
more BMI measures. BMI measures where excluded in 2001, 2007, and 2011 if participants 
were pregnant at the time of examination. Participants or their parents provided written informed 
consent, and the study was approved by local ethics committees (The Ethics Committee of the 
Hospital District of Southwest Finland) in agreement with the Declaration of Helsinki. 
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6.3.2 Definition of adult high cardiometabolic risk phenotypes  
Adult cadiometabolic risk outcomes of diabetes, hypertension, dyslipidaemia, and increased 
cIMT (indicating pre-atherosclerosis of the carotid artery) were assessed in 2001, 2007 and 2011. 
For each participant, the presence of absence of each CVD risk at the latest available 
examination was determined using the following definitions 326: Participants were classified as 
having T2DM if they had a fasting plasma glucose level of 7 mmol per litre (126 mg per 
decilitre) or higher, reported the use of oral glucose-lowering medication or insulin but had not 
reported having type 1 diabetes, or had received a diagnosis of T2DM from a physician at any of 
their adult follow-up examinations (2001, 2007 or 2011). Participants were classified as having 
hypertension if they had a systolic blood pressure of 140 mm Hg or higher or a diastolic blood 
pressure of 90 mm Hg or higher, or if they reported the use of blood pressure–lowering 
medication. High-risk lipid levels (dyslipidemia) was defined according to NCEP guidelines, as 
LDL-C levels of 160 mg/dl (4.14 mmol/l) or higher, HDL-C levels of less than 40 mg/dl (1.03 
mmol/l), and triglyceride levels of 200 mg/dl (2.26 mmol/l) or higher 245. For LDL-C, 
participants who indicated they were currently taking lipid-lowering medication were classified 
as having high-risk levels. cIMT in adulthood was measured in the left common carotid far-wall 
using established protocols 12, with high cIMT defined as values equal to or greater than the 90th 
percentile for age-, and sex-specific values 326. 
 
6.3.3 Statistical methods  
Identification of latent BMI trajectories  
Heterogeneity in the longitudinal development of BMI was investigated using LCGMM to 
identify subgroups of YFS participants who shared similar underlying BMI trajectories between 
6 and 49 years of age. A series of LCGMMs considering several polynomial specifications of 
BMI as a function of age and a number of variance-covariance structures for the random-effects 
were fit using the lcmm package in R 360, which regroups a series of functions to estimate latent 
class mixed models for Gaussian and non-Gaussian longitudinal outcomes 361. As recommended 
in the literature 220, 225, 226, 231, 362, various LGCMM models were fit and compared before 
choosing a final model. Participants’ ages in the analyses were centrered around 25 years, the 
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mean age in the population sample, to facilitate the interpretation of the intercepts and improve 
numerical stability. Three possible polynomial specifications were considered to describe the 
within-person shape of the longitudinal BMI response as a function of age: a linear, and also a 
quadratic and a cubic specification, which allowed for curvilinear developmental patterns of 
BMI. Each of these polynomial models (order 1 to 3) were respectively modeled as a one to 
seven class solution, starting with a standard one-class heterogeneous mixed model where all 
subjects are assumed to follow the same underlying trajectory over time, and increasing the 
number of latent classes progressively.  
 
For each of these models the specification of the intercept and slope(s) variance (i.e. random 
effects) was considered to allow for between-person heterogeneity in the BMI response. To limit 
the number of potential models tested, the variances of random intercept and slopes were 
constrained to be equal across classes, and the systematic approach of Feldman et al 363 was used 
to relax the constraints on the variance/covariance matrix. The linear, quadratic, and cubic 
growth mixture models were tested respectively with intercept variance only and with intercept 
and slopes variances. When relevant, each model was tested with all possible covariances 
estimated, and with all covariances constrained to zero. In general, the more estimated 
covariances; the fewer classes could be successfully extracted from the models, that is models 
with large number of classes failing to converged (i.e. singular matrix) or were unable to 
generate standard error of parameters. However, all classes could successfully be estimated when 
the covariances of all random effects were constrained to zero for all models (data not shown). 
All models presented in Appendix 6.2 were defined with a block diagonal structure for the 
random intercept and slopes, which represent varying but uncorrelated growth parameters.   
 
As recommended by Proust-Lima et al. 361, models with two or more classes were ran several 
times with different sets of initial values to avoid convergence towards local maxima, a problem 
commonly encountered when fitting mixture models. Each model was fit with (1) initial values 
generated from the maximum likelihood estimates of the corresponding 1–class model, (2) initial 
values randomly generated from the asymptotic distribution of the corresponding 1-class model, 
and (3) initial values obtained via grid searching (with a maximum of 20 iterations from 30 
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random vectors of values from the 1-class model)361. The results of the series of models that 
were fitted solely to ensure the correct convergence of the program algorithm towards global 
maximum of the log-likelihood are not shown. The models results presented in chapter 6 are 
those of growth mixture models that showed satisfactory evidence of convergence. 
 
For each model involving latent classes, posterior class-membership probabilities were used to 
obtain a posterior classification of the participants in each latent class to evaluate goodness-of-fit 
and to characterise the discrimination of latent clusters (See lcmm documentation for details on 
post-fit computations). The proportion of subjects classified in each class with a posterior 
probability above a threshold of 0.7 was also retrieved and indicates the proportion of subjects 
unambiguously classified in each latent class. Thirdly, the mean of posterior probabilities of 
belonging to the latent class among subjects classified a posteriori in each class was recorded 
(i.e. mean probabilities between 0.8 and 1 indicate a good classification). Model fit was further 
assessed by examination of model residuals and plots of weighted mean predictions of each 
model. As recommended in the literature, the choice of the best fitting model was based on BIC 
values, and on these other index of goodness of fit and discrimination 361. When comparing 
different LCGMM models, it is recommended that to be considered a significant improvement 
over an existing model, a reduction of BIC of at least 10 points is necessary in the competing 
model 229.The best fitting model in terms of BIC were the 7 class quadratic and cubic models, but 
these models had poor discrimination for some classes (mean posterior probabilities <0.65 for 
several classes, less than 60 % of participants classified in several classes with a posterior 
probability above 0.7). Furthermore, when seven classes were considered, some classes 
contained less than 1% of participants. In contrast, the six class quadratic model had only a 
slightly larger BIC, a higher mean posterior probability in all six classes (> 0.78), and a high 
proportion of participants were classified in each of the six classes above the 0.7 threshold (70% 
of participants or above in each class). The parameter estimates of the fixed and random 
components of the six class quadratic mixture model are given in Appendix 6.3. The necessity of 
random intercept and slope variance within-class was assessed for this final model, but the 
results of these further analyses are not shown since these additional models did not result in a 
sufficient increase in BIC to justify class-specific variance components.  
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Additional details on the strategies used for model building, including choice of specification of 
functional form and variance-covariance structure of the model, identification of the optimal 
number of distinct latent classes, and the computation and analyses of post-fit indices is given in 
the Appendix 6.1. 
 
Association with adult cardiometabolic outcomes 
To determine the association between trajectory group and the different CVD risk outcomes in 
adulthood, the trajectory group memberships identified by LCGMM were introduced as 
predictors of each adult cardiometabolic risk in Poisson regression models with robust error 
variance 364. In addition, for a subset of 2421 participants (N=1073 males), who had been 
assessed for all 6 high CVD risk phenotypes in mid-adulthood, a combined cardiometabolic load 
risk-score ranging from 0 to 6 was calculated as the arithmetic sum of the number of adverse 
cardiometabolic outcomes recorded for each participant at his/her latest adult follow-up 
(Appendix 6.6). The association between the BMI trajectory groups with the combined CVD-
risk load variable (collapsed to 0, 1, and 2 or more risk phenotypes) was assessed using ordinal 
logistic regression. The adjusted models included year of birth (YOB) and sex as covariates. 
Model fit was assessed using the Hosmer-Lemeshow goodness-of-fit chi-square statistics. 
 
6.4 Results 
6.4.1 Latent Class BMI trajectories 
Using BIC criterion, class membership posterior probabilities, and classification were used to 
assess the goodness-of-fit of the competing LCGMM models (Appendix 6.1 and Appendix 6.2), 
six discrete life course BMI trajectories were identified among the 2631 YFS participants 
considered in the analyses (Fig 6.1 and Fig 6.2): 55.2% of participants maintained normal weight 
status throughout follow-up  (‘normal stable’ group (class 1, N=1453)), 33.4% followed a 
trajectory of increasing BMI that lead to overweight from the mid 30s (‘progressively 
overweight stabilising’ group (class 3, N=879)), 4.2 % had BMI levels increasing rapidly from 
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childhood, resulting in an overweight status in early adulthood and worsening obesity by early-
mid adulthood (‘progressively obese increasing’ group (class 4, N=110)), 4.3% were borderline 
overweight in early childhood, overweight in mid-childhood and obese but stabilising by age 20 
years (‘rapidly overweight stabilising obese’ group (class 5, N=113)), 1.2% followed a trajectory 
of persistent and increasing obesity throughout their life course, leading to BMI levels ≥ 40 
kg/m2 in mid-adulthood (‘overweight / obese persisting’ group, (class 6, N=33)), and 1.6% were 
overweight or obese in childhood increasing to obese by 25 years but progressively reversed 
their elevated BMI status between 30 and 50 years of age (‘high BMI resolving’ group (class 2, 
N=43)). Although some of these identified classes have low percentages of participants (<6%), 
they are highly discriminated with high mean a posteriori probabilities and high posterior 
probabilities (Appendices 6.1 and 6.2).   
 
The parameter estimates of the fixed and random components of the six-class quadratic mixture 
model are given in Appendix 6.3. Basic characterisation of the participants in the identified 
classes showed that although the age range (6 to 49 years) was adequately represented in all the  
latent classes, there were differences in the average age across follow-ups, as well as the mean 
age at baseline among the classes. Sex differences were noted in specific classes of trajectories. 
For example, females were over-represented in the normal stable trajectory group (class 1), but 
the groups that stabilised their BMI in adulthood (i.e. ‘progressively overweight stabilising’ and 
‘rapidly overweight stabilising obese’ groups (classes 4 and 5, respectively)) contained more 
males (Table 6.1). The incident “progressively obese increasing” group and the 
“overweight/obese persisting” groups also had more female participants, although females were 
also more likely than males to belong to the group who reversed their BMI status in mid-
adulthood (high BMI resolving group, class 2, Table 6.1).  
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Fig 6.1. Class-specific mean predicted trajectories as a function of age in the best fitting six-class body mass index (BMI) growth 
mixture model (LCGMM) (solid lines) in the Cardiovascular Risk in Young Finns Study. Dashed lines indicate estimated 95% 
confidence intervals, and shaded background areas indicate normal, overweight, and obese BMI status across the life course 
(International childhood sex-specific cut points 338, were averaged across sexs at each age to improve readability). Number of 
participants attributed to each class is shown.  
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Fig 6.2.  Latent trajectory classes identified for body mass index (BMI) between 6 and 49 years of age in the Cardiovascular Risk in 
Young Finns Study through latent class growth mixture modeling (LCGMM). Shown are the individual BMI profiles colour-coded 
according to posterior class membership (thin lines), and the loess-smoothed BMI trajectories for the six identified latent subgroups 
obtained by smoothing across all BMI data attributed for each class (solid lines). 
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Table 6.1. Basic demographic characteristics of YFS participants classified in the six identified latent BMI trajectory groups.  
 
 
Normal 
stable 
Complete High 
BMI resolving  
Progressively 
overweight 
stabilising 
Progressively 
obese 
increasing 
Rapidly 
overweight 
stabilising 
obese 
Overweight 
/ obese 
persisting 
P-
value* 
 (class	1)	 (class 2) (class 3) (class 4) (class 5) (class 6)  
 N=1453 N=43 N=879 N=110 N=113 N=33  
Mean age (sd) 25.1 (12.8) 22.3 (12.6) 21.4 (12.0) 23.6 (12.7) 24.7(12.5) 24.7 (12.5) 0.001 
Min(age) –Max(age) 
(years) 
6-49 6-49 6-49 6-49 6-49 6-49 1 
Mean baseline 
age (sd) (years) 
12.1 (4.2) 11.8 (4.0) 9.9 (3.8) 11.4 (4.0) 11.9 (3.9) 9.9 (3.6) <0.001 
Male, % 37.7 46.5 59.6 39 53.1 36.3 0.02 
* Reported p-values from anova F-tests (for comparisons of means) and of chi-square tests of independence (for the comparison of 
proportions).
Appendices 
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6.4.2 Association of BMI trajectory groups with high cardiometabolic risk 
phenotypes 
Appendix 6.5 shows the prevalence of adult T2DM, hypertension, high-risk LDL-C, HDL-C, 
triglycerides level, and high-risk cIMT (marker of pre-atherosclerosis) in the subset of YFS of 
participants considered in the analyses. The prevalence of all 6 adult cardiovascular outcomes 
increased substantially between the group of participants who maintained ideal BMI levels 
across the life course (class 1) and the other BMI trajectory classes, with the highest prevalence 
obtained for the ‘persistently overweight/obese’ group (class 6), (Table 6.2). Compared with 
participants who were classified in the stable normal BMI trajectory class (class 1), all other 
classes had significantly higher risks for all considered adult outcomes, except for participants in 
the high BMI resolving group (class 2, N=43), for whom the difference in risk for T2DM, 
hypertension, and abnormal lipid levels was not statistically significant (Table 6.2).  
 
Participants who completely resolved BMI in mid-adulthood (class 2, Table 6.2), had lower risks 
for developing adult T2DM than those who became overweight (class 3). Among those obese in 
adulthood, participants whose BMI kept increasing in adulthood (classes 4 and 6) had greater 
risks of developing T2DM compared with those whose obesity developed sooner in life but 
stabilised in their early adulthood (mid 30s) (class 5, Table 6.2). 
 
For hypertension, the risk ratios were also smaller in those who normalised their BMI by mid 
adulthood (class 2) compared with the incident overweight participants (class 3), but they were 
incremental in classes 4, ,  and 6, suggesting the number of years spent obese may be an 
important determinant of adult hypertension (Table 6.2).  
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Table 6.2. Adjusted risk ratios (RR), 95% confidence intervals (CI) and Wald z-statistic p-
values of the associations of BMI trajectory groups with high-risk cardiometbolic outcomes in 
adulthood and percent (%) of participants with the high risk outcomes in each BMI trajectory 
group.  
 
Outcome and Latent 
BMI Trajectory group 
% RRc 95% CIc P-value  
Type 2 diabetes 
Class 1a 1.4 1b - - 
Class 2 2.6 2.13 0.14 – 8.23 0.31 
Class 3 3.5 2.49 1.38 – 4.58 0.002 
Class 4 17.1 13.05 6.71 – 25.17 6.75. 10-15 
Class 5 12.6 9.33 4.39 – 19.08 1.1.10-9 
Class 6 20.1 19.45 8.63 – 31.16 7.5.10-10 
Sex Female 0.51 0.87 0.54 – 1.39 0.58 
YOB - 0.88 0.83 – 0.92 7.9.10-7 
Hypertension     
Class 1a 19.3 1 -  
Class 2 17.1 0.76 0.23 – 1.80 0.25 
Class 3 26.9 1.64 1.36 –1.99 2.3.10-9 
Class 4 33.1 2.20 1.52–3.08 1.1.10-6 
Class 5 36.5 2.35 1.65–3.26 2.9 10-8 
Class 6 40.6 3.18 1.77–5.35 1.6 .10-5 
Sex Female 41.3 0.54 0.44–0.66 3.3 10-9 
YOB - 0.89 0.87 –0.91 2.1 10-16 
High-risk cIMT     
Class 1a 7.8 1b -  
Class 2 25.1 3.37 1.80 –6.39 4.3 10-6 
Class 3 13.3 1.70 1.30–2.22 4.1 10-3 
Class 4 22.3 2.68 1.78 –4.40 1.3 10-6 
Class 5 24.5 3.27 2.11 –4.90 6.6 10-9 
Class 6 25.8 3.49 2.32 –5.71 0.002 
Sex Female 0.52 0.97 0.75–1.25 0.8 
YOB  0.98 0.95–1.01 0.2 
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Outcome and Latent  
BMI Trajectory group 
 % RRc 95% CId P-value (*) 
High-risk LDL-C  
Class 1a  9.4 1b - - 
Class 2  10.5 1.03 0.14 – 1.10 0.10 
Class 3  16.5 1.47 1.16 – 1.84 3.5. 10-5 
Class 4  17.9 1.59 1.37 – 1.95 0.04 
Class 5  18.7 1.65 1.21 – 2.63 0.006 
Class 6  19.8 1.78 1.11 – 2.72 0.023 
Sex Female  34.3 0.41 0.32 – 0.52 1.4.10-12 
YOB - 0.93 0.91 – 0.96 9.3.10-8 
High-risk HDL-C     
Class 1a 11.4 1 -  
Class 2 14.6 1.07 0.72 – 1.19 0.16 
Class 3 26.3 1.57 1.16 –1.84 2.1.10-11* 
Class 4 41.8 1.75 1.04–12.1 1.1.10-16 
Class 5 39.9 1.72 1.10 –2.72 1.9 10-9 
Class 6 40.6 1.77 1.56–2.96 2.45 .10-3 
Sex Female 51.5 0.26 0.21–0.32 2.3 10-12 
YOB - 1.01 0.98 –1.02 0.49 
High-risk triglycerides     
Class 1a 4.8 1b -  
Class 2 4.5 0.48 0.09 –2.4 0.42 
Class 3 17.7 3.06 2.31–4.10 2.1 10-15 
Class 4 27.7 5.62 3.61 –8.53 3.6 10-16 
Class 5 25.6 4.73 3.02 –7.23 4.3.10-15 
Class 6 18.9 4.03 1.56 –8.56 0.0001 
Sex Female 28.4 0.34 0.25–0.45 4.1 10-12 
YOB  0.96 0.94–0.99 0.01 
 
aLatent BMI trajectory classes are as follows Class 1, Normal stable trajectory (N=1359); Class 2, high 
BMI resolving (N=43); Class 3, progressively overweight stabilising (N= 879); Class 4, progressively 
obese increasing (N= 110); Class 5, rapidly overweight stabilising obese (N= 113); and Class 6, 
overweight/obese persisting (N=33). 
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b: The normative BMI trajectory class (class 1) is the reference group. Unadjusted models with only 
the trajectory groups were also fit but estimated Relative Risk Ratios (RRs) were not significantly 
different and the AIC suggested that the sex-and year of birth (YOB) adjusted models fit the data 
better (data not shown). 
cThe regression coefficients for each latent class, can be interpreted as the changes in relative ratios for 
belonging to a given class, vs. the reference latent class (class 1). For year of birth (YOB), the 
coefficients give the change in relative ratios of the outcome for a one unit increase in the predictor 
variable.  
dThe 95% CI for the relative risks was obtained by log-likelihood profiling of the robust standard 
errors. 
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Resolution of an elevated childhood BMI by mid-adulthood was not associated with a 
normalisation of the risk for cIMT, with participants in the high BMI resolving group (class 2) 
having nearly 3.5 times the risk for abnormal cIMT compared with participants in the normal 
stable BMI trajectory group (Table 6.2). Only those classified in the persistently obese increasing 
group (class 6) were at greater risk of developing greater cIMT in adulthood.  
 
Compared with participants who followed a normative BMI trajectory throughout their lives 
(class 1), the risk of raised adult LDL-C levels was not significantly elevated among participants 
in the high BMI resolving group (class 2, Table 6.2), but they were approximately 1.5 higher risk 
in the incident overweight group (class 3). Those who were obese in adulthood were almost 
twice the risk of developing abnormal LDL-C levels, regardless of their BMI latent class (i.e. 
classes 4, 5 and 6). Participants who became overweight or obese had greater risks of having 
lower HDL-C levels in mid-adulthood, especially those whose obesity persisted from childhood 
to adulthood (class 6, Table 6.2). A high circulating triglyceride level was approximately 3 times 
more likely in the incident overweight group (class 3) compared with the normal stable group 
(class 1), but those with the highest risk ratio were the participants who became obese in 
adulthood (class 4, Table 6.2). 
 
For the cumulative cardiometabolic risk load, the predicted probability plot derived from the 
proportional odd ratios estimated for the sex- and adult-age-adjusted ordinal logistic model (Fig 
6.3) shows that the probability of observing a null cumulative cardiometabolic risk load (i.e. no 
cardiometabolic high-risk phenotypes in adulthood) decreases from 0.7 to 0.2 as participants 
BMI trajectory changes from normative (‘normal stable’ group, class 1) to the most adverse class 
(‘overweight/obese persisting’ group, class 6). That is, compared to those who maintain ideal 
BMI levels from childhood to adulthood, following a trajectory with consistently high or 
increasing BMI levels decreases the probability of having an ideal cardiometabolic profile in 
adulthood. Although the highest probability of having a single high-risk CVD phenotype in mid-
adulthood was observed for participants who progressively became overweight (class 3), the 
probability of having 2 or more high-risk phenotypes in adulthood was 11 times higher in the 
‘overweight/obese persisting’ group (class 6) compared with the ‘normal stable’ group (class 1).
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Fig 6.3. Predicted probability of having a cumulative cardiometabolic risk load of 0 (N=1360), 1 (N=540), and 2 (N=521) or more in 
the Cardiovascular Risk in Young Finns Study for each latent body mass index (BMI) trajectory class. Data derived from 
proportional odd ratios of a sex- and adult age-adjusted ordinal logistic model.
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6.5 Discussion 
In this chapter, LCGMM was used to identify six distinct underlying BMI developmental 
patterns in the YFS from age 6 to 49 years old, and determined the association between these 
identified patterns and adult risk of T2DM, hypertension, dyslipidemia, and high cIMT. The 
identified BMI trajectories were not readily identifiable in previous studies that used the 
subjective clustering of YFS participants into 4 a priori groups based on pre-determined BMI 
cutpoints at one point in childhood and one point in adulthood. Compared with previous 
approaches, this analysis allowed discriminating between truly normative BMI profiles (class 1) 
and BMI trajectories that lead to progressive but stabilising overweight status in adulthood (class 
3). In addition, two groups with different patterns of obesity incidence were identified. One 
group of YFS participants had early onset of obesity but stabilisation to BMI levels to ~35 kg/m2 
in middle adulthood (class 5), and a second group that had later obesity onset, with adverse 
weight status appearing in their 20s, and BMI increasing throughout adulthood to reach worse 
asymptotic levels by mid-adulthood (class 4). 
 
Higher trajectories of BMI were generally associated with increased cardiometabolic risk in 
middle age, which is consistent with findings of several studies that have shown excess BMI-
years to increase risk of diabetes 16, 326, 365 and CVD risk.326. Participants who were normal 
weight in childhood but progressively became overweight in young adulthood (i.e. class 3), a 
group of individuals that could not be identified in previous analyses of this cohort in chapter 5 
33, had an increased risk in adulthood for all six high-risk cardiometabolic phenotypes 
considered. The prevalence of deleterious adult cardiovascular outcomes of developing T2DM, 
dyslipidemia and hypertension were higher among participants classified as progressively 
overweight (class 3) compared with participants who were obese in early life but who became 
normal weight by middle-age (class 2). These data suggest that completely reversing high BMI, 
even after childhood may lead to better outcomes than remaining stable overweight. However, 
incident overweight participants had less risk for high cIMT compared with the high BMI 
resolving group (class 2), suggesting that deleterious BMI status in early life may alter arterial 
structure in a way that is not reversible, even when normalising weight status later in life 52. This 
finding is in keeping with a number of recent clinical studies suggesting that childhood obesity 
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may initiate pathogenic processes in the arterial wall that are persistent even in the face of 
improvements in body weight in later life 48, 50, 358, 366, 367. Alternatively, childhood obesity may 
accelerate the progression of atherosclerosis in youth, leading to irreversible, established 
atherosclerotic lesions that can no longer be reversed by weight normalisation 47. The findings 
reported in this chapter are consistent with an observational study that reported that elevated 
BMI in adolescence was associated with the risk of later coronary heart disease (CHD) 
independent of adult BMI levels. The authors concluded that the processes causing incident 
CHD, particularly atherosclerosis, developed gradually such that a longer history of relative 
overweight /obesity starting earlier in life contributed additional risk 16.  
 
Of all cardiovascular outcomes considered, the highest relative risks were obtained for T2DM 
for two latent classes, the progressively obese increasing group (class 4) and the persisting 
overweight/obese increasing group (class 6) (RRs of 13 and 19, respectively, against other RRs < 
3), suggesting that the absence of BMI stabilisation in adulthood, rather than the age of obesity 
onset, is very strongly associated with adult T2DM risk. This is consistent with an observational 
study reporting that the risk of diabetes was mainly associated with increased BMI levels close to 
the time of diagnosis 16. In contrast, the results of this study suggest that the cumulative burden 
of the number of life-years spent obese may be a stronger predictor of the adult risk of 
hypertension.  
 
The findings also suggest that the mechanism by which excess BMI may increase circulating 
LDL-C and triglyceride levels is primarily immediate and that a longer exposure to obesity does 
not additionally increase the risk of developing abnormal lipids beyond the level of BMI 
attained. Finally, analyses of the combined cardiometabolic outcomes indicate that completely 
resolving high BMI in later life may benefit cumulative cardiometabolic risk load in adulthood, 
with high BMI resolving participants (class 2) more likely to have no residual adult risk 
compared with incident overweight participants (class 3) who in comparison, had over 50% 
chance of having one or more cardiometabolic outcomes. 
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The current analysis provides additional clinically important granularity to the previous analyses 
of the YFS that suggested that overcoming excess adiposity in the time between childhood and 
adulthood leads to a normalisation of all cardiovascular risk phenotypes. However, since the 
study participants were subjectively categorised into four groups based on their movement in 
BMI status between two examinations (performed up to 27 years apart in childhood and 
adulthood), it was not previously possible to investigate the potential between-participants 
differences in BMI profiles that may have occurred in the interval between those two 
measurement time-points 326. The way the ‘high-adiposity resolving’ group was defined in these 
previous analyses, did not allow to distinguish between ‘true adiposity resolvers’ (i.e. overweight 
or obese children who became normal weight adults), ‘adiposity improvers’ (i.e. overweight or 
obese children who became normal weight or overweight adults, respectively), or ‘overweight 
persistent’ (i.e. those overweight children who became overweight adults but did not develop 
obesity). Participants classified in a given BMI group, may also have resolved or developed 
elevated BMI at very different periods in their lives, in which case the age-BMI curves estimated 
for each group of interest may in fact be an amalgam of qualitatively different BMI pathways 223, 
362. In addition, despite a high prevalence of adult overweight in the different population samples 
(up to 36% overweight adults in the YFS, Appendix 6.4), the previous approaches collapsed 
adult overweight and normal weight into a single weight status category, preventing the 
discrimination of cardiometabolic risk between incident overweight and truly normative BMI 
trajectories. It is therefore possible that the definition used for the ‘high-adiposity resolving’ 
group and the potential misclassification of participants in this group, prevented the detection of 
the residual effect of elevated childhood BMI on adult cIMT risk in the previous analyses of this 
data 33. 
 
Unlike traditional person-centered growth modeling approaches (including the Bayesian 
Hierarchical Piecewise regression approach used to model BMI trajectories in the YFS cohort in 
Chapter 5), group-based trajectory modeling techniques such as LCGMM can be used 
disentangle underlying population heterogeneity and move beyond a ‘one size fits all’ approach 
to describe risk factors trajectory development across the life course 231, 232, 368. In classic 
approaches, the fundamental assumption is that all participants’ trajectories can be represented 
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by a unique curve, so that any potential trajectory variations within-group will thus be absorbed 
by the model’s random effects, representing the unexplained inter-individual variability around 
the average group trend 225 (see Appendix 6.1 for references and details). However, ignoring the 
potentially different ways in which obesity or overweight developed or normalised over time 
within an individual, and treating these as residual variance, may lead to a simplified or even 
biased picture of who is at increased risk in adulthood and the clinical relevance may be diluted. 
In LCGMM in contrast, the assumption is made that instead of the existence of a single 
developmental curve in the study population, individuals belong to distinct subpopulations with 
different developmental trajectories, and that individual children may have different pathways 
leading to the development of overweight/obesity 8, 20, 221, 223, 234. 
 
Qualitatively distinct life course progressions of CVD risk factors have been shown to be 
associated with different levels of cardiometabolic risk later in life 13, 369, 370. Consistent with the 
present findings, recent studies suggest that the cardiovascular consequences of obesity are 
possibly cumulative, and that the duration of obesity or overweight, notably, may be a stronger 
predictor of cardiometabolic outcomes in adulthood compared with a cruder measure of obesity-
resolution or obesity-onset between two time points 356, 371-373. Beyond the number of years spent 
living with an adverse weight status, the developmental period (i.e. childhood, puberty, mid-
adulthood) at obesity onset, or the age at obesity resolution, may itself contribute to the strength 
of the association between the change in BMI status and adult outcomes, or reduction of risk 285, 
325, 374. To overcome issues associated with discrete categorisation of participants based on 
dichotomous measures of obesity or overweight at different ages 69, 354, a life course perspective 
may thus be useful to evaluate and refine the understanding of the impact of long-term BMI 
trajectory patterns on later-life cardiometabolic risk. Indeed, identifying groups of individuals 
with similar patterns of BMI over age in distinct BMI trajectories may compliment the classic 
individual-based approaches, as it may identify pathways of overweight onset and development 
during childhood and increase understanding of how weight status fluctuations impacts on 
cardiometabolic risk in adulthood. 
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In this chapter, the statistical approach allowed investigating of how distinct BMI trajectories 
across the life course influence later cardiometabolic risk. Although the observational nature of 
the data precludes any firm establishment of causality, it is hypothesised that stabilising BMI 
among obese adults could help limit their adverse cardiometabolic risk profiles. The reduction in 
all risk phenotypes except high-risk cIMT also suggests that the complete resolution of high BMI 
even in young adulthood is beneficial, although to effectively attenuate pre-atherosclerosis risk, 
obesity prevention should ideally target young children.  
 
6.6 Strength and limitations 
In recent years, a number of studies have explored BMI trajectories from infancy to early 
childhood, or childhood crossing in to adolescence 8, 166, 234, 238, 359, 368, but none covered a study 
period large enough to examine the heterogeneity in BMI trajectories from young childhood until 
mid-adulthood. In contrast, the 31 years of follow-up in the YFS cohort allowed us to investigate 
developmental trajectories of BMI between 6 and 49 years, providing an opportunity to detect 
and quantify the adult cardiometabolic risk in groups of participants that have not been well 
studied before: those who resolve their elevated childhood BMI in adulthood and participants 
who progressively became overweight. 
 
This study also presents some limitations, in particular the lack of BMI observations in early 
childhood (< 3 years). As a consequence, this study did not allow the investigation of 
development of BMI across the entire life course, particularly during the critical period of 
adiposity rebound. In addition, these findings from a large cohort of European ancestry may not 
be generalisable to other study samples.  
 
Further research should be undertaken to better characterise the YFS participants assigned to the 
six latent classes identified in this study, in particular, whether these BMI trajectory groups are 
distinguishable in terms of pre-existing participant characteristics (i.e. family history, parents 
BMI, socio-economic status), or their relationship to trajectories for other outcomes (i.e. latent 
life course trajectories of LDL-C, or diastolic blood pressure). More specifically, since our 
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results suggest at least two distinct BMI-age trajectories among incident obese subjects, if 
predictors of latent class membership can be identified, it may be possible to refine intervention 
strategies by targeting specifically children at higher probability of becoming obese at earlier or 
later points in life. This may improve the effectiveness of interventions on overweight prevention 
which have largely been of limited success, particularly in the long term 231.  
 
6.7 Conclusion 
BMI trajectories from childhood to adulthood vary, with trajectories that reach or persist at high 
levels associated with increased cardiometabolic risk in middle age. Findings suggested that the 
absence of BMI stabilisation in adulthood may be a stronger determinant of adult T2DM risk 
compared with the age at which obesity first developed. In additional, the risk for adult 
hypertension appeared to be stronger in those trajectory groups that developed high BMI early in 
life and have thus been obese for many years. The results suggest that stabilising BMI in obese 
adults could help limit adverse cardiometabolic risk profiles. The reduction observed for all 
outcomes except high-risk cIMT suggest the complete resolution of high BMI even in young 
adulthood may be beneficial to long-term cardiometabolic risk. However, the markedly increased 
risk for high-risk cIMT in middle adulthood despite body weight normalisation between 
childhood and adulthood emphasizes the importance of childhood obesity prevention to 
effectively attenuate the risk of pre-atherosclerosis, as well as the potential importance of 
identifying other modifiable childhood determinants of atherosclerosis development.  
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KEY POINTS – CHAPTER 6 
 
• This chapter uses LCGMM, a group-based approach to GCM, to investigate between-person 
heterogeneity in the development of BMI trajectories in the YFS across the life course, and 
determined the association between different BMI patterns and adult risk of T2DM, 
hypertension, dyslipidemia, and high cIMT. 
 
• Compared to the approach used in Chapter 5, where study participants belonged to one of 
four groups based on their change in BMI status between two time points, this approach 
considers all existing individual BMI observations to determine common patterns within the 
population, minimising loss of information and the issues related to subjective categorisation 
of participants in groups  
 
• Six distinct BMI trajectories from age 6 to 49 years were identified in the YFS, including a 
trajectory of progressive overweight, which could not be discriminated from the truly 
normative BMI trajectory in Chapter 5, and two distinct trajectories leading to adult obesity. 
 
• Higher trajectories of BMI were associated with increased cardiometabolic risk phenotypes 
in middle age. Completely reversing high childhood BMI may lead to better outcomes, 
however, the effect of deleterious childhood BMI status on high cIMT may not be reversible 
even with weight normalisation in later life. The risk for adult T2DM is strongly associated 
with the absence of BMI stabilisation in adulthood, rather than with the age of obesity onset.  
 
• Completely resolving high BMI in later life reduced the cumulative cardiometabolic risk load 
in adulthood. Obese children who have normal adult BMI levels have less chance of having 
one or more cardiometabolic phenotype than participants who become overweight adults. 
 
• This chapter illustrates the use and application of LCGMM with an emphasis on how this 
method differs and compliment the GCM methods introduced and developed in chapter 3 to 
5, providing a further tool to investigate population heterogeneity in developmental 
trajectories of continuous outcomes. 
 
Box 4. Summary of key points from Chapter 6: Association between latent body mass index 
(BMI) trajectories and cardiometabolic risk markers in mid-adulthood. 
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7. DISCUSSION 
7.1 Background and overview of thesis aims  
There is increasing interest in modeling developmental trajectories that may provide 
clues as to the impact and timing of early-life exposures that influence the 
development of important chronic diseases. In relation to cardiometabolic research, 
understanding how risk factors change across the life course and being able to 
investigate determinants associated with deviations from ‘normal’ or ‘healthy’ 
trajectories is important because the development of CVD and comorbidities such as 
obesity, hypertension, dyslipidaemia, and T2DM, have their origins in childhood, and 
tend to manifest over time. By modeling trajectories of cardiometabolic risk factors 
across key stages of the life course that precede the clinical presentation of the 
disease (childhood, adolescence, young and mid adulthood), it is expected that 
prevention, screening, and treatment of risk factors could be improved or optimised to 
prevent or delay adverse cardiometabolic outcomes later in life. However, modeling 
trajectories of continuous risk factors across the life course for chronic disease 
outcomes remains under used in many settings owing to a number of specific and 
perceived technical challenges. 
 
The overall aim of this thesis has been to examine GCM approaches for the analysis 
of non-linear continuous biological response data that arise from long-term, cohort-
sequential, or accelerated longitudinal designs spanning different developmental 
periods (childhood, adolescence, and adulthood). The specific contribution was to 
review, develop, formulate, and apply a range of GCM approaches to analyse and 
model the life course trajectories of a number of important cardiometabolic risk 
factors and outcomes in a well-studied European cohort, the YFS. For this cohort, 
data on metabolic risk factors was collected on up to eight occasions over 31 years 
from childhood to adulthood among a large number of participants that were initially 
representative of Finnish children. Specifically, this work focused on the technical 
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aspects of growth curve methods that pertain to modeling non-linear age-related 
trajectories of continuous response variables in study designs where participants from 
unique birth cohorts contribute to different and, to some degree, overlapping 
segments of cohort member’s life course trajectory.  
 
This dissertation addressed the specific research aims identified in section 1.1 by:  
 
Aim 1. Reviewing a number of existing GCM approaches, their strengths, weakness 
and identifying areas for further methodological development or extension for the 
analyses of continuous outcomes collected across decades in long-running 
prospective cohort studies (Chapter 2).  
 
Aim 2. Tailoring and extending growth curve modeling theory to develop a novel 
analytical tool for epidemiologists, the BHPR method, which may help inform 
prevention and intervention strategies by allow the identification of the point in the 
life course at which participants from two identified groups start to diverge in their 
non-linear trajectories of continuous modifiable risk factors (Chapter 3).  
 
Aim 3. Applying the statistical methods reviewed in Aim 1 and developed in Aim 2 
to examine specific aims important in developmental cardiometabolic research using 
data from YFS in four original manuscripts (Chapters 3 to 6). 
 
7.2 Specific approaches and their importance 
More specifically, the first three original studies (Chapters 3 to 5) considered person-
based GCM approaches (1-4) to model individual trajectories of important continuous 
cardiometabolic risk factors using repeated measure data collected at up to eight time 
points in the YFS study, spread across the developmental period from childhood to 
adulthood. In these chapters, the grouping variables of interest were included as 
determinants or predictors, of between-person differences in the continuous response 
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over time (5, 6), a situation relevant in a variety of observational study settings (7) . 
Depending on the specific research question in each study, these chapters considered 
different types of grouping variables, commonly encountered by epidemiologists in 
practice. This included the stratification of participants into groups of interest related 
to  (1) pre-existing individual characteristics (i.e. high/low individual genetic risk 
scores, Chapter 3) that may influence the developmental response trajectory over 
time, or (2) the realisation (or not) of a dichotomous heath outcome at a later point in 
time for some of the participants (i.e. those who did or did not develop T2DM in 
adulthood, Chapter 4), or (3) the change in response status between two time points 
(i.e. change in BMI status between childhood and adulthood across four groups of 
clinical relevance, Chapter 5). In all examples, the categorical grouping variable was 
used to divide the longitudinal data into two or more non-overlapping, mutually 
exclusive subsets of data with the aim to determine when differences between these 
a-priori identified subsets occur (8-10). 
 
These types of approaches are important because grouping based on participant-level 
characteristics (e.g. sex, smoking status, etc.) allows researchers to test whether 
having the characteristic modifies the average level, the initial level, or the shape of 
the response variable over time (11). Moreover, when the stratification is based on the 
development of a distal outcome of clinical importance or change in response status, 
researchers can use these GMC approaches to examine the trajectories of the response 
profiles between groups, to determine if, and when, participants exhibit similar or 
different response trajectories. This allows the determination of the point or ages in 
the life course when risk factor trajectories diverge between the different groups, 
which are often of clinical interest for the researcher(12-14).  
 
In these three chapters, proposed approaches covered a range of possible model 
parameterisations that the researcher may consider to adequately represent the non-
linearity in response within-person over time. Chapter 3 illustrated the empirical 
determination of the within-person response shape in a classical non-Bayesian 
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multilevel framework, with genetic risk score groups used as level-2 predictors of 
between-person differences in higher-order polynomial age terms describing 
individual lipid trajectories in the YFS cohort from age 6 to 49 years (15-17). In 
Chapters 4 and 5, the Bayesian formulation and estimation of a piecewise linear 
random effect multilevel model was developed and applied to model within- and 
between-person trajectories of BMI from childhood to adulthood (18-20). In these 
models, the change points were estimated from the data and allowed to vary between 
participants (i.e. random change points), mapping onto known aspects of BMI 
development from childhood to adulthood. In this chapter, this developed modeling 
approach was applied to the YFS data to determine the age at which two groups 
(those with, and those without adult T2DM) who share the same population-average 
BMI trajectory until a certain point in time, go on to separate BMI paths later in the 
life course. In chapter 5, an alternative formulation of the Bayesian hierarchical 
piecewise modeling approach developed in Chapter 4 was proposed to allow the 
estimation and comparison of average trajectories of BMI in the YFS according to 
four adiposity groups to enhance understanding of the developmental BMI patterns of 
participants in four clinically important groups. 
 
The fourth original chapter, Chapter 6, took a different approach from the other three 
chapters by considering Latent Class Growth Mixture modeling (LCGMM), a state of 
the art group-based approach to GCM (21-24). Rather than analysing pre-assigned 
groups, this method allows latent classes of unobserved trajectory patterns to be 
identified within a population. Despite its promising features to analyse longitudinal 
data, this recent approach is technically quite challenging and remains largely 
underused by epidemiologists with long-term cohort sequential data (25, 26). This 
chapter illustrated the use of the LCGMM approach in the non-Bayesian framework 
with a polynomial parameterisation for the within-person model to investigate the 
heterogeneity in developmental patterns of BMI between age 6 and 49 years in the 
YFS.  
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The various statistical models considered in these four chapters were all formulated 
and fitted through the R interface, either using the nlme, lmer, or lcmm mixed 
and growth mixture modeling packages (Chapters 3 and 6) or using rjags and 
r2jags (Chapters 4 and 5). The latter two packages provide a linkage between the 
graphical and statistical capabilities of R and the MCMC sampling of JAGS (a clone 
of the Bayesian Analysis Using Gibbs Sampling program, BUGS). The Bayesian 
estimation method allowed complex models to be fitted, in particular the piecewise 
growth models with two linear segments and random change points in Chapters 4 and 
5, which could not have been estimated using popular likelihood–based software.  
 
The narrative of this thesis is recounted in the following section, where the statistical 
approaches, the major findings of individual studies (chapters 3 through 6), and 
implications for cardiometabolic health research are considered. As strengths and 
limitations of each study were identified and discussed at the end of each chapter, 
they will not be reiterated here unless they are central to the topics covered.  
 
7.3 Summary of study findings and implications 
Chapter 3 demonstrates the use of hierarchical higher-order polynomial specification 
of GCM to model response profiles that have complex non-linear forms overtime 
when no prior knowledge or existing biological theory can be used to inform the 
modeling over the time period of interest(27, 28). This chapter illustrates complex 
model building strategies to model of individual response trajectories and to 
investigate both the longitudinal and cross-sectional associations between the 
response and categorical or continuous risk factors. In this chapter, the polynomial 
GCM approach was applied to analyse blood lipid trajectories in the YFS between 3 
and 49 years of age, primarily to examine whether the polygenic effect of a 
predisposition for abnormal levels of circulating lipids was present at all ages, or 
whether it varied by age. The rationale for this study was that despite an increasing 
number of longitudinal and genetic studies in the past 10 years, the patterns of 
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lipoprotein trajectories across the life course, and how genetic factors influence these 
long-term patterns, remain poorly understood (29, 30). In this application, the 
polynomial specification of MLM growth curve models allowed the empirical 
determination of the shapes of individual longitudinal lipid profiles from childhood to 
adulthood in the YFS. Moreover, it allowed determining if identified risk alleles 
collectively predict lipid trait levels at all ages or whether they modify the intra-
individual progression of serum lipids as people age. This application illustrated key 
aspects of this advanced modeling technique, including the creation of interaction 
terms with all higher order polynomial terms to adjust for time-varying covariates or 
birth cohort effects, and strategies to address potential heterogeneity and within-
person autocorrelation of error. The main clinical finding from this study was that for 
LDL-C, HDL-C and triglycerides, the polygenic effects of GWAS-associated alleles 
were present at all ages in the YFS, even in early childhood, and strongest for LDL-
C. In addition, results suggested that for HDL-C levels, the combined genetic effect 
became weaker as participants aged, and conversely for triglyceride, stronger in 
males with age. The results of this study have important clinical implications, since 
they suggest that modifiable lifestyle factors may become important determinants of 
HDL-C levels in adulthood and that males with high genetic risk for high 
triglycerides levels may not respond as well as females to lipid-reducing lifestyle 
interventions. While complex, the modeling approach used in this study provided 
crucial insight on the influence of genetic risk factors in long-term lipid profiles. 
Since the functional form of within-person change in response over time is 
determined form the data itself, this approach is particularly suited to explore the 
development of cardiometabolic factors for which the typical development is not well 
characterised over the life course, when the main interest is to investigate the effect of 
determinants of interest on outcome trajectories. 
 
In Chapter 4, a novel individual-based growth modeling approach (BHPR) was 
formulated and developed to determine how and when two or more groups of 
participants diverge in their curvilinear trajectories of continuous outcomes in long-
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term observational studies. In this chapter, the motivation for the development, and 
subsequent application of this method was the lack of existing methods dedicated to 
between-group trajectory divergence analysis in longitudinal studies. Specifically in 
the YFS, the rationale for developing this tool was the ability to be able to refine the 
estimate of the age at which developmental BMI trajectories diverge between 
participants who do and do not develop adult T2DM (31). The developed approach 
considers segmented regression models with random change points to summarise and 
approximate individual BMI response profiles from childhood to adulthood, in line 
with biological knowledge from several decades of developmental research (32, 33). 
These complex models are formulated and fitted in the Bayesian framework to 
circumvent estimation issues often encountered with traditional maximum likelihood 
methods. To investigate trajectory divergence mechanisms between groups of 
participants, the proposed modeling approach sequentially introduces group 
differences in each trajectory parameters related to identified aspects of the age-
related change in BMI profiles, before choosing the best fitting model among the set 
of candidate models with the aid of Bayesian model selection tools. In addition, this 
chapter illustrates critical aspects of the proposed modeling technique, including the 
inclusion of cohort effects, time-varying covariates, and issues related to prior 
specification and sensitivity. Through simulation, this chapter demonstrates the 
significance of the developed approach for the chronic disease research community, 
by showing that the BHPR is less dependent of sample size and provides a more 
accurate estimate of the age at which the change occurs between group of 
participants, compared with more traditional modeling approaches. From a clinical 
perspective, when applied to the BMI and T2DM data in the YFS, the developed 
approach revealed the existence of a ‘critical window’ for weight management 
intervention in the years around puberty that may help inform strategies targeting the 
incidence of overweight-related T2DM. Although developed for a two-phase 
developmental process, this statistical tool could easily be extended to investigate 
between-group trajectory divergence in non-linear response of more complex shapes 
by defining a three or more piece functional form for the level-1 model. A three-piece 
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BHPR model with two random change points, would be particularly suited to model 
early life BMI trajectories, allowing the direct modeling of two crucial individual 
BMI milestones in early life, the infancy peak and the adiposity rebound. 
 
Chapter 5 illustrates a different application of the BHPR formulated in Chapter 4. 
Rather than trajectory divergence between groups, this chapter demonstrates how a 
slightly modified formulation of the linear-linear segmented model with random 
change points enables comparison of curvilinear response profiles between more than 
two groups. Specifically, this modified BHPR approach was used to model individual 
life course BMI profiles in the YFS cohort, and to compare them between four groups 
of clinical interest, determined a-priori based on participants’ change in BMI status 
between childhood and mid-adulthood (34). The rationale for this study was to build 
on and refine previous findings from a large multicentre study that found, using a 
limited number of time points, overweight or obese children who became non-obese 
in adulthood had a similar risk for adult cardiometabolic outcomes than those who 
had never been obese (34). Although these findings provide hope to paediatric care 
providers that a sustained change in BMI can normalise cardiometabolic risk among 
obese children, this multicentre study was only able to pinpoint that this group had 
transitioned status at some time over the 23-year period between child and adult 
measurement – limiting the broader implications of their findings to the public health 
and clinical setting. Using the full set of repeated BMI data in the YFS, Chapter 5 
used the novel modeling approach developed in Chapter 4 to refine the understanding 
on the dynamics of sex-specific BMI developmental in each of the four groups 
considered in the multicentre study. This chapter illustrated how Monte Carlo 
Markov Chain techniques can be used to compare BHPR trajectory parameters from 
two given growth curves, by sampling the marginal posterior density of the difference 
in growth parameters between groups (35, 36). Applying this modified BHPR 
approach to data from the YFS, the timing of BMI differences in early life between 
those who do or do not maintain high-BMI levels, or who develop incident obesity, 
from childhood to adulthood was determined. The findings from this trajectory 
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modeling application suggest that efforts to influence BMI trajectories that lead to 
adult obesity should begin early in life, ideally before age 6 years, with the existence 
of a ‘critical window’ in adolescence for secondary prevention. Significantly, the 
BHPR approach provided increased clarity to paediatric care providers on the critical 
age windows when prevention, screening, and intervention for elevated BMI levels or 
rates of change could be implemented – which was the major limitation of the 
previous multicentre study(34). 
 
Chapter 6 introduces, investigates, and formulates GCMs in a different statistical 
paradigm, which is becoming increasingly popular in the trajectory modeling in 
psychology and cognition research, but remains largely underused by the public 
health community, especially in the context of analysing data from long-term cohort 
sequential studies (37-39). In this chapter, LCGMM, a group-based GCM trajectory 
modeling approach, was used to reanalyse the developmental BMI trajectories YFS 
cohort from another perspective. Unlike the modeling approaches used in the three 
preceding chapters, the LCGMM used in this chapter does not rely on pre-determined 
groupings to categorise and contrast different subgroups of interest in the population. 
This recent approach thus decreases the potential for misclassification issues, as well 
as the loss of information related to discrete categorisation of longitudinal profiles 
(22, 23). This study was motivated by findings in Chapter 5, where model checks 
suggested unaccounted for variability in the model residuals. In contrast to the BHPR 
modeling approach used in Chapter 5, LCGMM allows the clustering of participants 
based on their entire response profiles. It was used to investigate the underlying 
heterogeneity that may exist in the developmental trajectories of BMI in the YFS 
with the aim of identifying common BMI patterns within this population and how 
these patterns predict important adult cardiometabolic risk phenotypes. Chapter 6 
considers issues pertaining to model building in LCGMM and illustrates the different 
steps to build these complex trajectory models. In particular, it shows how to fit and 
compare various LCGMMs before choosing a final model, considering solutions with 
increasing number of classes, and strategies to specify the variance-covariance of 
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growth parameters and within-class heterogeneity. In addition, it presents strategies to 
to evaluate model goodness-of-fit and to characterise the discrimination ability of 
estimated classes. Applied to the longitudinal BMI data in the YFS, this modeling 
approach enabled six distinct BMI trajectories to be identified, including a subgroup 
with a progressively overweight trajectory that could not be discriminated from the 
truly normative BMI trajectory group in Chapter 5. Two groups with distinct 
trajectories leading to adult obesity were also distinguished: one of early onset, 
stabilising obesity and another of later onset, worsening obesity. This reanalysis of 
the long-term BMI profiles in the YFS provided increased clinical granularity to the 
previous analyses of these data was part of the multicentre. The LCGMM used in 
Chapter 6 revealed that those with higher and increasing trajectories of BMI were 
generally associated with increased cardiometabolic risk phenotypes in middle age 
compared with those who remained on an ideal BMI trajectory throughout their life 
course. Although completely reversing elevated BMI later in life may decrease the 
risk for hypertension, dyslipidaemia and T2DM, the results of this study, in line with 
recent findings in the literature, suggested that the effect of deleterious BMI status in 
early life on cIMT might not be reversible even with normalisation of weight status in 
later life (40). The results obtained through this alternative approach to GCM analysis 
are important to paediatric care providers because the previous approach (prone to 
misclassification) used in the multicentre study suggested no residual risk of elevated 
child BMI (34). This Chapter illustrates the application of this complex method in 
practice, and highlighted its potential as an additional tool to analyse the 
heterogeneity in long-term trajectories among given populations 
 
7.4 Future directions 
The specific research findings obtained using the reviewed, applied, and developed 
statistical approaches in this thesis have implications for future cardiometabolic 
research, as well as for prevention and intervention of adverse cardiometabolic 
phenotypes in children, adolescents, and young adults. Based on findings from this 
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thesis, future research focusing on the trajectories that predispose to later 
cardiometabolic disease ought to investigate the following specific areas:  
 
• Importance of individual BMI trajectory parameters in the prediction of 
later cardiometabolic outcomes. In Chapter 4, since the focus was on the age at 
divergence in BMI trajectories between participants who do and do not develop 
adult T2DM, the association between the longitudinal BMI profiles and actual 
adult T2DM outcome was not investigated; rather, the outcome of T2DM was 
used to stratify the participants within two groups of interest. Future studies 
should investigate if faster rates of BMI increase estimated form the BHPR 
approach (i.e. greater velocity) in childhood, adulthood or older age at the change 
point (i.e. greater random deviations from population average in each growth 
parameters) associate with an increased risk for developing adult T2DM. Indeed, 
compared to existing risk prediction models commonly used in cardiometabolic 
research, which often include a single measure of risk in childhood or early 
adulthood (i.e. single lipid or single BMI measure) to predict later adult 
outcome(41), the addition of these individual trajectory parameters obtained by 
BHPR (or by traditional growth modeling techniques, such as the polynomial 
GCM in Chapter 3) may provide more accurate predictions of CVD outcomes. 
 
 
• Identification of the socio-demographic, biological and behavioural factors 
associated with distinct developmental BMI profiles. In the YFS, LCGMM 
modeling used in chapter 6 suggested the existence of six distinct BMI trajectory 
classes. Being able to identify predictors of class membership, and thus of distinct 
BMI life course patterns, could help identify those at increased risk of developing 
adverse BMI levels at different age periods. Characterising those participants who 
managed to completely normalise their BMI levels after being obese/overweight 
in youth is also of potential interest from a public health perspective. Determining 
the best times to intervene and the most appropriate strategies for intervention 
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will be an important challenge towards reducing the prevalence of overweight and 
obesity globally. 
 
• Age-dependent genetic effects on circulating lipid levels. Some of our findings 
in Chapter 3 are difficult to interpret clinically and will need further 
investigations. Notably, we found that the combined genetic effect of 24 common 
variants on circulating triglycerides becomes stronger in men as they age.  This is 
conflicting with the expected pattern, which is be that genetic effect remains 
constant or becomes weaker with age (as we found for HDL-C), with 
environmental, lifestyle and behavioural factors such as diet, smoking, and 
physical activity becoming more important determinants of adult lipid levels. 
While the increase in the means and variances of most lipid parameters as humans 
age has been well established in the literature, how much of that age dependency 
is due to increases in environmental or genetic variance, or both, is still largely 
undetermined1. For other complex traits (such as BMI and systolic blood 
pressure) preliminary studies suggest that, over time, while the contribution of 
genes to a phenotype remains relatively constant, environmental exposures tend to 
increase the phenotypic variance, contributing to between-person differences in 
trait 2. Thus, it is possible that the accumulation effects of environmental 
exposures (i.e. diet, physical activity, or smoking) increase the phenotypic 
variance of lipids over time, making it more difficult to detect genotype-
phenotype associations. Recent linkage analyses and GWAS studies, for a few 
lipids, have found evidence that age was a modifier of genetic associations 
between specific loci and HDL-C and LDL-C levels 1, 3 4and that the genetic 
architecture of lipid traits changes over time 5, but no study has yet considered 
combined genetic risk score with multiple loci. More research is indeed needed to 
understand the implications of our findings on triglycerides profiles. More 
research is needed to fill these gaps. 
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• Time-varying gene-environment interactions predicting important 
cardiometabolic outcomes. In chapter 3, it is interesting (and perhaps a little 
intriguing) that BMI change between childhood and adulthood did not seem to 
modify the genetic effect on adult lipid levels in our study sample. Indeed, despite 
having identified multiple loci robustly associated with plasma lipids and extreme 
lipid phenotypes, most recent GWAS studies also report that common genetic 
variants explain  <12% of variation in lipid traits. As adiposity is also an 
important determinant of plasma lipoproteins, particularly plasma TGs and HDL-
C concentrations, several studies have hypothesised and demonstrate that 
interactions between genes and adult clinical phenotypes may contribute to this 
unexplained heritability6. No study however, has looked at genetic effect 
modification as a function of longitudinal change in BMI across the life course. 
The apparent lack of gene-environment effect in this study could be due to other 
time-varying environmental variables likely to mediate the effect modification of 
longitudinal change in BMI (such as exercise and diet, that we did not consider in 
our analyses). In general, the gene-environment effect on lipid levels reported in 
the literature is equivocal, and gene–gene and gene–environment interactions, 
gene–environment correlations, and epigenetic mechanisms remain active areas of 
research in the field6, and warrants more research. 
 
• Relative impact of severity of obesity, duration of obesity, or a combination 
of both on future cardiometabolic outcomes. In Chapter 6, although the 
identified latent classes of BMI trajectories provide an idea of which aspects of 
BMI development across the life course might influence risk for each of the 
studied outcomes, the LCGGM modeling approach does not allow the researcher 
to formally investigate the associations between obesity duration or severity and 
later cardiometabolic outcomes. More research is needed in this area to determine 
what aspect of obesity best predicts adult cardiometabolic outcomes such as 
T2DM, high cIMT, dyslipidaemia and hypertension. Teasing apart the effect of 
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obesity duration from the effect of obesity severity on later outcomes is likely to 
require further methodological development in growth modeling techniques. 
 
• Life course trajectories of BMI and blood lipids of the metabolically healthy 
obese. Further research is needed to investigate the developmental patterns of 
BMI among obese adults who do not display the typical metabolic disorders 
associated with obesity (i.e. metabolically healthy obesity (42)), and how their 
cardiometabolic risk profile compares with those of obese participants who have 
developed other cardiometabolic complications. In particular, it would be useful 
to determine whether distinct developmental BMI profiles exist within this 
subgroup of metabolically healthy obese participants, to help determine if change 
in adiposity at different critical periods in the life course can help identify a 
metabolically healthy obese phenotype. This is important since it may provide 
additional insight for the identification of critical windows in the development of 
obesity and implications for future cardiometabolic risk. 
 
• Life course cardiometabolic risk factor trajectories and clinical endpoints. It 
should be noted that, with the exception of T2DM, the other risk factors 
considered throughout this thesis are risk factors for CVD. It would be important 
to replicate these analyses in samples where clinical endpoints such as confirmed 
CVD events or deaths are available.  
 
From the methodological point of view, although this thesis adds to the existing GCM 
literature for modeling longitudinal continuous outcomes in multi-cohort 
observational studies, more work is necessary in order to apply some of the more 
advanced GCM approaches to complex data sets with multiple groups and additional 
covariates. Growth modeling is an active and fast growing area of research, and the 
strength and the flexibility of GCMs provide opportunities for testing theoretically 
derived hypotheses in ways not previously possible. For example, it provides 
epidemiologists an opportunity to gain a better understanding of individual 
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differences in developmental change. There are many directions that can be taken to 
further enhance our understanding of the benefits of these models and to make them 
more useful in practice. This thesis identified a number of important remaining 
methodological issues that ought to be addressed in future GCM research. This 
includes: 
 
• GCMs with binary or discrete outcomes. The limited available literature on 
the treatment of longitudinal binary and ordinal outcomes in the CGM 
framework motivates further research (5). With the growing popularity of 
GCM modeling as the preferred analytical choice to test hypotheses related to 
individual differences in responses collected across the life course, significant 
resources have accumulated to instruct researchers in the application of GCMs 
with longitudinal continuous and count outcomes (6) (43-45). With the 
exception of three works (37, 46, 47), the discussion regarding binary and 
ordinal outcomes in GCM is by comparison, quite limited. In cardiometabolic 
research, such models may be particularly useful if the longitudinal outcome 
of interest is the presence vs. absence of early atherosclerosis, T2DM, or 
metabolic syndrome across the life course and the rationale to investigate 
population heterogeneity in the development of these CVD outcomes. 
 
• Non-parametric GCMs. The standard GCMs models considered in this 
thesis assume a parametric relationship between time and the response 
variable and covariates, however, this assumption is not always met and can 
lead to restrictive and inaccurate models (5). The recognition of the limitation 
of parametric models with practical data in biomedical research calls for the 
development of innovative non-parametric GCMs methods, which are more 
flexible in the shape of the underlying function than their parametric 
counterparts. These non-parametric approaches may be more adept at 
capturing the true underlying change pattern than existing parametric 
approaches, when the shape of the function over time is complex. At present, 
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frequentist current non-parametric GMC approaches, including methods based 
on polynomial kernel smoothing, regression splines, and smoothing remain 
underdeveloped and limited in their abilities. Bayesian framework is 
appealing for its ability to handle such complex models (i.e. varying sample 
sizes, non-normal outcomes and within subject correlation) but the 
implementation of such methods is not well studied and literature is relatively 
sparse (17, 48, 49). 
 
• Modeling multiple outcomes in GCM analyses. The multivariate GCM 
approach allows flexible modeling of relationships between two or more 
longitudinal response variables such as correlated residuals over time and 
regressions among different outcomes over time. Currently, GCM models for 
correlated, coupled, and conditional change remained under developed. In 
some situations, rather than considering them separately, the researcher may 
be interested in jointly modeling two outcome variables (e.g. parallel growth 
models – change in multiple CVD risk factors as a function of time, to 
determine if a positive change in lipid levels would occur in response to a 
reduction of say, BMI). Or it might be of interest to model simultaneously the 
same outcome measured on different (identifiable, nonexchangeable) but 
related individuals (e.g. change in spouse/sibling BMI as a response to an 
obesity intervention). At present, the three main approaches to investigate 
multivariate relationships among developmental functions (i.e. Multiple 
Correlated Growth Curves  - estimation of covariation among levels, slopes, 
and time-specific residuals, Curve-of-Factors - LGM based on measurement 
model, and Factor-of-Curves - evaluation of factor structure of covariance 
among levels and slopes) remain difficult to apply in practice (5, 50) and are 
mostly implemented in the SEM framework. These complex models, 
including multivariate change point models, are likely to be easier to estimate 
in the Bayesian framework but this area needs to be extended (51, 52). 
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• Estimating statistical power for GCMs. Power and sample size analysis is a 
critical aspect in study design. The power of a statistical test is usually defined 
as the probability that the test would reject a false null hypothesis. The main 
purpose of a prospective power analysis is to plan the sample size for a future 
study. A retrospective power analysis is conducted after data collection and 
analysis, the purpose of which is to determine if the obtained effect size is 
conclusive. Although GCMs have become among the most powerful tools in 
facilitating the analysis of change in the past 50 years, discussions on the 
determination of sample sizes or power analysis of these models (both in the 
SEM and MLM framework) are still relatively rare, with a few exceptions 
(53, 54) Some studies have investigated the power of LGC models by using 
the chi-square difference test or the likelihood ratio test from different 
perspectives (55, 56). In addition, some power analysis methods available for 
multilevel or mixed-effects models can be used to analyse certain types of 
GCMs (57, 58). However, procedures do no exist for more complex model 
structure. The ones that do exist often require the use of several pieces of 
software to compute power as they are based on chi-square difference test for 
covariance analysis. The two-step, two-software approach makes power 
analysis cumbersome and hinders the broader adoption of the method (54).  
 
7.5 Conclusions 
This thesis has contributed to the body of evidence examining modern statistical 
approaches suitable to (1) model complex non-linear trajectories of continuous risk 
factors in long-term cohort-sequential studies at the individual or group level, (2) 
identify distinctive profiles in these trajectories that may exist within a population 
sample, or (3) investigate critical phases of change in these trajectories that may be 
related to higher risk of a distal health outcome. In particular, this thesis has focused 
on growth modeling methods and their extensions, an expanding framework that has 
a tremendous amount to offer to a broad array of developmental research endeavours 
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and represent a powerful set of tools to better understand between-person differences 
in individual change over time. The focus of this thesis has been on how these 
methods can help gain insight in the development of a number of important 
cardiometabolic risks and outcomes. More broadly, concepts and methods reviewed, 
developed and applied throughout this thesis are relevant to research in other chronic 
diseases that typically manifest in later life, such as cancers. 
 
Studying long-term trajectories of risk factors for future disease and demonstrating 
the influence of these trajectories on later outcome brings several analytical 
challenges. Therefore, it likely that a combination of approaches will be necessary to 
unravel the complexities and nuances observed in life course research, such that the 
maximum information can be obtained from the available data. Each of the 
approaches illustrated and discussed throughout this thesis have their limitations and 
strengths, with the choice of methodological approach depending upon the nature of 
the available data and the specific research questions.  
 
To this end, this work has developed a novel GCM approach that allows the 
mechanisms of divergence in non-linear trajectories between groups of participants in 
long-running cohort studies to be characterised, and has demonstrated how different 
GCM approaches provide unique data that might help inform, refine, and improve 
prevention and intervention applications in clinical and public health settings. 
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Appendix 2.1. Custom-written self-starting non-linear functions in R allowing 
the estimation of 4 parameters Gompertz and 5 parameters Richards Growth 
Curve Models, respectively. 
 
################################################################### 
### Function to estimate a 4 parameters Gompertz Growth Curve model  
#################################################################### 
 
SSGompertzGR <- selfStart(y ~ g0 + g1*exp(-exp(-a1*(x-a0))), 
                          function(mCall,data,LHS) { 
                            xy <- sortedXyData(mCall[["x"]], LHS, 
data) 
                            if(nrow(xy) < 4) { 
                              stop("Too few distinct x values to fit 
a GompertzGR model") 
                            } 
                            xy["y"] <- cummax(xy["y"]) 
                            g0 <- 
stats:::NLSstLfAsymptote.sortedXyData(xy) 
                            g1 <- 
stats:::NLSstRtAsymptote.sortedXyData(xy)-g0 
                            xy[["z"]] <- log(-log((xy[["y"]]-
g0)/g1)) 
                            cs <- coef(lm(z ~ 1+x,data=xy)) 
                            a1 <- -cs[2] 
                            a0 <- cs[1]/a1 
                            setNames(c(g0,g1,a0,a1), 
                                     mCall[c("g0","g1","a0","a1")]) 
                          }, 
                          c("g0","g1","a0","a1"), 
                          function(x,g0,g1,a0,a1) {}) 
 
 
 
 
################################################################### 
### Function to estimate a 5 parameters Richards Growth Curve model  
#################################################################### 
 
SSRichardsGR <- selfStart(y ~ g0 + g1/(1+a2*exp(-a1*(x-a0)))^(1/a2), 
                          function(mCall,data,LHS) { 
                            xy <- sortedXyData(mCall[["x"]], LHS, 
data) 
                            if(nrow(xy) < 5) { 
                              stop("Too few distinct x values to fit 
a RichardsGR model") 
                            } 
                            xy["y"] <- cummax(xy["y"]) 
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                            a2 <- 1 
                            g0 <- 
stats:::NLSstLfAsymptote.sortedXyData(xy) 
                            g1 <- 
stats:::NLSstRtAsymptote.sortedXyData(xy)-g0 
                            xy[["z"]] <- log( ((g1/(xy[["y"]]-
g0))^a2 - 1)/a2 ) 
                            cs <- coef(lm(z ~ 1+x,data=xy)) 
                            a1 <- -cs[2] 
                            a0 <- cs[1]/a1 
                            
setNames(c(g0,g1,a0,a1,a2),mCall[c("g0","g1","a0","a1","a2")]) 
                          }, 
                          c("g0","g1","a0","a1","a2"), 
                          function(x,g0,g1,a0,a1,a2) {}) 
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Appendix 2.2. Illustrative annotated R code showing custom non-linear 
functions to estimate additive and multiplicative Gompertz growth curve models 
on simulated data from sequential cohort design.  
 
 
#################################################################### 
### Simulate Gompertz growth data with random effects for the 4 
parameters ##################################################### 
 
## t0=age 3 (initial age in the cohort) 
 
rm(d) 
library(mvtnorm) 
 
############################################# 
######### 4-parameters Gompertz model ######## 
############################################## 
 
# 4 parameters in the function: g0","g1","a0","a1" 
# fits : y ~ g0 + g1/(1+exp(-a1*(x-a0)) 
#d <- local({ 
 # x <- seq(3,50,3) 
 # y <- SSGompertzGR(x,15,30,9,0.2)+rnorm(length(x),0,0.2) 
 # data.frame(x=x,y=y) 
#}) 
#plot(y~x,data=d,pch=16,col="firebrick") 
 
# equivalent to : 
#param<-c(15,30,9,0.2) 
#x <- seq(3,50,3) 
#y<-param[1]+ param[2] /(1+exp(-param[4] *(x-param[3]))) 
#plot(y~x) 
 
##################### Simulate sparse-cohort sequential data with 
INDEPENDENT RANDOM EFFECTS for each of the Gompertz curve parameters 
################################## 
 
nid=100 # 100 subjects 
baseline <- c(3,6,9,12,15,18)# ages at baseline 
follow <- c(0,3,6,9,12,21,27,31)# up to 7 follow-ups  per person ==> 
maximum of 8 repeated obs. per person 
 
V <- diag(c(2,4,2,0.01)^2)# variance-covariance matrix for the 
random effects (i.e. 4 gompertz param) 
re <- rmvnorm(nid,sigma=V) 
 
 
d <- data.frame(id=factor(1:nid), 
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                Baseline=sample(baseline,nid,replace=T), 
                re=re)[rep(1:nid,each=length(follow)),] 
param<-c(15,30,9,0.2) # Gompertz parameters 
sigma <- 0.9 #error 
d$age <- d$Baseline+follow 
d$mu <- with(d,(param[1]+re.1)  + (param[2]+re.2 )/(1+exp(-
(param[4]+re.4) *(age-param[3]+re.3)))) # generate mu 
d$bmi <- rnorm(nrow(d),d$mu,sigma) # with residual error 
 
library(ggplot2) 
# Plot simulatedgompertz BMI data with smoother: 
ggplot(d,aes(x=age,y=bmi))+geom_point()+geom_smooth() 
# Show indivudal plots  
ggplot(d,aes(x=age,y=bmi,group=id,colour=id))+ 
  geom_point(size=1.2)+ 
  geom_path() 
 
# write csv file with simulated data 
# sim.csv contains simulated data with 8 observations per subj 
write.csv(d, file = "sim.csv") 
 
################################################### 
### 1- Fit custom-build Gompertz model function to simulated cohort-
sequential data ################################################## 
 
library(dplyr) 
d <- read.csv('sim.csv', header=TRUE,na.strings='.') %>% 
 # everyone has over 5 BMI obs in this situation 
  group_by(id) %>%  
  mutate(nobs=n()) %>%  
  filter(nobs >=5) %>%  
  ## Select a subset of columns 
  select(bmi,age,id) %>%  
  data.frame 
d$id <- factor(d$id) 
head(d) 
str(d) 
 
## =>everyone has 8 BMI observations. Due to different ages at 
baseline, the observations stretch across different periods across 
the life course 
 
## Custom-written Self-starting function to estimate 4 parameter 
Gompertz model## 
SSGompertzGR <- selfStart(y ~ g0 + g1*exp(-exp(-a1*(x-a0))), 
                          function(mCall,data,LHS) { 
                            xy <- sortedXyData(mCall[["x"]], LHS, 
data) 
                            if(nrow(xy) < 4) { 
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                              stop("Too few distinct x values to fit 
a GompertzGR model") 
                            } 
                            xy["y"] <- cummax(xy["y"]) 
                            g0 <- 
stats:::NLSstLfAsymptote.sortedXyData(xy) 
                            g1 <- 
stats:::NLSstRtAsymptote.sortedXyData(xy)-g0 
                            xy[["z"]] <- log(-log((xy[["y"]]-
g0)/g1)) 
                            cs <- coef(lm(z ~ 1+x,data=xy)) 
                            a1 <- -cs[2] 
                            a0 <- cs[1]/a1 
                            setNames(c(g0,g1,a0,a1), 
                                     mCall[c("g0","g1","a0","a1")]) 
                          }, 
                          c("g0","g1","a0","a1"), 
                          function(x,g0,g1,a0,a1) {}) 
 
# fit  Gompertz model as an NLS (non-least square model)(to get 
starting values for the parameters) 
fit1.0 <- nlsList(bmi~SSGompertzGR(age,g0,g1,a0,a1)|id, data=d)# 
fits it for most people 
fit1.0 #  
fixef(fit1.0)# estimated fixed effects # if age 3 is not xpecified 
as time 0 : go=23.23 
 
# Fit gompertz as a mixed model 
s <- fixef(fit1.0) 
 
# Additive gompertz: 
# random g0 
fit1.1 <- nlme(bmi~SSGompertzGR(age,g0,g1,a0,a1), 
             data=d, 
             fixed = g0+g1+a0+a1~1, 
             random = g0~1|id, 
             start = c(s[1],s[2],s[3],s[4])) 
summary(fit1.1) 
 
# random g1 (upper asymtote - lower asymptote) 
fit1.2 <- nlme(bmi~SSGompertzGR(age,g0,g1,a0,a1), 
             data=d, 
             fixed = g0+g1+a0+a1~1, 
             random = g1~1|id, 
             start = c(s[1],s[2],s[3],s[4])) 
summary(fit1.2) 
 
# random g0 and g1 
# random g1 (upper asymtote - lower asymptote) 
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fit1.3 <- nlme(bmi~SSGompertzGR(age,g0,g1,a0,a1), 
             data=d, 
             fixed = g0+g1+a0+a1~1, 
             random = g1+g0~1|id, 
             start = c(s[1],s[2],s[3],s[4])) 
summary(fit1.3) # neg correlation between both random effects 
 
AIC(fit1.2,fit1.3)# as expected fit 3 clearly better 
 
###### multiplicative random effects : 
# add random inflection point : a0 
fit1.4 <- nlme(bmi~SSGompertzGR(age,g0,g1,a0,a1), 
             data=d, 
             fixed = g0+g1+a0+a1~1, 
             random = g0+g1+a0~1|id, 
             start = c(s[1],s[2],s[3],s[4])) 
summary(fit1.4) # neg  
 
AIC (fit1.3,fit1.4) # better 
 
# add random growth rate : a1 
fit1.5 <- nlme(bmi~SSGompertzGR(age,g0,g1,a0,a1), 
             data=d, 
             fixed = g0+g1+a0+a1~1, 
             random =g0+g1+a0+ a1~1|id, 
             start = c(s[1],s[2],s[3],s[4])) 
summary(fit1.5)  
 
AIC(fit1.4,fit1.5) # fully multiplicative random effect model is 
superior 
 
# Fully non-linear random gompertz model : plot residuals vs. fitted 
plot(fit1.5) 
qqnorm(fit1.5,~ranef(.)) #normality random effects 
 
# visualize model prediction (population and individual) for all 100 
individuals (8 non missing observations each) 
plot(augPred(fit1.5,primary=~age,level=0:1)) 
plot(augPred(fit1.1,primary=~age,level=0:1)) 
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Appendix 2.3. R code illustrating syntax and different strategies to model 
potential birth cohort effects when fitting polynomial MLM growth curve 
models on data arising from cohort-sequential or accelerated longitudinal 
designs.  
 
The code below assumes that LongData is a data frame with variables: y=response, 
age=age (centred), BaselineAge=Participant’s initial age, id= participant factorial 
identifier (such as participant number), cohort=factor identifying cohort (i.e. year of 
birth), BaselineAge2=square of baseline age. 
 
library(lme4) 
 
### Using the lmer() function from package lme4: 
## FIXED COHORT EFFECT MODELS: 
#(1) Full interaction linear model: Each cohort can have a different 
linear trend and intercept (i.e. starting level of response) 
model1 <- lmer(y∼age*cohort+(age|id),data=LongData) 
 
#(2) All cohorts have the same linear slope but shift to the 
intercept that vary linearly with age at baseline: 
model2 <- lmer(y∼BaselineAge+age+(age|id),data=LongData) 
 
#(3) Full interaction linear model where effect of baseline age on 
each growth parameter is considered to be linear: 
model3 <- lmer(y∼BaselineAge*age+(age|id),data=LongData) 
 
#(4) Same model as above (3) but with a quadratic age trend: 
model4 <- 
lmer(y∼BaselineAge*age+BaselineAge2*age+(age|id),data=LongData) 
 
##RANDOM COHORT EFFECT MODELS: 
#linear  MLM growth model with random cohort effect: 
model5 <- lmer(y∼age+(age|id)+(age|cohortf),data=LongData) 
#Alternatively, using the lme function from package nlme: 
library(nlme) 
model6 <- lme(y∼age,random=∼1+age|cohortf/id,data=LongData) 
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Appendix 3.1. Original cohort and design of the Young Finns Study from 1980 through 2011 (Table A) and number of non-missing lipid 
measurements per study year in the subsample of the cohort participants considered in the present analyses (Table B). 
a ,b Limitations in the sampling size in 1989 are due to physical examinations and blood tests collected only in one centre (Turku).  
 
Table A 
Year No. Age               
1980 3596 3 6 9 12 15 18          
1983 2991  6 9 12 15 18 21         
1986 2799   9 12 15 18 21 24        
1989a 632    12 15 18 21 24 27       
1992b 891     15 18 21 24 27 30      
2001 2620        24 27 30 33 36 39   
2007 2159          30 33 36 39 42 45 
2011 1999           34 37 40 46 49 
 
Table B  Age (years) 
  3 6 9 12 15 18 21 24 27 30 33 34 36 37 39 40 42 42 45 46 49 No. Total 
St
ud
y 
ye
ar
s 
1980 363  397 420 425 426 383                2412 
1983  337 364 376 375 327 263               2042 
1986   339 340 340 298 268 246              1831 
1989    56 51 47 46 44 41             285 
1992     143 119 122 119 98 100            701 
2001        299 336 359 372  362  334       2062 
2007          296 314  324  354  349  302   1939 
2011            234  262  286  301  291 289 1663 
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Appendix 3.2. Histograms of composite genetic risk scores (wGRSs) (Figure A) and of 
the number of available lipid observations per participants (Figure B). 
 
For each lipid, green colour in histogram A denotes the lower GRS quartile (i.e. the 25th percentile); 
red colour, the upper GRS quartile (i.e. the 75th percentile); and white colour, the interquartile range. 
(i.e. the 50% of the data lying between upper and lower quartile). 
 
Figure A 
 
 
Figure B 
 
Average number of lipid observations per participants (sd): 5.31 (1.4).
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Appendix 3.3. Estimation of interaction between polygenic lipoprotein risk scores and 
change in BMI z-score between adulthood (ages>30 years) and childhood (ages up to 18 
years) on adult lipoprotein concentration prediction. 
 
Abbreviations: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein 
cholesterol, wGRS-HDL; HDLwGRS3 continuous combined genetic risk score for HDL (38 
SNPs); wGRS-HDL, LDLwGRS14, continuous combined genetic risk score for LDL-C (14 
SNPs); wGRS-TG, TGwGRS24, continuous combined genetic risk score for triglycerides (24 
SNPs); adult.age, age of participants at latest adult follow up (2001, 2007 or 2011),D BMI, 
change in BMI z-score between childhood and adulthood as described in Methods section. 
* For HDL-C and LDL-C, the effect of wGRSs is in mmol/L per 1-sd change in wGRS, and 
the effect of D BMI is in mmol/L per 1-sd change in D BMI. For triglycerides, the effect of 
wGRSs is in odds ratio per 1-sd change in wGRS, and the effect of D BMI is in odds ratios 
per 1-sd change in D BMI.
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Adult LDL-C model (N=2100) AIC/BIC β (se)*, p-val 
Model 1: 
Adult.LDL~ sex+ adult.age+ wGRS-LDL+D BMI + wGRS-LDL*D BMI 
 
3686/3716 β wGRS-LDL: 0.029 (0.02),p<2x10-16 * 
β DBMI : 0.09 (0.01), p=1.3x10-6 * 
βwGRS-LDL*DDBMI:--0.02(0.01), p=0.15 
Model 2:  
Adult.LDL~ sex+ adult.age+wGRS-LDL+D BMI 
3685/3723 β wGRS-LDL: 0.20 (0.02), p<1x10-16 * 
β DBMI : 0.09(0.02), p<1.0x10-7* 
Likelihood Ratio Test: Model 1 vs. model 2 
χ2(df=1)=2.04 p=0.15 
 
Adult HDL-C model (N=2034) AIC/BIC β (se)*, p-val 
Model 3: 
Adult.HDL ~ sex+adult.age+wGRS-HDL+D BMI + wGRS-HDL*D BMI  
486/418 β wGRS-HDL: 0.06(0.007), p <2x10-16  * 
β DBMI : -0.09 (0.007), p= 0.046 * 
βwGRS-HDL*DBMI:-0.003 (0.006),p=0.62 
Model 4:  
Adult.HDL ~sex+adult.age +wGRS-HDL+D BMI 
488/525 β wGRS-HDL: 0.06 (0.007), p<1x10-16 
β DBMI : - 0.09 (0.07), p<2x10-16 
Likelihood Ratio Test: Model 3 vs. model 4 
χ2(df=1)=0.24 p=0.62 
 
  
243 
Appendices 
Adult triglycerides model (N=2062) AIC/BIC β (se)*, p-val 
Model 5: 
 Log(Adult.TG)~sex+adult.age+wGRS-TG+DBM + wGRS- TG*D BMI BMI 
 
2645/2876 β wGRS-TG: 1.029 (0.02),p<2x10-8 * 
β DBMI : 1.09 (0.01), p=2.1x10-5 * 
βwGRS-TG*DDBMI:-1.002(0.01), p=0.3 
Model 6:  
Log(Adult.TG)~sex+adult.age+wGRS-TG+D BMI 
3685/3723 β wGRS-TG: 1.029  (0.02), p<1x10-8 * 
β DBMI : 1.08 (0.01), p<1.0x10-9* 
Likelihood Ratio Test: Model 5 vs. model 6 
χ2(df=1)=1.17 p=0.11 
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Appendix 3.4. Flowchart of the Individual Growth Curve (IGC) analyses used for 
modeling the blood lipid trajectories in the YFS cohort.  
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Appendix 3.5. List of lipid-associated SNPs used to generate the genetic risk scores for HDL-C and LDL-C in the YFS population 
(reported are the SNPs reference number, risk allele for the SNP, GWAS-derived effect size in md.dl-1).  
 
HDL-C (38 SNPs) Triglycerides (25 SNPs) LDL-C  (14 SNPs) 
SNP   beta  chr/ locus    Frq (%) SNP  beta   chr/ locus      Frq (%) SNP  beta   Chr/locus      Frq (%) 
rs4660293_A 0.48    1/PABPC4         22.1 
rs2814944_G 0.49    6/C6orf106       21.7 
rs4731702_A 0.59    7/KLF14             54.4 
rs2923084_A 0.41   11/AMPD3         13.6 
rs7134375_A 0.40   12/PDE3A          59.2 
rs7134594_A 0.44   12/MVK              53.2 
rs1532085_A 1.45   15/LIPC              42.4 
rs3764261_A 3.39   16/CETP             73.6 
rs2925979_C 0.45   16/CMIP             31.7 
rs4148008_C 0.42   17/ABCA8          31.4 
rs4129767_A 0.39   17/PGS1             36.5 
rs737337_A 0.64   19/LOC55908   8.0 
rs1800961_C 1.88   20/HNF4A         4.3 
rs6065906_T 0.93   20/PLTP             14.6 
rs1689800_A 0.47   1/ZNF648          26.9 
rs4846914_A 0.61   1/GALNT2         46.1 
rs12328675_C 0.68   2/COBLL1          9.8 
rs2972146_G 0.46   2/IRS1                36.4 
rs6450176_G 0.49   5/ARL15            14.6 
rs605066_T 0.39   6/CITED2           47.9   
rs1084651_A 1.95   6/LPA                  17.4 
rs9987289_G 1.21   8/PPP1R3B       15,5 
rs2293889_G 0.44   8/TRPS1             70.9 
rs581080_C 0.65   9/TTC39B          87 
rs1883025_C 0.94   9/ABCA1            80.1 
rs3136441_C 0.78   11/LRP4             22.7 
rs4759375_T 0.86   12/SBNO1         9.2 
rs4765127_T 0.44   12/ZNF664       28.4 
rs838880_C 0.61   12/SCARB1       41.9 
rs2652834_G 0.39   15/LACTB         76.3 
rs16942887_A 1.27   16/LCAT           15.9 
rs11869286_C 0.48   17/STARD3     32.1 
rs7241918_T          1.31   18/LIPG              83.6 
rs12967135_G 0.42   18/MC4R           82.4 
rs7255436_A          0.45   19/ANGPTL4    51.5 
rs386000_C 0.83   19/LILRA3        29.7 
rs181362_C 0.46   22/UBE2L3       67 
rs13107325_G  0.84   4/SLC39A8       98.7 
rs10195252_T 2.01    2/COBLL1             65.2 
rs1042034_T 5.99    2/APOB                 74.3 
rs10761731_A 2.38    10/JMJD1C           63.1 
rs11613352_C 2.70    12/LRP1               77.3 
rs11649653_C 2.13    16/CTF1               61.3 
rs11776767_C 2.01     8/PINX1              30.2 
rs1260326_A 8.76     2/APOB               35.4 
rs12678919_A 13.64  8/LPL                    91.2 
rs13238203_C 7.91     7/TYW1B            97.2 
rs1495741_G 2.85     8/NAT2                75.1 
rs17145738_C 9.32     7/MLXIPL            88.0 
rs174546_A 3.82     11/FADS1-2-3    40.3 
rs2068888_G 2.28     10/CYP26A1       54.1 
rs2131925_T 4.94     1/ANGPTL3         72.6 
rs2247056_C 2.99     6/HLA                    76.2 
rs2412710_A 7.00     15/CAPN3             3.1 
rs2929282_T 5.13     15/FRMD5            6.2 
rs2954029_A 5.64     8/TRIB1                54.3 
rs439401_C 5.50     19/APOE               72.4 
rs442177_T 2.25     4/KLH8                 52.4 
rs5756931_T 1.54     22/PL2G6             60.3 
rs645040_T 2.22     3/MSL2L1            85.8 
rs9686661_T 2.57     5/MAP3K1           14.3 
rs964184_C 16.95  11/APOA1            14.1 
 rs4299376_G 2.75     2/ABCG5/8        20.3 
rs3757354_C 1.43     6/MYLIP             75.1 
rs1800562_G 2.22     6/HFE                  96.5 
rs1564348_T 0.56     6/LPA                  14.3 
rs11220462_A 1.95     11/ST3GAL4      18.2 
rs8017377_A 1.14     14/NYNRIN        37.2 
rs6511720_G 6.99     19/LDLR             10.3 
rs2479409_G 2.01      1/PCSK9            28.6 
rs629301_T 5.65      1/SORT1            78.1 
rs1367117_A 4.05      2/APOB              30.5 
rs11136341_G 1.40      8/PLEC1            36.2 
rs7206971_A 0.78      17/OSBPL7       48.1 
rs4420638_G 7.14      19/APOE           25.1 
rs6029526_A 1.39      20/TOP1            53.3 
 
Note: The gene name listed under ‘locus’ is either plausible biological candidate gene in the locus or the nearest annotated gene to the SNP. ‘chr’ denotes 
chromosome. ‘Freq (%)’ denotes the risk allele frequency in the YF population, Adapted from Teslovitch et al. (2010)258 and Tikkanen et al. (2011) 267.  
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Appendix 3.6. Child and adult cutoffs used to define ‘normal’ and ‘high-risk’ serum 
lipid levels (in mmol/L). 
Childhood cutoffs apply to participants 19 years and younger. Chosen cutoffs are based on 
NCEP adult-panel treatment guidelines, NCEP pediatric and adolescent guidelines and AAP 
and AHA pediatric guidelines (see methods). 
 
 
 Normal Risk High Risk 
HDL-C 
Childhoood > 0.91 ≤ 0.91 
Adulthood > 1.03 ≤ 1.03 
LDL-C 
Childhoood < 4.14 ≥ 4.14 
Adulthood < 3.37 ≤ 3.37 
Triglycerides 
Childhoood <1.4 ≤ 1.4 
Adulthood < 1.7 ≤ 1.7 
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Appendix 3.7.  Sex-specific associations between categorical genetic risk score and lipid levels at selected ages (3 years, 15 years, 24 years 
and 45 or 46 years). 
Effect sizes β are in mmol/L for the number of risk allele differences between high and low wGRSs. Reported at each age are: Int (SE), the average lipid level 
in mmol/L (SE) in the high risk score group; β (SE), the difference in average lipid level in mmol/L for subjects in the low risk score group, the p-value for 
each cross-sectional association and the number of non-missing serum lipid observations considered in each regression (Nobs). (*: For each sex, the number 
of risk alleles difference between high and low wGRS groups are calculated as: median (Number of alleles in the High wGRS) – median ((Number of alleles in 
the Low wGRS)). 
 
wGRS 
Number of 
risk alleles 
 
Average Lipid Levels 
 
3 years 15 years 24 years 45/46 years 
LDL-C 
Males 
High 
Low 
16.72 
12.19 
Int: 3.57 (0.13) 
β: -0.49 (0.12) 
P-val=0.005 
Nobs=173 
Int: 3.01 (0.11) 
β: -0.42(0.12) 
P-val=9.1*10-7 
Nobs=617 
Int: 3.23 (0.13) 
β: -0.45 (0.11) 
P-val=8.3*10-6 
Nobs=313 
Int: 3.68(0.14) 
β: -0.56 (0.10) 
P-val=9.7*10-8 
Nobs=421 
Females 
High 
Low 
16.68 
 12.55 
Int: 3.78 (0.11) 
β:-0.35 (0.11) 
p-val=0.023 
Nobs=184 
Int: 3.31 (0.10) 
β: -0.39 (0.09) 
P-val=3.8*10-6 
Nobs=711 
Int: 3.16 (0.10) 
β: -0.41 (0.11) 
P-val=2.1*10-5 
Nobs=397 
Int: 3.57 (0.11) 
β: -0.51 (0.10) 
P-val=2.0*10-8 
Nobs=475 
HDL-C 
Males 
High 
Low 
48.08 
40.99 
Int: 1.56 (0.08) 
β: -0.15 (0.04) 
P-val=0.025 
Nobs=161 
Int: 1.48 (0.06) 
β: -0.15 (0.05) 
P-val=5.8*10-6 
Nobs=594 
Int: 1.3 (0.08) 
β: -0.13 (0.03) 
P-val=0.01 
Nobs=293 
Int: 1.40 (0.07) 
β: -0.16 (0.07) 
P-val=1.3*10-4 
Nobs=415 
Females 
High 
Low 
48.00 
41.01 
Int: 1.56 (0.06) 
β: -0.16 (0.05) 
P-val=0.004 
Int: 1.62 (0.06) 
β: -0.15 (0.04) 
P-val=2.5*10-6 
Int: 1.56 (0.04) 
β: -0.13 (0.04) 
P-val=0.017 
Int: 3.01 (0.08) 
β: -0.17 (0.05) 
P-val=3.7*10-5 
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Nobs=174 Nobs=688 Nobs=373 Nobs=446 
Triglycerides 
Males 
High 
Low 
28.99 
23.02 
Int: 0.70 (0.08) 
β: -0.17 (0.05) 
P-val=0.001 
Nobs=173 
Int: 0.96 (0.1) 
β: -0.23 (0.03) 
P-val=4.3*10-8 
Nobs=620 
Int: 1.5 (0.1) 
β: -0.46 (0.03) 
P-val=5.8*10-5 
Nobs=315 
Int: 1.77 (0.15) 
β: -0.53 (0.04) 
P-val=3.5*10-6 
Nobs=439 
Females 
High 
Low 
28.99 
23.07 
Int: 0.75 (0.09) 
β: -0.19 (0.07) 
P-val=8.5*10-6 
Nobs=186 
Int: 0.93(0.08) 
β: -0.17(0.05) 
P-val=1.1*10-6 
Nobs=717 
Int: 1.33 (0.07) 
β: -0.20 (0.06) 
P-val=0.0001 
Nobs=393 
Int: 1.65 (0.08) 
β: -0.23 (0.07) 
P-val=1.5*10-8 
Nobs=470 
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Appendix 3.8.  Step by step IGC model-building procedure, explicit parametrisation of 
the IGC submodels and references on IGC modeling.  
 
Data exploration 
Prior to all IGC analyses, plotting raw data trajectories of a number of randomly selected 
YFS participants suggested variability in individuals’ initial lipid levels and variability in 
how individuals’ lipid levels change as they age. The shape of each lipid trajectories across 
the life course was examined using individual empirical growth plots and generalised 
additive mixed models (GAMMs). GAMM is a well-suited modeling framework for 
uncovering potentially non-linear trends in correlated datasets. This approach allows flexible 
specification of regression splines to represent the functional relationships between a 
response variable and a temporal covariate that can be continuous or discrete (i.e. age) using 
smooth functions of the covariate (‘age’ in this case). The fitting of GAMMS can also 
suggest plausible polynomial models to describe the pattern of change in the lipid model (i.e. 
typically the model order is chosen by the number of bends needed in the predicted GAM 
trajectory (number of inflection points)).  
 
Note: To conduct IGC analysis, three or more waves of data collection are required; having 
two waves or less will limit the ability to identify shape of individual growth trajectories and 
to distinguish true growth from measurement error. Theoretically, it is possible to test for 
linear growth with a minimum of three data waves per subject, quadratic growth with four 
waves minimum, and so one. In this study sample there is a maximum of eight waves of data 
for each YFS participant so an age polynomial up to the order seven could be fit in theory. 
However, in practice, because participants had 5.31 lipid observations on average, the highest 
order age polynomial term considered to describe individual lipid profiles was age4 (i.e. 
quartic age growth). 
 
Individual Growth Curve modeling (IGC analysis) 
IGC modeling is a multilevel regression technique used for exploring longitudinal data on 
individuals over time. It allows investigating two levels of variability of the response 
variable: within and between subjects. In longitudinal data, measurements made on the same 
individual are correlated and it is this dependency that leads to the inadequacy of simple 
estimation procedures based on ordinary least squares. Observations taken over time are 
nested within subjects drawn from a population of interest giving a two-level hierarchical 
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structure. The variation of responses within subjects over time is at the lowest level (level-1) 
and the variation of the underlying mean responses between subjects is at level-2 23. Growth 
curve analysis allows to model and quantify change over time both at group-level (level-2) 
and individual-level (level 1). Sometimes in longitudinal data, the interest lies as much in the 
covariance matrix estimates as in the average growth parameters. IGC allows examination of 
both. In this case, the time-relevant predictor is age and the predictor of interest is genetic 
risk scores (wGRSs) as the purpose was to determine if wGRSs modify the trajectories of 
blood lipids across the lifetime. Because males and females have been shown to differ in their 
lipid trajectories profiles across the life course in previous research, a test of how ‘sex’ 
modifies the lipid trajectories was conducted. In practice, IGC modeling consists of 
sequentially testing a number of models as follows: 
 
Step 1) Unconditional means (UM) model  
The UM model is the simplest multilevel model containing no predictor (i.e. this is often 
viewed as a one-way ANOVA model with subject-level random intercept). It serves as a 
baseline model to examine individual variation in the outcome variable without regard to age. 
This model assesses (1) the grand mean of the outcome variable, and (2) the amount of 
outcome variation that exists at the intra- and inter-individual levels. It allows computing the 
ICC (intraclass correlation coefficient), which describes the amount of variance in the 
outcome that is attributed to differences between individuals. The ICC evaluates the necessity 
of modeling the nested data structure. For LDL-C, the UM model can be written as:  
  
Level 1: LDLij = boi + eij 
Level 2 :  boi= β0 + u0i 
Where eij ~iid N ( 0, σ2) and u0i ~iid N ( 0, τ2) 
 
Example of UM model for LDL-C in R notation (nlme package): 
UMmodel<- lme (LDL-C ~1, random= 1|subject,  method = "ML", 
na.action = na.omit) 
  
For example, when applying the UM model to LDL-C, an ICC of 0.67 was calculated, 
suggesting that about 67% of the total variation in the LDL-C level was due to inter-
individual difference, strongly supporting a multilevel model approach. 
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Step 2) Potential unconditional growth (UG) models  
The next step is to determine the Unconditional growth model (UG model), which in this 
case is a model where the response variable (i.e. lipid level) is modeled as a function of age, 
and where participant IDs are used as a random effect (i.e. random intercept). This is the 
level-1 model, which describes how each individual lipid levels change over time. In UG 
models, subjects are collapsed across all possible grouping variables of interests (i.e. sex, risk 
factors, etc), and age (or any other relevant time variable) is expressed as a deviation from 
average value in the cohort (i.e. centering the time-related variable will reduce 
multicollinearity between polynomial terms if a higher order polynomial is needed to fit the 
data). 
 
It is common practice to always fit an Unconditional Linear UG Model, even when data 
exploration suggests a non-linear response over time. The linear UG model is used as a 
baseline to compare curvilinear UG models for the response over time. Orthogonal 
polynomials are a possible choice to model non-linear response variables by IGC analysis. 
Unlike natural polynomials, orthogonal polynomials terms have the advantage to be 
interdependent (no multicollinearity between age, age2, age3…). When using orthogonal 
polynomials, the intercept term of the model will reflect the average overall curve height, 
rather than the height at the left edge of the time window, but higher order parameters are 
difficult to interpret. They are usually preferred when the main interest lies in prediction.  
 
For this application, natural polynomial terms were used to capture the curvature of the lipid 
profiles to determine if differences existed at the very beginning of the time window (i.e. age 
was centered around the youngest age in the cohort (age 3)). Also, the pattern of change in 
the response over time rather than which time component, was more important. Therefore, it 
was more desirable to interpret the output of the linear mixed effect models on the original 
time-scales. Additionally, collinearity between covariates does not tend to affect the quality 
of parameter estimation to a notable extent, so the age terms were centered (at around 3 years 
old) rather than using orthogonal polynomials as recommended by Liu and Engel 201586 
 
Example : Potential UG models for LDL-C: 
# linear UG model (with a random intercept only): 
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Level 1: LDLij = boi + b1.Ageij +eij   # Addition of age as a predictor at level 1 
Level 2 :  boi= β0 + u0i 
Where eij ~iid N ( 0, σ2) and u0i~iid N ( 0, τ2) 
 
In lme syntax, the linear UG can be written as: 
Linear. UG<- lme (LDL-C ~ age, random= 1|subject, method = 
"ML", correlation, na.action = na.omit) 
  
However, the fitting of GAM models in the data exploration step suggested that the lipid 
responses were curvilinear,  modeled with a cubic or 4th order polynomial polynomial. 
Therefore, the following potential UG models were fitted:  
 
# Quadratic UG model (with a random intercept): 
 
Level 1: LDLij = boi + b1.Ageij + b2.Age2ij +eij   # Addition of age-square as a predictor  
Level 2 :  boi= β0 + u0i 
Where eij ~iid N ( 0, σ2) and u0i ~ iid N ( 0, τ2) with eij  and u0i are independent for all i and j. 
 
In R notation, this model is written:  
Quadratic. UG<- lme (LDL-C ~ age+ I(age^2)+ , random= 
1|subject,    method = "ML", correlation, na.action = na.omit) 
 
 
Similarly, more complex level-1 submodels can be defined by including cubic or quartic 
growth predictors:  
 
# Cubic UG model   (with a random intercept) 
cubic. UG<- lme (LDL-C ~ age+ I(age^2)+ I(age^3) , random= 
1|subject,    method = "ML", correlation, na.action = na.omit) 
 
# Quartic UG model   (with a random intercept) 
quartic. UG<- lme (LDL-C ~ age+ I(age^2)+ I(age^3)+ I(age^4)+  
, random= 1|subject,    method = "ML", correlation, na.action 
= na.omit) 
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Unconditional Growth Model Comparisons: 
When comparing increasingly complex submodels throughout the IGC analyses, the 
improvement in model fit is assessed by the Likelihood Ratio Test (LRT) or by looking at 
AIC/BIC criteria. The best fitting UG model among these candidate level-1 submodelswas 
determined using both criteria. 
1) likelihood ratio tests (LRT): can only be used to compare models nested within one 
another (i.e. this is done by computing -2 times the difference between the two models 
residual log likelihoods (-2RLL), and comparing it to the χ2 distribution with degrees of 
freedom equal to the difference in the number of parameters for the two models). Models are 
preferred where the -2RLL is smaller.  
2) Akaike’s Information Criterion (AIC) is also useful as it is valid to compare non-nested 
models (i.e. the model with the smallest AIC is preferred).  
It is important that the candidate level 1 models are fit using full maximum likelihood 
(method="ML" argument in R), so that the LR tests can be used to evaluate the elimination of 
either fixed or random effects. The adequate UG model will then be retained as the baseline 
model for the next steps in the IGC analysis. 
 
Example:  
anova(UMmodel ,linear.UG, quadratic.UG, cubic.UG, quartic.UG) 
AIC(UMmodel ,linear.UG, quadratic.UG, cubic.UG, quartic.UG) 
 
At this stage, AIC criteria and LR tests showed the cubic growth model with variance in 
individual intercept was best at capturing the intra-individual growth of LDL-C over time.  
 
So far, LDL-C UG model, with ageij centered around 3 years old, can be written: 
Level 1 : Yij=boi +b1(ageij) + b2(ageij)2  + b3 (ageij)3 + eij 
Level 2 :  boi= β0 + u0i 
With  eij,the amount the response on occasion j deviates from person i's true change 
trajectory. 
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Step 3) Model the random effect structure  (i.e. subject-level intercept and slope 
variability) 
Once the best UG model has been determined, it is possible to explicitly model the random 
part of this model. Indeed, a potential limitation of the UG model chosen above for LDL-C 
(i.e. cubic growth model with random intercept) is that is assumes the relationship between 
time and LDL-C is constant for all individuals. An alternative model is one where 
unobserved individual characteristics would also explain variation in trajectory parameters. 
This means expanding the level 2 model by adding random terms for age-, age2-, and age3 
slopes. 
 
There are diverging views in the literature regarding the specific modeling of random effects 
in IGC analysis. Barr et al. 375, do not advocate model selection of the random growth 
parameters, suggesting that UG models should include all random effects that are licensed by 
the design (i.e. all the ones that could potentially vary across participants). This is sometimes 
referred to as the ‘beyond optimal random effect structure’, where all age terms in the fixed 
effect part of the growth model also appear in the random part of the model. The reason for 
allowing all possible slopes to vary across individual is because when a random effect does 
not improve model fit, it can still affect the fixed effect estimates and excluding it can elevate 
the false positive rate. However, estimating random effects is “expensive” in terms of the 
number of observations required, and estimating too many random effects can lead to 
computational difficulty (i.e. model failing to converge). Mirman et al.18, 19 include participant 
random effects on all time terms up to the cubic, as terms beyond this tends to capture less-
relevant effects in the tails. Others, including Pinheiro et al. 114, recommend testing the 
significance of all possible random terms when higher-level trends are significant, to 
determine if allowing the slopes of higher-level variables to vary randomly will improve 
model fit (i.e. test that a quadratic or cubic relationship varies in strength among individuals).  
 
 
The approach used here, when technically possible, was to test sequentially if each additional 
random parameter (i.e. random intercept, random linear slope, random quadratic slope…) 
improved the fit of the unconditional UG models using LR tests and AIC, as in Zuur et al. 
and Bliese 121, 376. This is done in our model by adding, in order of increasing complexity, the 
linear, quadratic, and cubic age terms as random effects in the cubic UG growth model. If one 
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wants to select at once of the optimal fixed effect and random effect structure, it is best to use 
ML estimation rather than REML 114. Here, because it was determined that the best model 
was the cubic UG mode, the restricted maximum likelihood “REML” estimation method was 
used, so that LRT tests evaluate the elimination of random effects only.   
 
Once the optimal random effect structure has been chosen for the UG model, one can 
visualise the variance covariance matrix of the random effects at level 1 (i.e for lme objects in 
R, one can access random effect variance and correlation estimates using the VarCorr () 
argument). It will reveal, for example, if within-individual lipid levels at baseline (intercept) 
are correlated with linear change in lipid across the life course. As is common with random 
effects, we apply no constraint on the variance-covariances of the random effect matrix (i.e. 
unstructured G-matrix). 
 
Example:  with age centered around 3 years old, LDL-C UG sub-models  with slope 
variability include: 
 
# cubic UG model  (with a random intercept) == best level 1 model as determined by LR test 
above 
cubic. UG<- lme (LDL-C ~ age+ I(age^2)+ I(age^3) , random= 
1|subject,    method = "REML", correlation, na.action = 
na.omit) 
 
# cubic UG model with a random intercept and  linear age slope: (2X2 unstructured variance 
covariance matrix): At this point we have three variance components: σ2, τ02 and τ12 . The 
correlation between intercept and linear slope is given by !"#. 
 
Level 1 : Yij=boi +b1i(ageij) + b2(ageij)2  + b3 (ageij)3 + eij 
Level 2 :  boi= β0 + u0i 
                b1i = β1+ u1i 
Where in addition : eij ~iid N ( 0, σ2) and ui= 
$%&$#& ~iid N '' , !%) !"#!"# !#)  
 
In R notation:  
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cubic. UG. 1<- lme (LDL-C ~ age+ I(age^2)+ I(age^3) , random= 
1+age|subject,  method = "REML", correlation, na.action = 
na.omit) 
 
It is also possible to add additional variance components at level 2 (i.e. random quadratic, 
and cubic slopes): 
 
# cubic UG with a random intercept and random linear and quadratic slopes: (3X3 
unstructured variance covariance matrix) 
Level 1 : Yij=boi +b1i(ageij) + b2i(ageij)2  + b3 (ageij)3 + eij 
Level 2 :  boi= β0 + u0i 
                b1i = β1+ u1i 
               b2i= β2 + u2i 
Where in addition : eij ~iid N ( 0, σ2), and ui= 
$"&$#&$)& ~iid ''' , !-
) !"# !")!"# !#) !#)!") !#) !))  
               
In R notation, this can be written as: 
cubic. UG. 2<- lme (LDL-C ~ age+ I(age^2)+ I(age^3) , random= 
1+age+ I(age^2)|subject,    method = "REML", correlation, 
na.action = na.omit) 
  
 
For a level 1 model with a 3rd order polynomial, the maximum possible random parameters 
for the variance covariance matrix is 4x4: 
 
# cubic UG  with a random intercept and random linear, quadratic and cubic slopes:  
cubic. UG. 3<- lme (LDL-C ~ age+ I(age^2)+ I(age^3) , random= 
1+age+ I(age^2) + I(age^3)|subject,    method = "REML", 
correlation, na.action = na.omit) 
  
 
Appendices 
 257 
To determine the best random effect structure, the increasingly complex submodels (in terms 
of additional variance and covariance components for the random effects) are then compared 
using AIC or LR tests.  
 
mod.aic<-sapply(list(cubic. UG, cubic. UG. 1, cubic. UG. 2, cubic. UG. 3), AIC) 
LR-test<-sapply(list(cubic. UG, cubic. UG. 1, cubic. UG. 2, cubic. UG. 3), anova) 
 
Example: 
In the case of the LDL-C UG model, all 4-candidate structures for random effects could be 
estimated with no convergence issue. The cubic growth model with a random intercept, linear 
and quadratic slopes was the best fit to the data as determined by LR test and AIC criteria  
(with a 3 x 3 unstructured variance covariance matrix for the random effects). In this model. 
τ02 refer to the variability in the intercepts of the subject-specific regression lines about the 
intercept of population-averaged line, τ12 is the variability of the individual slopes about the 
population linear slope, and τ22, the variability of the individual slopes about the population 
line quadratic slope. σ2 is the average variability of participants LDL-C values about their 
own individual regression line. 
 
 
Step 4) Model residual error structure  
It is very important to scrutinize level-1 error structure especially with unequally spaced and 
unbalanced data, because estimated variances of the parameter estimates are likely to be 
biased and affect the precision of estimating the appropriate model. The purpose of testing 
different error covariance matrices is to describe how UG model the error is distributed. It is 
likely that lipid measurements taken temporally close to each other will be more strongly 
related than those temporally far apart (i.e. autocorrelation). It is also likely that lipid levels 
will tend to become either more variable over time or less variable over time as participants 
age (i.e. heteroscedasticity). UG models need to be tested for both autocorrelation and 
heteroscedasticity. The Models fitted to select the optimal error structure are also fitted using 
ML (maximum likelihood) 121. 
 
A/ Residual correlation structure:  
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In the present study, three commonly examined types of error covariance structures were 
tested for the UG models: unstructured, compound symmetric, and first-order autoregressive 
variance covariance of the residuals’ matrix  (Pinheiro and bates 2013114): 
 
1) Unstructured (UN), often provides the best fit in longitudinal data as it requires no 
assumption in the error structure. The variance is not assumed constant between different 
ages and the correlations between observation times can all be different (estimation can be 
problematic as many parameters as number of timepoints -1 need to be estimated). In lme 
notation such a residual correlation structure is defined as: correlation = 
corSymm(form=~1|subject) within the model formulation. 
 
 
2) Compound Symmetry (CS), implies that the variance and correlation between each pair of 
observations are constant across time points (i.e. correlation = corCompSymm 
(form=~1|subject))  
 
 
3) Continuous First-Order Autoregressive (AR1), in which the variance is assumed to be 
heterogeneous and the correlations between the two adjacent time points decline across 
measurement occasions (i.e. correlation = corCAR1(form = ~ age| 
subject). 
 
Example: 
In the LDL-C UG model example, the LR-test showed that a model with an AR1 error 
structured fit the data better, so it will be retained when introducing level 2-predictors in the 
model.  
 
 
B/ Residual heteroscedasticity:  
Examining the variance of lipid concentrations at each age can give an idea of variance 
homogeneity. For each lipid UG model the error variance decrease or increase over ages was 
tested (i.e. weights=VarFixed(form=~age) or weights=VarExp(form=~age) 
arguments in the lme() call respectively). 
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Example: For all lipid UG models, residual variance did not exhibit significant increasing or 
decreasing trends over time so that subsequent models were not adjusted for 
heteroscedasticity.  
 
 
Step 5) The conditional growth  (CG) sub-models 
Once the fixed and random components of the unconditional growth model have been 
determined, the independent predictors (time-varying or time invariant) can be introduced 
into the lipid growth model: it becomes the conditional growth model. This level-2 model 
(i.e. between-person model) describes how the individual growth differs across individuals. 
The CG model represents the relationship between level 1 growth parameters (intercepts, 
linear, quadratic and cubic slopes) and time-invariant characteristics of the individuals (e.g. in 
this application, wGRS group (‘low’, ‘high’, “mid’) or continuous wGRS; and sex). The 
Level-2 model captures whether the rate of change varies across individuals in a systematic 
way. The growth parameters (i.e. the within-subject intercepts and slopes) of Level-1 are the 
outcome variables to be predicted by the between-subjects variables at Level 2. The CG 
model allows questions such as “are there differences between genetic risk group (High vs 
low) in the lipid change over time?”, or “ How does a 1-SD increase in wGRS will impact the 
average lipid trajectory as a person age?” to be answered. 
 
1- Add sex as level-2 predictor in the model:  
 
table(LDLgrsdata$sex) 
 
Female   Male  
  5192   4544 
Sex is a factor variable in R. By default dummy variables have been constructed to contrast 
temperate and male with female participants:   
 
contrasts(LDLgrsdata$sex) 
       Male 
Female    0 
Male      1 
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Now it is possible to explore how “sex’ modifies the basic level-1 relationship between LDL-
C and age. It can potentially affect the intercept, the slopes, or both. Similar to what is 
described above, we can sequentially test the 3 following models:  
 
1- Does sex affect the population LDL-C intercept (LDL-C levels at age 3) ? 
 
# Baseline level 1 model for comparison: 
cubic. UG. 2<- lme (LDL-C ~ age+ I(age^2)+ I(age^3) , random= 
1+age+ I(age^2)|subject,    method = "ML", correlation, 
na.action = na.omit) 
model3<-lme(LDL-C~I(LDL-C ~ age+ I(age^2)+ I(age^3) +sex, 
random= 1+age+ I(age^2) |subject,    method = "ML", 
correlation, na.action = na.omit) 
anova(model3, cubic. UG. 2)# LR-test, P-val= 0.45 
 
# Note: because ‘sex’ is a categorical variable with only two categories, the Wald tests shown 
in the summary output of model 3 will provide a test for the significance of “sex” for the 
intercept (this will not be different from the LR-test). However, it is good practice to use 
Likelihood Ratio testing, as for variables with more than 2 levels, it is necessary to apply LR-
test to obtain significance of the variable.  
 
It is possible to further quantify the relationship between sex and the intercept of the LDL-C 
model by computing a pseudo-R2 statistic:  
 
 
as.numeric(VarCorr(cubic. UG. 2)[2,1]) - 
as.numeric(VarCorr(model3)[2,1])) / as.numeric(VarCorr(cubic. 
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UG. 2)[2,1])= 0.04 
 
So only 3% of the individual-level variation in the intercept (i.e. LDL-C levels at age 3) is 
explained by “sex”. This is consistent with the fact that adding “sex” to the level-2 equation 
for the intercept did not significantly improve the model (LR test, p-value=0.45) 
 
2- Does sex affect the population linear slope? 
 
Similarly to what has been shown above, we can compute:  
model4<-lme(LDL-C~I(lntemp-~ age+ I(age^2)+ I(age^3) +sex:age, 
random= 1+age+ I(age^2) |subject, method = "ML", correlation, 
na.action = na.omit) 
 
anova(model4, cubic. UG. 2) 
 
The likelihood ratio test finds the effect of climate on the slope to be statistically significant. 
This is confirmed by looking at the AIC. We can also quantify the effect with a pseudo-
R2 statistic (i.e. this time it compares the change in !#) between the current model and random 
slopes and intercepts model (cubic.UG.2 model)):  
 
(as.numeric(VarCorr(cubic. UG. 2)[2,1]) - 
as.numeric(VarCorr(model3)[2,1])) / as.numeric(VarCorr(cubic. 
UG. 2)[2,1])= 0.04 
 
 
3- Does sex affects the all population trajectory parameters? 
Following the same approach, we use LR-T test, AIC and level 2 pseudo-R2  to test 
sequentially the effect of sex on every trajectory parameter: 
The most complex model, where sex affects all trajectory parameters, can be written as: 
 
Level 1 : Yij=boi +b1i(ageij) + b2i(ageij)2  + b3 (ageij)3 + eij 
Level 2 :  boi= β0 + β01 (sexi) +u0i 
                b1i = β1+ β11 (sexi) +u1i 
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               b2i= β2 + β21 (sexi) +  u2i 
 
In R notation:  
 
model5<-lme(LDL-C~I(lntemp-~ (age+ I(age^2)+ I(age^3) )*sex, 
random= 1+age+ I(age^2) |subject,    method = "ML", 
correlation, na.action = na.omit 
anova(model5, cubic. UG. 2) 
 
AIC and LR tests showed that model 5 was the best level 2 model for LDL-C at this stage. 
 
2- Add wGRS risk group as level-2 predictor in the model: 
Similar to what was demonstrated above for ‘sex’ above, the influence of wGRS group on  
individual growth parameters of LDL-C can be tested. In this mode,l contrasts where chosen 
to compare low and mid genetic risk groups with high genetic risk category:  
 
contrasts(LDLgrsdata$GRS) 
     low mid 
high   0   0 
low    1   0 
mid    0   1 
 
Similar to what was demonstrated for sex, the effect of GRS groups on LDL-C intercept and 
age slopes are tested using LR test and AIC. 
 
Example: Hypothetic level-2 model for LDL-C with wGRS group affecting all trajectory 
parameters:  
Level 1 : Yij=boi +b1i(ageij) + b2i(ageij)2 +  b3 (ageij)3 + eij 
Level 2:  
boi =β00 + β02 (wGRSi)  + ζ0i # individual intercept 
 
b1i =β10 + β12 (wGRSi) +  ζ1i # individual  linear slope 
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b2i =β20 + β22 (wGRSi) + ζ2i # individual  quadratic slope  
 
b3 =β30 + β31 (wGRSi) 
 
3- Test the combined effects of sex and wGRSs groups and their interaction as 
level 2 predictors: Final IGC model 
 
The final IGC model is the one where all level-2 predictors and their cross-products are 
added in the model. It allows the effect of the dichotomous genetic risk score category, sex, 
and their interaction (wGRS group by sex) on the shape of average LDL-C growth 
trajectories in the cohort to be tested. It is used to explore any group differences in change 
over time. The corresponding final IGC model can be written as:  
 
LDLserum.lme <- lme(LDLserum ~ sex*(age+I(age^2)+I(age^3))+ 
LDLwGRS14*(age+I(age^2)+I(age^3)) + (sex* LDLwGRS14)* (age+I(age^2)+I(age^3))  , 
random=list(Patients=~1+age+ I(age^2)), 
                      method = "ML",correlation = corCAR1(form = ~ age| subject),data = 
LDLgrsdata,na.action = na.omit,control=lmeControl(opt="optim")) 
 
Final IGC model, with level-2 predictors sex and wGRSs groups and their crossproducts:  
 
Level 1 : Yij=boi +b1i(ageij) + b2i(ageij)2 +  b3 (ageij)3 + eij 
Level 2:  
boi =β00 + β01 (sexi) + β02 (wGRSi) + β03 (sexi* wGRSi) + u0i # individual intercept 
 
b1i =β10 + β11 (sexi) + β12 (wGRSi) +  β13 (sexi* wGRSi) +  u1i # individual linear slope 
 
b2i =β20 + β21 (sexi) + β22 (wGRSi) +  β23 (sexi* wGRSi) + u2i # individual quadratic slope  
 
b3=β30 + β31 (sexi) + β32 (wGRSi) +  β33 (sexi* wGRSi) # population average cubic slope 
 
with : 
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• β00,  population level average intercept (fixed effect) and β10 = population average 
linear slope, β20==population average quadratic slope, b3=population average 
quadratic slope. 
• β01, β02, and β03: three predictors of intercept variability, respectively for sex, wGRS 
and sex*wGRS interaction.  
• u0i ,   u1i ,  u2i , the amount person i's intercept, linear slope, and quadratic slopes 
deviate from the population average parameters. 
• eij. the amount the response on occasion j deviates from person i's true change 
trajectory, and eij follows a AR1 structure. 
The significance of each predictor in the final UG model is assessed by t-statistics for the 
parameter (i.e. defined as the ratio of parameter estimate and SE). Reported in the Tables 3.2 
and 3.3 are the p-values provided in the LME () output in R. 
 
Example: Parameter estimates presented in Table 3.2 and 3.3 for LDL-C correspond to β02, 
β12 β22 and β32 parameters of the final IGC models, as all sex* wGRS interaction terms (i.e. 
β03, β13, β23 and β33) were unsignificant in the final model. The fixed estimates from the final 
IGC model output can be used to compute the slope estimates for the 6 relevant groups (i.e. 
male –High risk, male-mid risk, male -low risk, female-high risk, female-mid risk and female 
low-risk) (Figure 1).  
 
IGC modeling vs. ANOVA? 
The specification of an IGC model is different to an ANOVA model: Although individual 
growth curve models can treat age as a continuous variable across subjects, and model 
change in outcome at the individual level, the ANOVA model focuses on growth curves at 
the aggregate level. ANOVA assumes that all individuals are measured at the same time-
point for any given wave of data collection. One of the advantages of IGC models over 
ANOVA, is that they can treat age as a truly continuous variable. ANOVA also does not 
model individual variability in rates of change in the outcome over time. 
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Adjustment for confounding effects: 
 
1- Birth cohort effect 
To minimise potential confounding effects, a birth cohort effect on the age-related changes in 
lipids in the YF cohort was considered for each sex. Before introducing genetic risk scores 
(wGRSs) as predictors of lipid trajectories, the effect of ‘year of birth’ (yob) on each lipid’s 
unconditional growth model was thus assessed. This was performed by adding the variable 
“yob” and its interaction terms with age-related terms to each sex-specific lipid trajectory 
model (i.e. for female LDL-C model, for example: age, age2, age3, yob, yob*age, yob*age2 
and yob*age3). “yob” was used as a categorical variable with 6 levels, for the 6 possible birth 
cohorts represented in the data sample (i.e. participants born in 1977, 1974, 1971,  1968, 
1965,  and 1962 respectively). As described above for sex and wGRSs group, LRT test and 
AIC were used to test the significance of a birthcohort effect on trajectory parameters for 
each lipid.  
 
2-Period effect 
Before considering the predictive effect of the genetic risk scores on the lipid trajectories, the 
potential differences in lipid measurements between examinations or secular ‘period effect’ 
in lipids over the 31 years of follow-up were examined. To test for this, calendar ‘year’ 
(centered around 1980 (baseline)) was introduced in the sex-specific lipid unconditional 
growth models (i.e. for LDL-C the model included age, age2, age3, year, year*age, year*age2 
and year*age3).  
 
 
Example: 
In all sex-specific analyses of lipid profiles, we found no birth cohort effect. However, in each 
case, we found significant secular trends (see 3.4.2.). For this reason, all UG models were 
adjusted for ‘year’ before introducing subject-level trajectory predictors (i.e. wGRSs). For 
example, the final IGC model for LDL-C can be written as: 
 
LDLserumlme <- lme(LDLserum ~ sex*(age+I(age^2)+I(age^3)))+ 
LDLwGRS14*(age+I(age^2)+I(age^3))) + (sex* LDLwGRS14)* (age+I(age^2)+I(age^3))) 
+as.numeric(year), random=list(Patients=~1+age+ I(age^2)), 
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                      method = "ML",correlation = corCAR1(form = ~ age| subject),data = 
LDLgrsdata,na.action = na.omit,control=lmeControl(opt="optim")) 
 
 
Final model check and validation 
Each final IGC model was checked using graphic model validation tools for mixed-models 
described in Zuur et al 128. 
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Appendix 3.9. Kernel density plots and quantile-quantile plots of lipoprotein 
concentrations. 
 
LDL-C levels (mmol/L): 
 
 
 
 
 
 
 
 
HDL-C levels (mmol/L):  
 
 
Triglyceride levels (mmol/L):  
 (Before log transformation)  
 
QQ plot of triglycerides distribution after log transformation. 
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Appendix 3.10. Model Validation plots for the best fitting IGC model. (i) 
residuals vs. fitted values (homogeneity check), (ii) histograms and QQ-plot of 
the residuals (normality check), (iii) residuals vs. age (in years) (independence 
check). 
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Appendix 4.1. Subset of the YFS cohort used for the BMI trajectory analysis. 
Reported are the total number (No.) of participants seen at each clinic year, and 
their ages (Fig 1.), Density plot of the number of BMI measures per YFS 
participant in the subset of the cohort used for the BMI trajectory analysis (Fig 
2.), BMI profiles in 44 randomly selected YFS participants (Fig 3.) and average 
BMI values in kg/m2 at each age stratified by T2DM group (pink, no adult 
T2DM; blue, adult T2DM), with error bars representing the mean BMI ± SD 
(standard deviation) (Fig 4.). 
 
Fig 1. 
Year No. YOBa 77 74 71 68 65 62        
1980 2149  Ages  3* 6 9 12 15 18        
1983 2149   6 9 12 15 18 21       
1986 1970    9 12 15 18 21 24      
                
2001 2167      24 27 30 33 36 39    
2007 2058       30 33 36 39 42 45   
2011 1890        34 37 40 43 46 49  
aYOB (year of birth), corresponds to the 6 birth cohorts represented in the study 
sample.  
*Observations made on 3 years old were excluded from the analyses. 
 
Fig 2. 
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Fig 3. 
 
Values in each panel indicate the ID number of each randomly chosen participant. 
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Fig 4. 
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Appendix 4.2. Additional information on collection of BMI data, T2DM status 
and fasting insulin in the YFS subset used in the illustrative analyses in chapter 
4. 
 
The YFS is an ongoing population-based prospective cohort that started in Finland in 
1980 to investigate cardiovascular risk factors and their determinants from childhood 
to adulthood, with participants ranging from age 3 to 49 62. Between 1980 and 2011, 
along with other cardiovascular markers of interest, BMI, calculated as BMI = weight 
(kg) / [height (m)]2, was collected on a varying number of participants from the 
original cohort (consisting of 3596 children aged 3 to 18 years in 1980), with up to 6 
follow-up measurements per participants: 3 in childhood/young adulthood, and 3 in 
middle adulthood (Fig 1. and Fig 3. in Appendix 4.1). Fasting Insulin was also 
measured up to 6 times per participant using methods as previously described 292. 
 
For the calculations of BMI, standing height was measured to the nearest 0.5 cm 
using a wall-mounted Seca anthropometer, with the participant in bare feet. Weight 
was measured with participants in light clothes without shoes using bathroom digital 
Seca weighing scale that recorded to the nearest 0.1 kg. 
 
T2DM status in adulthood was determined at adult follow-ups (2001, 2007, and 
2011) as any of: a fasting plasma glucose ≥7 mmol/L (in the absence of type 1 
diabetes mellitus), a haemoglobin A1c ≥6.5% (48 mmol/mmol), self-reported in 
questionnaires of a diagnosis made by a physician, or currently taking an oral 
glucose-lowering medication. In the analysis, T2DM was used as a dichotomous 
outcome (i.e. dummy variable coded 0 for participants who remained healthy, and 1 
for those with T2DM at their latest adult follow-up, either 2001, 2007 or 2011.  
 
Participants or their parents provided informed consent, and the study was approved 
by local ethics committees in agreement with the Declaration of Helsinki.
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Appendix 4.3. Results of pairwise comparison of Least-square means of BMI in 
each group (No adult T2DM vs. adult T2DM) at each age 
 
Results of mixed models with age as a categorical predictor and log-insulin as a 
continuous predictor: LS means contrasts (No adult T2DM vs. adult T2DM) and 
significance at each age averaged over (Table 1), or adjusted for (Table 2), the levels 
of sex, and pairwise comparisons of Least-square means of BMI and 95% CIs at each 
age in each T2DM status group averaged over-sex (Fig 1), and adjusted for status 
group and sex group combination (M=males, F-females, 1 = No adult T2DM, 2= 
adult T2DM) (Fig 2) and adjusted for log(insulin). 
 
Table 1.Estimated LS means contrasts (in kg.m2) at each age averaged over the levels 
of sex. 
 
Age	(years)	 Estimate*	(kg/m2)	 SE	 t-ratio	 p-value	3	 1.52	 1.04	 1.455	 0.14	6	 0.54	 0.71	 0.76	 0.44	9	 0.26	 0.56	 0.47	 0.63	12	 -0.87	 0.50	 -1.72	 0.0851	15	 -1.11	 0.44	 -2.52	 0.0115	18	 -1.30	 0.42	 -3.05	 0.002	21	 -1.45	 0.51	 -2.8	 0.005	24	 -1.56	 0.59	 -2.64	 0.008	27	 -0.93	 1.33	 -0.70	 0.48	30	 -4.01	 0.72	 -5.54	 <.0001	33	 -2.62	 0.55	 -4.77	 <.0001	37	 -5.00	 0.51	 -9.73	 <.0001	40	 -4.39	 0.43	 -10.17	 <.0001	43	 -3.19	 0.49	 -6.4	 <.0001	46	 -3.39	 0.47	 -7.17	 <.0001	49	 -4.94	 0.56	 -8.81	 <.0001	
* Estimated contrast is obtained from a log(insulin) adjusted model (degrees of freedom is 
equal to 2339) 
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Fig 1. Pairwise comparisons of LS means of BMI (in kg.m2) at each age in each 
T2DM status group averaged over-sex 
 
Blue intervals represent the 95% CI for each predicted BMI LS-mean (in kg.m2). Red 
comparisons arrows show which LS-means differ significantly from one another based on 
whether or not they overlap. Comparisons are made using a 0.05 Tukey-adjusted significance 
level (1: non T2DM group, and 2: T2DM group). 
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Table 2. Estimated LS means contrasts at each age adjusted for sex. 
 
Age 
(years) 
Estimate 
(kg/m2) 
SE t-ratio p-value 
Females 
3 0.76 1.67 0.456 0.64 
6  -1.01 1.01 -0.10 0.91 
9 -0.28 0.74 -0.37 0.70 
12 -0.53 0.64 -0.87 0.41 
15 -0.6 0.58 -1.07 0.28 
18 -1.29 0.61 -2.1 0.03 
21 -1.61 0.74 -2.2 0.003 
24 -2.48 0.85 -2.9 0.003 
27 -0.18 1.37 -0.13 0.89 
30 -4.01 0.94 -5.54 <.0001 
33 -2.62 0.55 -5.1 <.0001 
37 -5.45 0.78 -8.1 <.0001 
40 -5.93 0.60 -9.8 <.0001 
43 -3.69 0.71 -5.15 <.0001 
46 -5.18 0.4 -7.35 <.0001 
49 -6.4 0.81 -7.87 <.0001 
Males 
3 2.28 1.35 1.82 0.06 
6 1.19 0.99 1.20 0.22 
9 0.82 0.84 0.97 0.33 
12 -1.21 0.65 -1.50 0.12 
15 -1.60 0.44 -2.43 0.015 
18 -1.31 0.57 -2.27 0.03 
21 -1.28 0.71 -1.8 0.06 
24 -0.64 0.81 -0.78 0.43 
27 -1.68 2.23 -0.74 0.47 
30 -2.81 1.09 -2.51 0.009 
33 -1.26 0.78 -1.6 0.1097 
37 -4.50 0.41 -5.83 <.0001 
40 -2.9 0.68 -4.6 <.0001 
43 -3.19 0.69 -3.8 <.0001 
46 -3.39 0.62 -2.5 0.01 
49 -3.47 0.76 -4.51 <.0001 
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Fig 2. Pairwise comparisons of LS means of BMI (in kg.m2) at each age in each 
T2DM status group for each sex. 
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Blue intervals represent the 95% CI for each predicted BMI LS-mean (in kg.m2). Red 
comparisons arrows show which LS-means differ significantly from one another based on 
whether or not they overlap. Comparisons are made using a 0,05 Tukey-adjusted significance 
level. (1: non T2DM group, 2: T2DM group, F: females, and M: males). 
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Appendix 4.4. Log-likelihood profiling method and R-code for the choice of 
priors of the change point mean (µcp). 
 
When investigating the effect of prior choice (Appendix 2) on the posterior 
parameters estimates when fitting the unconditional BMI trajectory model, the priors 
considered for the change point mean in the set ‘prior 3’, was based on the estimate of 
the fixed change points for each sex, based on profile-log likelihood in the maximum 
likelihood. The procedure passes the break point as a model parameter, and 
minimises the deviance of the fitted model conditional upon the break point using the 
optimize function in R. This maximizes the profile log likelihood for the break point, 
and the function interior to the wrapper (lmer() in this case) finds the maximum 
likelihood estimates conditional upon the change point, so the procedure finds the 
joint maximum likelihood estimates for all parameters. The following R code was 
used for each sex to generate the population-average estimates of the knots in the 
unconditional BMI trajectory model:  
 
library(lme4) 
# NOTE: In this formulation, intercept is expected BMI value at the 
change point itself 
#### Estimation of sex-specific average breakpoint based on deviance 
minimisation: 
#Basis functions 
bp = 4 
b1 <- function(x, bp) ifelse(x < bp, bp - x, 0)# before slope 
b2 <- function(x, bp) ifelse(x < bp, 0, x - bp) # after slope 
 
# Wrapper for Mixed effects model with variable break point 
foo <- function(bp) 
{ 
  mod <- lmer(bmi ~ b1(age, bp) + b2(age, bp) + (b1(age, bp) + 
b2(age, bp) | id), data = T2DMdataF) 
  deviance(mod) 
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} 
search.range <- c(min(T2DMdataF$age)+0.5,max(T2DMdataF$age)-0.5) # 
Vector of Possible knots (=the potential ages at which the 
transition in growth rate occurs) 
 
foo.opt <- optimize(foo, interval = search.range) 
bp <- foo.opt$minimum # breakpoint that minimises deviance 
print(bp)#=16.328 year for females (22 years for males) 
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Appendix 4.5. Prior sensitivity analyses methods and results.  
 
Convergence could not be reached for some parameters in initial analyses of the sex-
specific unconditional hierarchical BMI change point models with unrestricted 
covariance structure between all four random parameters (males and females BMI 
profiles were analysed separately). As explained in section 3, it was chosen to restrict 
each model with a correlation between individual childhood slopes (.#) and adult 
slopes (.)), and null correlations between other random effects leading to a block 
diagonal structure of the variance covariance matrix: 
 .#)~	012 .#)∗ , 4#)  ."	~		2(."∗, 4") Σ#)~	invWishart Σ#)∗ , 2  !A"	~	Gamma	(D"#, D"))	 !&	~	Gamma	(D#, D)) !EF	~	Gamma	(DEF#, DEF)) 
With: 4" the variances for the overall intercept (i.e BMI at 25 years), and 4#) the 
covariance matrix for .#) = (.#., .)). !A"		!&	!EF are the precisions (1/variance) for 
each corresponding parameter  (i.e. variances are inverse gamma distributed). Sex 
specific unconditional models with this block diagonal structure yield lower AIC 
compared to models with mutually independent random effects, indicating this was 
an appropriate way to represent the variance structure of the random effects (data not 
shown here). For the choice of priors for the change point means three potential 
distributions were considered: 
 
- Normal (IJ&	~		2(KEF∗ , 4EF)), with	KEF∗  and 4EF the mean and variance for 
the change point, respectively. (with KEF∗  =0, 4EF = 1000).  
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-  Exponential (IJ&	~		NOP(D)), where the change point mean is 1/	D	and the 
change point variance is 1/	D). (we chose D = 0.05	(R. S. ##T	, lowest expected 
age at transition). 
-  Uniform (IJ&	~		$URV'WX(Y, Z)), where the mean is b+a/2 and the variance 
is (b-a)2/12.  (we chose a= -16 (i.e 9-25 ),b=25 (i.e. 50-25), as ages range 
between 9 and 50 years and are centered around the grand mean age of 25 
years). 
 
The two sex-specific unconditional growth models were fitted with each of these 
three priors for the change point means (and the priors above for the other model 
parameters). For both sex the lowest AICs were obtained for IJ&	~		2(KEF∗ , 4EF)), 
suggesting that the uniform and exponential distributions are not the best distributions 
for the change point means (data not shown). As a result, only the prior IJ	~		2(KEF∗ , 4EF) was considered for the change point means in all subsequent 
analyses. 
 
Additionally, to investigate the sensitivity of the unconditional trajectory model’s 
results to the choice of the different hyperparameters, three sets of hyperparameters 
were considered (Table 1):  
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Table 1. Three different sets of hyperparameters used for the prior sensitivity 
analysis. 
Hyperparameter Priors 1 Priors 2 Priors 3 ."∗ 0 15 25 .#)∗  (0,0) (0.5,0.2) (0,0) KEF∗  0 for both sexes 10 for both sexes 16 for females 21 for males 4" 10 100 100 4#) 10 00 10  10 00 10  100 00 100  4EF 10 100 100 Σ#)∗  10 00 10  1 00 1  0.1 00 0.1  D"# 0.01 0.1 0.001 D") 0.01 0.1 0.001 DEF# 0.1 0.01 0.001 DEF) 0.1 0.01 0.001 D# 0.1 0.01 0.001 D) 0.1 0.01 0.001 
AIC Males 20130 19995 19716 
AIC females 28756 27405 26910 
 
The posterior distributions of the model parameters did not have a lot of influence on 
the marginal posterior distributions of the unconditional model parameters (see Table 
2 and Table 3 of estimated parameters for males and females below). The set of priors 
‘priors 3’ was used in all subsequent conditional analyses as they showed the lowest 
AIC, and also significantly reduced computation time. 
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Table 2. Estimated parameters for the three considered sets of priors for females. 
Parameters 
Females 
Prior 1  Prior 2 Prior 3 
β0 27.25 (0.17) 25.91 (0.47) 26.45 (0.17) 
β1 0.63 (0.01) 0.58 (0.03) 0.61 (0.01) 
β2 -0.49 (0.014) -0.43 (0.01) -0.45 (0.014) 
CP 16.71 (0.2) 15.95 (0.3) 16.01 (0.2) [\" 2.44 (0.05) 2.68 (0.06) 2.12 (0.05) [\# 0.026 (0.005) 0.014 (0.004) 0.02 (0.003) [\) 0.15 (0.005) 0.16 (0.007) 0.19 (0.005) [EF 3.34 (1.14) 4.79 (1.21) 3.12 (1.07) [\#\) 0.09 (0.24) 0.14 (0.25) 0.10 (0.30) [ 1.60 (0.011) 1.66 (0.02) 1.42 (0.015) 
 
Table 3. Estimated parameters for the three considered sets of priors for males. 
Parameters 
Males 
Prior 1  Prior 2 Prior 3 
β0 27.25 (0.17) 25.91 (0.47) 26.510 (0.17) 
β1 0.63 (0.01) 0.58 (0.03) 0.62 (0.011) 
β2 -0.44 (0.05) -0.45 (0.04) -0.48 (0.02) 
CP 21.30 (0.62) 22.95 (0.53) 21.83 (0.46) [\" 2.44 (0.05) 2.68 (0.05) 2.38 (0.06) [\# 0.062 (0.005) 0.054 (0.004) 0.07 (0.004) [\) 0.08 (0.007) 0.08 (0.009) 0.05 (0.01) [EF 3.34 (1.14) 4.79 (1.21) 5.79 (0.21) [\#\) 0.017 (0.20) 0.13 (0.22) 0.14 (0.25) [ 1.50 (0.013) 1.36 (0.02) 1.21 (0.02) 
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Appendix 4.6. Annotated RJAGS sample code to fit a type 1 trajectory 
divergence model with a fully unstructured 4 by 4 covariance matrix for the 
random growth parameters 
 
Library(rjags) 
Library(mvtnorm) 
 
######################################## 
### Type 1 divergence Bayesian model :  
######################################## 
 
cat(" 
    data 
{ 
    # Zero means for random effect on the 4 growth parameters: 
    zero.u[1] <- 0 #mean ranef intercept 
    zero.u[2] <- 0 #mean ranef slope before CP 
    zero.u[3] <- 0 #mean ranef slope AFTER CP 
    zero.u[4] <- 0 #mean ranef CP timing 
} 
     
    model 
{ 
    # Random intercept,slopes and CP for each subject: 
    for( j in 1:M ) # 
{ 
    u[j,1:4] ~ dmnorm(zero.u[1:4],invSigma.u[1:4,1:4])# invSigma.u = 
full 4 x 4 precision matrix for random effects 
     
} 
     
    # Define likelihood for each observational unit: 
    for( k in 1:N ) 
     
{ 
     
    # Linear-linear piecewise model (b2 switches off once b3 
switches on) : 
    mu[k] <- b[1]+u[id[k],1]+(b[2]+u[id[k],2])*Age[k]*(1-
step(Age[k]-(CP+betaGroup*(Grp[k]-1))-u[id[k],4])) 
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    +(b[3]+u[id[k],3])*step(Age[k]-CP-betaGroup*(Grp[k]-1)-
u[id[k],4])*(Age[k]-CP-betaGroup*(Grp[k]-1)-u[id[k],4]) 
    +b[2]*(CP+betaGroup*(Grp[k]-1)+u[id[k],4])*step(Age[k]-CP-
betaGroup*(Grp[k]-1)-u[id[k],4]) 
    y[k] ~ dnorm(mu[k],tau.e) 
     
    # Other formulatiOn of Random CP (b2 = common slope, b3 =change 
to b2 after CP)  
    # mu[k] <- 
b[1]+u[id[k],1]+(b[2]+u[id[k],2])*Age[k]+(b[3]+u[id[k],3])*step(Age[
k]-CP[Grp[k]]-u[id[k],4])*(Age[k]-CP[Grp[k]]-u[id[k],4]) 
    #y[k] ~ dnorm(mu[k],tau.e) 
     
} 
     
    # Fixed intercept, slopes and CP (uninformative) 
    b[1] ~ dnorm(0.0,1.0E-5) 
    b[2] ~ dnorm(0.0,1.0E-5) 
    b[3] ~ dnorm(0.0,1.0E-5) 
    CP~ dnorm(16.0,1.0E-5)# CP group 1 
    betaGroup~ dnorm(0.0,1.0E-5) # difference to CP in group2 
    
    # Residual variance 
    tau.e ~dgamma(0.01,0.01) 
    sigma.e <-1/1/sqrt( tau.e ) 
     
    # Define 4x4 variance-covariance matrix of subject ranefs 
    #u[j,1:4] ~ dmnorm(zero.u,invSigma.u) 
    invSigma.u[1:4,1:4] ~ dwish(R[1:4,1:4],4) # precision matrix 
    Sigma.u[1:4,1:4]<-inverse(invSigma.u[1:4,1:4])# var-cov matrix 
    Sigma.u1<-Sigma.u[1,1] # variance intercept 
    Sigma.u2<-Sigma.u[2,2] # variance first slope 
    Sigma.u3<-Sigma.u[3,3]# variance second slope 
    Sigma.u4<-Sigma.u[4,4] ## variance CP 
    # correlations 
r12<-Sigma.u[1,2]/sqrt(  Sigma.u1*  Sigma.u2) 
r13<-Sigma.u[1,3]/sqrt(  Sigma.u1*  Sigma.u3) 
r14<-Sigma.u[1,4]/sqrt(  Sigma.u1*  Sigma.u4) 
r23<-Sigma.u[2,3]/sqrt(  Sigma.u2*  Sigma.u3) 
r24<-Sigma.u[2,4]/sqrt(  Sigma.u2*  Sigma.u4) 
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r34<-Sigma.u[3,4]/sqrt(  Sigma.u3*  Sigma.u4) 
 
 
    
}",file="otherCPmodel.jag") 
 
########################################################### 
### fit models 
########################################################### 
track.variables<-c("b","CP" 
,"betaGroup","sigma.e","Sigma.u1","Sigma.u2","Sigma.u3","Sigma.u4", 
                   "r12","r13","r14","r23","r24","r34") 
 
head(MCdata) 
 
inits=list(b=c(26,0.5,-
0.5),CP=16,betaGroup=0,tau.e=100,invSigma.u=matrix(c(10,0,0,0,0,0.1,
0,0,0,0,0.1,0,0,0,0,10),nrow=4)) 
 
R<- matrix(c(0.1,0,0,0,0,0.1,0,0,0,0,0.1,0,0,0,0,0.1),nrow=4) 
data=  list("y" = MCdata$mu, 
            "Age" = MCdata$age-25, 
            "id" =  as.integer(MCdata$id), 
            "Grp" = as.integer(MCdata$groupnames), 
            "N" = as.integer(nrow(MCdata)), 
            "M" = as.integer(length(unique(MCdata$id))), 
            "R"=R) 
 
# fit model : 
otherCPmodel <- jags.model( 
  file = "otherCPmodel.jag", 
  data = data, 
  inits=inits, 
  n.chains = 4, 
  n.adapt = 500) 
 
update(otherCPmodel,1000) 
 
sampleotherCPmodel<- coda.samples(otherCPmodel, 
                            var = track.variables, 
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                            n.iter = 1000, 
                            thin = 10 ) 
summary(sampleotherCPmodel)  
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Appendix 4.7. Function written to retrieve DIC directly from coda.samples() 
runs in RJAGS  
 
During model estimation, when using the coda.samples() function in RJAGS to 
MCMC sample, it is not usually possible to estimate the DIC from these sample, 
therefore another run with the dic.samples() function is necessary. For complex 
models that take several hours to run, it can be a severe overhead. The coda.samples() 
source code was thus modified to set up a modified dic.coda.samples() function as 
follows that returns both the DIC and the coda-structure for the MCMC samples. 
 
dic.coda.samples <- function (model, variable.names = NULL, 
n.iter, thin = 1, ...)  
{               load.module('dic') # necessary for pD and 
deviance monitor                 
start <- model$iter() + thin                
varnames=c(variable.names, c('deviance', 'pD'))                
out <- jags.samples(model, varnames, n.iter, thin,  type = 
"trace", ...)               deviance <- out$deviance               
 pD <- out$pD               
 out$deviance <- NULL               
 out$pD <- NULL               
 ans <- vector("list", nchain(model))                
for (ch in 1: model$nchain()) {                        
 ans.ch <- vector("list", length(out))                         
vnames.ch <- NULL                         
for (i in seq(along = out)) {                                  
varname <- names(out)[[i]]                                  
d <- dim(out[[i]])                                  
if (length(d) < 3) {                                               
 stop("Invalid dimensions for sampled 
output")                                 }                                  
vardim <- d[1:(length(d) - 2)]                                 
 nvar <- prod(vardim)                                 
 niter <- d[length(d) - 1]                                 
 nchain <- d[length(d)]                                  
values <- as.vector(out[[i]])                           
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 var.i <- matrix(NA, nrow = niter, ncol = nvar)                                 
 for (j in 1:nvar) {                                                
var.i[, j] <- values[j + (0:(niter - 1)) * 
nvar +                                               
(ch - 1) * niter * nvar]                                  
}                                  
vnames.ch <- c(vnames.ch, rjags:::coda.names(varname, 
vardim))  
  ans.ch[[i]] <-var.i                         
}                         
ans.ch <- do.call("cbind", ans.ch)                         
colnames(ans.ch) <- vnames.ch                         
ans[[ch]] <- mcmc(ans.ch, start = start, thin = thin)                
}                 
dic <- list(deviance = mean(as.vector(deviance)), penalty = 
mean(as.vector(pD)), type = 'pD')                
class(dic) <- "dic"                
return(list(samples=mcmc.list(ans), dic=dic))  
} 
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Appendix 4.8. Model Validation plots for the best fitting model for females 
(model E). Similar plots were obtained for males but are not displayed here due 
to space limitations. Fig (A) Traceplots displaying iterations vs. sampled values 
for all variables of interest in the 4 chains, use to assess the mixing of the chains, 
Fig (B) density plots showing the posterior probability density function of all 
estimated parameters. 
 
Fig (A) 
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Fig (B) 
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Appendix 4.9. Additional model validation diagnostic statistics obtained for the 
best fitting model for females (model E):  the Geweke, Gelman-Rubin, 
Heidelberger-Welch, and the Raftery-Lewis diagnostics, respectively. 
 
Number of chains = 4  
Number of iterations = 500 per chain before discarding the burn-in period 
The burn-in period = 100 per chain 
Sample size in total = 1600  
 
********** The Geweke diagnostic: ********** 
Z-scores: 
                       chain1    chain 2    chain 3     chain 4 
age3               1.87790409 -0.9116443  1.9562705  0.08257904 
b.post             0.37392027  1.8108930  0.3126379  0.94049454 
b.pre              0.68937062  0.4609849 -1.6319973  0.12470341 
betaGroup          0.51433394 -0.5308812  1.6467914  0.15191896 
cpA               -0.90531483 -1.0411778  1.4292255  0.86148340 
cpB               -1.35870994 -0.4896347 -1.4099419  0.60453047 
sigma              0.01517389  0.7292286  1.0197183 -1.17322858 
sigma1            -1.71732317 -0.4743896 -0.8881653  0.53244460 
sigma2             1.29401726  0.2975920  1.2663673  0.06317473 
sigma3             0.08981785 -1.4389448  1.2047930  0.14767469 
sigma4            -0.05636982 -1.9683511  0.2852076  1.17909705 
Window From Start  0.10000000  0.4683000  0.7741100  0.49450000 
Window From Stop   0.50000000  0.3296200  0.0123300  0.23903000 
 
********** The Gelman-Rubin diagnostic: ********** 
Potential scale reduction factors: 
 
          Point est. Upper C.I. 
age3            1.05       1.14 
b.post          1.00       1.01 
b.pre           1.02       1.06 
betaGroup       1.01       1.03 
cpA             1.00       1.00 
cpB             1.02       1.05 
sigma           1.00       1.00 
sigma1          1.00       1.01 
sigma2          1.01       1.04 
sigma3          1.01       1.02 
sigma4          1.05       1.15 
 
Multivariate psrf 
 
1.09 
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********** The Heidelberger-Welch diagnostic: ********** 
 
Chain 1, epsilon=0.1, alpha=0.05                                         
          Stationarity start     p-value 
          test         iteration         
age3      passed       1         0.404   
b.post    passed       1         0.852   
b.pre     passed       1         0.824   
betaGroup passed       1         0.802   
cpA       passed       1         0.902   
cpB       passed       1         0.585   
sigma     passed       1         0.518   
sigma1    passed       1         0.846   
sigma2    passed       1         0.093   
sigma3    passed       1         0.939   
sigma4    passed       1         0.987   
                                       
          Halfwidth Mean     Halfwidth 
          test                         
age3      passed    18.34540 7.64e-03  
b.post    passed    -0.03953 2.32e-04  
b.pre     passed     0.47091 3.83e-04  
betaGroup passed    -9.91759 1.52e-02  
cpA       passed    19.03645 1.18e-02  
cpB       passed    28.95404 1.04e-02  
sigma     passed     0.09374 3.02e-04  
sigma1    passed     0.31858 1.93e-03  
sigma2    passed     0.00772 6.82e-05  
sigma3    passed     0.01113 1.31e-04  
sigma4    passed     0.24822 7.98e-03  
 
Chain 2, epsilon=0.058, alpha=0.1                                         
          Stationarity start     p-value 
          test         iteration         
age3      passed         1       0.603   
b.post    passed       161       0.380   
b.pre     passed         1       0.825   
betaGroup passed         1       0.593   
cpA       passed         1       0.179   
cpB       passed         1       0.426   
sigma     passed         1       0.409   
sigma1    passed         1       0.136   
sigma2    passed         1       0.866   
sigma3    passed         1       0.248   
sigma4    passed         1       0.280   
                                       
          Halfwidth Mean     Halfwidth 
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          test                         
age3      passed    18.34950 6.14e-03  
b.post    passed    -0.03969 3.83e-04  
b.pre     passed     0.47048 2.81e-04  
betaGroup passed    -9.93687 8.98e-03  
cpA       passed    19.03428 9.92e-03  
cpB       passed    28.97114 9.06e-03  
sigma     passed     0.09377 3.07e-04  
sigma1    passed     0.31778 1.72e-03  
sigma2    passed     0.00775 7.33e-05  
sigma3    passed     0.01121 1.40e-04  
sigma4    passed     0.25132 6.44e-03  
 
Chain 3, epsilon=0.036, alpha=0.025                                         
          Stationarity start     p-value 
          test         iteration         
age3      passed       1         0.464   
b.post    passed       1         0.480   
b.pre     passed       1         0.101   
betaGroup passed       1         0.104   
cpA       passed       1         0.235   
cpB       passed       1         0.378   
sigma     passed       1         0.385   
sigma1    passed       1         0.576   
sigma2    passed       1         0.129   
sigma3    passed       1         0.474   
sigma4    passed       1         0.241   
                                       
          Halfwidth Mean     Halfwidth 
          test                         
age3      passed    18.34128 8.06e-03  
b.post    passed    -0.03959 3.32e-04  
b.pre     passed     0.47071 3.82e-04  
betaGroup passed    -9.93246 8.71e-03  
cpA       passed    19.03534 9.14e-03  
cpB       passed    28.96780 9.84e-03  
sigma     passed     0.09363 2.54e-04  
sigma1    passed     0.31592 1.89e-03  
sigma2    passed     0.00764 8.11e-05  
sigma3    passed     0.01118 1.73e-04  
sigma4    passed     0.26110 6.85e-03  
 
Chain 4, epsilon=0.116, alpha=0.05                                         
          Stationarity start     p-value 
          test         iteration         
age3      passed       1         0.255   
b.post    passed       1         0.374   
b.pre     passed       1         0.709   
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betaGroup passed       1         0.946   
cpA       passed       1         0.310   
cpB       passed       1         0.445   
sigma     passed       1         0.319   
sigma1    passed       1         0.377   
sigma2    passed       1         0.833   
sigma3    passed       1         0.949   
sigma4    passed       1         0.374   
                                       
          Halfwidth Mean     Halfwidth 
          test                         
age3      passed    18.34039 9.24e-03  
b.post    passed    -0.03955 2.06e-04  
b.pre     passed     0.47062 2.84e-04  
betaGroup passed    -9.92315 1.01e-02  
cpA       passed    19.04328 9.31e-03  
cpB       passed    28.96643 8.27e-03  
sigma     passed     0.09348 2.54e-04  
sigma1    passed     0.31756 1.61e-03  
sigma2    passed     0.00779 7.21e-05  
sigma3    passed     0.01110 1.31e-04  
sigma4    passed     0.25037 5.59e-03  
 
********** The Raftery-Lewis diagnostic: ********** 
 
Chain 1, converge.eps = 0.001 
Quantile (q) = 0.025 
Accuracy (r) = +/- 0.005 
Probability (s) = 0.95  
 
You need a sample size of at least 3746 with these values of q, r and s 
 
Chain 2, converge.eps = 0.005 
Quantile (q) = 0.1 
Accuracy (r) = +/- 0.005 
Probability (s) = 0.975  
 
You need a sample size of at least 18086 with these values of q, r and s 
 
Chain 3, converge.eps = 5e-04 
Quantile (q) = 0.05 
Accuracy (r) = +/- 0.001 
Probability (s) = 0.95  
 
You need a sample size of at least 182470 with these values of q, r and s 
 
Chain 4, converge.eps = 5e-04 
Quantile (q) = 0.25 
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Accuracy (r) = +/- 0.001 
Probability (s) = 0.975  
 
You need a sample size of at least 941979 with these values of q, r and s.
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Appendix 4.10. Autocorrelation plots for best fitting Model (Model E)  
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Appendix 4.11 Pairwise correlation plots for parameters estimated in the best 
fitting Model (Model E) for females: Marginal densities (diagonal), pairwise 
densities (lower panels) and correlation coefficient (upper panels) for the fit. 
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Appendix 5.1. Subset of the Cardiovascular Risk in Young Finns study cohort used for the BMI trajectory analysis in 
Chapter 5 (Table 1), and Number of repeated BMI measures per person for included participants (Ntotal =2717 
participants) (Table 2).  
  
 
Table 1. Subset of the Cardiovascular Risk in Young Finns study cohort used for the BMI trajectory analysis in Chapter 5 
Year No.    Ages 
1980 2717    3* 6 9 12 15 18          
1983 2279    6 9 12 15 18 21         
1986 2036     9 12 15 18 21 24        
1989 317      12 15 18 21 24 27       
1992 504       15 18 21 24 27 30      
                   
2001 2236          24 27 30 33 36 39   
2007 2134            30 33 36 39 42 45  
2011 2015             34 37 40 43 46 49 
Reported are; numbers  (No.) of participants with non-missing BMI data at each follow-up who also had non-missing childhood adiposity 
status at baseline (in 1980) and non-missing obesity status at least once in adulthood (either in 2001, 2007, or 2011); and age at each 
measurement. (*: Observations made at 3 years old (from individuals born in 1977) were excluded from the analyses). The birth year of the 
six cohorts were 1977, 1974, 1971, 1968, 1965, and 1962 
.
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Table 2. Number of repeated BMI measures per person for included participants 
(Ntotal =2717 participants).  
 No. BMI measures 
 2 3 4 5 6 7 8 
Number of participants 86 185 548 609 907 224 224 
Proportion (%) of participants 3.2 6.8 20.2 22.4 33.4 8.3 5.8 
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Appendix 5.2. Number of participants (%) and mean age (SD) in each adiposity status group stratified by sex.  
 
 Group I 
(Reference) 
 
Group II 
(Resolving high adiposity) 
 
Group III 
(Persisting high adiposity) 
 
Group IV 
(Incident obese) 
 
Total 
Number of participants (%) 
Males 961 (76.7%) 35 (2.8%) 73 (5.8%) 183 (14.7%) 1252 
Females 1124 (76.7%) 58 (3.9%) 62 (4.2%) 221 (15.1%) 1465 
Total 2085 (76.7%) 93 (3.4%) 135 (4.9%) 404 (14.9%) 2717 
Mean (SD) age in years 
Males 23.7 (13.1) 24.5 (12.9) 26.0 (13.1) 24.9 (12.9) 24.9 (12.9) 
Females 24.3 (13.1) 21.5 (12.5) 25.1 (12.8) 24.8 (13.1) 24.3 (13.0) 
Total 24.0 (13.1) 22.6 (12.8) 25.6 (12.9) 24.9 (13.0) 24.6 (13.1) 
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Appendix 5.3. Marginal posterior means, standard deviation (sd) and density distribution (95% credible interval (CI: 
(2.5th, 97.5th) percentile) of the average BMI trajectory parameters for each sex (M, males and F, females) and obesity-
group (I, II, III and IV) between age 6 and 49 years  (i.e. intercept (in kg m2), childhood slope (S1, in kg m2/year), 
difference between childhood and adult slope (S2, in kg m2/year) and change point (CP, in years)).  
 
All parameters estimates in the table are significantly different from zero (none of the reported 95% CI includes zero). 
 
    Males   Females 
Parameter Obesity  Group  Mean (sd) 95% CI    Group Mean (sd) 95% CI 
Intercept* Reference  I M  23.97 (0.09) 23.73 – 24.14    I F 24.21 (0.11) (24.00, 24.51) 
 Resolving  II M  28.56 (0.6) 27.95 – 30.03   II F 28.02 (0.75) (27.34, 29.87) 
 Persistent  III M  30.5 (1.12) 25.51 – 33.47   III F 31.4 (1.2) (26.42, 34.80) 
 Incident  IV M  28.65 (0.24) 28.14 – 29.07   IV F 27.62 (0.33) (27.03, 29.12) 
S1 Reference    I M  0.46 (0.008) 0.45 – 0.48    I F 0.48 (0.008) (0.47, 0.50) 
 Resolving  II M  0.48 (0.04) 0.42 – 0.53   II F 0.46 (0.04) (0.40, 0.50) 
 Persistent  III M  0.55 (0.06) 0.43 – 0.60   III F 0.56 (0.06) (0.45, 0.60) 
 Incident  IV M  0.63 (0.01) 0.61 – 0.65   IV F 0.62 (0.01) (0.60, 0.63) 
CP Reference   I M  24.1 (0.41) 22.9 – 26.0   I F 17.2 (0.34) (16.1, 18.3) 
 Resolving  II M  21.4 (1.74) 19.2 – 24.5   II F 16.1 (1.4) (14.6, 19.1) 
 Persistent  III M  24.7 (3.36) 18.5  – 27.8   III F 27.1 (2.58) (22.7, 30.2) 
 Incident  IV M  30.1 (0.8) 28.6 – 32.3   IV F 29.7 (0.41) (28.2, 31.2) 
S2** Reference   I M  -0.40 (0.007) -0.39 – -0.40   I F -0.39 (0.009) (-0.38, -0.39) 
 Resolving  II M  -0.44 (0.05) -0.43 – -0.46   II F -0.390 (0.03) (-0.37, -0.41) 
 Persistent  III M  -0.33 (0.01) -0.31 – -0.34   III F -0.255 (0.01) (-0.25, -0.27) 
 Incident  IV M  -0.55 (0.007) -0.55 – -0.56   IV F -0.47 (0.009) (-0.46, -0.48) 
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*Reported intercepts correspond to the expected BMI levels (in kg/m2) at 25 years (“age” variable centered around 25 years in 
the model) provided they are in the first phase of growth. The intercepts control for the initial BMI level at age 6 years and the 
predicted BMI levels at 6 years of age for each group (as seen in Fig 5.1. and 5.2) can be retrieved via the youth slopes as 
follows: !"#$%&' = #)*+,-+.* + 01 ∗ (25 − 6). 
**S2 is the difference (i.e. deviation) between adult slopes and childhood slopes (S1). Adult slopes can thus be calculated as 
S1+S2. 
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Appendix 5.4. Marginal posterior means, standard deviations (sd), density distribution and 
significance (*) of the differences in BMI trajectory parameters between sex and adiposity groups.  
 
Parameter Group differencesd  Posterior mean (sd) 95% CI  (*) 
Intercept a I M-I F -0.24 (0.16) (-0.6, 0.07)  
 IV M –IV F 0.44 (0.41) (-0.3, 1.2)  
 I M- IV M -0.83 (0.25) (-0.59, -1.07) * 
 I F- IV F -0.84 (0.36) (-0.48, -1.18)  * 
 II M-II F 0.5 (0.31) (-0.09,1.08)  
 III M –III F -0.9 (0.76) (-2.30, 0.51)  
 II M- III M -2.01 (0.63) (-3.24, -0.77) * 
 II F- III F -3.4 (0.78) (-4.5, -1.79) * 
S1 b I M-I F -0.02 (0.01) (-0.039, -4.10-4) * 
 IV M –IV F -0.015 (0.02) (-0.05, 0.02)  
 I M- IV M -0.17 (0.03) (-0.22, -0.11)  * 
 I F- IV F -0.135 (0.04) (-0.20, -0.06)  * 
 II M-II F 0.023 (0.06) (-0.09, 0.14)  
 III M –III F -0.01 (0.04) (-0.08, 0.07)  
 II M- III M -0.06 (0.03) (-0.12, -0.01)  * 
 II F- III F -0.09 (0.03) (-0.15, -0.03) * 
S2 b I M-I F -0.007 (0.01) (-0.02, 0.01)  
 IV M –IV F -0.008 (0.02) (-0.04,0.03)  
 I M- IV M 0.08 (0.04) (-0.001,0.12)  
 I F- IV F 0.15 (0.05) (0.21,0.04) * 
 II M-II F -0.055 (0.06) (-0.16, 0.06)  
 III M –III F -0.082 (0.03) (-0.14, -0.02) * 
 II M- III M -0.11 (0.04)  (-0.18, -0.03) * 
 II F- III F -0.14 (0.03) (-0.19, -0.08) * 
CP c I M-I F 6.31 (0.54) (5.25, 7.36)  * 
 IV M -IV F 0.2 (0.08) (-0.01, 0.33)    
 I M-IV M -5.89 (1.03) (-7.9, -3.7) * 
 I F- IV F -12.06 (2.1) (-15.1, -6.5) * 
 II M-II F 5.32 (1.26) (2.81, 7.91) * 
 III M-II F -2.1 (1.8) (-5.21, 1.32)  
 II M- III M -3.6 (0.72) (-5.23, -2.48)  * 
 II F- III F -2.1 (0.7) (-15.32, -5.76) * 
Shown in the table are: (1) differences in BMI trajectory parameters (i.e. intercept at age 6, childhood 
slope (S1), adult slope (S2) and change point (CP)) between sexes (Male (M) vs. Females (F)*); and, (2) 
the differences in BMI trajectory parameters between persistent-non obese and incident obese 
participants (Group I vs. Group IV*), and between obesity resolving and persistent obese participants 
(Group II vs. Group III*), for males (M) and females (F) respectively. To help readability, the table cells 
concerned with the sex differences in parameters for each specific obesity groups are shaded in grey, 
while the cells concerned with the differences between obesity groups for a given sex are in white.  
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a :Between-group differences in intercept are reported in Kg.m2. For ease of interpretation, intercepts 
presented in this table are the expected BMI level at 6 years. 
b : Between-group differences in slopes (S1 and S2) are reported in Kgm2/year. 
c : Between-group differences in change point timing (CP) are reported in years. 
d : The differences in parameters are reported as !"#$%& −	!)%*#$%& and as !+%,%-%./% −	!0./12%.3, or !+%&4$51.6 −	!7%-&1&3%.3	, where ! represent the four trajectory parameters (Intercepts, slopes S1 and S2, 
and change points CP), respectively.  
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Appendix 5.5. Empirical posterior mean, Bayesian standard deviation (SD) and 
posterior density quantiles (95% credible interval (CI): 2.5th, 97.5th percentile) for 
cohort effects on each of the four growth parameters (estimated from the sex and 
adiposity status adjusted Bayesian hierarchical piecewise regression model). 
 
Parameter * Mean SD 95% CI  89:;4< 0.0046 0.013 -0.02, 0.003 =1;4< -4.12.10-4 0.013 -0.001, 0.002 =2;4< 0.0004 0.0008 -0.002, 0.001 @A;4< 0.038 0.046 -0.05, 0.12 
*Each !;4< parameter, where ! = intercept, S1, S2, or CP, can be interpreted as the expected 
linear change in the corresponding growth parameter for a 1 year increase in calendar year 
of birth. 
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Appendix 5.6. Posterior mean parameter estimates, standard deviation (SD) and 
posterior distribution interval  (95% credible interval (CI): 2.5th , 97.5th percentile) for 
the variance parameters (random effects and error term) of the sex-and adiposity 
specific Bayesian hierarchical piecewise regression model.  
 
*σ coefficients are standard deviations of the corresponding growth parameters (intercept, 
S1, S2, and CP) or the residual (level-1) error. 
a All estimated parameter estimated are significant. 
 
Appendix 5.7. Age- and sex-specific and average prevalence of childhood overweight, 
obesity and overweight or obesity at baseline in 1980 in the YFS subset used for BMI 
trajectory analyses (2717 participants). 
 
Baseline 
Age 
(years) 
No. 
Participants* 
 
No. 
Overweight* 
 
No. 
Obese* 
 
% Overweight or 
obese* 
 
3 415 (201 / 214) 14 (6 / 8) 1 (0/1) 3.0 (2.9 /4.2) 
6 446 (194 / 252) 35(11 / 24) 13 (6/7) 10.3 (8.6 / 12.3) 
9 477 (227 / 250) 47 (21 / 26) 6 (3/3) 11.1 (10.5 / 11.6) 
12 482 (213 / 269) 39 (18 / 21) 6(3/3) 8.9 (9.8 / 8.9) 
15 468 (221 / 247) 25 (13 /12) 3 (3 /0) 5.9 (7.2 / 4.8) 
18 429 (196 / 233) 35 (21 / 14) 4 (3 / 1) 8.1 (12.7 / 6.4) 
Ntotal 
2717 (1252 / 
1465) 
179 (96/83) 34 (18/16) 8.4 (9.1/ 6.7) 
*data are total (males /females)). 
Parameter* Posterior mean (SD) 95% CIa 
σintercept 1.36 (0.011) 1.34, 1.38 
σS1 1.51 (0.03) 1.45, 1.57 
σS2 0.03 (0.003) 0.024, 0.038 BCD 0.07 (0.005) 0.065, 0.086 B 5.04 (0.19) 4.65, 5.38 
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Appendix 5.8. Supplementary Methods – Additional information on Bayesian 
Hierarchical Piecewise Growth model formulation and R code used to fit the models 
used in chapter 5 
 
Model formulation 
Chaper 5 uses the Bayesian hierarchical piecewise regression approach formulated in 
chapter 4  
 
Consistent with well-established between-sexes differences in the development of BMI 
between childhood and adulthood in normal weight individuals 308, 309, exploratory analyses 
in this study suggested sex differences in BMI patterns over age in the YFS sample when 
participants were stratified according to their obesity resolution status. As in chapter 4, the 
analyses in chapter 5 did not consider BMI measures from 3 years old in the trajectory 
analyses, because the low number of follow-up clinics in young children in the YFS 
prevented to model the BMI turning points of adiposity rebound that usually occurs at 
around 5 years old 15. 
 
In chapter 5, sex- and obesity- group specific means were estimated for the trajectory 
parameters, simultaneously adjusting for any potential birth cohort effect on the BMI 
trajectories by including centered “year of birth” (YOB) of each participant as a continuous 
level-2 covariate (i.e.YOB is centered around 1962, the year of birth of the oldest cohort in 
the sample). This strategy considers that the fixed growth parameters potentially vary 
linearly with year of birth, which is a simpler alternative than allowing for a completely 
different time trend in the response for each of the six birth cohorts 78. 
 
The model used in this application can be written as follows:  
 
Level-1 model:            (1.1) 	EF81G = IJ1 +	IL1MNO1G	. (1 − RS7T(MNO1G)) + 	IV1 MNO1G − @A1 . RS7T MNO1G +W1G  
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Level -2 model:        (1.2)   
          IJ1 = !JX + !J;4<YZE1 + [J1 IL1 = !LX + !L;4<YZE1 + [L1 IV1 = !VX + !V;4<YZE1 + [V1 @A1 = @AX + !S7;4<YZE1 + [S71 
 
And:         (1.3) [J1[L1[V1[S71 ~]
0000 ,
5`JV … ⋯ …5`JL 5`LV … …5`JV 5`LV `5VV …5`JS7 5`LS7 5`VS7 S`7V  
 
 
Where EF81G	is the BMI response of participant i at age j. RS7T(MNO1G) is a unit heavyside 
step function where RS7T(MNO1G)=1 if MNO1G ≥ @A1 and RS7T MNO1G = 0, if MNO1G < @A1. 
Each participant i belong to a single group k (k=1…8) which identifies individual sex and 
obesity status group as in the Table 1 below. 
 
Table 1. Eight sex by adiposity groups of participants considered in Chapter 5 analyses  
K Obesity status Sex 
1 Reference (normative) Males 
2 Reference (normative) Females 
3 Resolving obese Males 
4 Resolving obese Females 
5 Persistent obese Males 
6 Persistent obese Females 
7 Incident obese Males 
8 Incident obese Females 
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!JX, !LX, !VX	 and @AX in equation (1.2) are the expected trajectory parameters:  !JX,  the 
intercept is the expected BMI at 25 years of age in group k given the participant is in the first 
phase of growth ILe.;  !LX, the slope in childhood (S1) which can be interpreted as the rate 
of change in BMI in the first phase of development; !VX	, the deviation between the 
childhood and adult slopes (S2 =adult rate - S1) ; and CP, the change point for each sex and 
obesity status group k. Respectively, !J;4<,	!L;4<, !V;4<	M9f	!S7;4< are the expected linear 
increase in each trajectory parameters for each 1 year increase in year of birth (YOB). 
 W1G are the level 1 residual (i.e. random within-person error for person i at age j and are 
independent and normally distributed (i.e. W1G~ggf	] 0, %`V , and [J1, [L1, [V1 and [S71	are 
the level 2 random deviations for person i from the group on initial BMI levels, rates of 
increase in BMI, and age at change point after controlling for group differences in the mean 
trajectory parameters. These random effects are multivariate normally distributed with zero 
mean and variances 5`JV  ,	 5`LV  , 5`VV  and	 S`7V  respectively and full covariance matrix shown in 
1.3. The variance-covariance matrix is not-group specific but estimated for the entire sample 
(N=2717 participants) since some of the k groups had less than 60 participants. 
 
This parameterisation of the model with group-specific trajectory parameters is equivalent to 
the more traditional parameterisation that introduces group differences in the marginal 
growth parameters by considering group-specific deflections from population average for 
each growth-parameters 339 .  
 
Note that the equations shown above are for a mode adjusted for a sex and obesity groups 
(i.e. 8 groups model). To decide whether potential sex heterogeneity needed to be accounted 
for in the trajectory model within obesity groups (i.e. whether there was a group and sex 
interaction on each growth parameters), three Bayesian hierarchical piecewise regression 
models were initially fitted with different level-2 sub models: one with adiposity group-
specific growth parameters and no adjustment for sex (Model 1); one where growth 
parameters were allowed to vary by adiposity group with a main effect of sex (i.e. additive 
model 2); and one where all adiposity group-specific parameters were also allowed to vary 
by sex (Model 3 : sex by adiposity group interaction) (Table 2 below). 
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In concordance with data exploration, two commonly used Bayesian indices of model fit, the 
deviance information criteria  (DIC) 306 and the Bayesian posterior predictive P-value (based 
on the sum of model residuals as a discrepancy measure 339), indicated that the sex-specific 
model (Model 3) was a better fit than  models that ignored potential developmental 
differences within obesity group between males and females, despite being more complex 
(see Table 2). Therefore, this more complex model was the one considered throughout the 
analyses in this chapter (see Chapter 4 for further details on model formulation and 
estimation). 
 
Table 2.  DIC and PP-values for the 3 considered parameterisation of the model. 
Model Level 2 Model # parameters DIC (pd) Bayesian PP-val 
1 ~ Obesity group 16 19450 (2341) 0.45 
2 ~Obesity +sex 20 19467 (2235) 0.42 
3 ~Obesity * sex 32 19003 (2790) 0.51 
 
One of the advantages of using MCMC techniques is that new samples of marginal posterior 
distributions of new variables can be derived from the chains obtained in the Gibbs sampling 
process. Thus, to compare parameters from two different growth curves (i.e. Group I males 
vs. Group I females), the marginal posterior density of the difference between parameters 
was thus obtained by calculating the difference between chains in each sample. If the density 
distribution (95% Credible interval) of each new variable of interest (i.e. difference in 
trajectory parameter between 2 groups) included zero, that there was no evidence to support 
the hypothesis that the two groups have significantly different parameters 125, 377. 
 
Uninformative priors and hyper priors were used to fit the sex- and adiposity group-specific 
Bayesian hierarchical piecewise regression model. In this application, a restricted variance 
covariance structure was considered and specified with mutually independent random effects hJ1, hL1 , hV1 and @A1.	 This particular structure was used because the model is quite heavily 
parametrised and the primary focus is on the comparison of marginal means of growth 
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parameters between sex-and adiposity groups rather than the within-person correlations 
between different aspects of BMI change over time. All normal distributions were 
parameterised in terms of a mean and a precision (1/variance).  !JX , !LX	M9f	!VX for each 
sex and obesity group were normally distributed  with a mean of 0 and a large variance. The 
population average change points estimated by log-likelihood profiling were used as priors 
for the change point means in each group as follows: @AX~N(16, 0.001) for female sex-
adiposity groups, and @AX~N( 22,0.001) ) for male sex-adiposity groups (see Chapter 4 for 
more details). All cohort effect priors (!J;4<,	!L;4<, !V;4<	M9f	!S7;4<) were also given a 
flat normal prior (N(16,0.001)). The mutually independent random effects hJ1, hL1, hV1 and @A1 were normally distributed around 0 and a precision term Tau (i =1/variance) that 
followed a gamma (i	~	jMkkM	(0.01,0.01)).  The variance of the error term was also 
given a gamma prior (1/ %`V~	jMkkM	(0.01,0.01)). The BHPR model was ran using four 
parallel chains, and after a burn-in of 20000 iterations, each sequence was taken to 50000 
iterations and thinned by 1/10 to reduce serial autocorrelation of the MC chains. The 
posterior distribution for the mean parameters (fixed effects) and the variance-covariance 
parameters (random effects) were obtained by mixing the four sequences. The convergence 
of the chains was assessed visually using traceplots and based on the Gelman-Rubin 
convergence criteria 124. 
 
Note:  Model convergence was not reached when we repeated the analyses using a “high-
BMI resolving” group that considered strictly obese participants in childhood (which 
reduced the group to only 34 persons). It was therefore not possible to describe the growth 
of such a subsample with a four parameters model, and we only reported results for the same 
categories defined by Juoanala et al. in the previous study. 
 
 
R code used to fit the models in Chapter 5: 
 
########################################################################## 
### SEX/OBESITY GROUP SPECIFIC MODEL : ALL GROUPS MODELLED SIMULTEANOULSY ### 
########################################################################## 
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## BUGS model 
bugs.model <- " 
model { 
## Likelihood 
for(k in 1:N) { 
y[k] ~ dnorm(mu[k],tau) 
# formulation that works for the fixed effects : 
#mu[k] <- 
(b1[Grp[k],sex[k]]+re1[id[k]])+(b2[Grp[k],sex[k]]+re2[id[k]])*Age[k]+(b2[Grp[k],sex[k]]+
re3[id[k]])*step(Age[k]-CP[Grp[k],sex[k]]-re4[id[k]])*(Age[k]-CP[Grp[k],sex[k]]-
re4[id[k]]) 
 
# with obesity*sex interaction in the reference grid  ( 8 groups):one formulation that works 
() 
mu[k] <- 
(b1[Grp[k]]+re1[id[k]])+(b2[Grp[k]]+re2[id[k]])*Age[k]+(b3[Grp[k]]+re3[id[k]])*step(Age
[k]-CP[Grp[k]]-re4[id[k]])*(Age[k]-CP[Grp[k]]-re4[id[k]]) 
#mu[k] <- b[1]+re1[id[k]]+(b[2]+re2[id[k]])*Age[k]+(b[3]+re3[id[k]])*step(Age[k]-
(CP+betaGroup*(Grp[k]-1))-re4[id[k]])*(Age[k]-CP-betaGroup*(Grp[k]-1)-re4[id[k]]) 
 
# likelihood FORMULATION with cohort effect : 
#mu[k] <- 
(b1[Grp[k]]+re1[id[k]]+b1yob*YOB[k])+(b2[Grp[k]]+re2[id[k]]+b2yob*YOB[k])*Age[k]+
(b3[Grp[k]]+re3[id[k]]+b3yob*YOB[k])*step(Age[k]-CP[Grp[k]]-re4[id[k]]-
CPyob*YOB[k])*(Age[k]-CP[Grp[k]]-re4[id[k]]-CPyob*YOB[k]) 
# or is it more like : 
#mu[k] <- 
(b1[Grp[k]]+re1[id[k]]+b1yob*YOB[id[k]])+(b2[Grp[k]]+re2[id[k]]+b2yob*YOB[id[k]])*
Age[k]+(b3[Grp[k]]+re3[id[k]]+b3yob*YOB[id[k]])*step(Age[k]-CP[Grp[k]]-re4[id[k]]-
CPyob*YOB[id[k]])*(Age[k]-CP[Grp[k]]-re4[id[k]]-CPyob*YOB[id[k]]) 
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} 
 
##independent  Random Effects : idem 
for(k in 1:M) { 
re1[k] ~ dnorm(0,tau1) 
re2[k] ~ dnorm(0,tau2) 
re3[k] ~ dnorm(0,tau3) 
re4[k] ~ dnorm(0,tau4) 
} 
 
 
## Priors - precision for independet random effects 
tau ~ dgamma(0.001,0.001) 
tau1 ~ dgamma(0.001,0.001) 
tau2 ~ dgamma(0.001,0.001) 
tau3 ~ dgamma(0.001,0.001) 
tau4 ~ dgamma(0.001,0.001) 
 
## Mean is zero here because we subtract 25 from Age 
#for(g in 1:G) { #G = nb groups 
#for(s in 1:2){ # two sexes 
#CP[g,s] ~ dnorm(0,0.0001) 
#} 
#} 
 
 
#for(g in 1:G) { #G = nb groups 
#for(s in 1:2){ # two sexes 
#b1[g,s] ~ dnorm(25,0.0001) 
#} 
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#} 
 
#for(g in 1:G) { #G = nb groups 
#for(s in 1:2){ # two sexes 
##b2[g,s] ~ dnorm(0,0.0001) 
#} 
#} 
 
#for(g in 1:G) { #G = nb groups 
#for(s in 1:2){ # two sexes 
#b3[g,s] ~ dnorm(0,0.0001) 
#} 
#} 
 
# WITH INTERACTION IN REF GRID: 
#for(i in 1:8){ 
#b1[i] ~ dnorm(25,0.0001) 
#b2[i] ~ dnorm(0,0.0001) 
#b3[i] ~ dnorm(0,0.0001) 
#CP[i] ~ dnorm(0,0.0001) 
#} 
 
# more informative 
b1[1] ~ dnorm(28,0.0001) 
b1[2] ~ dnorm(28,0.0001) 
b1[3] ~ dnorm(31,0.0001) 
b1[4] ~ dnorm(32,0.0001) 
b1[5] ~ dnorm(28,0.0001) 
b1[6] ~ dnorm(27,0.0001) 
b1[7] ~ dnorm(24,0.0001) 
b1[8] ~ dnorm(24,0.0001) 
Appendices 
 316 
 
b2[1] ~ dnorm(0.5,0.0001) 
b2[2] ~ dnorm(0.5,0.0001) 
b2[3] ~ dnorm(0.52,0.0001) 
b2[4] ~ dnorm(0.54,0.0001) 
b2[5] ~ dnorm(0.6,0.0001) 
b2[6] ~ dnorm(0.6,0.0001) 
b2[7] ~ dnorm(0.45,0.0001) 
b2[8] ~ dnorm(0.48,0.0001) 
 
b3[1] ~ dnorm(-0.5,0.0001) 
b3[2] ~ dnorm(-0.5,0.0001) 
b3[3] ~ dnorm(-0.3,0.0001) 
b3[4] ~ dnorm(-0.2,0.0001) 
b3[5] ~ dnorm(-0.6,0.0001) 
b3[6] ~ dnorm(-0.5,0.0001) 
b3[7] ~ dnorm(-0.39,0.0001) 
b3[8] ~ dnorm(-0.38,0.0001) 
 
CP[1] ~ dnorm(-2.6,0.0001) 
CP[2] ~ dnorm(-9,0.0001) 
CP[3] ~ dnorm(0,0.0001) 
CP[4] ~ dnorm(4,0.0001) 
CP[5] ~ dnorm(5,0.0001) 
CP[6] ~ dnorm(5,0.0001) 
CP[7] ~ dnorm(-0.3,0.0001) 
CP[8] ~ dnorm(-7,0.0001) 
 
# PRIORS FOR cohort effects : 
b1yob ~ dnorm(0,0.0001) 
b2yob ~ dnorm(0,0.0001) 
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b3yob ~ dnorm(0,0.0001) 
CPyob ~ dnorm(0,0.0001) 
 
## Transform parameters 
# intercepts : 
# resolving 
#b1gp0males <-b1[1,1] 
#b1gp0females <-b1[1,2] 
 
# persisent 
#b1gp1males <-b1[2,1] 
#b1gp1females <-b1[2,2] 
# differences : 
#b1diffmales <-b1gp0males-b1gp1males 
#b1difffemales <-b1gp0females-b1gp1females 
 
# incidend 
#b1gp2males <-b1[3,1] 
#b1gp2females <-b1[3,2] 
 
# reference : 
#b1gp3males <-b1[4,1] 
#b1gp3females <-b1[4,2] 
 
sigma <- 1/sqrt(tau) 
sigma1 <- 1/sqrt(tau1) 
sigma2 <- 1/sqrt(tau2) 
sigma3 <- 1/sqrt(tau3) 
sigma4 <- 1/sqrt(tau4) 
 
## Predictions 
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re1.pr ~ dnorm(0,tau1) 
re2.pr ~ dnorm(0,tau2) 
re3.pr ~ dnorm(0,tau3) 
re4.pr ~ dnorm(0,tau4) 
 
# retrieve random effects? 
#for(k in 1:M) { 
#re1<-re1[k] 
#} 
#RE1<-re1 
 
# RETRIEVE AVERAGE CURVES FOR EACH OF THE 8 GROUPS :  
 
for(k in 1:P){ 
y1[k] <- b1[1]+(b2[1])*Age.pr[k]+(b3[1])*step(Age.pr[k]-CP[1])*(Age.pr[k]-CP[1]) 
y2[k] <- b1[2]+(b2[2])*Age.pr[k]+(b3[2])*step(Age.pr[k]-CP[2])*(Age.pr[k]-CP[2]) 
y3[k] <- b1[3]+(b2[3])*Age.pr[k]+(b3[3])*step(Age.pr[k]-CP[3])*(Age.pr[k]-CP[3]) 
y4[k] <- b1[1]+(b2[4])*Age.pr[k]+(b3[4])*step(Age.pr[k]-CP[4])*(Age.pr[k]-CP[4]) 
y5[k] <- b1[5]+(b2[5])*Age.pr[k]+(b3[5])*step(Age.pr[k]-CP[5])*(Age.pr[k]-CP[5]) 
y6[k] <- b1[6]+(b2[6])*Age.pr[k]+(b3[6])*step(Age.pr[k]-CP[6])*(Age.pr[k]-CP[6]) 
y7[k] <- b1[7]+(b2[7])*Age.pr[k]+(b3[7])*step(Age.pr[k]-CP[7])*(Age.pr[k]-CP[7]) 
y8[k] <- b1[8]+(b2[8])*Age.pr[k]+(b3[8])*step(Age.pr[k]-CP[8])*(Age.pr[k]-CP[8]) 
} 
 
####################################### 
## SAMPLE BETWEEN-GROUP DIFFERENCES : 
####################################### 
 
###### INTERCEPT ######## 
###RESOLVE/PERSIST : 
b1FMres<-b1[1]-b1[2] #males -females 
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b1FMpersis<-b1[3]-b1[4] 
b1MpersisResolv<-b1[1]-b1[3]#resolv-persis 
b1FpersisResolv<-b1[2]-b1[4] 
###REFERENCE/INCIDENT : 
b1FMinc<-b1[5]-b1[6] #males -females incident 
b1FMref<-b1[7]-b1[8] 
b1Mincref<-b1[5]-b1[7]# male incident-male ref 
b1Fincref<-b1[6]-b1[8]# female incident-female ref 
 
###### childhood slope  ######## 
###RESOLVE/PERSIST : 
b2FMres<-b2[1]-b2[2] #males -females 
b2FMpersis<-b2[3]-b2[4] 
b2MpersisResolv<-b2[1]-b2[3]#resolv-persis 
b2FpersisResolv<-b2[2]-b2[4] 
###REFERENCE/INCIDENT : 
b2FMinc<-b2[5]-b2[6] #males -females incident 
b2FMref<-b2[7]-b2[8] 
b2Mincref<-b2[5]-b2[7]# male incident-male ref 
b2Fincref<-b2[6]-b2[8]# female incident-female ref 
 
###### adult slope ######## 
###RESOLVE/PERSIST : 
b3FMres<-b3[1]-b3[2] #males -females 
b3FMpersis<-b3[3]-b3[4] 
b3MpersisResolv<-b3[1]-b3[3]#resolv-persis 
b3FpersisResolv<-b3[2]-b3[4] 
###REFERENCE/INCIDENT : 
b3FMinc<-b3[5]-b3[6] #males -females incident 
b3FMref<-b3[7]-b3[8] 
b3Mincref<-b3[5]-b3[7]# male incident-male ref 
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b3Fincref<-b3[6]-b3[8]# female incident-female ref 
 
###### changepoint ######### 
###RESOLVE/PERSIST : 
CPFMres<-CP[1]-CP[2] #males -females 
CPFMpersis<-CP[3]-CP[4] 
CPMpersisResolv<-CP[1]-CP[3]#resolv-persis 
CPFpersisResolv<-CP[2]-CP[4] 
###REFERENCE/INCIDENT : 
CPFMinc<-CP[5]-CP[6] #males -females incident 
CPFMref<-CP[7]-CP[8] 
CPMincref<-CP[5]-CP[7]# male incident-male ref 
CPFincref<-CP[6]-CP[8]# female incident-female ref 
 
 
} 
" 
## Initialize JAGS 
library(rjags) 
 
# creat interaction term to get 8 groups base on sex and obseity status : 
BMIdata$group =interaction(BMIdata$sex,BMIdata$obesity) # 8 possible Levels: 1.0 2.0 
1.1 2.1 1.2 2.2 1.3 2.3 
inits=list(b1=c(28,25,30,30,28,28,22,23),b2=c(0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5),b3=c(-0.45,-
0.45,-0.1,0,-0.35,-0.35,-0.35,-0.35),CP=c(-3,-9,2,10,2,2,-3,-9),tau=100) 
 
Age.pr <- c(6,10,12, 15,17,20,25,30,40,50) # AGES FOR PREDICTION 
BMIdata=subset(BMIdata,subset=!is.na(obesity)) 
model <- jags.model(textConnection(bugs.model), 
                    data = list("y" = BMIdata$bmi, 
                                "Age" = as.numeric(BMIdata$age)-25, 
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                                "YOB"= as.numeric(BMIdata$YOB)-69, 
                                "Age.pr" = Age.pr-25, 
                                "id" =  as.integer(as.factor(BMIdata$id)),# 
                                "G"=as.integer(nlevels(as.factor(BMIdata$obesity))),# 4 obesity gp 
                                "Grp" = as.integer(BMIdata$group), # 1,2,3,4 to 8 
                                "N" = as.integer(nrow(BMIdata)),# rows 
                                "M" = as.integer(nlevels(as.factor(BMIdata$id))),#3546 
                                "P" = length(Age.pr)), 
                    inits=inits, 
                    n.chains = 3, 
                    n.adapt = 5000) 
 
 
update(model,1000) 
# MCMC SAMPLING: 
# what do we retrieve? 
s <- coda.samples(model, 
                  
var=c("b1","b2","CP","b3","sigma","sigma1","sigma2","sigma3","sigma4","b1FMres","b1F
Mpersis","b1MpersisResolv","b1FpersisResolv","b1FMinc","b1FMref","b1Mincref","b1Fin
cref","b2FMres","b2FMpersis","b2MpersisResolv","b2FpersisResolv","b2FMinc","b2FMre
f","b2Mincref","b2Fincref","b3FMres","b3FMpersis","b3MpersisResolv","b3FpersisResolv
","b3FMinc","b3FMref","b3Mincref","b3Fincref", 
                        
"CPFMres","CPFMpersis","CPMpersisResolv","CPFpersisResolv","CPFMinc","CPFMref",
"CPMincref","CPFincref"), 
                  n.iter=30000,thin=20) 
# sample cohort effects:  
scohort <- coda.samples(model, 
                  var=c("b1yob","b2yob","b3yob","CPyob"), 
                  n.iter=10000,thin=10) 
Appendices 
 322 
# smaple predictions  
sy <- coda.samples(model, 
                  var=c("y1","y2","y3","y4","y5","y6","y7","y8"),n.iter=30000,thin=20) 
#write.csv(summary(s), file = "summary.csv") ;NOT WORKING 
 
#"b1FMres","b1FMpersis","b1MpersisResolv","b1FpersisResolv","b1FMinc","b1FMref","b
1Mincref","b1FpersisResolv" 
levels(BMIdata$group) #"1.0" "2.0" "1.1" "2.1" "1.2" "2.2" "1.3" "2.3" 
summary(s)# actual parameters 
plot(s[,"b1[8]"]) 
summary(sy)# average trajectories for each of the 8 group 
 
# Predicted values:  
summary(sy)$stat[,1]# all values (10 for each group) 
 
 
# create prediction data.frame 
pred<-data.frame(group=rep(c("1.0", "2.0", "1.1", "2.1" ,"1.2", "2.2" ,"1.3" 
,"2.3"),each=length(Age.pr)), 
                 Age=rep(Age.pr,8), 
                 y=summary(sy)$stat[,1]) 
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Appendix 5.9. Model Validation traceplots for the best fitting model used to compute 
BMI trajectory parameters for the 4 adiposity groups for males and females in 
Chapter 5.  
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Appendix 5.10. Other model validation plots and Bayesian model-fitting diagnostic 
statistics for the best fitting model used to compute BMI trajectory parameters for the 
4 adiposity groups for males and females in Chapter 5.  
 
Posterior density plots of parameters: 
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Posterior density plots of parameters: (continued): 
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Comparison of partial and full chain:  
 
 
 
 
 
 
Appendices 
 327 
Running means: 
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Autocorrelation plot:  
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Crosscorrelation plot: 
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Geweke z-score diagnostic plot: 
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Appendix 6.1. Growth Mixture modeling for identifying latent Class BMI trajectories 
 
 
The estimation of latent class models were performed with the lcmm package in R, which 
regroups a series of functions to estimate latent class mixed models for Gaussian and non-
Gaussian longitudinal outcomes 361. As recommended in the literature 220, 225, 226, 231, 362, 
various LGCMM models were fit and compared before choosing a final model. Participants’ 
ages in the analyses were centrered around 25 years, the mean age in the population sample, 
to facilitate the interpretation of the intercepts and improve numerical stability. Three 
possible polynomial specifications were considered to describe the within-person shape of 
the longitudinal BMI response as a function of age: a linear, and also a quadratic and a cubic 
specification, which allowed for curvilinear developmental patterns of BMI. Each of these 
polynomial models (order 1 to 3) were respectively modeled as a one to seven class solution, 
starting with a standard one-class heterogeneous mixed model where all subjects are 
assumed to follow the same underlying trajectory over time, and increasing the number of 
latent classes progressively.  
 
For each of these models the specification of the intercept and slope(s) variance (i.e. random 
effects) was considered to allow for between-person heterogeneity in the BMI response. To 
limit the number of potential models tested, the variances of random intercept and slopes 
were constrained to be equal across classes, and the systematic approach of Feldman et al 363 
was used to relax the constraints on the variance/covariance matrix. The linear, quadratic, 
and cubic growth mixture models were tested respectively with intercept variance only and 
with intercept and slopes variances. When relevant, each model was tested with all possible 
covariances estimated, and with all covariances constrained to zero. In general, the more 
estimated covariances; the fewer classes could be successfully extracted from the models, 
that is models with large number of classes failing to converged (i.e. singular matrix) or 
were unable to generate standard error of parameters. However, all classes could 
successfully be estimated when the covariances of all random effects were constrained to 
zero for all models (data not shown). All models presented in Appendix 6.2 were defined 
with a block diagonal structure for the random intercept and slopes, which represent varying 
but uncorrelated growth parameters.   
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As recommended by Proust-Lima et al. 361, models with two or more classes were ran 
several times with different sets of initial values to avoid convergence towards local 
maxima, a problem commonly encountered when fitting mixture models. Each model was fit 
with (1) initial values generated from the maximum likelihood estimates of the 
corresponding 1–class model, (2) initial values randomly generated from the asymptotic 
distribution of the corresponding 1-class model, and (3) initial values obtained via grid 
searching (with a maximum of 20 iterations from 30 random vectors of values from the 1-
class model)361. The results of the series of models that were fitted solely to ensure the 
correct convergence of the program algorithm towards global maximum of the log-
likelihood are not shown. The models results presented in chapter 6 are those of growth 
mixture models that showed satisfactory evidence of convergence. 
 
For each model involving latent classes, posterior class-membership probabilities were used 
to obtain a posterior classification of the participants in each latent class to evaluate 
goodness-of-fit and to characterise the discrimination of latent clusters (See lcmm 
documentation for details on post-fit computations). The proportion of subjects classified in 
each class with a posterior probability above a threshold of 0.7 was also retrieved and 
indicates the proportion of subjects unambiguously classified in each latent class. Thirdly, 
the mean of posterior probabilities of belonging to the latent class among subjects classified 
a posteriori in each class was recorded (i.e. mean probabilities between 0.8 and 1 indicate a 
good classification). Model fit was further assessed by examination of model residuals and 
plots of weighted mean predictions of each model. As recommended in the literature, the 
choice of the best fitting model was based on BIC values, and on these other index of 
goodness of fit and discrimination 361. When comparing different LCGMM models, it is 
recommended that to be considered a significant improvement over an existing model, a 
reduction of BIC of at least 10 points is necessary in the competing model 229.The best 
fitting model in terms of BIC were the 7 class quadratic and cubic models, but these models 
had poor discrimination for some classes (mean posterior probabilities <0.65 for several 
classes, less than 60 % of participants classified in several classes with a posterior 
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probability above 0.7). Furthermore, when seven classes were considered, some classes 
contained less than 1% of participants. In contrast, the six class quadratic model had only a 
slightly larger BIC, a higher mean posterior probability in all six classes (> 0.78), and a high 
proportion of participants were classified in each of the six classes above the 0.7 threshold 
(70% of participants or above in each class). The parameter estimates of the fixed and 
random components of the six class quadratic mixture model are given in Appendix 6.3. The 
necessity of random intercept and slope variance within-class was assessed for this final 
model, but the results of these further analyses are not shown since these additional models 
did not result in a sufficient increase in BIC to justify class-specific variance components.  
 
Note that when fitting the suite of LCGMM models on the entire subset of 2717 participants, 
including the 86 participant who only had 2 BMI records (one at baseline and one in 
adulthood) resulted in largely identical latent trajectories, but the mean posterior 
probabilities in each class were slightly worse, as expected, since it is difficult to assign 
these participants to one of the six identified trajectories when they only have two 
observations (see table 3. below). 
 
Table 3. Best fitting LCGMM model restuls for the sample that included 86 participants 
with only two BMI records 
 
6 classes- 
quadratic 
model 
Nb. Participants 
in each class 
Mean posterior 
Probabilities 
Posterior probabilities 
> 0.7 (%) 
N= 2717 
1495 /40 /902/ 129 
/115/36 
0.88 /0.76 /0.80 /0.79 / 0.80 
/0.92 
86.1/ 62.5/ 73.5/ 65.2 /66.1/ 
91.61 
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Appendix 6.2. Latent Class Growth Mixture models (LCGMM) results.  
 
Nb. 
Latent 
classes 
Polynomial  
degree 
Log-Lik BIC % Participants per class Mean posterior probabilities  Posterior probabilities > 0.7 (%) 
1 
Linear -33513.66 67066.86 100 n.a n.a 
Quadratic -32599.90  65259.99 100 n.a n.a 
Cubic -32597.43   65266.02   100 n.a n.a 
2 
Linear -32793.43   65650.12 86.8 /13. 2 0.97 / 0.91 97.33 / 87.43 
Quadratic -31859.42 63805.81 86.3 /13.7 0.98 / 0.92 97.92 / 88.12 
Cubic -32597.43 63829.9   85.2 /14. 8 0.97 / 0.88 97.2 / 82.43 
3 Linear -32565.23 65217.45   74.1 / 22.6 /3.2 0.93 / 0.85 /0.93 92.4 / 81.9/ 91.0 
 Quadratic -31608.36 63335.33 71.4 / 24.8 /3.7 0.93 / 0.85 /0.94 92.3 / 85.7 / 94 
 Cubic -31754.48   63359.19 70.6 / 25.4  / 4.0 0.92 / 0.84 /0.93 91.6 / 8.5 / 91.7 
4 Linear -32474.81 65060.32 55.8 / 33.2 / 9.2 /1.7 0.88 /0.82 / 0.85/ 0.93 85.3/ 69.0 / 81/ 84.4 
 Quadratic 31467.54   63085. 2 62.5 /4.8 / 29.7/ 3.0 0.91 / 0.84 /0.81/0.90 89.7 / 80.00 / 73.9 / 81.7 
 Cubic -31461.75   63083.27 2.6  / 61.2 / 31.2 / 4.9 0.85 /0.90/ 0.83 /0.87 72.2/ 87.9/ 75.8/ 85.0 
5 Linear -32390.99   64916.41 1.9 / 35.0 / 9.1 / 52.3 / 1.7 0.81 /0.80/ 0.86/ 0.88 / 0.94 70.3 / 73.0 / 83.1/ 85.8 / 95.7 
 Quadratic -31280.68   62774.86   55.0/ 1.5/ 33.2 / 4.8 / 4.2 /1.3 0.88/ 0.78/ 0.82 / 0.82 /0.94 86.1/ 62.5 /73.5/ 66.1/ 91.6 
 Cubic -31278.64   62786.6   53.8 / 34.4 / 4.6  / 1.4  / 5.9 0.88/ 0.80/ 0.82 / 0.96 /0.83 85.7 / 72.5 /75.8 /94.7 /67.9 
6 Linear -32363.13   64884.41 48.1 / 9.9 / 2.1/ 2.3/ 36.5/ 1.1 0.86/ 0.80/ 0.81 / 0.84 /0.78 /0.90 83.9/ 72.2 / 69.7 / 82.3 / 70.9 / 87.1 
 Quadratic -31280.68   62774.86 55.0 / 1.5 / 33.2 / 4.7/ 4.3/ 1.3 0.89 /0.78 / 0.81 / 0.80 /0.80 / 0.93 86.2 / 70.5 /73.50 /74.1 /71.1 / 92.7 
 Cubic -31272.73   62779.31 52.3 / 3.7 /34.8 / 4.0  / 3.7  / 1.7 0.89 / 0.77 /0.8 / 0.77 / 0.8 / 0.94 85.8 / 61.4/ 72.2/ 60.00 / 69 /94.59 
7 Linear -32358.8   64899.47 42.6/ 35.6/ 9.4/ 7.3/ 2.1/ 1.9/ 0.9 0.83 /0.68/0.59 /0.74 /0.81/0.79 /0.89 78.0 /49.7/ 14.8/ 61.6/ 68.9/ 73.5/ 80 
 Quadratic -31245.25   62765.62   56.4/18.1/ 0.77/14.2 /4.7/ 4.4/1.3 0.76 /0.65/0.59 /0.61 /0.74/0.80 /0.81 82.1/ 37.1/ 66.7 /30.6 / 55.8/ 68.1/ 91.7 
 Cubic -31118.31  62555.01 33.4/ 4.6/ 51.2/ 1.0/ 4.0 / 4.7 /1.1 0.78 /0.75/0.58 /0.77 /0.75/0.57 /0.86 69.5 / 57.3/ 85.7/ 85.7/ 59.3/ 54.5/ 96.7 
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Reported are the number of latent class considered, the polynomial form of the model, the maximum Log-Likelihood (Log-Lik), the Bayesian 
information Criterion (BIC), and for models with two or more classes, the a posteriori classification of participants in each class  (%), the mean of 
posterior probabilities in each latent class, and the % of participants classified in each class with a posterior probability above 0.7. The best fitting 
model is highlighted in bold characters. (n.a, not applicable). 
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Appendix 6.3. Parameter estimates for the best fitting six-class quadratic Latent 
Class Growth Mixture model fitted to the BMI data of 2631 YFS participants.  
 
Fixed effects 
Latent 
Class 
Intercept (se)* Linear slope** 
(se) 
Quadratic slope (se) ** 
1 21.40 (0.07) 0.20 (3.10-2) -0.005 (1.10-3) 
2 30.17 (0.52) 0.19 (0.02)  -0.02 (2.10-2) 
3 23.5 (0.13) 0.35 (5.10-2) -0.006 (3.10-3) 
4 27.11(0.25): 0.61 (0.01) 0.001(8.10-3)N 
5 30.87 (0.33) 0.49 (0.01) -0.01 (9.10-3) 
6 36.89 (0.41) 0.77 (0.01) -0.01 (1.10-2) 
Random effects: variance-covariance matrix  !"#$% =  2.56 !&"#'()	+&,-'% =  0.004 !./(0)($"1	+&,-'% =  0.001 !')),)%  1.39 (0.01) 
* Intercept interpreted as the expected level BMI at 25 years of age in Kg/m2 (due to centering 
of age around mean age in the sample). All reported slopes are significant (Wald test, p-value 
<0.05), unless indicated by the “N” subscript. 
**Slopes in kg/m2/year reported as: linear (se) /quadratic (se)/ cubic (se), when applicable. All 
reported slopes are significant (Wald test statistic with normal approximation, p-value <0.05), 
unless indicated by the “N” subscript. 
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Appendix 6.4. Prevalence of adult overweight and obesity in the YFS subset 
assessed for BMI in 2001, 2007, and 2011. 
 
Year* Sex Nb. Participants % Overweight % Obese 
2001 M 999 38.9 11.47 
F 1237 24.78 13.73 
Total 2236 31.2 12.4 
2007 M 962 45.9 18.7 
F 1172 28.4 16.2 
Total 2134 34.6 17.8 
2011 
 
M 912 43.4 0.2127 
F 1103 33.0 20.5 
Total 2015 36 20.85 
*mean age (sd) of participants seen in 2001, 2007, and 2011 were  31.7 (4.8), 37.7 (5), and 
41.9 (6) years, respectively. 
 
Appendix 6.5. Prevalence of each cardiometabolic risk outcome in adulthood in 
the YFS cohort. 
 
Adult cardiometabolic 
risk outcome 
% of 
original 
cohort 
Prevalence in 
assessed adults 
(%)* 
 
Nb. missing adult 
risk assessment  
(%)** 
Pre-atherosclerosis 8.6 11.6 944 (26.2) 
High-risk triglycerides 8.5 11.1 826 (22.9) 
High-risk HDL-C 15.1 19.6 826 (22.9) 
High-risk LDL-C 12.2 14.8 644 (17.9) 
Hypertension 16.4 19.1 644 (17.9) 
Diabetes 2.5 3.5 1030(28.6) 
* % of each adult cardiometolic outcome assessed in 2001, 2007, or 2011 (latest existing 
adult assessment) 
** % Participants form the original cohort missing cardioemtaobolic outcome in adulthood  
 
Appendices 
 338 
 
Appendix 6.6. Cumulative adult cardiometabolic risk load in adulthood.  
 
  Adult CVD risk score 
  0 1 2 3 4 5 
Latent BMI  
Trajectory class**  
1 930 250 144 29 7 2 
2 22 13 5 1 0 1 
3 347 222 136 56 31 5 
4 27 29 21 11 8 0 
5 29 18 26 18 5 2 
6 5 8 9 3 3 3 
Nb participants  1360 540 340 117 55 9 
%*  56.1 22.4 14.1 4.9 2.5 0.4 
The cumulative CVD risk load ranges from 0 to 6, depending on the number of deleterious 
CVD risk factors for each participant). (Mean score: 0.7588 (sd=1.05)). 
*% Nb. participants for each score category / Number of participants with non-missing CVD 
risk scores (N=2421). 
**Latent BMI trajectory classes are as follows: Class 1, normal stable trajectory; Class 2, 
High BMI resolving; Class 3, progressively overweight stabilising; Class 4, progressively 
obese increasing; Class 5, rapidly overweight stabilising obese; and Class 6, 
overweight/obese persisting. 
Appendices 
 339 
 
Appendix 6.7. Risk ratios (RR), 95% confidence intervals (CI) and Wald z-
statistic p-values of the associations of BMI trajectory groups with high-risk 
cardiometabolic outcomes in adulthood after further adjustment for family 
history of each outcome and for socio-economic status. 
 
Outcome	and	Latent	
BMI	Trajectory	group	 RR
c	 95%	CIc	 P-value		Class	1a	 1b	 -	 -	Class	2	 1.93	 0.11	–	9.73	 0.40	Class	3	 2.09	 1.09	–	5.11	 0.02	Class	4	 10.1	 3.13	–	19.72	 0.03	Class	5	 9.33	 4.12	–	16.15	 0.002	Class	6	 16.5	 6.30	–	22.61	 0.01	
Hypertension	 	 	 	Class	1a	 1	 -	 	Class	2	 0.52	 0.13	–	1.32	 0.15	Class	3	 1.24	 1.11	–1.99	 0.04	Class	4	 2.12	 1.15–2.89	 0.02	Class	5	 2.28	 1.32–3.02	 <0.01	Class	6	 2.98	 1.51–5.02	 0.03	
High-risk	cIMT	 	 	 	Class	1a	 1b	 -	 	Class	2	 3.12	 1.51	–6.03	 0.04	Class	3	 1.31	 1.01–2.14	 <0.01	Class	4	 2.19	 1.31	–3.90	 <0.01	Class	5	 3.10	 1.92	–3.45	 0.02	Class	6	 3.14	 2.21	–4.12	 <0.01	
High-risk	LDL-C	Class	1a	 	 1b	 -	 -	Class	2	 	 1.01	 0.1	–	1.08	 0.45	Class	3	 	 1.12	 1.06	–	1.49	 0.02	Class	4	 	 1.30	 1.17	–	2.57	 0.05	Class	5	 	 1.20	 1.11	–	2.30	 0.03	Class	6	 	 1.51	 1.05	–	2.94	 0.05	
High-risk	HDL-C	 	 	 	Class	1a	 1	 -	 	Class	2	 1.03	 0.22	–	1.11	 0.36	Class	3	 1.24	 1.12	–1.82	 0.03	Class	4	 1.35	 1.01–12.1	 <0.01	Class	5	 1.41	 1.02	–2.22	 <0.01	Class	6	 1.37	 1.26–2.60	 0.04	
High-risk	triglycerides	 	 	 	Class	1a	 1b	 -	 	Class	2	 0.31	 0.06	–2.12	 0.42	Class	3	 2.89	 2.02–4.08	 <0.01	Class	4	 5.11	 3.11	–9.58	 0.03	Class	5	 4.24	 3.02	–7.34	 0.02	Class	6	 3.21	 1.22	–9.60	 0.04	
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aLatent BMI trajectory classes are as follows Class 1, Normal stable trajectory (N=1359); 
Class 2, high BMI resolving (N=43); Class 3, progressively overweight stabilising (N= 879); 
Class 4, progressively obese increasing (N= 110); Class 5, rapidly overweight stabilising 
obese (N= 113); and Class 6, overweight/obese persisting (N=33). 
 
b: The normative BMI trajectory class (class 1) is the reference group. Unadjusted models 
with only the trajectory groups were also fit but estimated dd Ratios (RRs) were not 
significantly different and the AIC suggested that the sex-and year of birth (YOB) adjusted 
models fit the data better (data not shown). 
 
cThe regression coefficients for each latent class, can be interpreted as the changes in relative 
ratios for belonging to a given class, vs. the reference latent class (class 1). For year of birth 
(YOB), the coefficients give the change in relative ratios of the outcome for a one unit 
increase in the predictor variable.  
dThe 95% CI for the relative risks was obtained by log-likelihood profiling of the robust 
standard errors. 
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